Annotation Detail for IFNG
Basic Information Top
| Gene Symbol: | IFNG ( IFG,IFI ) |
|---|---|
| Gene Full Name: | interferon, gamma |
| Band: | 12q15 |
| Quick Links | Entrez ID:3458; OMIM: 147570; Uniprot ID:IFNG_HUMAN; ENSEMBL ID: ENSG00000111537; HGNC ID: 5438 |
| Relate to Another Database: | SFARIGene; denovo-db |
| No data |
| Pathway ID | Pathway Name |
|---|---|
| hsa03050 | Proteasome |
| hsa05332 | Graft-versus-host disease |
| hsa04650 | Natural killer cell mediated cytotoxicity |
| hsa04140 | Regulation of autophagy |
| hsa05142 | Chagas disease |
| hsa05140 | Leishmaniasis |
| hsa05146 | Amoebiasis |
| hsa05144 | Malaria |
| hsa05145 | Toxoplasmosis |
| hsa05322 | Systemic lupus erythematosus |
| hsa05330 | Allograft rejection |
| hsa04630 | Jak-STAT signaling pathway |
| hsa04350 | TGF-beta signaling pathway |
| hsa04612 | Antigen processing and presentation |
| hsa04940 | Type I diabetes mellitus |
| hsa04060 | Cytokine-cytokine receptor interaction |
| hsa04660 | T cell receptor signaling pathway |
| No data |
| Pathway ID | Pathway Name |
|---|---|
| 200034 | IL12-mediated signaling events |
| 200039 | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
| 200184 | Downstream signaling in naive CD8+ T cells |
| 200131 | IL23-mediated signaling events |
| 200159 | Calcium signaling in the CD4+ TCR pathway |
| 200082 | IL2-mediated signaling events |
| 200140 | PDGFR-alpha signaling pathway |
| 200077 | Glucocorticoid receptor regulatory network |
| 200118 | AP-1 transcription factor network |
| 200110 | IFN-gamma pathway |
| 200116 | ATF-2 transcription factor network |
| 200023 | IL27-mediated signaling events |
| 200197 | IL12 signaling mediated by STAT4 |
| Pathway ID | Pathway Name |
|---|---|
| P00035 | Interferon-gamma signaling pathway |
| P00031 | Inflammation mediated by chemokine and cytokine signaling pathway |
| No data |
| Desease ID | Desease Name |
|---|---|
| H00084 | Graft-versus-host disease |
| H00083 | Allograft rejection |
| Immune system diseases | |
| Allergies and autoimmune diseases |
| Desease ID | Desease Name |
|---|---|
| 1707 | Multiple myeloma |
| 1709 | Parkinson disease |
| 1711 | Familial Mediterranean fever |
| 1720 | Fanconi's anemia |
| 1723 | Brucellosis |
| 1740 | Alzheimer's disease |
| 1753 | Hyperthyroidism |
| 1779 | Cervical cancer |
| 1784 | Choriocarcinoma |
| 1803 | Periodontitis |
| 1831 | Prostate cancer |
| 1838 | Lichen planus |
| 1848 | Embryoma |
| 1859 | Ovarian cancer |
| 1869 | Behcet syndrome |
| 1873 | Neutropenia |
| 1877 | Multiple sclerosis |
| 2243 | Bronchiolitis obliterans |
| 1886 | Angiomyolipoma |
| 1894 | Abortion |
| 1901 | Endometriosis |
| 1904 | Diabetes mellitus |
| 1918 | Atherosclerosis |
| 1932 | Pancreatitis |
| 1939 | Serous cancer |
| 1942 | Emphysema |
| 1944 | Breast cancer |
| 1970 | Virus disease |
| 1976 | Squamous cell cancer |
| 1989 | Vaccinia |
| 1998 | Enteritis |
| 2004 | Solid tumor |
| 2006 | Anorexia nervosa |
| 2008 | Liver disease |
| 2022 | Liver cancer |
| 1764 | Purpura, Thrombocytopenic, Idiopathic |
| 2028 | Nasopharyngeal cancer |
| 2044 | Pre-Eclampsia |
| 2051 | Leukemia |
| 2052 | Infection |
| 2053 | Colon cancer |
| 2059 | Communicable disease |
| 2066 | Lung cancer |
| 2073 | Bronchiectasis |
| 2074 | Asthma |
| 2083 | IGA glomerulonephritis |
| 2094 | Ulcerative colitis |
| 2100 | Hepatitis C |
| 2106 | Pancreas cancer |
| 2111 | Systemic infection |
| 2146 | Lupus erythematosus |
| 2149 | Pelvic inflammatory disease |
| 2166 | Influenza |
| 2171 | Celiac disease |
| 2193 | Helicobacter infection |
| 2200 | Intraocular melanoma |
| 2204 | Hemolytic anemia |
| 2205 | Uveitis |
| 2220 | Dermatitis |
| 2230 | Alopecia |
| 2231 | Arthritis |
| 2237 | Neoplasm metastasis |
| 2240 | Anemia |
| 1805 | Mycobacterium infection, Atypical |
| Desease Name |
|---|
| SPT |
| HEMATOLOGICAL |
| rheumatoid arthritis |
| Sjogren's syndrome |
| giant cell arteritis |
| coeliac disease |
| kidney angiomyolipomas |
| leishmaniasis, cutaneous |
| AGING |
| tuberculosis |
| CARDIOVASCULAR |
| diabetes, type 1 |
| endometriosis |
| renal transplant |
| CHEMDEPENDENCY |
| Graves' disease Hashimoto's thyroiditis |
| aplastic anemia, acquired |
| cirrhosis hepatitis C, chronic |
| Graves' disease Hashimoto's thryoiditis |
| graft-versus-host disease |
| Childhood atopic asthma |
| nephropathy |
| Celiac Disease |
| Grave`s disease |
| bronchiolitis obliterans syndrome |
| allograft outcome |
| CANCER |
| lung function |
| ulcerative colitis |
| PHARMACOGENOMIC |
| Asthma |
| esophageal cancer |
| RENAL |
| hepatitis B, intrauterine |
| breast cancer |
| multiple sclerosis |
| allergic rhinitis |
| brucellosis |
| IMMUNE |
| polymyalgia rheumatica |
| parvovirus |
| acute and chronic kidney transplant outcome |
| parvovirus B19 infection |
| smoking cessation |
| sepsis |
| METABOLIC |
| preterm delivery |
| Common Cold |
| tryptophan catabolism |
| lung allograft fibrosis |
| birth weight perinatal complications |
| hepatitis E |
| hepatitis B |
| respiratory syncytial virus bronchiolitis |
| Langerhans cell histiocytosis |
| purpura |
| REPRODUCTION |
| diabetes, type 2 |
| allergies |
| Atopic asthma |
| longevity |
| cervical cancer |
| INFECTION |
| Heart Failure |
| recurrent pregnancy loss |
| angiomyolipomas, renal |
| SARS (severe acute respiratory syndrome) |
| Desease Name |
|---|
| Ulcerative colitis |
| Desease Name |
|---|
| AIDS, rapid progression to |
| TSC2 angiomyolipomas, renal, modifier of |
| Hepatitis C virus, response to therapy of |
| Aplastic anemia |
| Tuberculosis, protection against |
| Chemical ID | Chemical Name | Interaction | Interaction Action | Publication |
|---|---|---|---|---|
| D014013 | 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt | 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [Manganese inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Nitric Oxide]] | affects cotreatment|decreases reaction|increases abundance | 16488514 |
| D014013 | 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt | 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [Manganese promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Free Radicals]] | affects cotreatment|decreases reaction|increases abundance|increases reaction | 16488514 |
| D014013 | 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt | 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [Manganese promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mRNA]] | affects cotreatment|decreases reaction|increases expression|increases reaction | 16488514 |
| D014013 | 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt | 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [Manganese promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of TNF mRNA]] | affects cotreatment|decreases reaction|increases expression|increases reaction | 16488514 |
| D014013 | 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt | 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [Manganese promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of TNF protein]] | affects cotreatment|decreases reaction|increases expression|increases reaction | 16488514 |
| C097240 | 15-deoxy-delta(12,14)-prostaglandin J2 | 15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [IFNG protein results in increased activity of and results in increased localization of [STAT1 protein binds to STAT1 protein]] | affects binding|decreases reaction|increases activity|increases localization | 12847270 |
| C097240 | 15-deoxy-delta(12,14)-prostaglandin J2 | 15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [IFNG protein results in increased expression of IRF1 mRNA] | decreases reaction|increases expression | 12847270 |
| C097240 | 15-deoxy-delta(12,14)-prostaglandin J2 | 15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [IFNG protein results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 12847270 |
| C097240 | 15-deoxy-delta(12,14)-prostaglandin J2 | 15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [[IFNG protein results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide] | decreases reaction|increases chemical synthesis|increases expression | 12847270 |
| C097240 | 15-deoxy-delta(12,14)-prostaglandin J2 | 15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [IFNG protein results in increased phosphorylation of and results in increased activity of JAK2 protein] | decreases reaction|increases activity|increases phosphorylation | 12847270 |
| C097240 | 15-deoxy-delta(12,14)-prostaglandin J2 | 15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [IFNG protein results in increased phosphorylation of STAT1 protein] | decreases reaction|increases phosphorylation | 12847270 |
| C097240 | 15-deoxy-delta(12,14)-prostaglandin J2 | 15-deoxy-delta(12,14)-prostaglandin J2 results in decreased secretion of IFNG protein | decreases secretion | 16844232 |
| C097240 | 15-deoxy-delta(12,14)-prostaglandin J2 | 2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [15-deoxy-delta(12,14)-prostaglandin J2 results in decreased secretion of IFNG protein] | decreases reaction|decreases secretion | 16844232 |
| C097240 | 15-deoxy-delta(12,14)-prostaglandin J2 | Acetylcysteine inhibits the reaction [15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [IFNG protein results in increased phosphorylation of and results in increased activity of JAK2 protein]] | decreases reaction|increases activity|increases phosphorylation | 12847270 |
| C097240 | 15-deoxy-delta(12,14)-prostaglandin J2 | Acetylcysteine inhibits the reaction [15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [IFNG protein results in increased phosphorylation of STAT1 protein]] | decreases reaction|increases phosphorylation | 12847270 |
| C097240 | 15-deoxy-delta(12,14)-prostaglandin J2 | CAT protein inhibits the reaction [15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [IFNG protein results in increased phosphorylation of STAT1 protein]] | decreases reaction|increases phosphorylation | 12847270 |
| C097240 | 15-deoxy-delta(12,14)-prostaglandin J2 | Glutathione inhibits the reaction [15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [IFNG protein results in increased phosphorylation of and results in increased activity of JAK2 protein]] | decreases reaction|increases activity|increases phosphorylation | 12847270 |
| C097240 | 15-deoxy-delta(12,14)-prostaglandin J2 | Glutathione inhibits the reaction [15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [IFNG protein results in increased phosphorylation of STAT1 protein]] | decreases reaction|increases phosphorylation | 12847270 |
| C097240 | 15-deoxy-delta(12,14)-prostaglandin J2 | Hydrogen Peroxide promotes the reaction [15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [IFNG protein results in increased phosphorylation of STAT1 protein]] | decreases reaction|increases phosphorylation|increases reaction | 12847270 |
| C097240 | 15-deoxy-delta(12,14)-prostaglandin J2 | peroxyvanadate inhibits the reaction [15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [IFNG protein results in increased abundance of Nitric Oxide]] | decreases reaction|increases abundance | 12847270 |
| C097240 | 15-deoxy-delta(12,14)-prostaglandin J2 | peroxyvanadate inhibits the reaction [15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [IFNG protein results in increased phosphorylation of STAT1 protein]] | decreases reaction|increases phosphorylation | 12847270 |
| C097240 | 15-deoxy-delta(12,14)-prostaglandin J2 | T 0070907 inhibits the reaction [15-deoxy-delta(12,14)-prostaglandin J2 results in decreased secretion of IFNG protein] | decreases reaction|decreases secretion | 16844232 |
| C015262 | 1,6-hexamethylene diisocyanate | 1,6-hexamethylene diisocyanate results in increased expression of IFNG protein | increases expression | 12884401 |
| C495109 | 1-(beta-naphthylmethyl)-6,7-dihydroxy-1,2,3,4-tetra-hydroisoquinoline | 1-(beta-naphthylmethyl)-6,7-dihydroxy-1,2,3,4-tetra-hydroisoquinoline inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased activity of RELA protein] | affects cotreatment|decreases reaction|increases activity | 11961057 |
| C495109 | 1-(beta-naphthylmethyl)-6,7-dihydroxy-1,2,3,4-tetra-hydroisoquinoline | 1-(beta-naphthylmethyl)-6,7-dihydroxy-1,2,3,4-tetra-hydroisoquinoline inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mRNA] | affects cotreatment|decreases reaction|increases expression | 11961057 |
| C471009 | 1-naphthylethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline | 1-naphthylethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mRNA] | affects cotreatment|decreases reaction|increases expression | 12527339 |
| C471009 | 1-naphthylethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline | 1-naphthylethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of TNF mRNA] | affects cotreatment|decreases reaction|increases expression | 12527339 |
| C520323 | 1-oleoyl-2-acetoyl-sn-glycerol | IFNG protein promotes the reaction [1-oleoyl-2-acetoyl-sn-glycerol results in increased expression of TNF protein] | increases expression|increases reaction | 11404395 |
| C019273 | 2,2-bis(4-glycidyloxyphenyl)propane | 2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [15-deoxy-delta(12,14)-prostaglandin J2 results in decreased secretion of IFNG protein] | decreases reaction|decreases secretion | 16844232 |
| C019273 | 2,2-bis(4-glycidyloxyphenyl)propane | 2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [ciglitazone results in decreased secretion of IFNG protein] | decreases reaction|decreases secretion | 16844232 |
| C019273 | 2,2-bis(4-glycidyloxyphenyl)propane | 2,2-bis(4-glycidyloxyphenyl)propane results in decreased expression of and results in decreased secretion of IFNG protein | decreases expression|decreases secretion | 16091293 |
| C014024 | 2,4,5,2',4',5'-hexachlorobiphenyl | 2,4,5,2',4',5'-hexachlorobiphenyl results in decreased expression of IFNG protein | decreases expression | 15319175 |
| C469683 | 2-(6-((3-(4-(diphenylmethoxy)piperidino)propyl)amino)imidazo(1,2-b)pyridazin-2-yl)-2-methylpropionic acid | 2-(6-((3-(4-(diphenylmethoxy)piperidino)propyl)amino)imidazo(1,2-b)pyridazin-2-yl)-2-methylpropionic acid inhibits the reaction [Dexamethasone results in increased expression of IFNG mRNA] | decreases reaction|increases expression | 12438553 |
| C012796 | 2-butenal | 2-butenal results in decreased secretion of IFNG protein | decreases secretion | 17491020 |
| C518860 | 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid ethyl amide | 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid ethyl amide inhibits the reaction [IFNG protein results in increased expression of NOS2] | decreases reaction|increases expression | 17363558 |
| C433771 | 2-methyl-3-(2-((4-nitrooxybutyloxy)carbonyl)vinyl)phenyl ursodeoxycholic acid ester | 2-methyl-3-(2-((4-nitrooxybutyloxy)carbonyl)vinyl)phenyl ursodeoxycholic acid ester inhibits the reaction [Acetaminophen results in increased expression of IFNG mRNA] | decreases reaction|increases expression | 15345658 |
| C054649 | 3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol | 3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol inhibits the reaction [IFNG protein results in increased expression of CIITA mRNA] | decreases reaction|increases expression | 14757364 |
| C054649 | 3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol | [3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol binds to and results in increased activity of CNR1 protein] inhibits the reaction [IFNG protein affects the reaction [Lipopolysaccharides results in increased abundance of Nitric Oxide]] | affects binding|affects reaction|decreases reaction|increases abundance|increases activity | 11727767 |
| C054649 | 3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol | rimonabant inhibits the reaction [[3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol binds to and results in increased activity of CNR1 protein] inhibits the reaction [IFNG protein affects the reaction [Lipopolysaccharides results in increased abundance of Nitric Oxide]]] | affects binding|affects reaction|decreases reaction|increases abundance|increases activity | 11727767 |
| C041525 | 3,3',4,5'-tetrahydroxystilbene | 3,3',4,5'-tetrahydroxystilbene inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of IL8 mRNA] | affects cotreatment|decreases reaction|increases expression | 15779068 |
| C041525 | 3,3',4,5'-tetrahydroxystilbene | 3,3',4,5'-tetrahydroxystilbene inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of IL8 protein] | affects cotreatment|decreases reaction|increases expression | 15779068 |
| C041525 | 3,3',4,5'-tetrahydroxystilbene | 3,3',4,5'-tetrahydroxystilbene inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of TNF mRNA] | affects cotreatment|decreases reaction|increases expression | 15779068 |
| C041525 | 3,3',4,5'-tetrahydroxystilbene | 3,3',4,5'-tetrahydroxystilbene inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of TNF protein] | affects cotreatment|decreases reaction|increases expression | 15779068 |
| C454323 | 3-(3-chloro-4-methoxyphenyl)-1,1-dimethylurea | 3-(3-chloro-4-methoxyphenyl)-1,1-dimethylurea results in decreased expression of IFNG protein | decreases expression | 10883730 |
| C434003 | 3-(4-methylphenylsulfonyl)-2-propenenitrile | 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [IFNG protein results in increased expression of EFEMP1 mRNA] | decreases reaction|increases expression | 19208748 |
| C030682 | 3-chlorophenol | 3-chlorophenol results in increased expression of IFNG mRNA | increases expression | 18486366 |
| C090942 | 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole | 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Lipopolysaccharides results in increased expression of IFNG mRNA] | decreases reaction|increases expression | 16880258 |
| C006821 | 4-bromophenacyl bromide | 4-bromophenacyl bromide results in increased expression of IFNG protein | increases expression | 15454121 |
| C029728 | 4-phenylenediamine | 4-phenylenediamine results in increased expression of IFNG mRNA | increases expression | 11531941 |
| C039465 | 5-dimethylamiloride | 5-dimethylamiloride inhibits the reaction [[lipopolysaccharide, E coli O55-B5 co-treated with IFNG protein] results in increased secretion of IL12B protein] | affects cotreatment|decreases reaction|increases secretion | 11420121 |
| C058176 | 5-nitro-2-(3-phenylpropylamino)benzoic acid | 5-nitro-2-(3-phenylpropylamino)benzoic acid inhibits the reaction [IFNG protein results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 19446535 |
| C058176 | 5-nitro-2-(3-phenylpropylamino)benzoic acid | 5-nitro-2-(3-phenylpropylamino)benzoic acid inhibits the reaction [IFNG protein results in increased metabolism of Nitric Oxide] | decreases reaction|increases metabolic processing | 19446535 |
| C056369 | 5-(N-methyl-N-isobutyl)amiloride | 5-(N-methyl-N-isobutyl)amiloride inhibits the reaction [[lipopolysaccharide, E coli O55-B5 co-treated with IFNG protein] results in increased secretion of IL12B protein] | affects cotreatment|decreases reaction|increases secretion | 11420121 |
| D000082 | Acetaminophen | 2-methyl-3-(2-((4-nitrooxybutyloxy)carbonyl)vinyl)phenyl ursodeoxycholic acid ester inhibits the reaction [Acetaminophen results in increased expression of IFNG mRNA] | decreases reaction|increases expression | 15345658 |
| D000082 | Acetaminophen | Acetaminophen results in increased expression of IFNG mRNA | increases expression | 15578514 19164858 19739265 12051698 15345658 12153990 14557383 |
| D000082 | Acetaminophen | Acetaminophen results in increased expression of IFNG protein | increases expression | 19739265 17185352 |
| D000082 | Acetaminophen | Aspirin inhibits the reaction [Acetaminophen results in increased expression of IFNG mRNA] | decreases reaction|increases expression | 19164858 |
| D000082 | Acetaminophen | IFNG protein promotes the reaction [Acetaminophen results in increased expression of CCL2 mRNA] | increases expression|increases reaction | 12153990 |
| D000082 | Acetaminophen | IFNG protein promotes the reaction [Acetaminophen results in increased expression of CCL3 mRNA] | increases expression|increases reaction | 12153990 |
| D000082 | Acetaminophen | IFNG protein promotes the reaction [Acetaminophen results in increased expression of CXCL10 mRNA] | increases expression|increases reaction | 12153990 |
| D000082 | Acetaminophen | IFNG protein promotes the reaction [Acetaminophen results in increased expression of CXCL1 mRNA] | increases expression|increases reaction | 12153990 |
| D000082 | Acetaminophen | IFNG protein promotes the reaction [Acetaminophen results in increased expression of CXCL2 mRNA] | increases expression|increases reaction | 12153990 |
| D000082 | Acetaminophen | IFNG protein promotes the reaction [Acetaminophen results in increased expression of CXCL9 mRNA] | increases expression|increases reaction | 12153990 |
| D000082 | Acetaminophen | IFNG protein promotes the reaction [Acetaminophen results in increased expression of FAS mRNA] | increases expression|increases reaction | 12153990 |
| D000082 | Acetaminophen | IFNG protein promotes the reaction [Acetaminophen results in increased expression of ICAM1 mRNA] | increases expression|increases reaction | 12153990 |
| D000082 | Acetaminophen | IFNG protein promotes the reaction [Acetaminophen results in increased expression of IL1A mRNA] | increases expression|increases reaction | 12153990 |
| D000082 | Acetaminophen | IFNG protein promotes the reaction [Acetaminophen results in increased expression of IL1B mRNA] | increases expression|increases reaction | 12153990 |
| D000082 | Acetaminophen | IFNG protein promotes the reaction [Acetaminophen results in increased expression of IL6 mRNA] | increases expression|increases reaction | 12153990 |
| D000082 | Acetaminophen | IFNG protein promotes the reaction [Acetaminophen results in increased expression of NOS2 mRNA] | increases expression|increases reaction | 12153990 |
| D000082 | Acetaminophen | IFNG protein promotes the reaction [Acetaminophen results in increased expression of TNF mRNA] | increases expression|increases reaction | 12153990 |
| D000082 | Acetaminophen | IFNG protein promotes the reaction [Acetaminophen results in increased expression of VCAM1 mRNA] | increases expression|increases reaction | 12153990 |
| D000082 | Acetaminophen | KLRB1C protein promotes the reaction [Acetaminophen results in increased expression of IFNG mRNA] | increases expression|increases reaction | 15578514 |
| D000082 | Acetaminophen | manumycin inhibits the reaction [Acetaminophen results in increased expression of IFNG mRNA] | decreases reaction|increases expression | 19739265 |
| D000082 | Acetaminophen | manumycin inhibits the reaction [Acetaminophen results in increased expression of IFNG protein] | decreases reaction|increases expression | 19739265 |
| D000082 | Acetaminophen | Methionine inhibits the reaction [Acetaminophen results in increased expression of IFNG mRNA] | decreases reaction|increases expression | 19739265 |
| D000082 | Acetaminophen | Methionine inhibits the reaction [Acetaminophen results in increased expression of IFNG protein] | decreases reaction|increases expression | 19739265 |
| D000082 | Acetaminophen | S100A9 protein promotes the reaction [Acetaminophen results in increased expression of IFNG mRNA] | increases expression|increases reaction | 12051698 |
| D000082 | Acetaminophen | TNFRSF1A protein promotes the reaction [Acetaminophen results in increased expression of IFNG mRNA] | increases expression|increases reaction | 14557383 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [IFNG protein results in increased phosphorylation of and results in increased activity of JAK2 protein]] | decreases reaction|increases activity|increases phosphorylation | 12847270 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [IFNG protein results in increased phosphorylation of STAT1 protein]] | decreases reaction|increases phosphorylation | 12847270 |
| D000111 | Acetylcysteine | Acetylcysteine promotes the reaction [IFNG protein results in increased phosphorylation of and results in increased activity of JAK2 protein] | increases activity|increases phosphorylation|increases reaction | 12847270 |
| D000111 | Acetylcysteine | Acetylcysteine promotes the reaction [IFNG protein results in increased phosphorylation of STAT1 protein] | increases phosphorylation|increases reaction | 12847270 |
| D000119 | Acetylmuramyl-Alanyl-Isoglutamine | [Acetylmuramyl-Alanyl-Isoglutamine co-treated with Lipid A] results in increased expression of IFNG mRNA | affects cotreatment|increases expression | 16299289 |
| D000119 | Acetylmuramyl-Alanyl-Isoglutamine | [Acetylmuramyl-Alanyl-Isoglutamine co-treated with Lipid A] results in increased expression of IFNG protein | affects cotreatment|increases expression | 16299289 |
| D000119 | Acetylmuramyl-Alanyl-Isoglutamine | [Acetylmuramyl-Alanyl-Isoglutamine co-treated with Pam(3)CSK(4) peptide co-treated with IFNG protein] results in increased expression of [IL12A protein binds to IL12B protein] | affects binding|affects cotreatment|increases expression | 18490488 |
| D000119 | Acetylmuramyl-Alanyl-Isoglutamine | [Acetylmuramyl-Alanyl-Isoglutamine co-treated with Pam(3)CSK(4) peptide co-treated with IFNG protein] results in increased expression of IL12B protein | affects cotreatment|increases expression | 18490488 |
| D000119 | Acetylmuramyl-Alanyl-Isoglutamine | [Acetylmuramyl-Alanyl-Isoglutamine co-treated with Pam(3)CSK(4) peptide co-treated with IFNG protein] results in increased expression of [IL12B protein binds to IL23A protein] | affects binding|affects cotreatment|increases expression | 18490488 |
| D000119 | Acetylmuramyl-Alanyl-Isoglutamine | [Acetylmuramyl-Alanyl-Isoglutamine co-treated with R 848 co-treated with IFNG protein] results in increased expression of IL12A mRNA | affects cotreatment|increases expression | 18490488 |
| D000119 | Acetylmuramyl-Alanyl-Isoglutamine | [Acetylmuramyl-Alanyl-Isoglutamine co-treated with R 848 co-treated with IFNG protein] results in increased expression of [IL12A protein binds to IL12B protein] | affects binding|affects cotreatment|increases expression | 18490488 |
| D000119 | Acetylmuramyl-Alanyl-Isoglutamine | [Acetylmuramyl-Alanyl-Isoglutamine co-treated with R 848 co-treated with IFNG protein] results in increased expression of IL12B mRNA | affects cotreatment|increases expression | 18490488 |
| D000119 | Acetylmuramyl-Alanyl-Isoglutamine | R 848 promotes the reaction [[Acetylmuramyl-Alanyl-Isoglutamine co-treated with Pam(3)CSK(4) peptide co-treated with IFNG protein] results in increased expression of [IL12A protein binds to IL12B protein]] | affects binding|affects cotreatment|increases expression|increases reaction | 18490488 |
| D000119 | Acetylmuramyl-Alanyl-Isoglutamine | R 848 promotes the reaction [[Acetylmuramyl-Alanyl-Isoglutamine co-treated with Pam(3)CSK(4) peptide co-treated with IFNG protein] results in increased expression of IL12B protein] | affects cotreatment|increases expression|increases reaction | 18490488 |
| D000171 | Acrolein | Acrolein results in decreased secretion of IFNG protein | decreases secretion | 17491020 |
| D000171 | Acrolein | Acrolein results in increased expression of IFNG mRNA | increases expression | 17950725 |
| D000171 | Acrolein | CD8A gene mutant form inhibits the reaction [Acrolein results in increased expression of IFNG mRNA] | decreases reaction|increases expression | 17950725 |
| C109238 | acyline | acyline results in decreased expression of IFNG mRNA | decreases expression | 16352669 |
| C103303 | alitretinoin | alitretinoin results in decreased expression of IFNG mRNA | decreases expression | 17118196 |
| C103303 | alitretinoin | alitretinoin results in decreased expression of IFNG protein | decreases expression | 17118196 |
| D000468 | Alkalies | [Alkalies co-treated with Minerals] results in decreased expression of IFNG mRNA | affects cotreatment|decreases expression | 11767050 |
| C099681 | allergovit | allergovit results in increased expression of IFNG protein | increases expression | 12239597 |
| C095512 | alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide | alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide inhibits the reaction [IFNG protein results in increased expression of BIRC3 mRNA] | decreases reaction|increases expression | 15845643 |
| C095512 | alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide | alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide inhibits the reaction [IFNG protein results in increased expression of BIRC3 protein] | decreases reaction|increases expression | 15845643 |
| C095512 | alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide | alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide inhibits the reaction [IFNG protein results in increased expression of TYMP mRNA] | decreases reaction|increases expression | 15937643 |
| C095512 | alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide | alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide inhibits the reaction [IFNG protein results in increased phosphorylation of STAT1 protein] | decreases reaction|increases phosphorylation | 15937643 |
| C095512 | alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide | alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide inhibits the reaction [IFNG protein results in increased phosphorylation of STAT3 mRNA] | decreases reaction|increases phosphorylation | 15845643 |
| C095512 | alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide | alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide inhibits the reaction [IFNG protein results in increased abundance of Nitric Oxide] | decreases reaction|increases abundance | 12847270 |
| C493154 | alpha-galactosylceramide | alpha-galactosylceramide results in increased secretion of IFNG protein | increases secretion | 12482940 |
| D000584 | Amiloride | Amiloride inhibits the reaction [IFNG protein results in increased expression of PLAUR mRNA] | decreases reaction|increases expression | 12070711 |
| D000584 | Amiloride | Amiloride inhibits the reaction [[lipopolysaccharide, E coli O55-B5 co-treated with IFNG protein] results in increased secretion of IL12B protein] | affects cotreatment|decreases reaction|increases secretion | 11420121 |
| D000643 | Ammonium Chloride | Ammonium Chloride affects the expression of IFNG mRNA | affects expression | 16483693 |
| D000666 | Amphotericin B | [Antimony Sodium Gluconate co-treated with Amphotericin B] results in increased expression of IFNG protein | affects cotreatment|increases expression | 17911647 |
| C432165 | anthra(1,9-cd)pyrazol-6(2H)-one | [anthra(1,9-cd)pyrazol-6(2H)-one co-treated with Manganese] inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Nitric Oxide] | affects cotreatment|decreases reaction|increases abundance | 16488514 |
| C432165 | anthra(1,9-cd)pyrazol-6(2H)-one | anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Nitric Oxide] | affects cotreatment|decreases reaction|increases abundance | 16488514 |
| C432165 | anthra(1,9-cd)pyrazol-6(2H)-one | anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [Manganese promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mRNA]] | affects cotreatment|decreases reaction|increases expression|increases reaction | 16488514 |
| C432165 | anthra(1,9-cd)pyrazol-6(2H)-one | anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [Manganese promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of TNF protein]] | affects cotreatment|decreases reaction|increases expression|increases reaction | 16488514 |
| C031385 | anthranilic acid | anthranilic acid analog inhibits the reaction [[IL12A protein binds to IL12B protein] which results in increased secretion of IFNG protein] | affects binding|decreases reaction|increases secretion | 15799959 |
| C031385 | anthranilic acid | anthranilic acid analog inhibits the reaction [IL18 protein results in increased secretion of IFNG protein] | decreases reaction|increases secretion | 15799959 |
| D019380 | Anti-HIV Agents | Anti-HIV Agents results in decreased expression of IFNG mRNA | decreases expression | 10202824 |
| D000941 | Antigens | Antigens results in increased secretion of IFNG protein | increases secretion | 16160912 |
| D000941 | Antigens | [zafirlukast co-treated with Prednisone co-treated with Budesonide] inhibits the reaction [Antigens results in increased secretion of IFNG protein] | affects cotreatment|decreases reaction|increases secretion | 16160912 |
| D000965 | Antimony | IFNG protein affects the susceptibility to Antimony | affects response to substance | 11035738 |
| D000967 | Antimony Sodium Gluconate | [Antimony Sodium Gluconate co-treated with Amphotericin B] results in increased expression of IFNG protein | affects cotreatment|increases expression | 17911647 |
| D000967 | Antimony Sodium Gluconate | Antimony Sodium Gluconate results in decreased expression of IFNG mRNA | decreases expression | 9498473 20102417 |
| D000967 | Antimony Sodium Gluconate | IFNG protein affects the reaction [IL10RA protein affects the susceptibility to Antimony Sodium Gluconate] | affects reaction|affects response to substance | 12870129 |
| D000967 | Antimony Sodium Gluconate | IFNG protein affects the susceptibility to Antimony Sodium Gluconate | affects response to substance | 10603400 |
| D000967 | Antimony Sodium Gluconate | [IFNG protein co-treated with Antimony Sodium Gluconate] results in decreased expression of IL10 mRNA | affects cotreatment|decreases expression | 9234779 |
| D000967 | Antimony Sodium Gluconate | [IFNG protein co-treated with Antimony Sodium Gluconate] results in decreased expression of IL4 mRNA | affects cotreatment|decreases expression | 9234779 |
| D000967 | Antimony Sodium Gluconate | [IFNG protein co-treated with Antimony Sodium Gluconate] results in increased expression of IL12B mRNA | affects cotreatment|increases expression | 9234779 |
| D000967 | Antimony Sodium Gluconate | [IFNG protein co-treated with Antimony Sodium Gluconate] results in increased expression of NOS2 mRNA | affects cotreatment|increases expression | 9234779 |
| D047310 | Apigenin | Apigenin inhibits the reaction [[IL1B protein co-treated with IFNG protein] affects the localization of and results in increased activity of NFKB1 protein] | affects cotreatment|affects localization|decreases reaction|increases activity | 18090225 |
| D047310 | Apigenin | Apigenin inhibits the reaction [[IL1B protein co-treated with IFNG protein] affects the localization of and results in increased activity of RELA protein] | affects cotreatment|affects localization|decreases reaction|increases activity | 18090225 |
| D047310 | Apigenin | Apigenin inhibits the reaction [[IL1B protein co-treated with IFNG protein] results in decreased secretion of INS1 protein] | affects cotreatment|decreases reaction|decreases secretion | 18090225 |
| D047310 | Apigenin | Apigenin inhibits the reaction [[IL1B protein co-treated with IFNG protein] results in increased abundance of Nitric Oxide] | affects cotreatment|decreases reaction|increases abundance | 18090225 |
| D047310 | Apigenin | Apigenin inhibits the reaction [[IL1B protein co-treated with IFNG protein] results in increased degradation of NFKBIA protein] | affects cotreatment|decreases reaction|increases degradation | 18090225 |
| D047310 | Apigenin | Apigenin inhibits the reaction [[IL1B protein co-treated with IFNG protein] results in increased expression of NOS2 mRNA] | affects cotreatment|decreases reaction|increases expression | 18090225 |
| D047310 | Apigenin | Apigenin inhibits the reaction [[IL1B protein co-treated with IFNG protein] results in increased expression of NOS2 protein] | affects cotreatment|decreases reaction|increases expression | 18090225 |
| C006632 | arsenic trioxide | arsenic trioxide promotes the reaction [IFNG protein results in increased activity of STAT1 protein] | increases activity|increases reaction | 14668793 |
| C006632 | arsenic trioxide | arsenic trioxide promotes the reaction [[IFNG protein results in increased activity of STAT1 protein] which results in increased expression of IRF1 mRNA] | increases activity|increases expression|increases reaction | 14668793 |
| C006632 | arsenic trioxide | arsenic trioxide promotes the reaction [IFNG protein results in increased expression of IRF1 mRNA] | increases expression|increases reaction | 14668793 |
| C006632 | arsenic trioxide | arsenic trioxide promotes the reaction [IFNG protein results in increased expression of IRF1 protein] | increases expression|increases reaction | 14668793 |
| C006632 | arsenic trioxide | arsenic trioxide promotes the reaction [IFNG protein results in increased phosphorylation of STAT1 protein] | increases phosphorylation|increases reaction | 16914093 |
| C006632 | arsenic trioxide | arsenic trioxide results in increased activity of IFNG protein | increases activity | 14668793 |
| C006632 | arsenic trioxide | CASP3 protein promotes the reaction [arsenic trioxide results in increased activity of IFNG protein] | increases activity|increases reaction | 14668793 |
| D001205 | Ascorbic Acid | Ascorbic Acid results in decreased expression of IFNG protein | decreases expression | 14624943 |
| D001205 | Ascorbic Acid | IFNG protein promotes the reaction [Ascorbic Acid promotes the reaction [Quartz results in increased secretion of TNF protein]] | increases reaction|increases secretion | 19298665 |
| D001241 | Aspirin | Aspirin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased secretion of [IL12A protein binds to IL12B protein]] | affects binding|affects cotreatment|decreases reaction|increases secretion | 15379866 |
| D001241 | Aspirin | Aspirin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased secretion of IFNG protein] | affects cotreatment|decreases reaction|increases secretion | 15379866 |
| D001241 | Aspirin | Aspirin inhibits the reaction [Acetaminophen results in increased expression of IFNG mRNA] | decreases reaction|increases expression | 19164858 |
| D001280 | Atrazine | Atrazine results in decreased expression of IFNG protein | decreases expression | 10883730 15319175 |
| D001280 | Atrazine | Atrazine results in decreased expression of IFNG protein | decreases expression | 12504806 |
| D001374 | Azacitidine | [Azacitidine promotes the reaction [IFNG protein results in increased expression of CIITA mRNA]] which results in increased expression of HLA-DRA protein | increases expression|increases reaction | 18829986 |
| D001374 | Azacitidine | [Azacitidine results in decreased methylation of CIITA promoter] promotes the reaction [IFNG protein results in increased expression of CIITA mRNA] | decreases methylation|increases expression|increases reaction | 18829986 |
| D001374 | Azacitidine | [Azacitidine results in increased expression of KIR2DL4 protein] which results in increased secretion of IFNG protein | increases expression|increases secretion | 18945643 |
| C108181 | BCH 1393 | BCH 1393 results in increased expression of IFNG mRNA | increases expression | 17827067 |
| C108181 | BCH 1393 | BCH 1393 results in increased expression of IFNG protein | increases expression | 17827067 |
| C013407 | benzamil | benzamil inhibits the reaction [[lipopolysaccharide, E coli O55-B5 co-treated with IFNG protein] results in increased secretion of IL12B protein] | affects cotreatment|decreases reaction|increases secretion | 11420121 |
| D001554 | Benzene | Benzene results in decreased expression of IFNG mRNA | decreases expression | 15929907 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of IFNG mRNA | increases expression | 9465272 |
| C072553 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [IFNG protein results in increased activity of CASP1 protein] | decreases reaction|increases activity | 15914627 |
| C072553 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [IFNG protein results in increased activity of CASP6 protein] | decreases reaction|increases activity | 15914627 |
| C072553 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [IFNG protein results in increased activity of CASP8 protein] | decreases reaction|increases activity | 15914627 |
| C072553 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | Quercetin inhibits the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [IFNG protein results in increased activity of CASP1 protein]] | decreases reaction|increases activity | 15914627 |
| C072553 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | Quercetin inhibits the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [IFNG protein results in increased activity of CASP6 protein]] | decreases reaction|increases activity | 15914627 |
| C072553 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | Quercetin inhibits the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [IFNG protein results in increased activity of CASP8 protein]] | decreases reaction|increases activity | 15914627 |
| C020711 | beryllium sulfate | [beryllium sulfate co-treated with IFNG protein] results in increased expression of CREB1 protein | affects cotreatment|increases expression | 10755711 |
| C020711 | beryllium sulfate | [beryllium sulfate co-treated with IFNG protein] results in increased expression of JUNB protein | affects cotreatment|increases expression | 10755711 |
| C020711 | beryllium sulfate | [beryllium sulfate co-treated with IFNG protein] results in increased expression of JUN protein | affects cotreatment|increases expression | 10755711 |
| C020711 | beryllium sulfate | [beryllium sulfate co-treated with IFNG protein] results in increased expression of NFKB1 protein | affects cotreatment|increases expression | 10755711 |
| C020711 | beryllium sulfate | beryllium sulfate promotes the reaction [IFNG protein results in increased expression of TNF protein] | increases expression|increases reaction | 10755711 10755710 |
| D047071 | beta-Glucans | [beta-Glucans co-treated with R 848 co-treated with IFNG protein] results in increased expression of IL12A mRNA | affects cotreatment|increases expression | 18490488 |
| D047071 | beta-Glucans | IFNG protein inhibits the reaction [beta-Glucans results in increased expression of IL10 mRNA] | decreases reaction|increases expression | 18490488 |
| D047071 | beta-Glucans | IFNG protein inhibits the reaction [beta-Glucans results in increased expression of IL10 protein] | decreases reaction|increases expression | 18490488 |
| D047071 | beta-Glucans | IFNG protein inhibits the reaction [beta-Glucans results in increased expression of [IL12B protein binds to IL23A protein]] | affects binding|decreases reaction|increases expression | 18490488 |
| D047071 | beta-Glucans | IFNG protein inhibits the reaction [beta-Glucans results in increased expression of IL23A mRNA] | decreases reaction|increases expression | 18490488 |
| D047071 | beta-Glucans | IFNG protein promotes the reaction [beta-Glucans results in increased expression of [IL12A protein binds to IL12B protein]] | affects binding|increases expression|increases reaction | 18490488 |
| D001664 | Biliverdine | [Methylene Chloride co-treated with Biliverdine] inhibits the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in increased expression of IFNG protein] | affects cotreatment|decreases reaction|increases expression | 15486963 |
| C018465 | bioallethrin | bioallethrin affects the expression of IFNG protein | affects expression | 9860237 |
| C018465 | bioallethrin | [bioallethrin co-treated with Piperonyl Butoxide] results in increased expression of IFNG protein | affects cotreatment|increases expression | 10414782 |
| C006780 | bisphenol A | bisphenol A results in increased expression of IFNG mRNA | increases expression | 19415476 |
| C006780 | bisphenol A | Drugs, Chinese Herbal inhibits the reaction [bisphenol A results in increased expression of IFNG mRNA] | decreases reaction|increases expression | 19415476 |
| C006780 | bisphenol A | bisphenol A results in decreased expression of IFNG mRNA | decreases expression | 18569609 19267065 |
| C005961 | bis(tri-n-butyltin)oxide | bis(tri-n-butyltin)oxide results in increased expression of IFNG mRNA | increases expression | 9465272 |
| D001761 | Bleomycin | Bleomycin results in increased expression of IFNG mRNA | increases expression | 11350791 |
| C072125 | BRL 44408 | BRL 44408 inhibits the reaction [Clonidine inhibits the reaction [Zymosan results in increased expression of IFNG protein]] | decreases reaction|increases expression | 16192389 |
| D019819 | Budesonide | [zafirlukast co-treated with Prednisone co-treated with Budesonide] inhibits the reaction [Antigens results in increased secretion of IFNG protein] | affects cotreatment|decreases reaction|increases secretion | 16160912 |
| D002085 | Butylhydroxybutylnitrosamine | 2-Acetylaminofluorene inhibits the reaction [[Diethylnitrosamine co-treated with Methylnitrosourea co-treated with Butylhydroxybutylnitrosamine co-treated with diisopropanolnitrosamine co-treated with 1,2-Dimethylhydrazine] results in decreased expression of IFNG protein] | affects cotreatment|decreases expression|decreases reaction | 14736494 |
| D002085 | Butylhydroxybutylnitrosamine | [Diethylnitrosamine co-treated with Methylnitrosourea co-treated with Butylhydroxybutylnitrosamine co-treated with diisopropanolnitrosamine co-treated with 1,2-Dimethylhydrazine] results in decreased expression of IFNG protein | affects cotreatment|decreases expression | 14736494 |
| D002087 | Butyrates | Butyrates inhibits the reaction [IFNG protein results in increased expression of PLAUR mRNA] | decreases reaction|increases expression | 12070711 |
| D002087 | Butyrates | Butyrates results in decreased secretion of IFNG protein | decreases secretion | 11024006 |
| D002104 | Cadmium | Cadmium inhibits the reaction [IFNG protein results in increased phosphorylation of STAT1 protein] | decreases reaction|increases phosphorylation | 16843830 |
| C028031 | cadmium acetate | cadmium acetate results in decreased secretion of IFNG protein | decreases secretion | 16510232 |
| D019256 | Cadmium Chloride | Cadmium Chloride inhibits the reaction [IFNG protein results in increased phosphorylation of STAT1 protein] | decreases reaction|increases phosphorylation | 16843830 |
| C055494 | caffeic acid phenethyl ester | caffeic acid phenethyl ester inhibits the reaction [IFNG protein promotes the reaction [decitabine results in increased expression of PLA2G2A protein]] | decreases reaction|increases expression|increases reaction | 18953428 |
| D000001 | Calcimycin | [Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of IFNG protein | affects cotreatment|increases expression | 14994387 |
| D002219 | Carbamates | Carbamates analog results in increased expression of IFNG protein | increases expression | 19111005 |
| D002248 | Carbon Monoxide | Carbon Monoxide inhibits the reaction [IFNG protein promotes the reaction [Lipopolysaccharides results in increased expression of IL12B protein]] | decreases reaction|increases expression|increases reaction | 16365149 |
| D002248 | Carbon Monoxide | Carbon Monoxide inhibits the reaction [IFNG protein results in decreased expression of HMOX1 protein] | decreases expression|decreases reaction | 16365149 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in increased expression of IFNG mRNA | increases expression | 18395288 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in increased expression of IFNG protein | increases expression | 18279442 17698563 17412915 17133483 17038628 |
| D002251 | Carbon Tetrachloride | CD44 protein affects the reaction [Carbon Tetrachloride results in increased expression of IFNG mRNA] | affects reaction|increases expression | 18395288 |
| D002251 | Carbon Tetrachloride | Glucosylceramides affects the reaction [Carbon Tetrachloride results in increased expression of IFNG protein] | affects reaction|increases expression | 17698563 |
| D002251 | Carbon Tetrachloride | PLAT protein affects the reaction [Carbon Tetrachloride results in increased expression of IFNG protein] | affects reaction|increases expression | 18279442 |
| D002251 | Carbon Tetrachloride | PLAU protein affects the reaction [Carbon Tetrachloride results in increased expression of IFNG protein] | affects reaction|increases expression | 18279442 |
| D002251 | Carbon Tetrachloride | PLAUR protein affects the reaction [Carbon Tetrachloride results in increased expression of IFNG protein] | affects reaction|increases expression | 18279442 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in decreased expression of IFNG protein | decreases expression | 15603720 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in increased expression of IFNG protein | increases expression | 18006644 15123359 |
| D002251 | Carbon Tetrachloride | Curcumin inhibits the reaction [Carbon Tetrachloride results in increased expression of IFNG protein] | decreases reaction|increases expression | 18006644 |
| D002251 | Carbon Tetrachloride | IFNG protein inhibits the reaction [Carbon Tetrachloride results in increased expression of FN1 protein] | decreases reaction|increases expression | 15030980 |
| D002251 | Carbon Tetrachloride | IFNG protein inhibits the reaction [Carbon Tetrachloride results in increased expression of HGF mRNA] | decreases reaction|increases expression | 12445174 |
| D002251 | Carbon Tetrachloride | oxymatrine inhibits the reaction [Carbon Tetrachloride results in decreased expression of IFNG protein] | decreases expression|decreases reaction | 15603720 |
| D002713 | Chlorine | [Ozone co-treated with Chlorine] affects the expression of IFNG mRNA | affects cotreatment|affects expression | 18636392 |
| D002725 | Chloroform | Chloroform results in decreased expression of IFNG protein | decreases expression | 16879906 |
| C007020 | chlorophyllin | chlorophyllin inhibits the reaction [Lipopolysaccharides results in increased expression of IFNG mRNA] | decreases reaction|increases expression | 16275627 |
| D002772 | Cholera Toxin | Cholera Toxin inhibits the reaction [Lipopolysaccharides results in increased expression of IFNG protein] | decreases reaction|increases expression | 9927516 |
| C039671 | ciglitazone | 2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [ciglitazone results in decreased secretion of IFNG protein] | decreases reaction|decreases secretion | 16844232 |
| C039671 | ciglitazone | ciglitazone inhibits the reaction [IFNG protein results in increased expression of IRF1 mRNA] | decreases reaction|increases expression | 12847270 |
| C039671 | ciglitazone | ciglitazone inhibits the reaction [IFNG protein results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 12847270 |
| C039671 | ciglitazone | ciglitazone inhibits the reaction [[IFNG protein results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide] | decreases reaction|increases chemical synthesis|increases expression | 12847270 |
| C039671 | ciglitazone | ciglitazone results in decreased secretion of IFNG protein | decreases secretion | 16844232 |
| C039671 | ciglitazone | T 0070907 inhibits the reaction [ciglitazone results in decreased secretion of IFNG protein] | decreases reaction|decreases secretion | 16844232 |
| C433247 | Cilomilast | Cilomilast results in increased expression of IFNG mRNA | increases expression | 16956605 |
| D002927 | Cimetidine | Cimetidine inhibits the reaction [Histamine inhibits the reaction [Lipopolysaccharides results in increased expression of IFNG protein]] | decreases reaction|increases expression | 10569698 |
| D002927 | Cimetidine | Cimetidine results in increased expression of IFNG mRNA | increases expression | 10569698 |
| D002927 | Cimetidine | Cimetidine results in increased expression of IFNG protein | increases expression | 10569698 |
| C012843 | cinnamic aldehyde | cinnamic aldehyde results in increased expression of IFNG protein | increases expression | 11244134 |
| D002939 | Ciprofloxacin | Ciprofloxacin inhibits the reaction [[IL1A protein co-treated with TNF protein co-treated with IFNG protein] results in increased abundance of Nitric Oxide] | affects cotreatment|decreases reaction|increases abundance | 16968468 |
| D002939 | Ciprofloxacin | Ciprofloxacin results in decreased expression of IFNG protein | decreases expression | 16006447 |
| D002939 | Ciprofloxacin | wortmannin inhibits the reaction [Ciprofloxacin inhibits the reaction [[IL1A protein co-treated with TNF protein co-treated with IFNG protein] results in increased abundance of Nitric Oxide]] | affects cotreatment|decreases reaction|increases abundance | 16968468 |
| D002939 | Ciprofloxacin | [Ciprofloxacin co-treated with Cyclosporine] results in increased expression of IFNG mRNA | affects cotreatment|increases expression | 18337667 |
| D004002 | Clodronic Acid | Clodronic Acid inhibits the reaction [Streptozocin results in increased expression of IFNG protein] | decreases reaction|increases expression | 15892581 |
| D003000 | Clonidine | BRL 44408 inhibits the reaction [Clonidine inhibits the reaction [Zymosan results in increased expression of IFNG protein]] | decreases reaction|increases expression | 16192389 |
| D003000 | Clonidine | Clonidine inhibits the reaction [Zymosan results in increased expression of IFNG protein] | decreases reaction|increases expression | 16192389 |
| C007095 | cobaltiprotoporphyrin | cobaltiprotoporphyrin inhibits the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in increased expression of IFNG mRNA] | affects cotreatment|decreases reaction|increases expression | 15486963 |
| C007095 | cobaltiprotoporphyrin | cobaltiprotoporphyrin inhibits the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in increased expression of IFNG protein] | affects cotreatment|decreases reaction|increases expression | 15486963 |
| C513533 | CpG ODN 2006 | CpG ODN 2006 results in increased expression of IFNG mRNA | increases expression | 16973119 |
| D003474 | Curcumin | Curcumin inhibits the reaction [IFNG protein results in increased expression of and results in increased phosphorylation of STAT1 protein] | decreases reaction|increases expression|increases phosphorylation | 16959222 |
| D003474 | Curcumin | Curcumin inhibits the reaction [IFNG protein results in increased expression of and results in increased phosphorylation of STAT3 protein] | decreases reaction|increases expression|increases phosphorylation | 16959222 |
| D003474 | Curcumin | Curcumin inhibits the reaction [Carbon Tetrachloride results in increased expression of IFNG protein] | decreases reaction|increases expression | 18006644 |
| D003474 | Curcumin | Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IFNG mRNA] | decreases reaction|increases expression | 16867261 16782535 |
| D003474 | Curcumin | Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IFNG protein] | decreases reaction|increases expression | 16867261 |
| D003513 | Cycloheximide | [Cycloheximide co-treated with IFNG protein] results in increased expression of PLAUR mRNA | affects cotreatment|increases expression | 12070711 |
| D003513 | Cycloheximide | Cycloheximide inhibits the reaction [IFNG protein results in increased expression of ICAM1 protein] | decreases reaction|increases expression | 16087364 |
| D003513 | Cycloheximide | Cycloheximide inhibits the reaction [IFNG protein results in increased expression of TJP1 protein] | decreases reaction|increases expression | 16087364 |
| D003520 | Cyclophosphamide | Cyclophosphamide results in decreased expression of IFNG mRNA | decreases expression | 11014644 |
| D003520 | Cyclophosphamide | Cyclophosphamide results in increased expression of IFNG mRNA | increases expression | 11006010 15331540 |
| D003520 | Cyclophosphamide | IFNG protein inhibits the reaction [Cyclophosphamide results in increased abundance of Nitric Oxide] | decreases reaction|increases abundance | 10607705 |
| D016572 | Cyclosporine | Cyclosporine promotes the reaction [Picryl Chloride results in increased expression of IFNG protein] | increases expression|increases reaction | 16442096 |
| D016572 | Cyclosporine | [Ciprofloxacin co-treated with Cyclosporine] results in increased expression of IFNG mRNA | affects cotreatment|increases expression | 18337667 |
| C004712 | cytisine | cytisine analog results in decreased secretion of IFNG protein | decreases secretion | 17630191 |
| D003606 | Dacarbazine | [Dacarbazine co-treated with Dinitrochlorobenzene] results in increased expression of IFNG mRNA | affects cotreatment|increases expression | 12202904 |
| D003609 | Dactinomycin | Dactinomycin inhibits the reaction [IFNG protein results in increased expression of TYMP mRNA] | decreases reaction|increases expression | 15937643 |
| D003609 | Dactinomycin | Dactinomycin inhibits the reaction [Tretinoin promotes the reaction [IFNG protein results in increased expression of IRF1 protein]] | decreases reaction|increases expression|increases reaction | 16085646 |
| C014347 | decitabine | caffeic acid phenethyl ester inhibits the reaction [IFNG protein promotes the reaction [decitabine results in increased expression of PLA2G2A protein]] | decreases reaction|increases expression|increases reaction | 18953428 |
| C014347 | decitabine | [decitabine co-treated with IFNG protein] results in increased expression of PLA2G5 mRNA | affects cotreatment|increases expression | 18953428 |
| C014347 | decitabine | [[decitabine co-treated with TGFB1 protein] results in increased expression of FOXP3 protein] which results in increased expression of IFNG protein | affects cotreatment|increases expression | 18567616 |
| C014347 | decitabine | decitabine promotes the reaction [IFNG protein results in increased expression of CIITA mRNA] | increases expression|increases reaction | 16650406 |
| C014347 | decitabine | decitabine results in increased secretion of IFNG protein | increases secretion | 17545540 |
| C014347 | decitabine | Forskolin inhibits the reaction [IFNG protein promotes the reaction [decitabine results in increased expression of PLA2G2A protein]] | decreases reaction|increases expression|increases reaction | 18953428 |
| C014347 | decitabine | IFNG protein promotes the reaction [decitabine results in increased expression of PLA2G2A protein] | increases expression|increases reaction | 18953428 |
| C014347 | decitabine | PD 98059 promotes the reaction [IFNG protein promotes the reaction [decitabine results in increased expression of PLA2G2A protein]] | increases expression|increases reaction | 18953428 |
| C014347 | decitabine | Plicamycin inhibits the reaction [IFNG protein promotes the reaction [decitabine results in increased expression of PLA2G2A protein]] | decreases reaction|increases expression|increases reaction | 18953428 |
| C014347 | decitabine | Tetradecanoylphorbol Acetate inhibits the reaction [IFNG protein promotes the reaction [decitabine results in increased expression of PLA2G2A protein]] | decreases reaction|increases expression|increases reaction | 18953428 |
| D013759 | Tetrahydrocannabinol | Tetrahydrocannabinol affects the secretion of IFNG protein | affects secretion | 15815632 |
| D013759 | Tetrahydrocannabinol | Tetrahydrocannabinol results in decreased expression of IFNG | decreases expression | 14741435 |
| C007262 | deoxynivalenol | deoxynivalenol affects the expression of IFNG mRNA | affects expression | 17166736 |
| C007262 | deoxynivalenol | deoxynivalenol inhibits the reaction [IFNG protein results in increased expression of CD14 protein] | decreases reaction|increases expression | 19549553 |
| C007262 | deoxynivalenol | deoxynivalenol inhibits the reaction [IFNG protein results in increased expression of ICAM1 protein] | decreases reaction|increases expression | 19549553 |
| C007262 | deoxynivalenol | deoxynivalenol inhibits the reaction [IFNG protein results in increased expression of IFNGR1 protein] | decreases reaction|increases expression | 19549553 |
| C007262 | deoxynivalenol | deoxynivalenol promotes the reaction [Lipopolysaccharides results in increased expression of IFNG mRNA] | increases expression|increases reaction | 14644621 |
| C007262 | deoxynivalenol | deoxynivalenol results in increased expression of IFNG mRNA | increases expression | 9707511 14644621 17090620 9194413 |
| C007262 | deoxynivalenol | deoxynivalenol results in increased expression of IFNG protein | increases expression | 9194413 |
| C007262 | deoxynivalenol | deoxynivalenol results in decreased expression of IFNG mRNA | decreases expression | 18329193 |
| C007262 | deoxynivalenol | [Zearalenone co-treated with deoxynivalenol] results in decreased expression of IFNG mRNA | affects cotreatment|decreases expression | 18296887 |
| D003907 | Dexamethasone | 2-(6-((3-(4-(diphenylmethoxy)piperidino)propyl)amino)imidazo(1,2-b)pyridazin-2-yl)-2-methylpropionic acid inhibits the reaction [Dexamethasone results in increased expression of IFNG mRNA] | decreases reaction|increases expression | 12438553 |
| D003907 | Dexamethasone | Dexamethasone results in decreased expression of IFNG protein | decreases expression | 10883730 9743329 |
| D003907 | Dexamethasone | IFNG protein inhibits the reaction [[Dexamethasone co-treated with IL4 protein] results in increased expression of CHID1 mRNA] | affects cotreatment|decreases reaction|increases expression | 16357325 |
| D003907 | Dexamethasone | Dexamethasone inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mRNA] | affects cotreatment|decreases reaction|increases expression | 12794164 |
| D003907 | Dexamethasone | Dexamethasone inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 protein] | affects cotreatment|decreases reaction|increases expression | 12794164 |
| D003907 | Dexamethasone | Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased expression of IFNG mRNA] | decreases reaction|increases expression | 16880258 |
| D003907 | Dexamethasone | Dexamethasone results in decreased expression of IFNG protein | decreases expression | 12760963 12504806 |
| D003907 | Dexamethasone | DUSP1 gene mutant form inhibits the reaction [Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased expression of IFNG mRNA]] | decreases reaction|increases expression | 16880258 |
| D003907 | Dexamethasone | Mifepristone inhibits the reaction [Dexamethasone results in decreased expression of IFNG protein] | decreases expression|decreases reaction | 12504806 |
| D003907 | Dexamethasone | Dexamethasone inhibits the reaction [[lipopolysaccharide, Escherichia coli 0111 B4 co-treated with IFNG protein] results in increased expression of NOS2 mRNA] | affects cotreatment|decreases reaction|increases expression | 12694877 |
| D003907 | Dexamethasone | Dexamethasone inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IFNG mRNA] | decreases reaction|increases expression | 16867261 16782535 |
| D003907 | Dexamethasone | Dexamethasone inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IFNG protein] | decreases reaction|increases expression | 16867261 |
| D003976 | Diazinon | Diazinon affects the expression of IFNG protein | affects expression | 17499902 |
| D003976 | Diazinon | Diazinon results in decreased expression of IFNG mRNA | decreases expression | 17499902 |
| C028000 | dibenzothiazyl disulfide | [dibenzothiazyl disulfide co-treated with Sodium Dodecyl Sulfate] results in increased expression of IFNG protein | affects cotreatment|increases expression | 12062936 |
| D002945 | Cisplatin | Cisplatin results in increased expression of IFNG mRNA | increases expression | 15814532 |
| D002945 | Cisplatin | pirinixic acid inhibits the reaction [Cisplatin results in increased expression of IFNG mRNA] | decreases reaction|increases expression | 15814532 |
| D004006 | Dichlorvos | Dichlorvos results in decreased expression of IFNG protein | decreases expression | 19145326 |
| C034281 | diethylamine | [diethylamine co-treated with Sodium Dodecyl Sulfate] results in increased expression of IFNG protein | affects cotreatment|increases expression | 12062936 |
| D004052 | Diethylnitrosamine | 2-Acetylaminofluorene inhibits the reaction [[Diethylnitrosamine co-treated with Methylnitrosourea co-treated with Butylhydroxybutylnitrosamine co-treated with diisopropanolnitrosamine co-treated with 1,2-Dimethylhydrazine] results in decreased expression of IFNG protein] | affects cotreatment|decreases expression|decreases reaction | 14736494 |
| D004052 | Diethylnitrosamine | [Diethylnitrosamine co-treated with Methylnitrosourea co-treated with Butylhydroxybutylnitrosamine co-treated with diisopropanolnitrosamine co-treated with 1,2-Dimethylhydrazine] results in decreased expression of IFNG protein | affects cotreatment|decreases expression | 14736494 |
| D004054 | Diethylstilbestrol | Diethylstilbestrol affects the expression of IFNG mRNA | affects expression | 14636701 |
| D002117 | Calcitriol | Calcitriol inhibits the reaction [isopentenyl pyrophosphate results in increased expression of IFNG protein] | decreases reaction|increases expression | 15879110 |
| D002117 | Calcitriol | Calcitriol results in decreased expression of IFNG protein | decreases expression | 15939587 |
| C012457 | diisopropanolnitrosamine | 2-Acetylaminofluorene inhibits the reaction [[Diethylnitrosamine co-treated with Methylnitrosourea co-treated with Butylhydroxybutylnitrosamine co-treated with diisopropanolnitrosamine co-treated with 1,2-Dimethylhydrazine] results in decreased expression of IFNG protein] | affects cotreatment|decreases expression|decreases reaction | 14736494 |
| C012457 | diisopropanolnitrosamine | [Diethylnitrosamine co-treated with Methylnitrosourea co-treated with Butylhydroxybutylnitrosamine co-treated with diisopropanolnitrosamine co-treated with 1,2-Dimethylhydrazine] results in decreased expression of IFNG protein | affects cotreatment|decreases expression | 14736494 |
| D017878 | 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid | 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of IL12B protein] | affects cotreatment|decreases reaction|increases expression | 11907163 |
| D019813 | 1,2-Dimethylhydrazine | 2-Acetylaminofluorene inhibits the reaction [[Diethylnitrosamine co-treated with Methylnitrosourea co-treated with Butylhydroxybutylnitrosamine co-treated with diisopropanolnitrosamine co-treated with 1,2-Dimethylhydrazine] results in decreased expression of IFNG protein] | affects cotreatment|decreases expression|decreases reaction | 14736494 |
| D019813 | 1,2-Dimethylhydrazine | [Diethylnitrosamine co-treated with Methylnitrosourea co-treated with Butylhydroxybutylnitrosamine co-treated with diisopropanolnitrosamine co-treated with 1,2-Dimethylhydrazine] results in decreased expression of IFNG protein | affects cotreatment|decreases expression | 14736494 |
| D004137 | Dinitrochlorobenzene | [Dacarbazine co-treated with Dinitrochlorobenzene] results in increased expression of IFNG mRNA | affects cotreatment|increases expression | 12202904 |
| D004137 | Dinitrochlorobenzene | Dinitrochlorobenzene results in increased expression of IFNG mRNA | increases expression | 18242016 19042193 11708898 10637130 18652873 |
| D004137 | Dinitrochlorobenzene | Dinitrochlorobenzene results in increased expression of IFNG protein | increases expression | 12884401 18652873 |
| D004137 | Dinitrochlorobenzene | Dinitrochlorobenzene results in increased secretion of IFNG protein | increases secretion | 15588915 |
| D004139 | Dinitrofluorobenzene | Dinitrofluorobenzene results in increased expression of IFNG mRNA | increases expression | 11244134 11243917 |
| D004139 | Dinitrofluorobenzene | Dinitrofluorobenzene results in increased expression of IFNG protein | increases expression | 11244134 |
| D004139 | Dinitrofluorobenzene | Dinitrofluorobenzene results in increased expression of IFNG protein | increases expression | 11418644 |
| D004178 | Diquat | Diquat promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased metabolism of Nitric Oxide] | affects cotreatment|increases metabolic processing|increases reaction | 11498278 |
| D004050 | Ditiocarb | Ditiocarb inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased metabolism of Nitric Oxide] | affects cotreatment|decreases reaction|increases metabolic processing | 11498278 |
| D004237 | Diuron | Diuron results in decreased expression of IFNG protein | decreases expression | 10883730 |
| C025034 | doxifluridine | [IFNG protein results in increased expression of TYMP protein] which results in increased susceptibility to doxifluridine | increases expression|increases response to substance | 15301717 |
| D004317 | Doxorubicin | Doxorubicin affects the expression of IFNG protein | affects expression | 17634555 |
| D004317 | Doxorubicin | IFNG gene mutant form inhibits the reaction [TNF protein modified form results in increased susceptibility to Doxorubicin] | decreases reaction|increases response to substance | 15466213 |
| D004365 | Drugs, Chinese Herbal | Drugs, Chinese Herbal inhibits the reaction [bisphenol A results in increased expression of IFNG mRNA] | decreases reaction|increases expression | 19415476 |
| D004365 | Drugs, Chinese Herbal | Drugs, Chinese Herbal results in increased secretion of IFNG protein | increases secretion | 15894585 |
| D004365 | Drugs, Chinese Herbal | Drugs, Chinese Herbal affects the expression of IFNG protein | affects expression | 16316537 |
| D004365 | Drugs, Chinese Herbal | Drugs, Chinese Herbal results in decreased expression of IFNG protein | decreases expression | 15504547 |
| D004391 | Dust | Dust results in increased expression of IFNG protein | increases expression | 17805423 |
| D004394 | Dydrogesterone | Dydrogesterone results in decreased expression of IFNG protein | decreases expression | 16045524 |
| D004394 | Dydrogesterone | Mifepristone inhibits the reaction [Dydrogesterone results in decreased expression of IFNG protein] | decreases expression|decreases reaction | 16045524 |
| C042986 | ebselen | ebselen inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mRNA] | affects cotreatment|decreases reaction|increases expression | 12794164 |
| C042986 | ebselen | ebselen inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 protein] | affects cotreatment|decreases reaction|increases expression | 12794164 |
| D004737 | Enflurane | Enflurane results in increased expression of IFNG mRNA | increases expression | 10422944 |
| C031818 | enterotoxin B, staphylococcal | enterotoxin B, staphylococcal results in increased expression of IFNG protein | increases expression | 12496413 |
| C031818 | enterotoxin B, staphylococcal | enterotoxin B, staphylococcal results in increased expression of IFNG mRNA | increases expression | 16368982 |
| C031818 | enterotoxin B, staphylococcal | enterotoxin B, staphylococcal results in increased secretion of IFNG protein | increases secretion | 16368982 |
| C045651 | epigallocatechin gallate | epigallocatechin gallate inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mRNA] | affects cotreatment|decreases reaction|increases expression | 12794164 |
| C045651 | epigallocatechin gallate | epigallocatechin gallate inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 protein] | affects cotreatment|decreases reaction|increases expression | 12794164 |
| D004852 | Epoxy Compounds | Epoxy Compounds results in increased expression of IFNG protein | increases expression | 12504350 |
| D004958 | Estradiol | Estradiol affects the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of and results in increased secretion of IFNG protein] | affects cotreatment|affects reaction|increases expression|increases secretion | 16716911 |
| D004958 | Estradiol | Estradiol affects the secretion of IFNG protein | affects secretion | 12538720 |
| D004966 | Estrogens, Conjugated (USP) | [Estrogens, Conjugated (USP) co-treated with Medroxyprogesterone Acetate] results in decreased secretion of IFNG protein | affects cotreatment|decreases secretion | 16236362 |
| D000431 | Ethanol | Ethanol inhibits the reaction [IFNG protein results in increased activity of STAT1 protein] | decreases reaction|increases activity | 18166357 |
| D000431 | Ethanol | Ethanol results in decreased expression of IFNG protein | decreases expression | 18166357 |
| D000431 | Ethanol | Ethanol results in increased expression of IFNG protein | increases expression | 16374292 |
| D004997 | Ethinyl Estradiol | Ethinyl Estradiol affects the expression of IFNG mRNA | affects expression | 15885639 |
| D004997 | Ethinyl Estradiol | Ethinyl Estradiol affects the secretion of IFNG protein | affects secretion | 12538720 |
| D004997 | Ethinyl Estradiol | Ethinyl Estradiol results in decreased secretion of IFNG protein | decreases secretion | 15885639 |
| C039614 | ethylisopropylamiloride | ethylisopropylamiloride inhibits the reaction [[lipopolysaccharide, E coli O55-B5 co-treated with IFNG protein] results in increased secretion of IL12B protein] | affects cotreatment|decreases reaction|increases secretion | 11420121 |
| D015025 | Zearalenone | [Zearalenone co-treated with deoxynivalenol] results in decreased expression of IFNG mRNA | affects cotreatment|decreases expression | 18296887 |
| D015525 | Fatty Acids, Omega-3 | Fatty Acids, Omega-3 results in decreased expression of IFNG mRNA | decreases expression | 10065739 |
| D015525 | Fatty Acids, Omega-3 | Fatty Acids, Omega-3 results in decreased expression of IFNG protein | decreases expression | 10065739 |
| C052498 | FEC protocol | FEC protocol results in increased expression of IFNG protein | increases expression | 18488220 |
| C039537 | FK 565 | [FK 565 co-treated with Lipid A] results in increased expression of IFNG mRNA | affects cotreatment|increases expression | 16299289 |
| C039537 | FK 565 | [FK 565 co-treated with Lipid A] results in increased expression of IFNG protein | affects cotreatment|increases expression | 16299289 |
| D015073 | 2-Acetylaminofluorene | 2-Acetylaminofluorene inhibits the reaction [[Diethylnitrosamine co-treated with Methylnitrosourea co-treated with Butylhydroxybutylnitrosamine co-treated with diisopropanolnitrosamine co-treated with 1,2-Dimethylhydrazine] results in decreased expression of IFNG protein] | affects cotreatment|decreases expression|decreases reaction | 14736494 |
| D005472 | Fluorouracil | Fluorouracil promotes the reaction [IL18 protein modified form results in increased expression of IFNG protein] | increases expression|increases reaction | 15162350 |
| D005472 | Fluorouracil | IFNG protein inhibits the reaction [GADD45B protein results in decreased susceptibility to Fluorouracil] | decreases reaction|decreases response to substance | 17711513 |
| D005472 | Fluorouracil | IFNG protein results in increased abundance of Fluorouracil | increases abundance | 16568373 |
| D005472 | Fluorouracil | [IFNG protein results in increased expression of TYMP protein] which results in increased susceptibility to Fluorouracil | increases expression|increases response to substance | 15301717 |
| D005472 | Fluorouracil | Fluorouracil results in decreased expression of IFNG protein | decreases expression | 15754409 |
| D005557 | Formaldehyde | Formaldehyde results in increased expression of and results in increased secretion of IFNG protein | increases expression|increases secretion | 18082304 |
| D005557 | Formaldehyde | Formaldehyde results in increased expression of IFNG protein | increases expression | 19042193 |
| D005576 | Forskolin | Forskolin inhibits the reaction [IFNG protein promotes the reaction [decitabine results in increased expression of PLA2G2A protein]] | decreases reaction|increases expression|increases reaction | 18953428 |
| D005609 | Free Radicals | 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [Manganese promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Free Radicals]] | affects cotreatment|decreases reaction|increases abundance|increases reaction | 16488514 |
| D005609 | Free Radicals | [Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Free Radicals | affects cotreatment|increases abundance | 16488514 |
| D005609 | Free Radicals | Manganese promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Free Radicals] | affects cotreatment|increases abundance|increases reaction | 16488514 |
| D005620 | Freund's Adjuvant | Freund's Adjuvant inhibits the reaction [Urethane results in decreased expression of IFNG mRNA] | decreases expression|decreases reaction | 12810352 |
| C492995 | fumigaclavine C | fumigaclavine C results in decreased expression of IFNG mRNA | decreases expression | 16023606 |
| C492995 | fumigaclavine C | fumigaclavine C results in decreased expression of IFNG protein | decreases expression | 16023606 |
| D005688 | Galactosamine | cobaltiprotoporphyrin inhibits the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in increased expression of IFNG mRNA] | affects cotreatment|decreases reaction|increases expression | 15486963 |
| D005688 | Galactosamine | cobaltiprotoporphyrin inhibits the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in increased expression of IFNG protein] | affects cotreatment|decreases reaction|increases expression | 15486963 |
| D005688 | Galactosamine | [Lipopolysaccharides co-treated with Galactosamine] results in increased expression of IFNG mRNA | affects cotreatment|increases expression | 15486963 |
| D005688 | Galactosamine | [Lipopolysaccharides co-treated with Galactosamine] results in increased expression of IFNG protein | affects cotreatment|increases expression | 15486963 |
| D005688 | Galactosamine | [Methylene Chloride co-treated with Biliverdine] inhibits the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in increased expression of IFNG protein] | affects cotreatment|decreases reaction|increases expression | 15486963 |
| C043055 | gallium arsenide | gallium arsenide results in increased expression of IFNG mRNA | increases expression | 14560044 |
| D019833 | Genistein | Genistein inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of IL8 mRNA] | affects cotreatment|decreases reaction|increases expression | 15779068 |
| D019833 | Genistein | Genistein inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of IL8 protein] | affects cotreatment|decreases reaction|increases expression | 15779068 |
| D019833 | Genistein | Genistein inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of TNF mRNA] | affects cotreatment|decreases reaction|increases expression | 15779068 |
| D019833 | Genistein | Genistein inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of TNF protein] | affects cotreatment|decreases reaction|increases expression | 15779068 |
| D019833 | Genistein | Genistein affects the expression of IFNG mRNA | affects expression | 14636701 |
| D019833 | Genistein | Genistein inhibits the reaction [IFNG protein results in increased abundance of Nitric Oxide] | decreases reaction|increases abundance | 12847270 |
| D019833 | Genistein | Genistein results in decreased secretion of IFNG protein | decreases secretion | 14636701 |
| D019833 | Genistein | Genistein inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein co-treated with TNF protein] results in increased abundance of Nitric Oxide] | affects cotreatment|decreases reaction|increases abundance | 16366677 |
| D019833 | Genistein | Genistein promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein co-treated with TNF protein] results in increased expression of SOD2 protein] | affects cotreatment|increases expression|increases reaction | 16366677 |
| C112772 | ginsenoside M1 | ginsenoside M1 results in decreased expression of IFNG mRNA | decreases expression | 15914323 |
| D005936 | Glucans | Glucans inhibits the reaction [Thioglycolates results in increased expression of IFNG protein] | decreases reaction|increases expression | 19804847 |
| D005944 | Glucosamine | Glucosamine results in decreased secretion of IFNG protein | decreases secretion | 14507305 |
| D005963 | Glucosylceramides | Glucosylceramides affects the reaction [Carbon Tetrachloride results in increased expression of IFNG protein] | affects reaction|increases expression | 17698563 |
| D005978 | Glutathione | Glutathione inhibits the reaction [15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [IFNG protein results in increased phosphorylation of and results in increased activity of JAK2 protein]] | decreases reaction|increases activity|increases phosphorylation | 12847270 |
| D005978 | Glutathione | Glutathione inhibits the reaction [15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [IFNG protein results in increased phosphorylation of STAT1 protein]] | decreases reaction|increases phosphorylation | 12847270 |
| D005978 | Glutathione | Glutathione promotes the reaction [IFNG protein results in increased phosphorylation of and results in increased activity of JAK2 protein] | increases activity|increases phosphorylation|increases reaction | 12847270 |
| D005978 | Glutathione | Glutathione promotes the reaction [IFNG protein results in increased phosphorylation of STAT1 protein] | increases phosphorylation|increases reaction | 12847270 |
| D005905 | Glyburide | Glyburide inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Nitric Oxide] | affects cotreatment|decreases reaction|increases abundance | 11907163 |
| D005905 | Glyburide | Glyburide inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of IL12B protein] | affects cotreatment|decreases reaction|increases expression | 11907163 |
| C117499 | (glycyl-glycyl)GLP-2 | (glycyl-glycyl)GLP-2 inhibits the reaction [Indomethacin results in increased expression of IFNG protein] | decreases reaction|increases expression | 10567023 |
| D012739 | Gonadal Steroid Hormones | Gonadal Steroid Hormones affects the reaction [Melatonin affects the expression of IFNG protein] | affects expression|affects reaction | 16373423 |
| C119543 | GW0072 | GW0072 inhibits the reaction [Ibuprofen inhibits the reaction [[IFNG protein co-treated with TNF protein] results in increased expression of BACE1 mRNA]] | affects cotreatment|decreases reaction|increases expression | 14586007 |
| C119543 | GW0072 | GW0072 inhibits the reaction [Indomethacin inhibits the reaction [[IFNG protein co-treated with TNF protein] results in increased expression of BACE1 mRNA]] | affects cotreatment|decreases reaction|increases expression | 14586007 |
| C120099 | GW 1929 | GW 1929 inhibits the reaction [IFNG protein results in increased expression of IRF1 mRNA] | decreases reaction|increases expression | 12847270 |
| C120099 | GW 1929 | GW 1929 inhibits the reaction [IFNG protein results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 12847270 |
| C120099 | GW 1929 | GW 1929 inhibits the reaction [[IFNG protein results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide] | decreases reaction|increases chemical synthesis|increases expression | 12847270 |
| D006221 | Halothane | Halothane results in increased expression of IFNG mRNA | increases expression | 10422944 |
| C020754 | herbimycin | herbimycin inhibits the reaction [IFNG protein results in increased expression of ICAM1 mRNA] | decreases reaction|increases expression | 12044887 |
| C020754 | herbimycin | herbimycin inhibits the reaction [IFNG protein results in increased expression of ICAM1 protein] | decreases reaction|increases expression | 12044887 |
| D007975 | Leukotriene B4 | [Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Leukotriene B4 | affects cotreatment|increases abundance | 15177302 |
| D007975 | Leukotriene B4 | Mangifera indica extract inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Leukotriene B4] | affects cotreatment|decreases reaction|increases abundance | 15177302 |
| D007975 | Leukotriene B4 | mangiferin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Leukotriene B4] | affects cotreatment|decreases reaction|increases abundance | 15177302 |
| D006581 | Hexachlorobenzene | Hexachlorobenzene results in decreased expression of IFNG protein | decreases expression | 15319175 11266329 |
| D006581 | Hexachlorobenzene | Hexachlorobenzene affects the expression of IFNG mRNA | affects expression | 11119253 |
| D006581 | Hexachlorobenzene | Hexachlorobenzene results in increased expression of IFNG mRNA | increases expression | 9465272 |
| D006632 | Histamine | Cimetidine inhibits the reaction [Histamine inhibits the reaction [Lipopolysaccharides results in increased expression of IFNG protein]] | decreases reaction|increases expression | 10569698 |
| D006632 | Histamine | [Histamine binds to and results in increased activity of HRH2 protein] which results in decreased expression of IFNG mRNA | affects binding|decreases expression|increases activity | 10569698 |
| D006632 | Histamine | Histamine inhibits the reaction [Lipopolysaccharides results in increased expression of IFNG mRNA] | decreases reaction|increases expression | 10569698 |
| D006632 | Histamine | Histamine inhibits the reaction [Lipopolysaccharides results in increased expression of IFNG protein] | decreases reaction|increases expression | 10569698 |
| D006632 | Histamine | HRH2 protein promotes the reaction [Histamine inhibits the reaction [Lipopolysaccharides results in increased expression of IFNG mRNA]] | decreases reaction|increases expression|increases reaction | 10569698 |
| D006632 | Histamine | HRH2 protein promotes the reaction [Histamine inhibits the reaction [Lipopolysaccharides results in increased expression of IFNG protein]] | decreases reaction|increases expression|increases reaction | 10569698 |
| D006632 | Histamine | Ranitidine inhibits the reaction [Histamine inhibits the reaction [Lipopolysaccharides results in increased expression of IFNG protein]] | decreases reaction|increases expression | 10569698 |
| D006861 | Hydrogen Peroxide | Hydrogen Peroxide inhibits the reaction [IFNG protein affects the localization of STAT1 protein] | affects localization|decreases reaction | 15748169 |
| D006861 | Hydrogen Peroxide | Hydrogen Peroxide inhibits the reaction [IFNG protein results in increased phosphorylation of and results in increased activity of STAT1 protein] | decreases reaction|increases activity|increases phosphorylation | 15748169 |
| D006861 | Hydrogen Peroxide | Hydrogen Peroxide inhibits the reaction [IFNG protein results in increased phosphorylation of and results in increased activity of JAK2 protein] | decreases reaction|increases activity|increases phosphorylation | 12847270 |
| D006861 | Hydrogen Peroxide | Hydrogen Peroxide inhibits the reaction [IFNG protein results in increased phosphorylation of STAT1 protein] | decreases reaction|increases phosphorylation | 12847270 |
| D006861 | Hydrogen Peroxide | Hydrogen Peroxide promotes the reaction [15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [IFNG protein results in increased phosphorylation of STAT1 protein]] | decreases reaction|increases phosphorylation|increases reaction | 12847270 |
| C038366 | ibudilast | ibudilast results in decreased expression of IFNG protein | decreases expression | 14664469 |
| D007052 | Ibuprofen | GW0072 inhibits the reaction [Ibuprofen inhibits the reaction [[IFNG protein co-treated with TNF protein] results in increased expression of BACE1 mRNA]] | affects cotreatment|decreases reaction|increases expression | 14586007 |
| D007052 | Ibuprofen | Ibuprofen inhibits the reaction [[IFNG protein co-treated with IL1B protein] results in increased metabolism of and results in increased secretion of APP protein alternative form] | affects cotreatment|decreases reaction|increases metabolic processing|increases secretion | 14586007 |
| D007052 | Ibuprofen | Ibuprofen inhibits the reaction [[IFNG protein co-treated with TNF protein] results in increased expression of and results in increased activity of BACE1 protein] | affects cotreatment|decreases reaction|increases activity|increases expression | 14586007 |
| D007052 | Ibuprofen | Ibuprofen inhibits the reaction [[IFNG protein co-treated with TNF protein] results in increased expression of BACE1 mRNA] | affects cotreatment|decreases reaction|increases expression | 14586007 |
| D007052 | Ibuprofen | Ibuprofen inhibits the reaction [[IFNG protein co-treated with TNF protein] results in increased metabolism of and results in increased secretion of APP protein alternative form] | affects cotreatment|decreases reaction|increases metabolic processing|increases secretion | 14586007 |
| D007052 | Ibuprofen | Ibuprofen analog results in decreased secretion of IFNG protein | decreases secretion | 17630191 |
| D007052 | Ibuprofen | Ibuprofen inhibits the reaction [[APP protein co-treated with IFNG protein] results in increased abundance of Nitric Oxide] | affects cotreatment|decreases reaction|increases abundance | 11080519 |
| D007052 | Ibuprofen | Ibuprofen inhibits the reaction [[APP protein co-treated with IFNG protein] results in increased expression of NOS2 mRNA] | affects cotreatment|decreases reaction|increases expression | 11080519 |
| D007052 | Ibuprofen | Ibuprofen inhibits the reaction [[TNF protein co-treated with IFNG protein] results in decreased expression of PPARG mRNA] | affects cotreatment|decreases expression|decreases reaction | 16407166 |
| D007052 | Ibuprofen | Ibuprofen results in decreased secretion of IFNG protein | decreases secretion | 17630191 |
| C056493 | imiquimod | imiquimod results in increased expression of IFNG | increases expression | 16368197 |
| C027185 | indirubin | indirubin results in decreased expression of IFNG protein | decreases expression | 11134660 |
| C027185 | indirubin | indirubin results in decreased expression of IFNG protein | decreases expression | 11134660 |
| D007213 | Indomethacin | GW0072 inhibits the reaction [Indomethacin inhibits the reaction [[IFNG protein co-treated with TNF protein] results in increased expression of BACE1 mRNA]] | affects cotreatment|decreases reaction|increases expression | 14586007 |
| D007213 | Indomethacin | Indomethacin inhibits the reaction [[IFNG protein co-treated with TNF protein] results in increased metabolism of and results in increased secretion of APP protein alternative form] | affects cotreatment|decreases reaction|increases metabolic processing|increases secretion | 14586007 |
| D007213 | Indomethacin | Indomethacin inhibits the reaction [[TNF protein co-treated with IFNG protein] results in decreased expression of PPARG mRNA] | affects cotreatment|decreases expression|decreases reaction | 16407166 |
| D007213 | Indomethacin | (glycyl-glycyl)GLP-2 inhibits the reaction [Indomethacin results in increased expression of IFNG protein] | decreases reaction|increases expression | 10567023 |
| D007213 | Indomethacin | Indomethacin affects the expression of IFNG protein | affects expression | 12228301 |
| D007213 | Indomethacin | Indomethacin inhibits the reaction [[APP protein co-treated with IFNG protein] results in increased abundance of Nitric Oxide] | affects cotreatment|decreases reaction|increases abundance | 11080519 |
| D007213 | Indomethacin | Indomethacin inhibits the reaction [[APP protein co-treated with IFNG protein] results in increased expression of NOS2 mRNA] | affects cotreatment|decreases reaction|increases expression | 11080519 |
| D007213 | Indomethacin | Indomethacin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Dinoprostone] | affects cotreatment|decreases reaction|increases abundance | 15177302 16716910 |
| D007213 | Indomethacin | Indomethacin results in increased expression of IFNG protein | increases expression | 11703811 |
| D007213 | Indomethacin | Indomethacin inhibits the reaction [[IFNG protein co-treated with Lipopolysaccharides] results in increased abundance of Dinoprostone] | affects cotreatment|decreases reaction|increases abundance | 12911628 |
| D007213 | Indomethacin | Indomethacin inhibits the reaction [[IFNG protein co-treated with Lipopolysaccharides] results in increased abundance of Nitric Oxide] | affects cotreatment|decreases reaction|increases abundance | 12911628 |
| D015759 | Ionomycin | Aspirin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased secretion of IFNG protein] | affects cotreatment|decreases reaction|increases secretion | 15379866 |
| D015759 | Ionomycin | resveratrol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of IFNG protein] | affects cotreatment|decreases reaction|increases expression | 16154495 |
| D015759 | Ionomycin | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of IFNG protein | affects cotreatment|increases expression | 15358692 16154495 17572062 |
| D015759 | Ionomycin | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased secretion of IFNG protein | affects cotreatment|increases secretion | 15379866 |
| D015759 | Ionomycin | Estradiol affects the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of and results in increased secretion of IFNG protein] | affects cotreatment|affects reaction|increases expression|increases secretion | 16716911 |
| D015759 | Ionomycin | resveratrol affects the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of and results in increased secretion of IFNG protein] | affects cotreatment|affects reaction|increases expression|increases secretion | 16716911 |
| D015759 | Ionomycin | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of and results in increased secretion of IFNG protein | affects cotreatment|increases expression|increases secretion | 16716911 |
| C051890 | irinotecan | irinotecan results in increased expression of IFNG protein | increases expression | 16815871 |
| C051890 | irinotecan | Thalidomide inhibits the reaction [irinotecan results in increased expression of IFNG protein] | decreases reaction|increases expression | 16815871 |
| C051890 | irinotecan | Thalidomide promotes the reaction [irinotecan results in increased expression of IFNG protein] | increases expression|increases reaction | 16815871 |
| D007501 | Iron | Iron affects the reaction [[IL12A protein binds to IL12B protein] which results in increased secretion of IFNG protein] | affects binding|affects reaction|increases secretion | 15799959 |
| D007501 | Iron | Iron affects the reaction [IL18 protein results in increased secretion of IFNG protein] | affects reaction|increases secretion | 15799959 |
| D007502 | Iron Chelating Agents | Iron Chelating Agents analog inhibits the reaction [[IL12A protein binds to IL12B protein] which results in increased secretion of IFNG protein] | affects binding|decreases reaction|increases secretion | 15799959 |
| D007502 | Iron Chelating Agents | Iron Chelating Agents analog inhibits the reaction [IL18 protein results in increased secretion of IFNG protein] | decreases reaction|increases secretion | 15799959 |
| D017953 | Isocyanates | Isocyanates analog results in increased expression of IFNG protein | increases expression | 19111005 |
| C004809 | isopentenyl pyrophosphate | Calcitriol inhibits the reaction [isopentenyl pyrophosphate results in increased expression of IFNG protein] | decreases reaction|increases expression | 15879110 |
| C004809 | isopentenyl pyrophosphate | isopentenyl pyrophosphate results in increased expression of IFNG protein | increases expression | 15879110 |
| D007854 | Lead | Lead results in decreased expression of IFNG protein | decreases expression | 17164472 |
| D001556 | Lindane | Lindane results in decreased expression of IFNG protein | decreases expression | 15319175 |
| D008050 | Lipid A | [Acetylmuramyl-Alanyl-Isoglutamine co-treated with Lipid A] results in increased expression of IFNG mRNA | affects cotreatment|increases expression | 16299289 |
| D008050 | Lipid A | [Acetylmuramyl-Alanyl-Isoglutamine co-treated with Lipid A] results in increased expression of IFNG protein | affects cotreatment|increases expression | 16299289 |
| D008050 | Lipid A | [FK 565 co-treated with Lipid A] results in increased expression of IFNG mRNA | affects cotreatment|increases expression | 16299289 |
| D008050 | Lipid A | [FK 565 co-treated with Lipid A] results in increased expression of IFNG protein | affects cotreatment|increases expression | 16299289 |
| D008050 | Lipid A | Lipid A results in increased expression of IFNG mRNA | increases expression | 16299289 |
| D008050 | Lipid A | Lipid A results in increased expression of IFNG protein | increases expression | 16299289 |
| C482199 | lipopolysaccharide, E coli O55-B5 | 5-dimethylamiloride inhibits the reaction [[lipopolysaccharide, E coli O55-B5 co-treated with IFNG protein] results in increased secretion of IL12B protein] | affects cotreatment|decreases reaction|increases secretion | 11420121 |
| C482199 | lipopolysaccharide, E coli O55-B5 | 5-(N-methyl-N-isobutyl)amiloride inhibits the reaction [[lipopolysaccharide, E coli O55-B5 co-treated with IFNG protein] results in increased secretion of IL12B protein] | affects cotreatment|decreases reaction|increases secretion | 11420121 |
| C482199 | lipopolysaccharide, E coli O55-B5 | Amiloride inhibits the reaction [[lipopolysaccharide, E coli O55-B5 co-treated with IFNG protein] results in increased secretion of IL12B protein] | affects cotreatment|decreases reaction|increases secretion | 11420121 |
| C482199 | lipopolysaccharide, E coli O55-B5 | benzamil inhibits the reaction [[lipopolysaccharide, E coli O55-B5 co-treated with IFNG protein] results in increased secretion of IL12B protein] | affects cotreatment|decreases reaction|increases secretion | 11420121 |
| C482199 | lipopolysaccharide, E coli O55-B5 | ethylisopropylamiloride inhibits the reaction [[lipopolysaccharide, E coli O55-B5 co-treated with IFNG protein] results in increased secretion of IL12B protein] | affects cotreatment|decreases reaction|increases secretion | 11420121 |
| C482199 | lipopolysaccharide, E coli O55-B5 | IFNG protein promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of NOS2 mRNA] | increases expression|increases reaction | 10868913 |
| C482199 | lipopolysaccharide, E coli O55-B5 | IFNG protein promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of SPP1 mRNA] | increases expression|increases reaction | 10868913 |
| C482199 | lipopolysaccharide, E coli O55-B5 | [lipopolysaccharide, E coli O55-B5 co-treated with IFNG protein] results in increased expression of IL12B mRNA | affects cotreatment|increases expression | 11420121 |
| C482199 | lipopolysaccharide, E coli O55-B5 | [lipopolysaccharide, E coli O55-B5 co-treated with IFNG protein] results in increased phosphorylation of MAPK1 protein | affects cotreatment|increases phosphorylation | 11420121 |
| C482199 | lipopolysaccharide, E coli O55-B5 | [lipopolysaccharide, E coli O55-B5 co-treated with IFNG protein] results in increased phosphorylation of MAPK3 protein | affects cotreatment|increases phosphorylation | 11420121 |
| C482199 | lipopolysaccharide, E coli O55-B5 | [lipopolysaccharide, E coli O55-B5 co-treated with IFNG protein] results in increased secretion of IL12B protein | affects cotreatment|increases secretion | 11420121 |
| C482199 | lipopolysaccharide, E coli O55-B5 | lipopolysaccharide, E coli O55-B5 results in increased expression of IFNG mRNA | increases expression | 9328138 |
| C482199 | lipopolysaccharide, E coli O55-B5 | SPP1 protein inhibits the reaction [IFNG protein promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of NOS2 mRNA]] | decreases reaction|increases expression|increases reaction | 10868913 |
| C482199 | lipopolysaccharide, E coli O55-B5 | Thiourea analog inhibits the reaction [IFNG protein promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of SPP1 mRNA]] | decreases reaction|increases expression|increases reaction | 10868913 |
| C440499 | lipopolysaccharide, Escherichia coli 0111 B4 | Dexamethasone inhibits the reaction [[lipopolysaccharide, Escherichia coli 0111 B4 co-treated with IFNG protein] results in increased expression of NOS2 mRNA] | affects cotreatment|decreases reaction|increases expression | 12694877 |
| C440499 | lipopolysaccharide, Escherichia coli 0111 B4 | lipopolysaccharide, Escherichia coli 0111 B4 results in increased expression of IFNG mRNA | increases expression | 12954792 |
| C440499 | lipopolysaccharide, Escherichia coli 0111 B4 | mangiferin inhibits the reaction [[lipopolysaccharide, Escherichia coli 0111 B4 co-treated with IFNG protein] results in increased expression of NOS2 mRNA] | affects cotreatment|decreases reaction|increases expression | 12694877 |
| C440499 | lipopolysaccharide, Escherichia coli 0111 B4 | phenylmethylpyrazolone inhibits the reaction [lipopolysaccharide, Escherichia coli 0111 B4 results in increased expression of IFNG mRNA] | decreases reaction|increases expression | 12954792 |
| D008070 | Lipopolysaccharides | IFNG protein inhibits the reaction [Lipopolysaccharides results in increased secretion of IL10 protein] | decreases reaction|increases secretion | 14678198 |
| D008070 | Lipopolysaccharides | 3,3',4,5'-tetrahydroxystilbene inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of IL8 mRNA] | affects cotreatment|decreases reaction|increases expression | 15779068 |
| D008070 | Lipopolysaccharides | 3,3',4,5'-tetrahydroxystilbene inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of IL8 protein] | affects cotreatment|decreases reaction|increases expression | 15779068 |
| D008070 | Lipopolysaccharides | 3,3',4,5'-tetrahydroxystilbene inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of TNF mRNA] | affects cotreatment|decreases reaction|increases expression | 15779068 |
| D008070 | Lipopolysaccharides | 3,3',4,5'-tetrahydroxystilbene inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of TNF protein] | affects cotreatment|decreases reaction|increases expression | 15779068 |
| D008070 | Lipopolysaccharides | Aspirin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased secretion of [IL12A protein binds to IL12B protein]] | affects binding|affects cotreatment|decreases reaction|increases secretion | 15379866 |
| D008070 | Lipopolysaccharides | Cimetidine inhibits the reaction [Histamine inhibits the reaction [Lipopolysaccharides results in increased expression of IFNG protein]] | decreases reaction|increases expression | 10569698 |
| D008070 | Lipopolysaccharides | Genistein inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of IL8 mRNA] | affects cotreatment|decreases reaction|increases expression | 15779068 |
| D008070 | Lipopolysaccharides | Genistein inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of IL8 protein] | affects cotreatment|decreases reaction|increases expression | 15779068 |
| D008070 | Lipopolysaccharides | Genistein inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of TNF mRNA] | affects cotreatment|decreases reaction|increases expression | 15779068 |
| D008070 | Lipopolysaccharides | Genistein inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of TNF protein] | affects cotreatment|decreases reaction|increases expression | 15779068 |
| D008070 | Lipopolysaccharides | Histamine inhibits the reaction [Lipopolysaccharides results in increased expression of IFNG mRNA] | decreases reaction|increases expression | 10569698 |
| D008070 | Lipopolysaccharides | Histamine inhibits the reaction [Lipopolysaccharides results in increased expression of IFNG protein] | decreases reaction|increases expression | 10569698 |
| D008070 | Lipopolysaccharides | HRH2 protein promotes the reaction [Histamine inhibits the reaction [Lipopolysaccharides results in increased expression of IFNG mRNA]] | decreases reaction|increases expression|increases reaction | 10569698 |
| D008070 | Lipopolysaccharides | HRH2 protein promotes the reaction [Histamine inhibits the reaction [Lipopolysaccharides results in increased expression of IFNG protein]] | decreases reaction|increases expression|increases reaction | 10569698 |
| D008070 | Lipopolysaccharides | [IFNG protein co-treated with Lipopolysaccharides] inhibits the reaction [Terbutaline results in increased secretion of REN protein] | affects cotreatment|decreases reaction|increases secretion | 9256163 |
| D008070 | Lipopolysaccharides | [IFNG protein co-treated with Lipopolysaccharides] results in increased expression of NOS2A mRNA | affects cotreatment|increases expression | 16380391 |
| D008070 | Lipopolysaccharides | IFNG protein inhibits the reaction [Lipopolysaccharides results in increased expression of IL10 protein] | decreases reaction|increases expression | 16713974 |
| D008070 | Lipopolysaccharides | IL18 protein promotes the reaction [Lipopolysaccharides results in increased expression of IFNG mRNA] | increases expression|increases reaction | 17399992 |
| D008070 | Lipopolysaccharides | IL18 protein promotes the reaction [Lipopolysaccharides results in increased expression of IFNG protein] | increases expression|increases reaction | 17399992 |
| D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with IFNG protein] results in increased expression of IL1A mRNA | affects cotreatment|increases expression | 15779068 |
| D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with IFNG protein] results in increased expression of IL1A protein | affects cotreatment|increases expression | 15779068 |
| D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with IFNG protein] results in increased expression of IL6 mRNA | affects cotreatment|increases expression | 15779068 |
| D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with IFNG protein] results in increased expression of IL6 protein | affects cotreatment|increases expression | 15779068 |
| D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with IFNG protein] results in increased expression of IL8 mRNA | affects cotreatment|increases expression | 15779068 |
| D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with IFNG protein] results in increased expression of IL8 protein | affects cotreatment|increases expression | 15779068 |
| D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with IFNG protein] results in increased expression of PTGES2 protein | affects cotreatment|increases expression | 15779068 |
| D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with IFNG protein] results in increased expression of PTGS2 mRNA | affects cotreatment|increases expression | 15779068 |
| D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with IFNG protein] results in increased expression of PTGS2 protein | affects cotreatment|increases expression | 15779068 |
| D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with IFNG protein] results in increased expression of TNF mRNA | affects cotreatment|increases expression | 15779068 |
| D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with IFNG protein] results in increased expression of TNF protein | affects cotreatment|increases expression | 15779068 |
| D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with IFNG protein] results in increased secretion of [IL12A protein binds to IL12B protein] | affects binding|affects cotreatment|increases secretion | 15379866 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased expression of IFNG mRNA | increases expression | 10569698 17399992 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased expression of IFNG protein | increases expression | 10569698 19020770 15358692 17399992 |
| D008070 | Lipopolysaccharides | Ranitidine inhibits the reaction [Histamine inhibits the reaction [Lipopolysaccharides results in increased expression of IFNG protein]] | decreases reaction|increases expression | 10569698 |
| D008070 | Lipopolysaccharides | resveratrol inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of IL8 mRNA] | affects cotreatment|decreases reaction|increases expression | 15779068 |
| D008070 | Lipopolysaccharides | resveratrol inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of IL8 protein] | affects cotreatment|decreases reaction|increases expression | 15779068 |
| D008070 | Lipopolysaccharides | resveratrol inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of PTGES2 protein] | affects cotreatment|decreases reaction|increases expression | 15779068 |
| D008070 | Lipopolysaccharides | resveratrol inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of TNF mRNA] | affects cotreatment|decreases reaction|increases expression | 15779068 |
| D008070 | Lipopolysaccharides | resveratrol inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of TNF protein] | affects cotreatment|decreases reaction|increases expression | 15779068 |
| D008070 | Lipopolysaccharides | 1-(beta-naphthylmethyl)-6,7-dihydroxy-1,2,3,4-tetra-hydroisoquinoline inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased activity of RELA protein] | affects cotreatment|decreases reaction|increases activity | 11961057 |
| D008070 | Lipopolysaccharides | 1-(beta-naphthylmethyl)-6,7-dihydroxy-1,2,3,4-tetra-hydroisoquinoline inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mRNA] | affects cotreatment|decreases reaction|increases expression | 11961057 |
| D008070 | Lipopolysaccharides | 1-naphthylethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mRNA] | affects cotreatment|decreases reaction|increases expression | 12527339 |
| D008070 | Lipopolysaccharides | 1-naphthylethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of TNF mRNA] | affects cotreatment|decreases reaction|increases expression | 12527339 |
| D008070 | Lipopolysaccharides | 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of IL12B protein] | affects cotreatment|decreases reaction|increases expression | 11907163 |
| D008070 | Lipopolysaccharides | 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Lipopolysaccharides results in increased expression of IFNG mRNA] | decreases reaction|increases expression | 16880258 |
| D008070 | Lipopolysaccharides | Carbon Monoxide inhibits the reaction [IFNG protein promotes the reaction [Lipopolysaccharides results in increased expression of IL12B protein]] | decreases reaction|increases expression|increases reaction | 16365149 |
| D008070 | Lipopolysaccharides | chlorophyllin inhibits the reaction [Lipopolysaccharides results in increased expression of IFNG mRNA] | decreases reaction|increases expression | 16275627 |
| D008070 | Lipopolysaccharides | Cholera Toxin inhibits the reaction [Lipopolysaccharides results in increased expression of IFNG protein] | decreases reaction|increases expression | 9927516 |
| D008070 | Lipopolysaccharides | cobaltiprotoporphyrin inhibits the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in increased expression of IFNG mRNA] | affects cotreatment|decreases reaction|increases expression | 15486963 |
| D008070 | Lipopolysaccharides | cobaltiprotoporphyrin inhibits the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in increased expression of IFNG protein] | affects cotreatment|decreases reaction|increases expression | 15486963 |
| D008070 | Lipopolysaccharides | deoxynivalenol promotes the reaction [Lipopolysaccharides results in increased expression of IFNG mRNA] | increases expression|increases reaction | 14644621 |
| D008070 | Lipopolysaccharides | Dexamethasone inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mRNA] | affects cotreatment|decreases reaction|increases expression | 12794164 |
| D008070 | Lipopolysaccharides | Dexamethasone inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 protein] | affects cotreatment|decreases reaction|increases expression | 12794164 |
| D008070 | Lipopolysaccharides | Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased expression of IFNG mRNA] | decreases reaction|increases expression | 16880258 |
| D008070 | Lipopolysaccharides | Diquat promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased metabolism of Nitric Oxide] | affects cotreatment|increases metabolic processing|increases reaction | 11498278 |
| D008070 | Lipopolysaccharides | Ditiocarb inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased metabolism of Nitric Oxide] | affects cotreatment|decreases reaction|increases metabolic processing | 11498278 |
| D008070 | Lipopolysaccharides | DUSP1 gene mutant form inhibits the reaction [Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased expression of IFNG mRNA]] | decreases reaction|increases expression | 16880258 |
| D008070 | Lipopolysaccharides | ebselen inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mRNA] | affects cotreatment|decreases reaction|increases expression | 12794164 |
| D008070 | Lipopolysaccharides | ebselen inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 protein] | affects cotreatment|decreases reaction|increases expression | 12794164 |
| D008070 | Lipopolysaccharides | epigallocatechin gallate inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mRNA] | affects cotreatment|decreases reaction|increases expression | 12794164 |
| D008070 | Lipopolysaccharides | epigallocatechin gallate inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 protein] | affects cotreatment|decreases reaction|increases expression | 12794164 |
| D008070 | Lipopolysaccharides | Glyburide inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Nitric Oxide] | affects cotreatment|decreases reaction|increases abundance | 11907163 |
| D008070 | Lipopolysaccharides | Glyburide inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of IL12B protein] | affects cotreatment|decreases reaction|increases expression | 11907163 |
| D008070 | Lipopolysaccharides | GPX1 protein affects the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased metabolism of Nitric Oxide] | affects cotreatment|affects reaction|increases metabolic processing | 11498278 |
| D008070 | Lipopolysaccharides | IFNG protein affects the reaction [Lipopolysaccharides results in increased expression of IL12A mRNA] | affects reaction|increases expression | 10415056 |
| D008070 | Lipopolysaccharides | IFNG protein promotes the reaction [Lipopolysaccharides results in increased expression of IL12B mRNA] | increases expression|increases reaction | 10415056 |
| D008070 | Lipopolysaccharides | IFNG protein promotes the reaction [Lipopolysaccharides results in increased expression of SLC11A2 mRNA] | increases expression|increases reaction | 11054110 |
| D008070 | Lipopolysaccharides | IFNG protein promotes the reaction [Lipopolysaccharides results in increased expression of VCAM1 protein] | increases expression|increases reaction | 12892526 |
| D008070 | Lipopolysaccharides | IL12B protein affects the reaction [Lipopolysaccharides results in increased expression of IFNG mRNA] | affects reaction|increases expression | 10415056 |
| D008070 | Lipopolysaccharides | Indomethacin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Dinoprostone] | affects cotreatment|decreases reaction|increases abundance | 15177302 16716910 |
| D008070 | Lipopolysaccharides | IRF1 protein affects the reaction [IFNG protein affects the reaction [Lipopolysaccharides results in increased expression of IL12A mRNA]] | affects reaction|increases expression | 10415056 |
| D008070 | Lipopolysaccharides | IRF1 protein affects the reaction [IFNG protein promotes the reaction [Lipopolysaccharides results in increased expression of IL12B mRNA]] | affects reaction|increases expression|increases reaction | 10415056 |
| D008070 | Lipopolysaccharides | IRF2 protein affects the reaction [IFNG protein promotes the reaction [Lipopolysaccharides results in increased expression of IL12B mRNA]] | affects reaction|increases expression|increases reaction | 10415056 |
| D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with Galactosamine] results in increased expression of IFNG mRNA | affects cotreatment|increases expression | 15486963 |
| D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with Galactosamine] results in increased expression of IFNG protein | affects cotreatment|increases expression | 15486963 |
| D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with IFNG protein] results in decreased activity of IREB2 protein | affects cotreatment|decreases activity | 11054110 |
| D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with IFNG protein] results in decreased expression of TFRC mRNA | affects cotreatment|decreases expression | 11054110 |
| D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Dinoprostone | affects cotreatment|increases abundance | 15177302 16716910 |
| D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Leukotriene B4 | affects cotreatment|increases abundance | 15177302 |
| D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Nitric Oxide | affects cotreatment|increases abundance | 11907163 15177305 |
| D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with IFNG protein] results in increased activity of ACO1 protein | affects cotreatment|increases activity | 11054110 |
| D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with IFNG protein] results in increased activity of NOS2 protein | affects cotreatment|increases activity | 12892526 |
| D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with IFNG protein] results in increased expression of CCL5 protein | affects cotreatment|increases expression | 15135318 |
| D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with IFNG protein] results in increased expression of CSF2 mRNA | affects cotreatment|increases expression | 15222974 |
| D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with IFNG protein] results in increased expression of CSF2 protein | affects cotreatment|increases expression | 15135318 |
| D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with IFNG protein] results in increased expression of CSF3 protein | affects cotreatment|increases expression | 15135318 |
| D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with IFNG protein] results in increased expression of CXCL9 mRNA | affects cotreatment|increases expression | 15154616 |
| D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with IFNG protein] results in increased expression of IL12B protein | affects cotreatment|increases expression | 11907163 |
| D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with IFNG protein] results in increased expression of IL1B mRNA | affects cotreatment|increases expression | 15222974 |
| D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with IFNG protein] results in increased expression of IL6 protein | affects cotreatment|increases expression | 15135318 |
| D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with IFNG protein] results in increased expression of IRF8 mRNA | affects cotreatment|increases expression | 10415056 |
| D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mRNA | affects cotreatment|increases expression | 12794164 11054110 12694877 15222974 |
| D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 protein | affects cotreatment|increases expression | 12794164 15222974 |
| D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with IFNG protein] results in increased expression of PTGS2 mRNA | affects cotreatment|increases expression | 15222974 |
| D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with IFNG protein] results in increased expression of PTGS2 protein | affects cotreatment|increases expression | 15222974 |
| D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with IFNG protein] results in increased expression of SOD2 mRNA | affects cotreatment|increases expression | 15650415 |
| D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with IFNG protein] results in increased expression of TGFB1 mRNA | affects cotreatment|increases expression | 12694877 |
| D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with IFNG protein] results in increased expression of TNF mRNA | affects cotreatment|increases expression | 12694877 15222974 |
| D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with IFNG protein] results in increased expression of TNF protein | affects cotreatment|increases expression | 15135318 7679225 15177305 |
| D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with IFNG protein] results in increased expression of UCP2 mRNA | affects cotreatment|increases expression | 15650415 |
| D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with IFNG protein] results in increased metabolism of Nitric Oxide | affects cotreatment|increases metabolic processing | 11498278 |
| D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with IFNG protein] results in increased secretion of TNF protein | affects cotreatment|increases secretion | 15222974 |
| D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with Zymosan] results in increased expression of IFNG mRNA | affects cotreatment|increases expression | 15213630 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides promotes the reaction [IFNG protein results in increased abundance of Nitric Oxide] | increases abundance|increases reaction | 7689037 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides promotes the reaction [IFNG protein results in increased expression of NOS2 protein] | increases expression|increases reaction | 7689037 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides promotes the reaction [Propanil results in increased expression of IFNG mRNA] | increases expression|increases reaction | 7679225 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides promotes the reaction [Propanil results in increased expression of IFNG protein] | increases expression|increases reaction | 7679225 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased expression of IFNG mRNA | increases expression | 10415056 14644621 16880258 10223745 16275627 16002565 16179587 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased expression of IFNG protein | increases expression | 17321468 9927516 16179587 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased secretion of IFNG protein | increases secretion | 19339665 |
| D008070 | Lipopolysaccharides | mancozeb affects the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased secretion of TNF protein] | affects cotreatment|affects reaction|increases secretion | 15742816 |
| D008070 | Lipopolysaccharides | Mangifera indica extract inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Dinoprostone] | affects cotreatment|decreases reaction|increases abundance | 15177302 16716910 |
| D008070 | Lipopolysaccharides | Mangifera indica extract inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Leukotriene B4] | affects cotreatment|decreases reaction|increases abundance | 15177302 |
| D008070 | Lipopolysaccharides | Mangifera indica extract inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Nitric Oxide] | affects cotreatment|decreases reaction|increases abundance | 15177305 |
| D008070 | Lipopolysaccharides | Mangifera indica extract inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of CSF2 mRNA] | affects cotreatment|decreases reaction|increases expression | 15222974 |
| D008070 | Lipopolysaccharides | Mangifera indica extract inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of IL1B mRNA] | affects cotreatment|decreases reaction|increases expression | 15222974 |
| D008070 | Lipopolysaccharides | Mangifera indica extract inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mRNA] | affects cotreatment|decreases reaction|increases expression | 15222974 |
| D008070 | Lipopolysaccharides | Mangifera indica extract inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 protein] | affects cotreatment|decreases reaction|increases expression | 15222974 |
| D008070 | Lipopolysaccharides | Mangifera indica extract inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of PTGS2 mRNA] | affects cotreatment|decreases reaction|increases expression | 15222974 |
| D008070 | Lipopolysaccharides | Mangifera indica extract inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of PTGS2 protein] | affects cotreatment|decreases reaction|increases expression | 15222974 |
| D008070 | Lipopolysaccharides | Mangifera indica extract inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of TNF mRNA] | affects cotreatment|decreases reaction|increases expression | 15222974 |
| D008070 | Lipopolysaccharides | Mangifera indica extract inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of TNF protein] | affects cotreatment|decreases reaction|increases expression | 15177305 |
| D008070 | Lipopolysaccharides | Mangifera indica extract inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased secretion of TNF protein] | affects cotreatment|decreases reaction|increases secretion | 15222974 |
| D008070 | Lipopolysaccharides | mangiferin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Dinoprostone] | affects cotreatment|decreases reaction|increases abundance | 16716910 15177302 |
| D008070 | Lipopolysaccharides | mangiferin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Leukotriene B4] | affects cotreatment|decreases reaction|increases abundance | 15177302 |
| D008070 | Lipopolysaccharides | mangiferin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Nitric Oxide] | affects cotreatment|decreases reaction|increases abundance | 15177305 |
| D008070 | Lipopolysaccharides | mangiferin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of CCL5 protein] | affects cotreatment|decreases reaction|increases expression | 15135318 |
| D008070 | Lipopolysaccharides | mangiferin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of CSF2 protein] | affects cotreatment|decreases reaction|increases expression | 15135318 |
| D008070 | Lipopolysaccharides | mangiferin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of CSF3 protein] | affects cotreatment|decreases reaction|increases expression | 15135318 |
| D008070 | Lipopolysaccharides | mangiferin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of IL6 protein] | affects cotreatment|decreases reaction|increases expression | 15135318 |
| D008070 | Lipopolysaccharides | mangiferin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mRNA] | affects cotreatment|decreases reaction|increases expression | 12694877 |
| D008070 | Lipopolysaccharides | mangiferin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of TNF mRNA] | affects cotreatment|decreases reaction|increases expression | 12694877 |
| D008070 | Lipopolysaccharides | mangiferin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of TNF protein] | affects cotreatment|decreases reaction|increases expression | 15135318 |
| D008070 | Lipopolysaccharides | mangiferin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased secretion of TNF protein] | affects cotreatment|decreases reaction|increases secretion | 15222974 |
| D008070 | Lipopolysaccharides | mangiferin promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of TGFB1 mRNA] | affects cotreatment|increases expression|increases reaction | 12694877 |
| D008070 | Lipopolysaccharides | methyldithiocarbamate inhibits the reaction [Lipopolysaccharides results in increased expression of IFNG mRNA] | decreases reaction|increases expression | 15933225 |
| D008070 | Lipopolysaccharides | methyldithiocarbamate inhibits the reaction [Lipopolysaccharides results in increased secretion of IFNG protein] | decreases reaction|increases secretion | 19339665 |
| D008070 | Lipopolysaccharides | [Methylene Chloride co-treated with Biliverdine] inhibits the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in increased expression of IFNG protein] | affects cotreatment|decreases reaction|increases expression | 15486963 |
| D008070 | Lipopolysaccharides | NFKB1 gene mutant form inhibits the reaction [Ozone promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased activity of NOS2 protein]] | affects cotreatment|decreases reaction|increases activity|increases reaction | 15064226 |
| D008070 | Lipopolysaccharides | NFKB1 protein promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of CXCL9 mRNA] | affects cotreatment|increases expression|increases reaction | 15154616 |
| D008070 | Lipopolysaccharides | Ozone promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased activity of NOS2 protein] | affects cotreatment|increases activity|increases reaction | 15064226 |
| D008070 | Lipopolysaccharides | phenyl-N-tert-butylnitrone inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mRNA] | affects cotreatment|decreases reaction|increases expression | 12794164 |
| D008070 | Lipopolysaccharides | phenyl-N-tert-butylnitrone inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 protein] | affects cotreatment|decreases reaction|increases expression | 12794164 |
| D008070 | Lipopolysaccharides | pimagedine inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased activity of NOS2 protein] | affects cotreatment|decreases reaction|increases activity | 12892526 |
| D008070 | Lipopolysaccharides | pimagedine inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased metabolism of Nitric Oxide] | affects cotreatment|decreases reaction|increases metabolic processing | 11498278 |
| D008070 | Lipopolysaccharides | pimagedine inhibits the reaction [Lipopolysaccharides promotes the reaction [IFNG protein results in increased abundance of Nitric Oxide]] | decreases reaction|increases abundance|increases reaction | 7689037 |
| D008070 | Lipopolysaccharides | RELA protein affects the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of CXCL9 mRNA] | affects cotreatment|affects reaction|increases expression | 15154616 |
| D008070 | Lipopolysaccharides | Sodium Selenite inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased activity of SP1 protein] | affects cotreatment|decreases reaction|increases activity | 15650415 |
| D008070 | Lipopolysaccharides | Sodium Selenite inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of SOD2 mRNA] | affects cotreatment|decreases reaction|increases expression | 15650415 |
| D008070 | Lipopolysaccharides | Sodium Selenite inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of UCP2 mRNA] | affects cotreatment|decreases reaction|increases expression | 15650415 |
| D008070 | Lipopolysaccharides | Sulfobromophthalein inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of IL12B protein] | affects cotreatment|decreases reaction|increases expression | 11907163 |
| D008070 | Lipopolysaccharides | 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [Manganese inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Nitric Oxide]] | affects cotreatment|decreases reaction|increases abundance | 16488514 |
| D008070 | Lipopolysaccharides | 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [Manganese promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Free Radicals]] | affects cotreatment|decreases reaction|increases abundance|increases reaction | 16488514 |
| D008070 | Lipopolysaccharides | 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [Manganese promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mRNA]] | affects cotreatment|decreases reaction|increases expression|increases reaction | 16488514 |
| D008070 | Lipopolysaccharides | 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [Manganese promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of TNF mRNA]] | affects cotreatment|decreases reaction|increases expression|increases reaction | 16488514 |
| D008070 | Lipopolysaccharides | 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [Manganese promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of TNF protein]] | affects cotreatment|decreases reaction|increases expression|increases reaction | 16488514 |
| D008070 | Lipopolysaccharides | [3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol binds to and results in increased activity of CNR1 protein] inhibits the reaction [IFNG protein affects the reaction [Lipopolysaccharides results in increased abundance of Nitric Oxide]] | affects binding|affects reaction|decreases reaction|increases abundance|increases activity | 11727767 |
| D008070 | Lipopolysaccharides | [anthra(1,9-cd)pyrazol-6(2H)-one co-treated with Manganese] inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Nitric Oxide] | affects cotreatment|decreases reaction|increases abundance | 16488514 |
| D008070 | Lipopolysaccharides | anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Nitric Oxide] | affects cotreatment|decreases reaction|increases abundance | 16488514 |
| D008070 | Lipopolysaccharides | anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [Manganese promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mRNA]] | affects cotreatment|decreases reaction|increases expression|increases reaction | 16488514 |
| D008070 | Lipopolysaccharides | anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [Manganese promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of TNF protein]] | affects cotreatment|decreases reaction|increases expression|increases reaction | 16488514 |
| D008070 | Lipopolysaccharides | Genistein inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein co-treated with TNF protein] results in increased abundance of Nitric Oxide] | affects cotreatment|decreases reaction|increases abundance | 16366677 |
| D008070 | Lipopolysaccharides | Genistein promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein co-treated with TNF protein] results in increased expression of SOD2 protein] | affects cotreatment|increases expression|increases reaction | 16366677 |
| D008070 | Lipopolysaccharides | IFNG protein affects the reaction [Lipopolysaccharides results in increased abundance of Nitric Oxide] | affects reaction|increases abundance | 11727767 |
| D008070 | Lipopolysaccharides | [IFNG protein co-treated with Lipopolysaccharides] results in increased abundance of Dinoprostone | affects cotreatment|increases abundance | 12911628 |
| D008070 | Lipopolysaccharides | [IFNG protein co-treated with Lipopolysaccharides] results in increased abundance of Nitric Oxide | affects cotreatment|increases abundance | 12911628 |
| D008070 | Lipopolysaccharides | [IFNG protein co-treated with Lipopolysaccharides] results in increased expression of NOS2 protein | affects cotreatment|increases expression | 12911628 |
| D008070 | Lipopolysaccharides | [IFNG protein co-treated with Lipopolysaccharides] results in increased expression of PTGS2 protein | affects cotreatment|increases expression | 12911628 |
| D008070 | Lipopolysaccharides | Indomethacin inhibits the reaction [[IFNG protein co-treated with Lipopolysaccharides] results in increased abundance of Dinoprostone] | affects cotreatment|decreases reaction|increases abundance | 12911628 |
| D008070 | Lipopolysaccharides | Indomethacin inhibits the reaction [[IFNG protein co-treated with Lipopolysaccharides] results in increased abundance of Nitric Oxide] | affects cotreatment|decreases reaction|increases abundance | 12911628 |
| D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with IFNG protein co-treated with Manganese] results in decreased abundance of Nitric Oxide | affects cotreatment|decreases abundance | 16488514 |
| D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with IFNG protein co-treated with TNF protein] results in increased abundance of Nitric Oxide | affects cotreatment|increases abundance | 16366677 |
| D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with IFNG protein co-treated with TNF protein] results in increased abundance of Reactive Oxygen Species | affects cotreatment|increases abundance | 16366677 |
| D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with IFNG protein co-treated with TNF protein] results in increased expression of NOS2 mRNA | affects cotreatment|increases expression | 16366677 |
| D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with IFNG protein co-treated with TNF protein] results in increased expression of NOS2 protein | affects cotreatment|increases expression | 16366677 |
| D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with IFNG protein co-treated with TNF protein] results in increased expression of SOD2 protein | affects cotreatment|increases expression | 16366677 |
| D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Free Radicals | affects cotreatment|increases abundance | 16488514 |
| D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Nitric Oxide | affects cotreatment|increases abundance | 16488514 |
| D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with IFNG protein] results in increased degradation of NFKBIA protein | affects cotreatment|increases degradation | 16488514 |
| D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mRNA | affects cotreatment|increases expression | 16488514 |
| D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 protein | affects cotreatment|increases expression | 16488514 |
| D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with IFNG protein] results in increased expression of TNF mRNA | affects cotreatment|increases expression | 16488514 |
| D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with IFNG protein] results in increased expression of TNF protein | affects cotreatment|increases expression | 16488514 |
| D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with IFNG protein] results in increased phosphorylation of MAPK1 protein | affects cotreatment|increases phosphorylation | 16488514 |
| D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with IFNG protein] results in increased phosphorylation of MAPK3 protein | affects cotreatment|increases phosphorylation | 16488514 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased expression of IFNG protein | increases expression | 15629513 |
| D008070 | Lipopolysaccharides | Manganese inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Nitric Oxide] | affects cotreatment|decreases reaction|increases abundance | 16488514 |
| D008070 | Lipopolysaccharides | Manganese promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Free Radicals] | affects cotreatment|increases abundance|increases reaction | 16488514 |
| D008070 | Lipopolysaccharides | Manganese promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased degradation of NFKBIA protein] | affects cotreatment|increases degradation|increases reaction | 16488514 |
| D008070 | Lipopolysaccharides | Manganese promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mRNA] | affects cotreatment|increases expression|increases reaction | 16488514 |
| D008070 | Lipopolysaccharides | Manganese promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 protein] | affects cotreatment|increases expression|increases reaction | 16488514 |
| D008070 | Lipopolysaccharides | Manganese promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of TNF mRNA] | affects cotreatment|increases expression|increases reaction | 16488514 |
| D008070 | Lipopolysaccharides | Manganese promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of TNF protein] | affects cotreatment|increases expression|increases reaction | 16488514 |
| D008070 | Lipopolysaccharides | Manganese promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased phosphorylation of MAPK1 protein] | affects cotreatment|increases phosphorylation|increases reaction | 16488514 |
| D008070 | Lipopolysaccharides | Manganese promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased phosphorylation of MAPK3 protein] | affects cotreatment|increases phosphorylation|increases reaction | 16488514 |
| D008070 | Lipopolysaccharides | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [[IFNG protein co-treated with Lipopolysaccharides] results in increased abundance of Dinoprostone] | affects cotreatment|decreases reaction|increases abundance | 12911628 |
| D008070 | Lipopolysaccharides | nimesulide inhibits the reaction [[IFNG protein co-treated with Lipopolysaccharides] results in increased abundance of Dinoprostone] | affects cotreatment|decreases reaction|increases abundance | 12911628 |
| D008070 | Lipopolysaccharides | phenylmethylpyrazolone inhibits the reaction [Lipopolysaccharides results in increased expression of IFNG protein] | decreases reaction|increases expression | 15629513 |
| D008070 | Lipopolysaccharides | pimagedine inhibits the reaction [[IFNG protein co-treated with Lipopolysaccharides] results in increased abundance of Nitric Oxide] | affects cotreatment|decreases reaction|increases abundance | 12911628 |
| D008070 | Lipopolysaccharides | polyphenols inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein co-treated with TNF protein] results in increased abundance of Nitric Oxide] | affects cotreatment|decreases reaction|increases abundance | 16366677 |
| D008070 | Lipopolysaccharides | polyphenols inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein co-treated with TNF protein] results in increased abundance of Reactive Oxygen Species] | affects cotreatment|decreases reaction|increases abundance | 16366677 |
| D008070 | Lipopolysaccharides | polyphenols inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein co-treated with TNF protein] results in increased expression of NOS2 mRNA] | affects cotreatment|decreases reaction|increases expression | 16366677 |
| D008070 | Lipopolysaccharides | polyphenols promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein co-treated with TNF protein] results in increased expression of SOD2 protein] | affects cotreatment|increases expression|increases reaction | 16366677 |
| D008070 | Lipopolysaccharides | Quercetin promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein co-treated with TNF protein] results in increased expression of SOD2 protein] | affects cotreatment|increases expression|increases reaction | 16366677 |
| D008070 | Lipopolysaccharides | resveratrol inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein co-treated with TNF protein] results in increased abundance of Nitric Oxide] | affects cotreatment|decreases reaction|increases abundance | 16366677 |
| D008070 | Lipopolysaccharides | resveratrol inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein co-treated with TNF protein] results in increased abundance of Reactive Oxygen Species] | affects cotreatment|decreases reaction|increases abundance | 16366677 |
| D008070 | Lipopolysaccharides | resveratrol inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein co-treated with TNF protein] results in increased expression of NOS2 mRNA] | affects cotreatment|decreases reaction|increases expression | 16366677 |
| D008070 | Lipopolysaccharides | resveratrol inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein co-treated with TNF protein] results in increased expression of NOS2 protein] | affects cotreatment|decreases reaction|increases expression | 16366677 |
| D008070 | Lipopolysaccharides | resveratrol promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein co-treated with TNF protein] results in increased expression of SOD2 protein] | affects cotreatment|increases expression|increases reaction | 16366677 |
| D008070 | Lipopolysaccharides | rimonabant inhibits the reaction [[3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol binds to and results in increased activity of CNR1 protein] inhibits the reaction [IFNG protein affects the reaction [Lipopolysaccharides results in increased abundance of Nitric Oxide]]] | affects binding|affects reaction|decreases reaction|increases abundance|increases activity | 11727767 |
| D008070 | Lipopolysaccharides | Saponins inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein co-treated with TNF protein] results in increased expression of NOS2 mRNA] | affects cotreatment|decreases reaction|increases expression | 16366677 |
| D008070 | Lipopolysaccharides | Saponins inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein co-treated with TNF protein] results in increased expression of NOS2 protein] | affects cotreatment|decreases reaction|increases expression | 16366677 |
| D008070 | Lipopolysaccharides | Saponins inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein co-treated with TNF protein] results in increased expression of SOD2 protein] | affects cotreatment|decreases reaction|increases expression | 16366677 |
| D008070 | Lipopolysaccharides | [SB 203580 co-treated with Manganese] inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Nitric Oxide] | affects cotreatment|decreases reaction|increases abundance | 16488514 |
| D008070 | Lipopolysaccharides | SB 203580 inhibits the reaction [[IFNG protein co-treated with Lipopolysaccharides] results in increased abundance of Nitric Oxide] | affects cotreatment|decreases reaction|increases abundance | 12911628 |
| D008070 | Lipopolysaccharides | SB 203580 inhibits the reaction [[IFNG protein co-treated with Lipopolysaccharides] results in increased expression of NOS2 protein] | affects cotreatment|decreases reaction|increases expression | 12911628 |
| D008070 | Lipopolysaccharides | SB 203580 inhibits the reaction [[IFNG protein co-treated with Lipopolysaccharides] results in increased expression of PTGS2 protein] | affects cotreatment|decreases reaction|increases expression | 12911628 |
| D008070 | Lipopolysaccharides | SB 203580 inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Nitric Oxide] | affects cotreatment|decreases reaction|increases abundance | 16488514 |
| D008070 | Lipopolysaccharides | SB 203580 inhibits the reaction [Manganese promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mRNA]] | affects cotreatment|decreases reaction|increases expression|increases reaction | 16488514 |
| D008070 | Lipopolysaccharides | SB 203580 inhibits the reaction [Manganese promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of TNF protein]] | affects cotreatment|decreases reaction|increases expression|increases reaction | 16488514 |
| D008070 | Lipopolysaccharides | [U 0126 co-treated with Manganese] inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Nitric Oxide] | affects cotreatment|decreases reaction|increases abundance | 16488514 |
| D008070 | Lipopolysaccharides | U 0126 inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Nitric Oxide] | affects cotreatment|decreases reaction|increases abundance | 16488514 |
| D008070 | Lipopolysaccharides | U 0126 inhibits the reaction [Manganese promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mRNA]] | affects cotreatment|decreases reaction|increases expression|increases reaction | 16488514 |
| D008070 | Lipopolysaccharides | U 0126 inhibits the reaction [Manganese promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of TNF protein]] | affects cotreatment|decreases reaction|increases expression|increases reaction | 16488514 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased expression of IFNG mRNA | increases expression | 15998543 |
| C009900 | lipoteichoic acid | lipoteichoic acid results in increased expression of IFNG mRNA | increases expression | 15998543 |
| D018021 | Lithium Chloride | Lithium Chloride results in increased expression of IFNG mRNA | increases expression | 9328138 |
| C480546 | lupane | lupane results in increased secretion of IFNG protein | increases secretion | 16388738 |
| D047311 | Luteolin | Luteolin results in increased expression of IFNG protein | increases expression | 12755373 |
| D047311 | Luteolin | Luteolin inhibits the reaction [[IL1B protein co-treated with IFNG protein] affects the localization of and results in increased activity of NFKB1 protein] | affects cotreatment|affects localization|decreases reaction|increases activity | 18090225 |
| D047311 | Luteolin | Luteolin inhibits the reaction [[IL1B protein co-treated with IFNG protein] affects the localization of and results in increased activity of RELA protein] | affects cotreatment|affects localization|decreases reaction|increases activity | 18090225 |
| D047311 | Luteolin | Luteolin inhibits the reaction [[IL1B protein co-treated with IFNG protein] results in decreased secretion of INS1 protein] | affects cotreatment|decreases reaction|decreases secretion | 18090225 |
| D047311 | Luteolin | Luteolin inhibits the reaction [[IL1B protein co-treated with IFNG protein] results in increased abundance of Nitric Oxide] | affects cotreatment|decreases reaction|increases abundance | 18090225 |
| D047311 | Luteolin | Luteolin inhibits the reaction [[IL1B protein co-treated with IFNG protein] results in increased degradation of NFKBIA protein] | affects cotreatment|decreases reaction|increases degradation | 18090225 |
| D047311 | Luteolin | Luteolin inhibits the reaction [[IL1B protein co-treated with IFNG protein] results in increased expression of NOS2 mRNA] | affects cotreatment|decreases reaction|increases expression | 18090225 |
| D047311 | Luteolin | Luteolin inhibits the reaction [[IL1B protein co-treated with IFNG protein] results in increased expression of NOS2 protein] | affects cotreatment|decreases reaction|increases expression | 18090225 |
| D008294 | Malathion | Malathion results in decreased expression of IFNG protein | decreases expression | 19145326 |
| C013099 | mancozeb | mancozeb affects the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased secretion of TNF protein] | affects cotreatment|affects reaction|increases secretion | 15742816 |
| D008345 | Manganese | 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [Manganese inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Nitric Oxide]] | affects cotreatment|decreases reaction|increases abundance | 16488514 |
| D008345 | Manganese | 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [Manganese promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Free Radicals]] | affects cotreatment|decreases reaction|increases abundance|increases reaction | 16488514 |
| D008345 | Manganese | 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [Manganese promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mRNA]] | affects cotreatment|decreases reaction|increases expression|increases reaction | 16488514 |
| D008345 | Manganese | 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [Manganese promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of TNF mRNA]] | affects cotreatment|decreases reaction|increases expression|increases reaction | 16488514 |
| D008345 | Manganese | 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [Manganese promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of TNF protein]] | affects cotreatment|decreases reaction|increases expression|increases reaction | 16488514 |
| D008345 | Manganese | [anthra(1,9-cd)pyrazol-6(2H)-one co-treated with Manganese] inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Nitric Oxide] | affects cotreatment|decreases reaction|increases abundance | 16488514 |
| D008345 | Manganese | anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [Manganese promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mRNA]] | affects cotreatment|decreases reaction|increases expression|increases reaction | 16488514 |
| D008345 | Manganese | anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [Manganese promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of TNF protein]] | affects cotreatment|decreases reaction|increases expression|increases reaction | 16488514 |
| D008345 | Manganese | [Lipopolysaccharides co-treated with IFNG protein co-treated with Manganese] results in decreased abundance of Nitric Oxide | affects cotreatment|decreases abundance | 16488514 |
| D008345 | Manganese | Manganese inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Nitric Oxide] | affects cotreatment|decreases reaction|increases abundance | 16488514 |
| D008345 | Manganese | Manganese promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Free Radicals] | affects cotreatment|increases abundance|increases reaction | 16488514 |
| D008345 | Manganese | Manganese promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased degradation of NFKBIA protein] | affects cotreatment|increases degradation|increases reaction | 16488514 |
| D008345 | Manganese | Manganese promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mRNA] | affects cotreatment|increases expression|increases reaction | 16488514 |
| D008345 | Manganese | Manganese promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 protein] | affects cotreatment|increases expression|increases reaction | 16488514 |
| D008345 | Manganese | Manganese promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of TNF mRNA] | affects cotreatment|increases expression|increases reaction | 16488514 |
| D008345 | Manganese | Manganese promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of TNF protein] | affects cotreatment|increases expression|increases reaction | 16488514 |
| D008345 | Manganese | Manganese promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased phosphorylation of MAPK1 protein] | affects cotreatment|increases phosphorylation|increases reaction | 16488514 |
| D008345 | Manganese | Manganese promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased phosphorylation of MAPK3 protein] | affects cotreatment|increases phosphorylation|increases reaction | 16488514 |
| D008345 | Manganese | [SB 203580 co-treated with Manganese] inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Nitric Oxide] | affects cotreatment|decreases reaction|increases abundance | 16488514 |
| D008345 | Manganese | SB 203580 inhibits the reaction [Manganese promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mRNA]] | affects cotreatment|decreases reaction|increases expression|increases reaction | 16488514 |
| D008345 | Manganese | SB 203580 inhibits the reaction [Manganese promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of TNF protein]] | affects cotreatment|decreases reaction|increases expression|increases reaction | 16488514 |
| D008345 | Manganese | [U 0126 co-treated with Manganese] inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Nitric Oxide] | affects cotreatment|decreases reaction|increases abundance | 16488514 |
| D008345 | Manganese | U 0126 inhibits the reaction [Manganese promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mRNA]] | affects cotreatment|decreases reaction|increases expression|increases reaction | 16488514 |
| D008345 | Manganese | U 0126 inhibits the reaction [Manganese promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of TNF protein]] | affects cotreatment|decreases reaction|increases expression|increases reaction | 16488514 |
| C501277 | Mangifera indica extract | Mangifera indica extract inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Dinoprostone] | affects cotreatment|decreases reaction|increases abundance | 15177302 16716910 |
| C501277 | Mangifera indica extract | Mangifera indica extract inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Leukotriene B4] | affects cotreatment|decreases reaction|increases abundance | 15177302 |
| C501277 | Mangifera indica extract | Mangifera indica extract inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Nitric Oxide] | affects cotreatment|decreases reaction|increases abundance | 15177305 |
| C501277 | Mangifera indica extract | Mangifera indica extract inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of CSF2 mRNA] | affects cotreatment|decreases reaction|increases expression | 15222974 |
| C501277 | Mangifera indica extract | Mangifera indica extract inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of IL1B mRNA] | affects cotreatment|decreases reaction|increases expression | 15222974 |
| C501277 | Mangifera indica extract | Mangifera indica extract inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mRNA] | affects cotreatment|decreases reaction|increases expression | 15222974 |
| C501277 | Mangifera indica extract | Mangifera indica extract inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 protein] | affects cotreatment|decreases reaction|increases expression | 15222974 |
| C501277 | Mangifera indica extract | Mangifera indica extract inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of PTGS2 mRNA] | affects cotreatment|decreases reaction|increases expression | 15222974 |
| C501277 | Mangifera indica extract | Mangifera indica extract inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of PTGS2 protein] | affects cotreatment|decreases reaction|increases expression | 15222974 |
| C501277 | Mangifera indica extract | Mangifera indica extract inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of TNF mRNA] | affects cotreatment|decreases reaction|increases expression | 15222974 |
| C501277 | Mangifera indica extract | Mangifera indica extract inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of TNF protein] | affects cotreatment|decreases reaction|increases expression | 15177305 |
| C501277 | Mangifera indica extract | Mangifera indica extract inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased secretion of TNF protein] | affects cotreatment|decreases reaction|increases secretion | 15222974 |
| C013592 | mangiferin | mangiferin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Dinoprostone] | affects cotreatment|decreases reaction|increases abundance | 16716910 15177302 |
| C013592 | mangiferin | mangiferin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Leukotriene B4] | affects cotreatment|decreases reaction|increases abundance | 15177302 |
| C013592 | mangiferin | mangiferin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Nitric Oxide] | affects cotreatment|decreases reaction|increases abundance | 15177305 |
| C013592 | mangiferin | mangiferin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of CCL5 protein] | affects cotreatment|decreases reaction|increases expression | 15135318 |
| C013592 | mangiferin | mangiferin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of CSF2 protein] | affects cotreatment|decreases reaction|increases expression | 15135318 |
| C013592 | mangiferin | mangiferin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of CSF3 protein] | affects cotreatment|decreases reaction|increases expression | 15135318 |
| C013592 | mangiferin | mangiferin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of IL6 protein] | affects cotreatment|decreases reaction|increases expression | 15135318 |
| C013592 | mangiferin | mangiferin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mRNA] | affects cotreatment|decreases reaction|increases expression | 12694877 |
| C013592 | mangiferin | mangiferin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of TNF mRNA] | affects cotreatment|decreases reaction|increases expression | 12694877 |
| C013592 | mangiferin | mangiferin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of TNF protein] | affects cotreatment|decreases reaction|increases expression | 15135318 |
| C013592 | mangiferin | mangiferin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased secretion of TNF protein] | affects cotreatment|decreases reaction|increases secretion | 15222974 |
| C013592 | mangiferin | mangiferin promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of TGFB1 mRNA] | affects cotreatment|increases expression|increases reaction | 12694877 |
| C013592 | mangiferin | mangiferin inhibits the reaction [[lipopolysaccharide, Escherichia coli 0111 B4 co-treated with IFNG protein] results in increased expression of NOS2 mRNA] | affects cotreatment|decreases reaction|increases expression | 12694877 |
| C054474 | manumycin | manumycin inhibits the reaction [Acetaminophen results in increased expression of IFNG mRNA] | decreases reaction|increases expression | 19739265 |
| C054474 | manumycin | manumycin inhibits the reaction [Acetaminophen results in increased expression of IFNG protein] | decreases reaction|increases expression | 19739265 |
| C008340 | mecoprop | mecoprop results in decreased expression of IFNG protein | decreases expression | 10883730 |
| D017258 | Medroxyprogesterone Acetate | [Estrogens, Conjugated (USP) co-treated with Medroxyprogesterone Acetate] results in decreased secretion of IFNG protein | affects cotreatment|decreases secretion | 16236362 |
| D008550 | Melatonin | Gonadal Steroid Hormones affects the reaction [Melatonin affects the expression of IFNG protein] | affects expression|affects reaction | 16373423 |
| C033266 | Menhaden oil | Menhaden oil results in decreased expression of IFNG mRNA | decreases expression | 10065739 |
| C033266 | Menhaden oil | Menhaden oil results in decreased expression of IFNG protein | decreases expression | 10065739 |
| D008627 | Mercuric Chloride | Mercuric Chloride results in increased expression of IFNG mRNA | increases expression | 10447925 |
| D008627 | Mercuric Chloride | Mercuric Chloride results in increased expression of IFNG protein | increases expression | 10447925 |
| D008715 | Methionine | Methionine inhibits the reaction [Acetaminophen results in increased expression of IFNG mRNA] | decreases reaction|increases expression | 19739265 |
| D008715 | Methionine | Methionine inhibits the reaction [Acetaminophen results in increased expression of IFNG protein] | decreases reaction|increases expression | 19739265 |
| C445068 | methyl 2-cyano-3,12-dioxoolean-1,9-dien-28-oate | methyl 2-cyano-3,12-dioxoolean-1,9-dien-28-oate inhibits the reaction [IFNG protein results in increased expression of NOS2] | decreases reaction|increases expression | 17363558 |
| C008435 | methyldithiocarbamate | methyldithiocarbamate inhibits the reaction [Lipopolysaccharides results in increased expression of IFNG mRNA] | decreases reaction|increases expression | 15933225 |
| C008435 | methyldithiocarbamate | methyldithiocarbamate inhibits the reaction [Lipopolysaccharides results in increased secretion of IFNG protein] | decreases reaction|increases secretion | 19339665 |
| D008752 | Methylene Chloride | [Methylene Chloride co-treated with Biliverdine] inhibits the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in increased expression of IFNG protein] | affects cotreatment|decreases reaction|increases expression | 15486963 |
| C008461 | methyl isocyanate | methyl isocyanate results in increased expression of IFNG protein | increases expression | 19295137 |
| D008770 | Methylnitrosourea | IFNG protein inhibits the reaction [Methylnitrosourea results in decreased expression of IL10 protein] | decreases expression|decreases reaction | 16822543 |
| D008770 | Methylnitrosourea | IFNG protein inhibits the reaction [Methylnitrosourea results in increased expression of CCL2 protein] | decreases reaction|increases expression | 16822543 |
| D008770 | Methylnitrosourea | IFNG protein inhibits the reaction [Methylnitrosourea results in increased expression of CSF2 protein] | decreases reaction|increases expression | 16822543 |
| D008770 | Methylnitrosourea | IFNG protein inhibits the reaction [Methylnitrosourea results in increased expression of IL2 protein] | decreases reaction|increases expression | 16822543 |
| D008770 | Methylnitrosourea | IFNG protein inhibits the reaction [Methylnitrosourea results in increased expression of IL4 protein] | decreases reaction|increases expression | 16822543 |
| D008770 | Methylnitrosourea | IFNG protein inhibits the reaction [Methylnitrosourea results in increased expression of LEP protein] | decreases reaction|increases expression | 16822543 |
| D008770 | Methylnitrosourea | IFNG protein inhibits the reaction [Methylnitrosourea results in increased expression of THPO protein] | decreases reaction|increases expression | 16822543 |
| D008770 | Methylnitrosourea | IFNG protein inhibits the reaction [Methylnitrosourea results in increased expression of TNF protein] | decreases reaction|increases expression | 16822543 |
| D008770 | Methylnitrosourea | IFNG protein inhibits the reaction [Methylnitrosourea results in increased expression of VEGFA protein] | decreases reaction|increases expression | 16822543 |
| D008770 | Methylnitrosourea | IFNG protein results in decreased susceptibility to Methylnitrosourea | decreases response to substance | 15240709 16080182 |
| D008770 | Methylnitrosourea | 2-Acetylaminofluorene inhibits the reaction [[Diethylnitrosamine co-treated with Methylnitrosourea co-treated with Butylhydroxybutylnitrosamine co-treated with diisopropanolnitrosamine co-treated with 1,2-Dimethylhydrazine] results in decreased expression of IFNG protein] | affects cotreatment|decreases expression|decreases reaction | 14736494 |
| D008770 | Methylnitrosourea | [Diethylnitrosamine co-treated with Methylnitrosourea co-treated with Butylhydroxybutylnitrosamine co-treated with diisopropanolnitrosamine co-treated with 1,2-Dimethylhydrazine] results in decreased expression of IFNG protein | affects cotreatment|decreases expression | 14736494 |
| D015735 | Mifepristone | Mifepristone inhibits the reaction [Dydrogesterone results in decreased expression of IFNG protein] | decreases expression|decreases reaction | 16045524 |
| D015735 | Mifepristone | Mifepristone inhibits the reaction [Dexamethasone results in decreased expression of IFNG protein] | decreases expression|decreases reaction | 12504806 |
| D008903 | Minerals | [Alkalies co-treated with Minerals] results in decreased expression of IFNG mRNA | affects cotreatment|decreases expression | 11767050 |
| C015765 | MK 473 | MK 473 inhibits the reaction [IFNG protein results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 19446535 |
| C015765 | MK 473 | MK 473 inhibits the reaction [IFNG protein results in increased metabolism of Nitric Oxide] | decreases reaction|increases metabolic processing | 19446535 |
| C430647 | monocyte locomotion inhibitory factor | monocyte locomotion inhibitory factor inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of IFNG protein] | decreases reaction|increases secretion | 16374615 |
| C430647 | monocyte locomotion inhibitory factor | monocyte locomotion inhibitory factor results in increased secretion of IFNG protein | increases secretion | 16374615 |
| C104727 | moxifloxacin | moxifloxacin results in decreased expression of IFNG protein | decreases expression | 16006447 |
| D009151 | Mustard Gas | Mustard Gas results in decreased expression of IFNG protein | decreases expression | 19145326 |
| D009173 | Mycophenolic Acid | Mycophenolic Acid results in decreased expression of IFNG mRNA | decreases expression | 11562063 |
| C080955 | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [[IFNG protein co-treated with Lipopolysaccharides] results in increased abundance of Dinoprostone] | affects cotreatment|decreases reaction|increases abundance | 12911628 |
| C517552 | N-(6-methylamino-3-nitrophenyl)-3-(3-indolyl)acrylamide | N-(6-methylamino-3-nitrophenyl)-3-(3-indolyl)acrylamide results in decreased secretion of IFNG protein | decreases secretion | 16787663 |
| D019810 | Sodium Azide | Sodium Azide inhibits the reaction [IFNG protein results in increased activity of DUOX2 protein] | decreases reaction|increases activity | 16970942 |
| D015058 | 1-Naphthylisothiocyanate | 1-Naphthylisothiocyanate results in increased expression of IFNG protein | increases expression | 12912871 |
| C012655 | nimesulide | nimesulide inhibits the reaction [[IFNG protein co-treated with Lipopolysaccharides] results in increased abundance of Dinoprostone] | affects cotreatment|decreases reaction|increases abundance | 12911628 |
| D009569 | Nitric Oxide | Ciprofloxacin inhibits the reaction [[IL1A protein co-treated with TNF protein co-treated with IFNG protein] results in increased abundance of Nitric Oxide] | affects cotreatment|decreases reaction|increases abundance | 16968468 |
| D009569 | Nitric Oxide | [IL1A protein co-treated with TNF protein co-treated with IFNG protein] results in increased abundance of Nitric Oxide | affects cotreatment|increases abundance | 16968468 |
| D009569 | Nitric Oxide | [IL5 protein co-treated with TNF protein co-treated with IFNG protein] results in increased abundance of Nitric Oxide | affects cotreatment|increases abundance | 18206661 |
| D009569 | Nitric Oxide | Nitric Oxide results in increased secretion of IFNG protein | increases secretion | 13678430 |
| D009569 | Nitric Oxide | wortmannin inhibits the reaction [Ciprofloxacin inhibits the reaction [[IL1A protein co-treated with TNF protein co-treated with IFNG protein] results in increased abundance of Nitric Oxide]] | affects cotreatment|decreases reaction|increases abundance | 16968468 |
| D009569 | Nitric Oxide | 15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [[IFNG protein results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide] | decreases reaction|increases chemical synthesis|increases expression | 12847270 |
| D009569 | Nitric Oxide | 5-nitro-2-(3-phenylpropylamino)benzoic acid inhibits the reaction [IFNG protein results in increased metabolism of Nitric Oxide] | decreases reaction|increases metabolic processing | 19446535 |
| D009569 | Nitric Oxide | alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide inhibits the reaction [IFNG protein results in increased abundance of Nitric Oxide] | decreases reaction|increases abundance | 12847270 |
| D009569 | Nitric Oxide | [APP protein co-treated with IFNG protein] results in increased abundance of Nitric Oxide | affects cotreatment|increases abundance | 11080519 |
| D009569 | Nitric Oxide | ciglitazone inhibits the reaction [[IFNG protein results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide] | decreases reaction|increases chemical synthesis|increases expression | 12847270 |
| D009569 | Nitric Oxide | Diquat promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased metabolism of Nitric Oxide] | affects cotreatment|increases metabolic processing|increases reaction | 11498278 |
| D009569 | Nitric Oxide | Ditiocarb inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased metabolism of Nitric Oxide] | affects cotreatment|decreases reaction|increases metabolic processing | 11498278 |
| D009569 | Nitric Oxide | Genistein inhibits the reaction [IFNG protein results in increased abundance of Nitric Oxide] | decreases reaction|increases abundance | 12847270 |
| D009569 | Nitric Oxide | Glyburide inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Nitric Oxide] | affects cotreatment|decreases reaction|increases abundance | 11907163 |
| D009569 | Nitric Oxide | GPX1 protein affects the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased metabolism of Nitric Oxide] | affects cotreatment|affects reaction|increases metabolic processing | 11498278 |
| D009569 | Nitric Oxide | GW 1929 inhibits the reaction [[IFNG protein results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide] | decreases reaction|increases chemical synthesis|increases expression | 12847270 |
| D009569 | Nitric Oxide | Ibuprofen inhibits the reaction [[APP protein co-treated with IFNG protein] results in increased abundance of Nitric Oxide] | affects cotreatment|decreases reaction|increases abundance | 11080519 |
| D009569 | Nitric Oxide | IFNG protein inhibits the reaction [Cyclophosphamide results in increased abundance of Nitric Oxide] | decreases reaction|increases abundance | 10607705 |
| D009569 | Nitric Oxide | [IFNG protein results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide | increases chemical synthesis|increases expression | 12847270 |
| D009569 | Nitric Oxide | Indomethacin inhibits the reaction [[APP protein co-treated with IFNG protein] results in increased abundance of Nitric Oxide] | affects cotreatment|decreases reaction|increases abundance | 11080519 |
| D009569 | Nitric Oxide | JAK2 protein promotes the reaction [IFNG protein results in increased abundance of Nitric Oxide] | increases abundance|increases reaction | 12847270 |
| D009569 | Nitric Oxide | [Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Nitric Oxide | affects cotreatment|increases abundance | 11907163 15177305 |
| D009569 | Nitric Oxide | [Lipopolysaccharides co-treated with IFNG protein] results in increased metabolism of Nitric Oxide | affects cotreatment|increases metabolic processing | 11498278 |
| D009569 | Nitric Oxide | Lipopolysaccharides promotes the reaction [IFNG protein results in increased abundance of Nitric Oxide] | increases abundance|increases reaction | 7689037 |
| D009569 | Nitric Oxide | Mangifera indica extract inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Nitric Oxide] | affects cotreatment|decreases reaction|increases abundance | 15177305 |
| D009569 | Nitric Oxide | mangiferin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Nitric Oxide] | affects cotreatment|decreases reaction|increases abundance | 15177305 |
| D009569 | Nitric Oxide | MK 473 inhibits the reaction [IFNG protein results in increased metabolism of Nitric Oxide] | decreases reaction|increases metabolic processing | 19446535 |
| D009569 | Nitric Oxide | NS 1652 inhibits the reaction [IFNG protein results in increased metabolism of Nitric Oxide] | decreases reaction|increases metabolic processing | 19446535 |
| D009569 | Nitric Oxide | NS3728 inhibits the reaction [IFNG protein results in increased metabolism of Nitric Oxide] | decreases reaction|increases metabolic processing | 19446535 |
| D009569 | Nitric Oxide | peroxyvanadate inhibits the reaction [15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [IFNG protein results in increased abundance of Nitric Oxide]] | decreases reaction|increases abundance | 12847270 |
| D009569 | Nitric Oxide | peroxyvanadate promotes the reaction [IFNG protein results in increased abundance of Nitric Oxide] | increases abundance|increases reaction | 12847270 |
| D009569 | Nitric Oxide | pimagedine inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased metabolism of Nitric Oxide] | affects cotreatment|decreases reaction|increases metabolic processing | 11498278 |
| D009569 | Nitric Oxide | pimagedine inhibits the reaction [Lipopolysaccharides promotes the reaction [IFNG protein results in increased abundance of Nitric Oxide]] | decreases reaction|increases abundance|increases reaction | 7689037 |
| D009569 | Nitric Oxide | PPARG protein affects the reaction [[IFNG protein results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide] | affects reaction|increases chemical synthesis|increases expression | 12847270 |
| D009569 | Nitric Oxide | Tamoxifen inhibits the reaction [IFNG protein results in increased metabolism of Nitric Oxide] | decreases reaction|increases metabolic processing | 19446535 |
| D009569 | Nitric Oxide | [TNF protein co-treated with IFNG protein] results in increased secretion of Nitric Oxide | affects cotreatment|increases secretion | 8341679 |
| D009569 | Nitric Oxide | 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [Manganese inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Nitric Oxide]] | affects cotreatment|decreases reaction|increases abundance | 16488514 |
| D009569 | Nitric Oxide | [3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol binds to and results in increased activity of CNR1 protein] inhibits the reaction [IFNG protein affects the reaction [Lipopolysaccharides results in increased abundance of Nitric Oxide]] | affects binding|affects reaction|decreases reaction|increases abundance|increases activity | 11727767 |
| D009569 | Nitric Oxide | [anthra(1,9-cd)pyrazol-6(2H)-one co-treated with Manganese] inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Nitric Oxide] | affects cotreatment|decreases reaction|increases abundance | 16488514 |
| D009569 | Nitric Oxide | anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Nitric Oxide] | affects cotreatment|decreases reaction|increases abundance | 16488514 |
| D009569 | Nitric Oxide | Apigenin inhibits the reaction [[IL1B protein co-treated with IFNG protein] results in increased abundance of Nitric Oxide] | affects cotreatment|decreases reaction|increases abundance | 18090225 |
| D009569 | Nitric Oxide | Genistein inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein co-treated with TNF protein] results in increased abundance of Nitric Oxide] | affects cotreatment|decreases reaction|increases abundance | 16366677 |
| D009569 | Nitric Oxide | IFNG protein affects the reaction [Lipopolysaccharides results in increased abundance of Nitric Oxide] | affects reaction|increases abundance | 11727767 |
| D009569 | Nitric Oxide | [IFNG protein co-treated with Lipopolysaccharides] results in increased abundance of Nitric Oxide | affects cotreatment|increases abundance | 12911628 |
| D009569 | Nitric Oxide | [IFNG protein co-treated with TNF protein] results in increased abundance of Nitric Oxide | affects cotreatment|increases abundance | 7519435 |
| D009569 | Nitric Oxide | IFNG protein results in increased abundance of Nitric Oxide | increases abundance | 7519435 |
| D009569 | Nitric Oxide | [IFNG protein results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide | increases chemical synthesis|increases expression | 7519435 |
| D009569 | Nitric Oxide | [IL1B protein co-treated with IFNG protein] results in increased abundance of Nitric Oxide | affects cotreatment|increases abundance | 18090225 |
| D009569 | Nitric Oxide | Indomethacin inhibits the reaction [[IFNG protein co-treated with Lipopolysaccharides] results in increased abundance of Nitric Oxide] | affects cotreatment|decreases reaction|increases abundance | 12911628 |
| D009569 | Nitric Oxide | [Lipopolysaccharides co-treated with IFNG protein co-treated with Manganese] results in decreased abundance of Nitric Oxide | affects cotreatment|decreases abundance | 16488514 |
| D009569 | Nitric Oxide | [Lipopolysaccharides co-treated with IFNG protein co-treated with TNF protein] results in increased abundance of Nitric Oxide | affects cotreatment|increases abundance | 16366677 |
| D009569 | Nitric Oxide | [Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Nitric Oxide | affects cotreatment|increases abundance | 16488514 |
| D009569 | Nitric Oxide | Luteolin inhibits the reaction [[IL1B protein co-treated with IFNG protein] results in increased abundance of Nitric Oxide] | affects cotreatment|decreases reaction|increases abundance | 18090225 |
| D009569 | Nitric Oxide | Manganese inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Nitric Oxide] | affects cotreatment|decreases reaction|increases abundance | 16488514 |
| D009569 | Nitric Oxide | Ozone promotes the reaction [IFNG protein results in increased abundance of Nitric Oxide] | increases abundance|increases reaction | 7519435 |
| D009569 | Nitric Oxide | Ozone promotes the reaction [[IFNG protein results in increased expression of NOS2 protein] which results in increased abundance of Nitric Oxide] | increases abundance|increases expression|increases reaction | 7519435 |
| D009569 | Nitric Oxide | pimagedine inhibits the reaction [[IFNG protein co-treated with Lipopolysaccharides] results in increased abundance of Nitric Oxide] | affects cotreatment|decreases reaction|increases abundance | 12911628 |
| D009569 | Nitric Oxide | polyphenols inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein co-treated with TNF protein] results in increased abundance of Nitric Oxide] | affects cotreatment|decreases reaction|increases abundance | 16366677 |
| D009569 | Nitric Oxide | Quercetin inhibits the reaction [[IL1B protein co-treated with IFNG protein] results in increased abundance of Nitric Oxide] | affects cotreatment|decreases reaction|increases abundance | 18090225 |
| D009569 | Nitric Oxide | resveratrol inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein co-treated with TNF protein] results in increased abundance of Nitric Oxide] | affects cotreatment|decreases reaction|increases abundance | 16366677 |
| D009569 | Nitric Oxide | rimonabant inhibits the reaction [[3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol binds to and results in increased activity of CNR1 protein] inhibits the reaction [IFNG protein affects the reaction [Lipopolysaccharides results in increased abundance of Nitric Oxide]]] | affects binding|affects reaction|decreases reaction|increases abundance|increases activity | 11727767 |
| D009569 | Nitric Oxide | [SB 203580 co-treated with Manganese] inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Nitric Oxide] | affects cotreatment|decreases reaction|increases abundance | 16488514 |
| D009569 | Nitric Oxide | SB 203580 inhibits the reaction [[IFNG protein co-treated with Lipopolysaccharides] results in increased abundance of Nitric Oxide] | affects cotreatment|decreases reaction|increases abundance | 12911628 |
| D009569 | Nitric Oxide | SB 203580 inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Nitric Oxide] | affects cotreatment|decreases reaction|increases abundance | 16488514 |
| D009569 | Nitric Oxide | [U 0126 co-treated with Manganese] inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Nitric Oxide] | affects cotreatment|decreases reaction|increases abundance | 16488514 |
| D009569 | Nitric Oxide | U 0126 inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Nitric Oxide] | affects cotreatment|decreases reaction|increases abundance | 16488514 |
| D020030 | Nitric Oxide Donors | Nitric Oxide Donors results in increased secretion of IFNG protein | increases secretion | 13678430 |
| D009573 | Nitrites | IFNG protein results in increased abundance of Nitrites | increases abundance | 12845421 |
| D009573 | Nitrites | pyrrolidine dithiocarbamic acid inhibits the reaction [IFNG protein results in increased abundance of Nitrites] | decreases reaction|increases abundance | 12845421 |
| D009573 | Nitrites | Tosyllysine Chloromethyl Ketone inhibits the reaction [IFNG protein results in increased abundance of Nitrites] | decreases reaction|increases abundance | 12845421 |
| D009573 | Nitrites | IFNG protein promotes the reaction [[TNF protein results in increased activity of NOS2 protein] which results in increased chemical synthesis of Nitrites] | increases activity|increases chemical synthesis|increases reaction | 7532384 |
| D009599 | Nitroprusside | Nitroprusside results in decreased expression of IFNG mRNA | decreases expression | 9201699 |
| D026423 | S-Nitroso-N-Acetylpenicillamine | S-Nitroso-N-Acetylpenicillamine inhibits the reaction [Streptozocin results in increased expression of IFNG protein] | decreases reaction|increases expression | 15892581 |
| D026422 | S-Nitrosoglutathione | S-Nitrosoglutathione results in increased secretion of IFNG protein | increases secretion | 13678430 |
| C038405 | nivalenol | nivalenol affects the expression of IFNG mRNA | affects expression | 17166736 |
| C044387 | N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine | [IFNG protein co-treated with TNF protein co-treated with N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine] results in increased activity of CASP3 protein | affects cotreatment|increases activity | 16844947 |
| C044387 | N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine | [IFNG protein co-treated with TNF protein co-treated with N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine] results in increased cleavage of CDH1 protein | affects cotreatment|increases cleavage | 16844947 |
| C044387 | N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine | [IFNG protein co-treated with TNF protein co-treated with N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine] results in increased cleavage of CTNNB1 protein | affects cotreatment|increases cleavage | 16844947 |
| C044387 | N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine | N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [Zinc results in increased secretion of IFNG protein] | decreases reaction|increases secretion | 17150331 |
| C044387 | N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine | Zinc inhibits the reaction [[IFNG protein co-treated with TNF protein co-treated with N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine] results in increased cleavage of CDH1 protein] | affects cotreatment|decreases reaction|increases cleavage | 16844947 |
| C044387 | N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine | Zinc inhibits the reaction [[IFNG protein co-treated with TNF protein co-treated with N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine] results in increased cleavage of CTNNB1 protein] | affects cotreatment|decreases reaction|increases cleavage | 16844947 |
| C405615 | NS 1652 | NS 1652 inhibits the reaction [IFNG protein results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 19446535 |
| C405615 | NS 1652 | NS 1652 inhibits the reaction [IFNG protein results in increased expression of NOS2 protein] | decreases reaction|increases expression | 19446535 |
| C405615 | NS 1652 | NS 1652 inhibits the reaction [IFNG protein results in increased metabolism of Nitric Oxide] | decreases reaction|increases metabolic processing | 19446535 |
| C517730 | NS3728 | NS3728 inhibits the reaction [IFNG protein results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 19446535 |
| C517730 | NS3728 | NS3728 inhibits the reaction [IFNG protein results in increased metabolism of Nitric Oxide] | decreases reaction|increases metabolic processing | 19446535 |
| D019787 | Linoleic Acid | Linoleic Acid results in increased expression of IFNG protein | increases expression | 16305726 |
| D010081 | Oxazolone | Oxazolone results in increased expression of IFNG mRNA | increases expression | 18242016 18652873 |
| D010081 | Oxazolone | Oxazolone results in increased expression of IFNG protein | increases expression | 18652873 |
| C037573 | oxymatrine | oxymatrine inhibits the reaction [Carbon Tetrachloride results in decreased expression of IFNG protein] | decreases expression|decreases reaction | 15603720 |
| D010126 | Ozone | NFKB1 gene mutant form inhibits the reaction [Ozone promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased activity of NOS2 protein]] | affects cotreatment|decreases reaction|increases activity|increases reaction | 15064226 |
| D010126 | Ozone | Ozone promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased activity of NOS2 protein] | affects cotreatment|increases activity|increases reaction | 15064226 |
| D010126 | Ozone | [Ozone co-treated with Chlorine] affects the expression of IFNG mRNA | affects cotreatment|affects expression | 18636392 |
| D010126 | Ozone | Ozone promotes the reaction [IFNG protein results in increased abundance of Nitric Oxide] | increases abundance|increases reaction | 7519435 |
| D010126 | Ozone | Ozone promotes the reaction [IFNG protein results in increased expression of NOS2 mRNA] | increases expression|increases reaction | 7519435 |
| D010126 | Ozone | Ozone promotes the reaction [IFNG protein results in increased expression of NOS2 protein] | increases expression|increases reaction | 7519435 |
| D010126 | Ozone | Ozone promotes the reaction [[IFNG protein results in increased expression of NOS2 protein] which results in increased abundance of Nitric Oxide] | increases abundance|increases expression|increases reaction | 7519435 |
| C508075 | Pam(3)CSK(4) peptide | [Acetylmuramyl-Alanyl-Isoglutamine co-treated with Pam(3)CSK(4) peptide co-treated with IFNG protein] results in increased expression of [IL12A protein binds to IL12B protein] | affects binding|affects cotreatment|increases expression | 18490488 |
| C508075 | Pam(3)CSK(4) peptide | [Acetylmuramyl-Alanyl-Isoglutamine co-treated with Pam(3)CSK(4) peptide co-treated with IFNG protein] results in increased expression of IL12B protein | affects cotreatment|increases expression | 18490488 |
| C508075 | Pam(3)CSK(4) peptide | [Acetylmuramyl-Alanyl-Isoglutamine co-treated with Pam(3)CSK(4) peptide co-treated with IFNG protein] results in increased expression of [IL12B protein binds to IL23A protein] | affects binding|affects cotreatment|increases expression | 18490488 |
| C508075 | Pam(3)CSK(4) peptide | R 848 promotes the reaction [[Acetylmuramyl-Alanyl-Isoglutamine co-treated with Pam(3)CSK(4) peptide co-treated with IFNG protein] results in increased expression of [IL12A protein binds to IL12B protein]] | affects binding|affects cotreatment|increases expression|increases reaction | 18490488 |
| C508075 | Pam(3)CSK(4) peptide | R 848 promotes the reaction [[Acetylmuramyl-Alanyl-Isoglutamine co-treated with Pam(3)CSK(4) peptide co-treated with IFNG protein] results in increased expression of IL12B protein] | affects cotreatment|increases expression|increases reaction | 18490488 |
| D010269 | Paraquat | Paraquat results in increased expression of IFNG protein | increases expression | 12504350 |
| C093973 | PD 98059 | PD 98059 promotes the reaction [IFNG protein promotes the reaction [decitabine results in increased expression of PLA2G2A protein]] | increases expression|increases reaction | 18953428 |
| D026023 | Permethrin | IFNG protein affects the susceptibility to [Permethrin co-treated with Urocanic Acid] | affects cotreatment|affects response to substance | 14617103 |
| C500599 | peroxyvanadate | peroxyvanadate inhibits the reaction [15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [IFNG protein results in increased abundance of Nitric Oxide]] | decreases reaction|increases abundance | 12847270 |
| C500599 | peroxyvanadate | peroxyvanadate inhibits the reaction [15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [IFNG protein results in increased phosphorylation of STAT1 protein]] | decreases reaction|increases phosphorylation | 12847270 |
| C500599 | peroxyvanadate | peroxyvanadate promotes the reaction [IFNG protein results in increased abundance of Nitric Oxide] | increases abundance|increases reaction | 12847270 |
| C500599 | peroxyvanadate | peroxyvanadate promotes the reaction [IFNG protein results in increased phosphorylation of STAT1 protein] | increases phosphorylation|increases reaction | 12847270 |
| D010654 | Phenylbutyrates | Phenylbutyrates promotes the reaction [IFNG protein results in increased expression of CDKN1A mRNA] | increases expression|increases reaction | 10866311 |
| C005435 | phenylmethylpyrazolone | phenylmethylpyrazolone inhibits the reaction [lipopolysaccharide, Escherichia coli 0111 B4 results in increased expression of IFNG mRNA] | decreases reaction|increases expression | 12954792 |
| C005435 | phenylmethylpyrazolone | phenylmethylpyrazolone inhibits the reaction [Lipopolysaccharides results in increased expression of IFNG protein] | decreases reaction|increases expression | 15629513 |
| C029217 | phenyl-N-tert-butylnitrone | phenyl-N-tert-butylnitrone inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mRNA] | affects cotreatment|decreases reaction|increases expression | 12794164 |
| C029217 | phenyl-N-tert-butylnitrone | phenyl-N-tert-butylnitrone inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 protein] | affects cotreatment|decreases reaction|increases expression | 12794164 |
| D010672 | Phenytoin | Phenytoin results in decreased expression of IFNG protein | decreases expression | 10982153 |
| C043103 | phthalic anhydride | phthalic anhydride results in increased expression of IFNG mRNA | increases expression | 10637130 |
| C043103 | phthalic anhydride | phthalic anhydride results in increased expression of IFNG protein | increases expression | 20219652 |
| C004479 | pimagedine | pimagedine inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased activity of NOS2 protein] | affects cotreatment|decreases reaction|increases activity | 12892526 |
| C004479 | pimagedine | pimagedine inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased metabolism of Nitric Oxide] | affects cotreatment|decreases reaction|increases metabolic processing | 11498278 |
| C004479 | pimagedine | pimagedine inhibits the reaction [Lipopolysaccharides promotes the reaction [IFNG protein results in increased abundance of Nitric Oxide]] | decreases reaction|increases abundance|increases reaction | 7689037 |
| C004479 | pimagedine | pimagedine inhibits the reaction [[IFNG protein co-treated with Lipopolysaccharides] results in increased abundance of Nitric Oxide] | affects cotreatment|decreases reaction|increases abundance | 12911628 |
| C060836 | pioglitazone | pioglitazone inhibits the reaction [[IFNG protein co-treated with IL1B protein] results in increased metabolism of and results in increased secretion of APP protein alternative form] | affects cotreatment|decreases reaction|increases metabolic processing|increases secretion | 14586007 |
| C060836 | pioglitazone | pioglitazone inhibits the reaction [[IFNG protein co-treated with TNF protein] results in increased expression of and results in increased activity of BACE1 protein] | affects cotreatment|decreases reaction|increases activity|increases expression | 14586007 |
| C060836 | pioglitazone | pioglitazone inhibits the reaction [[IFNG protein co-treated with TNF protein] results in increased metabolism of and results in increased secretion of APP protein alternative form] | affects cotreatment|decreases reaction|increases metabolic processing|increases secretion | 14586007 |
| D010882 | Piperonyl Butoxide | [bioallethrin co-treated with Piperonyl Butoxide] results in increased expression of IFNG protein | affects cotreatment|increases expression | 10414782 |
| C006253 | pirinixic acid | [Picryl Chloride co-treated with pirinixic acid] results in decreased expression of IFNG protein | affects cotreatment|decreases expression | 17371993 |
| C006253 | pirinixic acid | pirinixic acid inhibits the reaction [Cisplatin results in increased expression of IFNG mRNA] | decreases reaction|increases expression | 15814532 |
| C006253 | pirinixic acid | pirinixic acid results in decreased expression of IFNG mRNA | decreases expression | 17888025 18249437 |
| C006253 | pirinixic acid | PPARA protein affects the reaction [[Picryl Chloride co-treated with pirinixic acid] results in decreased expression of IFNG protein] | affects cotreatment|affects reaction|decreases expression | 17371993 |
| D010936 | Plant Extracts | Plant Extracts inhibits the reaction [IFNG protein results in increased expression of ICAM1 mRNA] | decreases reaction|increases expression | 19103272 |
| D010936 | Plant Extracts | Plant Extracts inhibits the reaction [IFNG protein results in increased expression of ICAM1 protein] | decreases reaction|increases expression | 19103272 |
| D010936 | Plant Extracts | Plant Extracts affects the expression of IFNG protein | affects expression | 14686799 |
| D008926 | Plicamycin | Plicamycin inhibits the reaction [IFNG protein promotes the reaction [decitabine results in increased expression of PLA2G2A protein]] | decreases reaction|increases expression|increases reaction | 18953428 |
| D011078 | Polychlorinated Biphenyls | Polychlorinated Biphenyls results in increased expression of IFNG mRNA | increases expression | 17396211 |
| D011070 | Poly I-C | IFNG protein inhibits the reaction [Poly I-C results in increased secretion of IL10 protein] | decreases reaction|increases secretion | 14678198 |
| D011070 | Poly I-C | Poly I-C results in increased expression of IFNG mRNA | increases expression | 9328138 |
| D011070 | Poly I-C | Poly I-C results in increased expression of IFNG protein | increases expression | 17321468 |
| C025299 | polyphenols | polyphenols inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein co-treated with TNF protein] results in increased abundance of Nitric Oxide] | affects cotreatment|decreases reaction|increases abundance | 16366677 |
| C025299 | polyphenols | polyphenols inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein co-treated with TNF protein] results in increased abundance of Reactive Oxygen Species] | affects cotreatment|decreases reaction|increases abundance | 16366677 |
| C025299 | polyphenols | polyphenols inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein co-treated with TNF protein] results in increased expression of NOS2 mRNA] | affects cotreatment|decreases reaction|increases expression | 16366677 |
| C025299 | polyphenols | polyphenols promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein co-treated with TNF protein] results in increased expression of SOD2 protein] | affects cotreatment|increases expression|increases reaction | 16366677 |
| C025299 | polyphenols | polyphenols results in decreased expression of IFNG mRNA | decreases expression | 16293270 |
| D011134 | Polysaccharides | Polysaccharides results in increased secretion of IFNG protein | increases secretion | 15894585 |
| C068291 | poractant alfa | poractant alfa results in decreased expression of IFNG protein | decreases expression | 14644929 |
| D011239 | Prednisolone | Prednisolone results in decreased expression of IFNG protein | decreases expression | 15821026 |
| D011241 | Prednisone | [zafirlukast co-treated with Prednisone co-treated with Budesonide] inhibits the reaction [Antigens results in increased secretion of IFNG protein] | affects cotreatment|decreases reaction|increases secretion | 16160912 |
| D011374 | Progesterone | Progesterone results in increased expression of IFNG protein | increases expression | 15804489 |
| D011411 | Propanil | Lipopolysaccharides promotes the reaction [Propanil results in increased expression of IFNG mRNA] | increases expression|increases reaction | 7679225 |
| D011411 | Propanil | Lipopolysaccharides promotes the reaction [Propanil results in increased expression of IFNG protein] | increases expression|increases reaction | 7679225 |
| D015232 | Dinoprostone | Dinoprostone results in decreased expression of IFNG protein | decreases expression | 9743329 15788148 |
| D015232 | Dinoprostone | Indomethacin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Dinoprostone] | affects cotreatment|decreases reaction|increases abundance | 16716910 15177302 |
| D015232 | Dinoprostone | [Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Dinoprostone | affects cotreatment|increases abundance | 16716910 15177302 |
| D015232 | Dinoprostone | Mangifera indica extract inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Dinoprostone] | affects cotreatment|decreases reaction|increases abundance | 16716910 15177302 |
| D015232 | Dinoprostone | mangiferin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Dinoprostone] | affects cotreatment|decreases reaction|increases abundance | 16716910 15177302 |
| D015232 | Dinoprostone | [IFNG protein co-treated with Lipopolysaccharides] results in increased abundance of Dinoprostone | affects cotreatment|increases abundance | 12911628 |
| D015232 | Dinoprostone | Indomethacin inhibits the reaction [[IFNG protein co-treated with Lipopolysaccharides] results in increased abundance of Dinoprostone] | affects cotreatment|decreases reaction|increases abundance | 12911628 |
| D015232 | Dinoprostone | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [[IFNG protein co-treated with Lipopolysaccharides] results in increased abundance of Dinoprostone] | affects cotreatment|decreases reaction|increases abundance | 12911628 |
| D015232 | Dinoprostone | nimesulide inhibits the reaction [[IFNG protein co-treated with Lipopolysaccharides] results in increased abundance of Dinoprostone] | affects cotreatment|decreases reaction|increases abundance | 12911628 |
| C526689 | punarnavine | punarnavine results in increased expression of IFNG protein | increases expression | 18075866 |
| C020972 | pyrrolidine dithiocarbamic acid | pyrrolidine dithiocarbamic acid inhibits the reaction [IFNG protein results in increased abundance of Nitrites] | decreases reaction|increases abundance | 12845421 |
| D011791 | Quartz | IFNG protein promotes the reaction [Ascorbic Acid promotes the reaction [Quartz results in increased secretion of TNF protein]] | increases reaction|increases secretion | 19298665 |
| D011791 | Quartz | IFNG protein promotes the reaction [Quartz results in increased secretion of TNF protein] | increases reaction|increases secretion | 19298665 |
| D011794 | Quercetin | Quercetin results in increased expression of IFNG mRNA | increases expression | 12431781 |
| D011794 | Quercetin | Quercetin results in increased expression of IFNG protein | increases expression | 12431781 |
| D011794 | Quercetin | Quercetin inhibits the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [IFNG protein results in increased activity of CASP1 protein]] | decreases reaction|increases activity | 15914627 |
| D011794 | Quercetin | Quercetin inhibits the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [IFNG protein results in increased activity of CASP6 protein]] | decreases reaction|increases activity | 15914627 |
| D011794 | Quercetin | Quercetin inhibits the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [IFNG protein results in increased activity of CASP8 protein]] | decreases reaction|increases activity | 15914627 |
| D011794 | Quercetin | Quercetin inhibits the reaction [IFNG protein results in increased expression of NOS2 mRNA] | decreases reaction|increases expression | 16171798 |
| D011794 | Quercetin | Quercetin inhibits the reaction [IFNG protein results in increased expression of NOS2 protein] | decreases reaction|increases expression | 16171798 |
| D011794 | Quercetin | Quercetin inhibits the reaction [IFNG protein results in increased phosphorylation of STAT1 protein] | decreases reaction|increases phosphorylation | 16171798 |
| D011794 | Quercetin | Quercetin inhibits the reaction [[IL1B protein co-treated with IFNG protein] affects the localization of and results in increased activity of NFKB1 protein] | affects cotreatment|affects localization|decreases reaction|increases activity | 18090225 |
| D011794 | Quercetin | Quercetin inhibits the reaction [[IL1B protein co-treated with IFNG protein] affects the localization of and results in increased activity of RELA protein] | affects cotreatment|affects localization|decreases reaction|increases activity | 18090225 |
| D011794 | Quercetin | Quercetin inhibits the reaction [[IL1B protein co-treated with IFNG protein] results in decreased secretion of INS1 protein] | affects cotreatment|decreases reaction|decreases secretion | 18090225 |
| D011794 | Quercetin | Quercetin inhibits the reaction [[IL1B protein co-treated with IFNG protein] results in increased abundance of Nitric Oxide] | affects cotreatment|decreases reaction|increases abundance | 18090225 |
| D011794 | Quercetin | Quercetin inhibits the reaction [[IL1B protein co-treated with IFNG protein] results in increased degradation of NFKBIA protein] | affects cotreatment|decreases reaction|increases degradation | 18090225 |
| D011794 | Quercetin | Quercetin inhibits the reaction [[IL1B protein co-treated with IFNG protein] results in increased expression of NOS2 mRNA] | affects cotreatment|decreases reaction|increases expression | 18090225 |
| D011794 | Quercetin | Quercetin inhibits the reaction [[IL1B protein co-treated with IFNG protein] results in increased expression of NOS2 protein] | affects cotreatment|decreases reaction|increases expression | 18090225 |
| D011794 | Quercetin | Quercetin promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein co-treated with TNF protein] results in increased expression of SOD2 protein] | affects cotreatment|increases expression|increases reaction | 16366677 |
| C402365 | R 848 | [Acetylmuramyl-Alanyl-Isoglutamine co-treated with R 848 co-treated with IFNG protein] results in increased expression of IL12A mRNA | affects cotreatment|increases expression | 18490488 |
| C402365 | R 848 | [Acetylmuramyl-Alanyl-Isoglutamine co-treated with R 848 co-treated with IFNG protein] results in increased expression of [IL12A protein binds to IL12B protein] | affects binding|affects cotreatment|increases expression | 18490488 |
| C402365 | R 848 | [Acetylmuramyl-Alanyl-Isoglutamine co-treated with R 848 co-treated with IFNG protein] results in increased expression of IL12B mRNA | affects cotreatment|increases expression | 18490488 |
| C402365 | R 848 | [beta-Glucans co-treated with R 848 co-treated with IFNG protein] results in increased expression of IL12A mRNA | affects cotreatment|increases expression | 18490488 |
| C402365 | R 848 | IFNG protein affects the reaction [[Zymosan co-treated with R 848] results in increased expression of IL10 protein] | affects cotreatment|affects reaction|increases expression | 18490488 |
| C402365 | R 848 | IFNG protein promotes the reaction [[Zymosan co-treated with R 848] results in increased expression of [IL12A protein binds to IL12B protein]] | affects binding|affects cotreatment|increases expression|increases reaction | 18490488 |
| C402365 | R 848 | IFNG protein promotes the reaction [[Zymosan co-treated with R 848] results in increased expression of IL12B protein] | affects cotreatment|increases expression|increases reaction | 18490488 |
| C402365 | R 848 | IFNG protein promotes the reaction [[Zymosan co-treated with R 848] results in increased expression of [IL12B protein binds to IL23A protein]] | affects binding|affects cotreatment|increases expression|increases reaction | 18490488 |
| C402365 | R 848 | R 848 promotes the reaction [[Acetylmuramyl-Alanyl-Isoglutamine co-treated with Pam(3)CSK(4) peptide co-treated with IFNG protein] results in increased expression of [IL12A protein binds to IL12B protein]] | affects binding|affects cotreatment|increases expression|increases reaction | 18490488 |
| C402365 | R 848 | R 848 promotes the reaction [[Acetylmuramyl-Alanyl-Isoglutamine co-treated with Pam(3)CSK(4) peptide co-treated with IFNG protein] results in increased expression of IL12B protein] | affects cotreatment|increases expression|increases reaction | 18490488 |
| D011899 | Ranitidine | Ranitidine inhibits the reaction [Histamine inhibits the reaction [Lipopolysaccharides results in increased expression of IFNG protein]] | decreases reaction|increases expression | 10569698 |
| D017382 | Reactive Oxygen Species | [Lipopolysaccharides co-treated with IFNG protein co-treated with TNF protein] results in increased abundance of Reactive Oxygen Species | affects cotreatment|increases abundance | 16366677 |
| D017382 | Reactive Oxygen Species | polyphenols inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein co-treated with TNF protein] results in increased abundance of Reactive Oxygen Species] | affects cotreatment|decreases reaction|increases abundance | 16366677 |
| D017382 | Reactive Oxygen Species | resveratrol inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein co-treated with TNF protein] results in increased abundance of Reactive Oxygen Species] | affects cotreatment|decreases reaction|increases abundance | 16366677 |
| C059514 | resveratrol | resveratrol inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of IL8 mRNA] | affects cotreatment|decreases reaction|increases expression | 15779068 |
| C059514 | resveratrol | resveratrol inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of IL8 protein] | affects cotreatment|decreases reaction|increases expression | 15779068 |
| C059514 | resveratrol | resveratrol inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of PTGES2 protein] | affects cotreatment|decreases reaction|increases expression | 15779068 |
| C059514 | resveratrol | resveratrol inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of TNF mRNA] | affects cotreatment|decreases reaction|increases expression | 15779068 |
| C059514 | resveratrol | resveratrol inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of TNF protein] | affects cotreatment|decreases reaction|increases expression | 15779068 |
| C059514 | resveratrol | resveratrol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of IFNG protein] | affects cotreatment|decreases reaction|increases expression | 16154495 |
| C059514 | resveratrol | resveratrol affects the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of and results in increased secretion of IFNG protein] | affects cotreatment|affects reaction|increases expression|increases secretion | 16716911 |
| C059514 | resveratrol | resveratrol results in decreased expression of IFNG mRNA | decreases expression | 16256029 |
| C059514 | resveratrol | resveratrol results in decreased expression of IFNG protein | decreases expression | 17872969 16256029 |
| C059514 | resveratrol | resveratrol inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein co-treated with TNF protein] results in increased abundance of Nitric Oxide] | affects cotreatment|decreases reaction|increases abundance | 16366677 |
| C059514 | resveratrol | resveratrol inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein co-treated with TNF protein] results in increased abundance of Reactive Oxygen Species] | affects cotreatment|decreases reaction|increases abundance | 16366677 |
| C059514 | resveratrol | resveratrol inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein co-treated with TNF protein] results in increased expression of NOS2 mRNA] | affects cotreatment|decreases reaction|increases expression | 16366677 |
| C059514 | resveratrol | resveratrol inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein co-treated with TNF protein] results in increased expression of NOS2 protein] | affects cotreatment|decreases reaction|increases expression | 16366677 |
| C059514 | resveratrol | resveratrol promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein co-treated with TNF protein] results in increased expression of SOD2 protein] | affects cotreatment|increases expression|increases reaction | 16366677 |
| C009674 | ribosome inactivating protein, Viscum | ribosome inactivating protein, Viscum results in increased secretion of IFNG protein | increases secretion | 18602257 |
| C089032 | rimonabant | rimonabant inhibits the reaction [[3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol binds to and results in increased activity of CNR1 protein] inhibits the reaction [IFNG protein affects the reaction [Lipopolysaccharides results in increased abundance of Nitric Oxide]]] | affects binding|affects reaction|decreases reaction|increases abundance|increases activity | 11727767 |
| C084904 | Ro 41-5253 | Ro 41-5253 inhibits the reaction [IFNG protein promotes the reaction [Tretinoin results in increased expression of MUC4 protein]] | decreases reaction|increases expression|increases reaction | 16007204 |
| C084904 | Ro 41-5253 | Ro 41-5253 inhibits the reaction [IFNG protein results in increased expression of MUC4 protein] | decreases reaction|increases expression | 16007204 |
| C084904 | Ro 41-5253 | Ro 41-5253 inhibits the reaction [Tretinoin results in decreased secretion of IFNG protein] | decreases reaction|decreases secretion | 16872382 |
| C045282 | roquinimex | roquinimex results in decreased expression of and results in decreased secretion of IFNG protein | decreases expression|decreases secretion | 15270847 |
| C045282 | roquinimex | roquinimex results in decreased expression of IFNG mRNA | decreases expression | 15270847 |
| D012402 | Rotenone | Rotenone inhibits the reaction [IFNG protein affects the localization of STAT1 protein] | affects localization|decreases reaction | 15748169 |
| D012402 | Rotenone | Rotenone inhibits the reaction [IFNG protein results in increased phosphorylation of and results in increased activity of STAT1 protein] | decreases reaction|increases activity|increases phosphorylation | 15748169 |
| C099445 | S 28463 | S 28463 results in decreased expression of IFNG protein | decreases expression | 16361354 |
| D012503 | Saponins | Saponins inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein co-treated with TNF protein] results in increased expression of NOS2 mRNA] | affects cotreatment|decreases reaction|increases expression | 16366677 |
| D012503 | Saponins | Saponins inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein co-treated with TNF protein] results in increased expression of NOS2 protein] | affects cotreatment|decreases reaction|increases expression | 16366677 |
| D012503 | Saponins | Saponins inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein co-treated with TNF protein] results in increased expression of SOD2 protein] | affects cotreatment|decreases reaction|increases expression | 16366677 |
| C093642 | SB 203580 | SB 203580 inhibits the reaction [[IL12A protein binds to IL12B protein] which results in increased expression of IFNG protein] | affects binding|decreases reaction|increases expression | 10952721 |
| C093642 | SB 203580 | [SB 203580 co-treated with Manganese] inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Nitric Oxide] | affects cotreatment|decreases reaction|increases abundance | 16488514 |
| C093642 | SB 203580 | SB 203580 inhibits the reaction [[IFNG protein co-treated with Lipopolysaccharides] results in increased abundance of Nitric Oxide] | affects cotreatment|decreases reaction|increases abundance | 12911628 |
| C093642 | SB 203580 | SB 203580 inhibits the reaction [[IFNG protein co-treated with Lipopolysaccharides] results in increased expression of NOS2 protein] | affects cotreatment|decreases reaction|increases expression | 12911628 |
| C093642 | SB 203580 | SB 203580 inhibits the reaction [[IFNG protein co-treated with Lipopolysaccharides] results in increased expression of PTGS2 protein] | affects cotreatment|decreases reaction|increases expression | 12911628 |
| C093642 | SB 203580 | SB 203580 inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Nitric Oxide] | affects cotreatment|decreases reaction|increases abundance | 16488514 |
| C093642 | SB 203580 | SB 203580 inhibits the reaction [Manganese promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mRNA]] | affects cotreatment|decreases reaction|increases expression|increases reaction | 16488514 |
| C093642 | SB 203580 | SB 203580 inhibits the reaction [Manganese promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of TNF protein]] | affects cotreatment|decreases reaction|increases expression|increases reaction | 16488514 |
| D012643 | Selenium | Selenium results in decreased expression of IFNG protein | decreases expression | 14624943 |
| D012834 | Silver | Silver results in decreased secretion of IFNG protein | decreases secretion | 17996693 |
| D012839 | Simazine | Simazine results in decreased expression of IFNG protein | decreases expression | 10883730 |
| C017947 | sodium arsenite | sodium arsenite results in decreased expression of IFNG mRNA | decreases expression | 20339924 |
| C017947 | sodium arsenite | IFNG protein inhibits the reaction [sodium arsenite results in increased expression of and results in increased phosphorylation of SMAD3 protein] | decreases reaction|increases expression|increases phosphorylation | 17003472 |
| C017947 | sodium arsenite | IFNG protein inhibits the reaction [sodium arsenite results in increased expression of ATF3 protein] | decreases reaction|increases expression | 17003472 |
| C017947 | sodium arsenite | IFNG protein inhibits the reaction [sodium arsenite results in increased expression of TGFB1 protein] | decreases reaction|increases expression | 17003472 |
| C017947 | sodium arsenite | IFNG protein promotes the reaction [sodium arsenite results in increased expression of ABCC1 protein] | increases expression|increases reaction | 17003472 |
| C017947 | sodium arsenite | IFNG protein results in decreased susceptibility to sodium arsenite | decreases response to substance | 17003472 |
| C017947 | sodium arsenite | sodium arsenite results in increased expression of IFNG mRNA | increases expression | 17003472 |
| C017947 | sodium arsenite | sodium arsenite results in decreased expression of IFNG protein | decreases expression | 19145326 |
| D012967 | Sodium Dodecyl Sulfate | [dibenzothiazyl disulfide co-treated with Sodium Dodecyl Sulfate] results in increased expression of IFNG protein | affects cotreatment|increases expression | 12062936 |
| D012967 | Sodium Dodecyl Sulfate | [diethylamine co-treated with Sodium Dodecyl Sulfate] results in increased expression of IFNG protein | affects cotreatment|increases expression | 12062936 |
| D018038 | Sodium Selenite | Sodium Selenite inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased activity of SP1 protein] | affects cotreatment|decreases reaction|increases activity | 15650415 |
| D018038 | Sodium Selenite | Sodium Selenite inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of SOD2 mRNA] | affects cotreatment|decreases reaction|increases expression | 15650415 |
| D018038 | Sodium Selenite | Sodium Selenite inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of UCP2 mRNA] | affects cotreatment|decreases reaction|increases expression | 15650415 |
| D018038 | Sodium Selenite | Sodium Selenite inhibits the reaction [Streptozocin results in increased expression of IFNG mRNA] | decreases reaction|increases expression | 18789669 |
| D013311 | Streptozocin | Clodronic Acid inhibits the reaction [Streptozocin results in increased expression of IFNG protein] | decreases reaction|increases expression | 15892581 |
| D013311 | Streptozocin | S-Nitroso-N-Acetylpenicillamine inhibits the reaction [Streptozocin results in increased expression of IFNG protein] | decreases reaction|increases expression | 15892581 |
| D013311 | Streptozocin | Sodium Selenite inhibits the reaction [Streptozocin results in increased expression of IFNG mRNA] | decreases reaction|increases expression | 18789669 |
| D013311 | Streptozocin | Streptozocin results in increased expression of IFNG mRNA | increases expression | 18789669 15862027 |
| D013311 | Streptozocin | Streptozocin results in increased expression of IFNG protein | increases expression | 15892581 |
| D013420 | Sulfamethoxazole | Sulfamethoxazole analog results in increased secretion of IFNG protein | increases secretion | 15588915 |
| D013448 | Sulfobromophthalein | Sulfobromophthalein inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of IL12B protein] | affects cotreatment|decreases reaction|increases expression | 11907163 |
| D013467 | Sulindac | Sulindac inhibits the reaction [IFNG protein results in increased expression of CXCL9 mRNA] | decreases reaction|increases expression | 17010317 |
| C029222 | sym-trinitrobenzene | sym-trinitrobenzene results in increased expression of IFNG mRNA | increases expression | 12901851 15890784 |
| C458508 | T 0070907 | T 0070907 inhibits the reaction [15-deoxy-delta(12,14)-prostaglandin J2 results in decreased secretion of IFNG protein] | decreases reaction|decreases secretion | 16844232 |
| C458508 | T 0070907 | T 0070907 inhibits the reaction [ciglitazone results in decreased secretion of IFNG protein] | decreases reaction|decreases secretion | 16844232 |
| C458508 | T 0070907 | T 0070907 results in decreased expression of and results in decreased secretion of IFNG protein | decreases expression|decreases secretion | 16091293 |
| D016559 | Tacrolimus | Tacrolimus results in decreased expression of IFNG mRNA | decreases expression | 16368244 |
| D013629 | Tamoxifen | Tamoxifen inhibits the reaction [IFNG protein results in increased metabolism of Nitric Oxide] | decreases reaction|increases metabolic processing | 19446535 |
| D013629 | Tamoxifen | Tamoxifen results in decreased expression of IFNG mRNA | decreases expression | 19031437 |
| D013629 | Tamoxifen | Tamoxifen results in decreased expression of IFNG protein | decreases expression | 19031437 |
| C003377 | taxifolin | taxifolin inhibits the reaction [IFNG protein results in increased activity of and results in increased localization of STAT1 protein] | decreases reaction|increases activity|increases localization | 12044887 |
| C003377 | taxifolin | taxifolin inhibits the reaction [IFNG protein results in increased expression of ICAM1 mRNA] | decreases reaction|increases expression | 12044887 19103272 |
| C003377 | taxifolin | taxifolin inhibits the reaction [IFNG protein results in increased expression of ICAM1 protein] | decreases reaction|increases expression | 19103272 12044887 |
| C003377 | taxifolin | taxifolin inhibits the reaction [IFNG protein results in increased phosphorylation of MAPK8 protein] | decreases reaction|increases phosphorylation | 12044887 |
| D013726 | Terbutaline | [IFNG protein co-treated with Lipopolysaccharides] inhibits the reaction [Terbutaline results in increased secretion of REN protein] | affects cotreatment|decreases reaction|increases secretion | 9256163 |
| D013745 | Tetanus Toxoid | Tetanus Toxoid results in increased secretion of IFNG protein | increases secretion | 16367942 |
| D013749 | Tetrachlorodibenzodioxin | IFNG protein affects the susceptibility to Tetrachlorodibenzodioxin | affects response to substance | 18948302 |
| D013749 | Tetrachlorodibenzodioxin | IFNG protein inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of IGJ mRNA] | decreases expression|decreases reaction | 18948302 |
| D013749 | Tetrachlorodibenzodioxin | IFNG protein inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of IGK mRNA] | decreases expression|decreases reaction | 18948302 |
| D013749 | Tetrachlorodibenzodioxin | IFNG protein inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA] | decreases reaction|increases expression | 18948302 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in decreased expression of IFNG mRNA | decreases expression | 16102516 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of IFNG mRNA | increases expression | 12819374 |
| D013750 | Tetrachloroethylene | Tetrachloroethylene results in decreased expression of IFNG protein | decreases expression | 12112628 |
| D013755 | Tetradecanoylphorbol Acetate | Aspirin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased secretion of IFNG protein] | affects cotreatment|decreases reaction|increases secretion | 15379866 |
| D013755 | Tetradecanoylphorbol Acetate | [Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of IFNG protein | affects cotreatment|increases expression | 14994387 |
| D013755 | Tetradecanoylphorbol Acetate | monocyte locomotion inhibitory factor inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of IFNG protein] | decreases reaction|increases secretion | 16374615 |
| D013755 | Tetradecanoylphorbol Acetate | resveratrol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of IFNG protein] | affects cotreatment|decreases reaction|increases expression | 16154495 |
| D013755 | Tetradecanoylphorbol Acetate | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of IFNG protein | affects cotreatment|increases expression | 16154495 17572062 15358692 |
| D013755 | Tetradecanoylphorbol Acetate | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased secretion of IFNG protein | affects cotreatment|increases secretion | 15379866 |
| D013755 | Tetradecanoylphorbol Acetate | Tetradecanoylphorbol Acetate inhibits the reaction [IFNG protein promotes the reaction [decitabine results in increased expression of PLA2G2A protein]] | decreases reaction|increases expression|increases reaction | 18953428 |
| D013755 | Tetradecanoylphorbol Acetate | Tetradecanoylphorbol Acetate results in increased secretion of IFNG protein | increases secretion | 16374615 |
| D013755 | Tetradecanoylphorbol Acetate | Estradiol affects the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of and results in increased secretion of IFNG protein] | affects cotreatment|affects reaction|increases expression|increases secretion | 16716911 |
| D013755 | Tetradecanoylphorbol Acetate | resveratrol affects the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of and results in increased secretion of IFNG protein] | affects cotreatment|affects reaction|increases expression|increases secretion | 16716911 |
| D013755 | Tetradecanoylphorbol Acetate | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of and results in increased secretion of IFNG protein | affects cotreatment|increases expression|increases secretion | 16716911 |
| D013792 | Thalidomide | Thalidomide affects the expression of IFNG mRNA | affects expression | 16454849 |
| D013792 | Thalidomide | Thalidomide results in increased expression of IFNG | increases expression | 17089043 |
| D013792 | Thalidomide | Thalidomide results in increased expression of IFNG protein | increases expression | 16514283 |
| D013792 | Thalidomide | Thalidomide inhibits the reaction [irinotecan results in increased expression of IFNG protein] | decreases reaction|increases expression | 16815871 |
| D013792 | Thalidomide | Thalidomide promotes the reaction [irinotecan results in increased expression of IFNG protein] | increases expression|increases reaction | 16815871 |
| D013792 | Thalidomide | Thalidomide results in decreased expression of IFNG protein | decreases expression | 16078585 |
| D013792 | Thalidomide | Thalidomide results in increased expression of IFNG | increases expression | 17013434 |
| D013864 | Thioglycolates | Glucans inhibits the reaction [Thioglycolates results in increased expression of IFNG protein] | decreases reaction|increases expression | 19804847 |
| D013864 | Thioglycolates | Thioglycolates results in increased expression of IFNG protein | increases expression | 19804847 |
| D013890 | Thiourea | Thiourea analog inhibits the reaction [IFNG protein promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of SPP1 mRNA]] | decreases reaction|increases expression|increases reaction | 10868913 |
| D013893 | Thiram | Thiram results in increased expression of IFNG protein | increases expression | 12062936 |
| D014051 | Toluene 2,4-Diisocyanate | CD4 protein affects the reaction [Toluene 2,4-Diisocyanate results in increased expression of IFNG mRNA] | affects reaction|increases expression | 15590890 |
| D014051 | Toluene 2,4-Diisocyanate | ICAM1 protein affects the reaction [Toluene 2,4-Diisocyanate results in increased expression of IFNG protein] | affects reaction|increases expression | 17014439 |
| D014051 | Toluene 2,4-Diisocyanate | Toluene 2,4-Diisocyanate results in decreased expression of IFNG mRNA | decreases expression | 12356572 |
| D014051 | Toluene 2,4-Diisocyanate | Toluene 2,4-Diisocyanate results in decreased expression of IFNG protein | decreases expression | 16271432 |
| D014051 | Toluene 2,4-Diisocyanate | Toluene 2,4-Diisocyanate results in increased expression of IFNG mRNA | increases expression | 10637130 18242016 15590890 17641053 18652873 11243917 |
| D014051 | Toluene 2,4-Diisocyanate | Toluene 2,4-Diisocyanate results in increased expression of IFNG protein | increases expression | 20219652 18652873 17014439 19042193 12884401 17980417 |
| D014107 | Tosyllysine Chloromethyl Ketone | Tosyllysine Chloromethyl Ketone inhibits the reaction [IFNG protein results in increased abundance of Nitrites] | decreases reaction|increases abundance | 12845421 |
| D014107 | Tosyllysine Chloromethyl Ketone | Tosyllysine Chloromethyl Ketone results in decreased expression of IFNG protein | decreases expression | 11266287 |
| D014212 | Tretinoin | Dactinomycin inhibits the reaction [Tretinoin promotes the reaction [IFNG protein results in increased expression of IRF1 protein]] | decreases reaction|increases expression|increases reaction | 16085646 |
| D014212 | Tretinoin | [IFNG protein co-treated with Tretinoin] results in increased expression of FAS mRNA | affects cotreatment|increases expression | 16136269 |
| D014212 | Tretinoin | [IFNG protein co-treated with Tretinoin] results in increased expression of FAS protein | affects cotreatment|increases expression | 16136269 |
| D014212 | Tretinoin | IFNG protein inhibits the reaction [Tretinoin results in increased expression of MUC4 mRNA] | decreases reaction|increases expression | 16007204 |
| D014212 | Tretinoin | IFNG protein inhibits the reaction [Tretinoin results in increased expression of MUC4 protein] | decreases reaction|increases expression | 16007204 |
| D014212 | Tretinoin | IFNG protein inhibits the reaction [Tretinoin results in increased expression of TGFB2 mRNA] | decreases reaction|increases expression | 16007204 |
| D014212 | Tretinoin | IFNG protein promotes the reaction [Tretinoin results in increased expression of IRF1 protein] | increases expression|increases reaction | 16636311 |
| D014212 | Tretinoin | IFNG protein promotes the reaction [Tretinoin results in increased expression of RARA mRNA] | increases expression|increases reaction | 16007204 |
| D014212 | Tretinoin | IFNG protein promotes the reaction [Tretinoin results in increased expression of RARG mRNA] | increases expression|increases reaction | 16007204 |
| D014212 | Tretinoin | RARA protein affects the reaction [Tretinoin results in decreased secretion of IFNG protein] | affects reaction|decreases secretion | 16872382 |
| D014212 | Tretinoin | Ro 41-5253 inhibits the reaction [IFNG protein promotes the reaction [Tretinoin results in increased expression of MUC4 protein]] | decreases reaction|increases expression|increases reaction | 16007204 |
| D014212 | Tretinoin | Ro 41-5253 inhibits the reaction [Tretinoin results in decreased secretion of IFNG protein] | decreases reaction|decreases secretion | 16872382 |
| D014212 | Tretinoin | Tretinoin inhibits the reaction [IFNG protein results in increased expression of STAT1 protein] | decreases reaction|increases expression | 16007204 |
| D014212 | Tretinoin | Tretinoin inhibits the reaction [IFNG protein results in increased phosphorylation of STAT1 protein] | decreases reaction|increases phosphorylation | 16636311 |
| D014212 | Tretinoin | Tretinoin promotes the reaction [IFNG protein promotes the reaction [IRF1 protein results in increased expression of CASP1 mRNA]] | increases expression|increases reaction | 16085646 |
| D014212 | Tretinoin | Tretinoin promotes the reaction [IFNG protein promotes the reaction [IRF1 protein results in increased expression of TNFSF10 mRNA]] | increases expression|increases reaction | 16085646 |
| D014212 | Tretinoin | Tretinoin promotes the reaction [IFNG protein results in increased expression of and results in increased localization of and results in increased activity of IRF1 protein] | increases activity|increases expression|increases localization|increases reaction | 16085646 |
| D014212 | Tretinoin | Tretinoin promotes the reaction [IFNG protein results in increased expression of CASP1 mRNA] | increases expression|increases reaction | 16085646 |
| D014212 | Tretinoin | Tretinoin promotes the reaction [IFNG protein results in increased expression of TNFSF10 mRNA] | increases expression|increases reaction | 16085646 |
| D014212 | Tretinoin | Tretinoin promotes the reaction [IFNG protein results in increased phosphorylation of and results in increased activity of STAT1 protein] | increases activity|increases phosphorylation|increases reaction | 16085646 |
| D014212 | Tretinoin | Tretinoin results in decreased expression of IFNG mRNA | decreases expression | 16292516 15189689 17118196 16872382 |
| D014212 | Tretinoin | Tretinoin results in decreased expression of IFNG protein | decreases expression | 17107666 17118196 16292516 |
| D014212 | Tretinoin | Tretinoin results in decreased secretion of IFNG protein | decreases secretion | 16872382 |
| C015559 | trimellitic anhydride | trimellitic anhydride results in increased expression of IFNG mRNA | increases expression | 10637130 |
| C015559 | trimellitic anhydride | trimellitic anhydride results in increased expression of IFNG protein | increases expression | 20219652 12884401 |
| D014302 | Trinitrobenzenesulfonic Acid | Trinitrobenzenesulfonic Acid results in increased expression of IFNG mRNA | increases expression | 15973123 |
| D014302 | Trinitrobenzenesulfonic Acid | Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IFNG mRNA] | decreases reaction|increases expression | 16782535 16867261 |
| D014302 | Trinitrobenzenesulfonic Acid | Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IFNG protein] | decreases reaction|increases expression | 16867261 |
| D014302 | Trinitrobenzenesulfonic Acid | Dexamethasone inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IFNG mRNA] | decreases reaction|increases expression | 16782535 16867261 |
| D014302 | Trinitrobenzenesulfonic Acid | Dexamethasone inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IFNG protein] | decreases reaction|increases expression | 16867261 |
| D014302 | Trinitrobenzenesulfonic Acid | Trinitrobenzenesulfonic Acid results in increased expression of IFNG mRNA | increases expression | 16867261 16782535 |
| D014302 | Trinitrobenzenesulfonic Acid | Trinitrobenzenesulfonic Acid results in increased expression of IFNG protein | increases expression | 16867261 |
| D010853 | Picryl Chloride | Cyclosporine promotes the reaction [Picryl Chloride results in increased expression of IFNG protein] | increases expression|increases reaction | 16442096 |
| D010853 | Picryl Chloride | [Picryl Chloride co-treated with pirinixic acid] results in decreased expression of IFNG protein | affects cotreatment|decreases expression | 17371993 |
| D010853 | Picryl Chloride | Picryl Chloride results in increased expression of IFNG mRNA | increases expression | 12484431 |
| D010853 | Picryl Chloride | Picryl Chloride results in increased expression of IFNG protein | increases expression | 16442096 |
| D010853 | Picryl Chloride | PPARA protein affects the reaction [[Picryl Chloride co-treated with pirinixic acid] results in decreased expression of IFNG protein] | affects cotreatment|affects reaction|decreases expression | 17371993 |
| D014307 | Trioxsalen | Trioxsalen analog inhibits the reaction [IFNG protein results in increased expression of NOS2 protein] | decreases reaction|increases expression | 16259964 |
| C050414 | tripterine | tripterine inhibits the reaction [IFNG protein results in increased expression of ICAM1 protein] | decreases reaction|increases expression | 16769766 |
| C050414 | tripterine | tripterine inhibits the reaction [IFNG protein results in increased expression of VCAM1 protein] | decreases reaction|increases expression | 16769766 |
| C113580 | U 0126 | U 0126 inhibits the reaction [[IL12A protein binds to IL12B protein] which results in increased expression of IFNG protein] | affects binding|decreases reaction|increases expression | 10952721 |
| C113580 | U 0126 | [U 0126 co-treated with Manganese] inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Nitric Oxide] | affects cotreatment|decreases reaction|increases abundance | 16488514 |
| C113580 | U 0126 | U 0126 inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Nitric Oxide] | affects cotreatment|decreases reaction|increases abundance | 16488514 |
| C113580 | U 0126 | U 0126 inhibits the reaction [Manganese promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mRNA]] | affects cotreatment|decreases reaction|increases expression|increases reaction | 16488514 |
| C113580 | U 0126 | U 0126 inhibits the reaction [Manganese promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of TNF protein]] | affects cotreatment|decreases reaction|increases expression|increases reaction | 16488514 |
| D014501 | Uranium | Uranium results in increased expression of IFNG mRNA | increases expression | 16854789 |
| D014520 | Urethane | Urethane results in increased expression of and results in increased secretion of IFNG protein | increases expression|increases secretion | 18082304 |
| D014520 | Urethane | Freund's Adjuvant inhibits the reaction [Urethane results in decreased expression of IFNG mRNA] | decreases expression|decreases reaction | 12810352 |
| D014520 | Urethane | IFNG protein inhibits the reaction [Urethane results in decreased expression of BCL2 mRNA] | decreases expression|decreases reaction | 11091364 |
| D014520 | Urethane | IFNG protein inhibits the reaction [Urethane results in decreased expression of CSF2 mRNA] | decreases expression|decreases reaction | 12810352 |
| D014520 | Urethane | IFNG protein inhibits the reaction [Urethane results in decreased expression of EDNRB mRNA] | decreases expression|decreases reaction | 12810352 |
| D014520 | Urethane | IFNG protein inhibits the reaction [Urethane results in decreased expression of FOS mRNA] | decreases expression|decreases reaction | 12810352 |
| D014520 | Urethane | IFNG protein inhibits the reaction [Urethane results in decreased expression of IFNG mRNA] | decreases expression|decreases reaction | 12810352 |
| D014520 | Urethane | IFNG protein inhibits the reaction [Urethane results in decreased expression of IL10 mRNA] | decreases expression|decreases reaction | 12810352 |
| D014520 | Urethane | IFNG protein inhibits the reaction [Urethane results in decreased expression of IL4 mRNA] | decreases expression|decreases reaction | 12810352 |
| D014520 | Urethane | IFNG protein inhibits the reaction [Urethane results in decreased expression of JUN mRNA] | decreases expression|decreases reaction | 12810352 |
| D014520 | Urethane | IFNG protein inhibits the reaction [Urethane results in decreased expression of PDGFB mRNA] | decreases expression|decreases reaction | 12810352 |
| D014520 | Urethane | IFNG protein inhibits the reaction [Urethane results in decreased expression of PRKCA mRNA] | decreases expression|decreases reaction | 11091364 |
| D014520 | Urethane | IFNG protein inhibits the reaction [Urethane results in decreased expression of TGFB1 mRNA] | decreases expression|decreases reaction | 12810352 |
| D014520 | Urethane | IFNG protein inhibits the reaction [Urethane results in decreased expression of TGFB2 mRNA] | decreases expression|decreases reaction | 12810352 |
| D014520 | Urethane | IFNG protein inhibits the reaction [Urethane results in decreased expression of TGFB3 mRNA] | decreases expression|decreases reaction | 12810352 |
| D014520 | Urethane | IFNG protein inhibits the reaction [Urethane results in decreased expression of TRP53 mRNA] | decreases expression|decreases reaction | 12810352 |
| D014520 | Urethane | IFNG protein promotes the reaction [Urethane results in increased expression of EGFR mRNA] | increases expression|increases reaction | 12810352 |
| D014520 | Urethane | IFNG protein promotes the reaction [Urethane results in increased expression of IGF1 mRNA] | increases expression|increases reaction | 12810352 |
| D014520 | Urethane | IFNG protein promotes the reaction [Urethane results in increased expression of IGF2 mRNA] | increases expression|increases reaction | 12810352 |
| D014520 | Urethane | IFNG protein promotes the reaction [Urethane results in increased expression of IL2 mRNA] | increases expression|increases reaction | 12810352 |
| D014520 | Urethane | IFNG protein promotes the reaction [Urethane results in increased expression of PTGER1 mRNA] | increases expression|increases reaction | 12810352 |
| D014520 | Urethane | [Urethane co-treated with IFNG protein] results in increased expression of PDGFA mRNA | affects cotreatment|increases expression | 12810352 |
| D014520 | Urethane | [Urethane co-treated with IFNG protein] results in increased expression of PRL mRNA | affects cotreatment|increases expression | 12810352 |
| D014520 | Urethane | [Urethane co-treated with IFNG protein] results in increased expression of PTGER2 mRNA | affects cotreatment|increases expression | 12810352 |
| D014520 | Urethane | [Urethane co-treated with IFNG protein] results in increased expression of WEE1 mRNA | affects cotreatment|increases expression | 12810352 |
| D014520 | Urethane | Urethane results in decreased expression of IFNG mRNA | decreases expression | 12810352 |
| D014560 | Urocanic Acid | IFNG protein affects the susceptibility to [Permethrin co-treated with Urocanic Acid] | affects cotreatment|affects response to substance | 14617103 |
| D014635 | Valproic Acid | Valproic Acid affects the expression of IFNG protein | affects expression | 18396377 |
| C029297 | vinylidene chloride | vinylidene chloride results in decreased expression of IFNG protein | decreases expression | 16879906 |
| C029297 | vinylidene chloride | vinylidene chloride results in increased expression of IFNG protein | increases expression | 12505375 |
| D014801 | Vitamin A | Vitamin A results in decreased expression of IFNG protein | decreases expression | 14624943 |
| D014801 | Vitamin A | Vitamin A affects the expression of IFNG protein | affects expression | 17289162 |
| D014810 | Vitamin E | Vitamin E results in decreased expression of IFNG protein | decreases expression | 14624943 |
| C009687 | wortmannin | wortmannin inhibits the reaction [Ciprofloxacin inhibits the reaction [[IL1A protein co-treated with TNF protein co-treated with IFNG protein] results in increased abundance of Nitric Oxide]] | affects cotreatment|decreases reaction|increases abundance | 16968468 |
| C062735 | zafirlukast | [zafirlukast co-treated with Prednisone co-treated with Budesonide] inhibits the reaction [Antigens results in increased secretion of IFNG protein] | affects cotreatment|decreases reaction|increases secretion | 16160912 |
| C094299 | ZD 9331 | IFNG protein results in increased susceptibility to ZD 9331 | increases response to substance | 15342418 |
| D015029 | Zeranol | Zeranol results in decreased secretion of IFNG protein | decreases secretion | 14636701 |
| D015215 | Zidovudine | Zidovudine affects the expression of IFNG protein | affects expression | 9612607 |
| D015032 | Zinc | N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [Zinc results in increased secretion of IFNG protein] | decreases reaction|increases secretion | 17150331 |
| D015032 | Zinc | Zinc inhibits the reaction [[IFNG protein co-treated with TNF protein co-treated with N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine] results in increased cleavage of CDH1 protein] | affects cotreatment|decreases reaction|increases cleavage | 16844947 |
| D015032 | Zinc | Zinc inhibits the reaction [[IFNG protein co-treated with TNF protein co-treated with N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine] results in increased cleavage of CTNNB1 protein] | affects cotreatment|decreases reaction|increases cleavage | 16844947 |
| D015032 | Zinc | Zinc results in increased expression of IFNG mRNA | increases expression | 16472982 |
| D015032 | Zinc | Zinc results in increased expression of IFNG protein | increases expression | 16472982 |
| D015032 | Zinc | Zinc results in increased secretion of IFNG protein | increases secretion | 17150331 |
| D015032 | Zinc | Zinc results in decreased expression of IFNG protein | decreases expression | 14624943 |
| D015039 | Ziram | Ziram results in increased expression of IFNG protein | increases expression | 12062936 |
| C088658 | zoledronic acid | zoledronic acid promotes the reaction [IL2 protein affects the expression of IFNG protein] | affects expression|increases reaction | 19400555 |
| C088658 | zoledronic acid | zoledronic acid results in increased expression of IFNG protein | increases expression | 19818098 |
| C022189 | zonisamide | zonisamide results in decreased expression of IFNG protein | decreases expression | 10982153 |
| D015054 | Zymosan | IFNG protein affects the reaction [[Zymosan co-treated with R 848] results in increased expression of IL10 protein] | affects cotreatment|affects reaction|increases expression | 18490488 |
| D015054 | Zymosan | IFNG protein affects the reaction [Zymosan results in increased expression of IL10 protein] | affects reaction|increases expression | 18490488 |
| D015054 | Zymosan | IFNG protein inhibits the reaction [Zymosan results in increased expression of IL10 protein] | decreases reaction|increases expression | 16713974 |
| D015054 | Zymosan | IFNG protein promotes the reaction [[Zymosan co-treated with R 848] results in increased expression of [IL12A protein binds to IL12B protein]] | affects binding|affects cotreatment|increases expression|increases reaction | 18490488 |
| D015054 | Zymosan | IFNG protein promotes the reaction [[Zymosan co-treated with R 848] results in increased expression of IL12B protein] | affects cotreatment|increases expression|increases reaction | 18490488 |
| D015054 | Zymosan | IFNG protein promotes the reaction [[Zymosan co-treated with R 848] results in increased expression of [IL12B protein binds to IL23A protein]] | affects binding|affects cotreatment|increases expression|increases reaction | 18490488 |
| D015054 | Zymosan | IFNG protein promotes the reaction [Zymosan results in increased expression of [IL12A protein binds to IL12B protein]] | affects binding|increases expression|increases reaction | 18490488 |
| D015054 | Zymosan | IFNG protein promotes the reaction [Zymosan results in increased expression of IL12B protein] | increases expression|increases reaction | 18490488 |
| D015054 | Zymosan | IFNG protein promotes the reaction [Zymosan results in increased expression of [IL12B protein binds to IL23A protein]] | affects binding|increases expression|increases reaction | 18490488 |
| D015054 | Zymosan | CCR2 protein affects the reaction [Zymosan results in increased expression of IFNG mRNA] | affects reaction|increases expression | 12845637 |
| D015054 | Zymosan | CCR2 protein affects the reaction [Zymosan results in increased expression of IFNG protein] | affects reaction|increases expression | 12845637 |
| D015054 | Zymosan | [Lipopolysaccharides co-treated with Zymosan] results in increased expression of IFNG mRNA | affects cotreatment|increases expression | 15213630 |
| D015054 | Zymosan | TLR2 protein promotes the reaction [Zymosan affects the activity of IFNG protein] | affects activity|increases reaction | 17257219 |
| D015054 | Zymosan | Zymosan affects the activity of IFNG protein | affects activity | 17257219 |
| D015054 | Zymosan | [Zymosan co-treated with IFNG protein] results in increased expression of CXCL9 mRNA | affects cotreatment|increases expression | 15154616 |
| D015054 | Zymosan | Zymosan results in increased expression of IFNG mRNA | increases expression | 14507659 12845637 |
| D015054 | Zymosan | Zymosan results in increased expression of IFNG protein | increases expression | 17321468 12845637 |
| D015054 | Zymosan | Zymosan results in increased secretion of IFNG protein | increases secretion | 15618177 |
| D015054 | Zymosan | BRL 44408 inhibits the reaction [Clonidine inhibits the reaction [Zymosan results in increased expression of IFNG protein]] | decreases reaction|increases expression | 16192389 |
| D015054 | Zymosan | Clonidine inhibits the reaction [Zymosan results in increased expression of IFNG protein] | decreases reaction|increases expression | 16192389 |
| D015054 | Zymosan | Zymosan results in increased expression of IFNG protein | increases expression | 18089291 |
| D015054 | Zymosan | Zymosan results in increased expression of IFNG mRNA | increases expression | 16973119 |
| Disease ID | Disease Name | Direct Evidence | Inference Chemical Name | Inference Score | Publication |
|---|---|---|---|---|---|
| MESH:D000008 | Abdominal Neoplasms | Sulindac | 8.23 | 14745880 | |
| MESH:D000008 | Abdominal Neoplasms | Tamoxifen | 8.23 | 14745880 | |
| MESH:D000014 | Abnormalities, Drug-Induced | Ethanol | 18.93 | 18926900 17676605 | |
| MESH:D000014 | Abnormalities, Drug-Induced | mancozeb | 18.93 | 982313 | |
| MESH:D000014 | Abnormalities, Drug-Induced | Phenytoin | 18.93 | 9118846 9677735 6195326 8986270 3425630 10563481 | |
| MESH:D000014 | Abnormalities, Drug-Induced | Terbutaline | 18.93 | 14610225 | |
| MESH:D000014 | Abnormalities, Drug-Induced | Tetrachlorodibenzodioxin | 18.93 | 15322242 11752688 14514962 | |
| MESH:D000014 | Abnormalities, Drug-Induced | Thalidomide | 18.93 | 8333272 | |
| MESH:D000014 | Abnormalities, Drug-Induced | Valproic Acid | 18.93 | 8875741 | |
| MESH:D000015 | Abnormalities, Multiple | Valproic Acid | 5.98 | 19490988 | |
| MESH:D000015 | Abnormalities, Multiple | Vitamin A | 5.98 | 10992263 | |
| MESH:D000033 | Abortion, Threatened | Dydrogesterone | 5.72 | 15760377 | |
| MESH:D000038 | Abscess | Drugs, Chinese Herbal | 4.86 | 15043669 | |
| MESH:D000138 | Acidosis | Ammonium Chloride | 5.78 | 18287403 | |
| MESH:D000138 | Acidosis | Ethanol | 5.78 | 11192467 | |
| MESH:D000140 | Acidosis, Lactic | methyl isocyanate | 5.29 | 8440870 | |
| MESH:D000152 | Acne Vulgaris | Ethinyl Estradiol | 2.50 | 17505938 | |
| MESH:D000163 | Acquired Immunodeficiency Syndrome | marker/mechanism | 9612607 | ||
| MESH:D000163 | Acquired Immunodeficiency Syndrome | Zidovudine | 3.43 | 9612607 | |
| MESH:D000168 | Acrocephalosyndactylia | U 0126 | 4.08 | 17694057 | |
| MESH:D000169 | Acrodermatitis | Zinc | 3.97 | 16889938 17190629 17202136 | |
| MESH:D058186 | Acute Kidney Injury | Cisplatin | 16.69 | 15814532 17670903 12690470 | |
| MESH:D058186 | Acute Kidney Injury | Ibuprofen | 16.69 | 6375363 | |
| MESH:D058186 | Acute Kidney Injury | Mercuric Chloride | 16.69 | 11274264 | |
| MESH:D058186 | Acute Kidney Injury | resveratrol | 16.69 | 16538975 | |
| MESH:D058186 | Acute Kidney Injury | Sulindac | 16.69 | 7897758 | |
| MESH:D058186 | Acute Kidney Injury | zoledronic acid | 16.69 | 19715164 | |
| MESH:D055371 | Acute Lung Injury | Acrolein | 14.56 | 21297076 20525806 | |
| MESH:D055371 | Acute Lung Injury | Bleomycin | 14.56 | 17118201 | |
| MESH:D055371 | Acute Lung Injury | Chlorine | 14.56 | 20601635 | |
| MESH:D055371 | Acute Lung Injury | Lipopolysaccharides | 14.56 | 18653653 11850527 | |
| MESH:D055371 | Acute Lung Injury | pirinixic acid | 14.56 | 18653653 | |
| MESH:D000210 | Acute-Phase Reaction | Thioglycolates | 8.44 | 9464241 | |
| MESH:D000210 | Acute-Phase Reaction | zoledronic acid | 8.44 | 20200999 | |
| MESH:D000230 | Adenocarcinoma | 1,2-Dimethylhydrazine | 31.37 | 1113308 1933837 | |
| MESH:D000230 | Adenocarcinoma | 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid ethyl amide | 31.37 | 17363558 | |
| MESH:D000230 | Adenocarcinoma | arsenic trioxide | 31.37 | 19825857 11798837 | |
| MESH:D000230 | Adenocarcinoma | Benzo(a)pyrene | 31.37 | 20127859 20464547 | |
| MESH:D000230 | Adenocarcinoma | Cisplatin | 31.37 | 17638652 11798837 | |
| MESH:D000230 | Adenocarcinoma | Doxorubicin | 31.37 | 17418594 | |
| MESH:D000230 | Adenocarcinoma | Estradiol | 31.37 | 11473722 | |
| MESH:D000230 | Adenocarcinoma | Ethinyl Estradiol | 31.37 | 14692618 | |
| MESH:D000230 | Adenocarcinoma | Fluorouracil | 31.37 | 17638652 | |
| MESH:D000230 | Adenocarcinoma | Genistein | 31.37 | 11473722 | |
| MESH:D000230 | Adenocarcinoma | Ibuprofen | 31.37 | 10697514 | |
| MESH:D000230 | Adenocarcinoma | Indomethacin | 31.37 | 16537180 | |
| MESH:D000230 | Adenocarcinoma | Methylnitrosourea | 31.37 | 15688392 15113128 | |
| MESH:D000230 | Adenocarcinoma | Sulindac | 31.37 | 11910360 | |
| MESH:D000230 | Adenocarcinoma | Urethane | 31.37 | 18316556 | |
| MESH:D002282 | Adenocarcinoma, Bronchiolo-Alveolar | Urethane | 4.26 | 15814487 | |
| MESH:D000236 | Adenoma | 2-Acetylaminofluorene | 22.20 | 10737359 | |
| MESH:D000236 | Adenoma | Benzo(a)pyrene | 22.20 | 6695378 | |
| MESH:D000236 | Adenoma | Diethylnitrosamine | 22.20 | 6695378 10737359 | |
| MESH:D000236 | Adenoma | diisopropanolnitrosamine | 22.20 | 10945294 | |
| MESH:D000236 | Adenoma | Indomethacin | 22.20 | 11497255 | |
| MESH:D000236 | Adenoma | Melatonin | 22.20 | 17195641 | |
| MESH:D000236 | Adenoma | resveratrol | 22.20 | 15688382 | |
| MESH:D000236 | Adenoma | Sulindac | 22.20 | 10223192 | |
| MESH:D000236 | Adenoma | Urethane | 22.20 | 11497255 17195641 10822126 10530776 16926031 17093202 6695378 | |
| MESH:D002759 | Adenoma, Bile Duct | 2-Acetylaminofluorene | 4.55 | 6705139 | |
| MESH:D018248 | Adenoma, Liver Cell | Diethylnitrosamine | 9.15 | 19052882 17162532 18056438 16434500 19061943 17620307 | |
| MESH:D018248 | Adenoma, Liver Cell | pirinixic acid | 9.15 | 16434500 | |
| MESH:D018248 | Adenoma, Liver Cell | Tetrachlorodibenzodioxin | 9.15 | 16835633 | |
| MESH:D011125 | Adenomatous Polyposis Coli | Dinoprostone | 9.07 | 17942926 | |
| MESH:D011125 | Adenomatous Polyposis Coli | Leukotriene B4 | 9.07 | 17942926 | |
| MESH:D011125 | Adenomatous Polyposis Coli | Sulindac | 9.07 | 16460482 11874996 17611924 11535846 12394442 19003578 15623613 | |
| MESH:D000310 | Adrenal Gland Neoplasms | sodium arsenite | 3.25 | 15276417 | |
| MESH:D018246 | Adrenocortical Adenoma | sodium arsenite | 3.45 | 16712894 17306315 | |
| MESH:D000382 | Agricultural Workers' Diseases | Atrazine | 22.61 | 11874814 | |
| MESH:D000382 | Agricultural Workers' Diseases | Diazinon | 22.61 | 16487989 | |
| MESH:D000382 | Agricultural Workers' Diseases | Dichlorvos | 22.61 | 16611668 17119214 12661182 | |
| MESH:D000382 | Agricultural Workers' Diseases | Lindane | 22.61 | 12661182 | |
| MESH:D000382 | Agricultural Workers' Diseases | Malathion | 22.61 | 17119214 11874814 | |
| MESH:D000382 | Agricultural Workers' Diseases | mancozeb | 22.61 | 8807224 15864902 16132792 | |
| MESH:D000382 | Agricultural Workers' Diseases | Paraquat | 22.61 | 11874814 | |
| MESH:D000382 | Agricultural Workers' Diseases | Simazine | 22.61 | 12661182 | |
| MESH:D000419 | Albuminuria | Doxorubicin | 3.17 | 21441931 | |
| MESH:D020268 | Alcohol-Induced Disorders, Nervous System | Ethanol | 3.87 | 15451040 15451039 | |
| MESH:D019973 | Alcohol-Related Disorders | Curcumin | 3.63 | 17887948 | |
| OMIM:607154 | ALLERGIC RHINITIS | zafirlukast | 4.12 | 16527031 | |
| MESH:D000505 | Alopecia | Tretinoin | 2.39 | 15955085 | |
| MESH:D019896 | alpha 1-Antitrypsin Deficiency | Iron | 4.22 | 16640825 | |
| MESH:D016301 | Alveolar Bone Loss | Indomethacin | 3.92 | 17225004 | |
| MESH:D000544 | Alzheimer Disease | 2-butenal | 20.93 | 16538519 | |
| MESH:D000544 | Alzheimer Disease | Acrolein | 20.93 | 17570602 14715435 15207723 | |
| MESH:D000544 | Alzheimer Disease | Amphotericin B | 20.93 | 12755626 | |
| MESH:D000544 | Alzheimer Disease | Curcumin | 20.93 | 15590663 | |
| MESH:D000544 | Alzheimer Disease | Ibuprofen | 20.93 | 18351690 | |
| MESH:D000544 | Alzheimer Disease | Indomethacin | 20.93 | 15579461 17627676 | |
| MESH:D000544 | Alzheimer Disease | Iron | 20.93 | 16640825 16563566 | |
| MESH:D000544 | Alzheimer Disease | Nitric Oxide | 20.93 | 17556102 | |
| MESH:D000544 | Alzheimer Disease | Ozone | 20.93 | 15513908 | |
| MESH:D000544 | Alzheimer Disease | Plant Extracts | 20.93 | 16962711 | |
| MESH:D000544 | Alzheimer Disease | resveratrol | 20.93 | 16183991 16162502 | |
| MESH:D000544 | Alzheimer Disease | Zinc | 20.93 | 17119284 16410023 16325427 16580781 | |
| MESH:D000550 | Amblyopia | Valproic Acid | 3.78 | 17688650 | |
| MESH:D000686 | Amyloidosis | Diethylstilbestrol | 7.03 | 15469931 | |
| MESH:D000686 | Amyloidosis | Terbutaline | 7.03 | 7986221 | |
| MESH:D000690 | Amyotrophic Lateral Sclerosis | 2-butenal | 7.36 | 17319283 | |
| MESH:D000690 | Amyotrophic Lateral Sclerosis | Tetrahydrocannabinol | 7.36 | 15204022 | |
| MESH:D000690 | Amyotrophic Lateral Sclerosis | Thalidomide | 7.36 | 16510725 | |
| MESH:D000707 | Anaphylaxis | Ibuprofen | 11.78 | 9532969 | |
| MESH:D000707 | Anaphylaxis | Mangifera indica extract | 11.78 | 14669257 16536907 | |
| MESH:D000707 | Anaphylaxis | mangiferin | 11.78 | 16536907 14669257 | |
| MESH:D000740 | Anemia | Drugs, Chinese Herbal | 18.06 | 17963324 15504547 | |
| MESH:D000740 | Anemia | Fluorouracil | 18.06 | 16511603 17963324 15504547 | |
| MESH:D000740 | Anemia | Iron | 18.06 | 16566752 16434484 | |
| MESH:D000740 | Anemia | Tetrachlorodibenzodioxin | 18.06 | 11748828 | |
| MESH:D000740 | Anemia | Vitamin A | 18.06 | 16960172 | |
| MESH:D000740 | Anemia | Zymosan | 18.06 | 18664788 | |
| MESH:D000741 | Anemia, Aplastic | marker/mechanism | |||
| MESH:D000741 | Anemia, Aplastic | Benzene | 3.15 | 14761424 11369114 17661222 | |
| MESH:D000743 | Anemia, Hemolytic | Quercetin | 2.92 | 17084956 | |
| MESH:D018798 | Anemia, Iron-Deficiency | Iron | 6.12 | 17375513 17162259 17147795 16569441 17163184 | |
| MESH:D018798 | Anemia, Iron-Deficiency | Vitamin A | 6.12 | 16960172 | |
| MESH:D000755 | Anemia, Sickle Cell | Zinc | 3.52 | 16916123 | |
| MESH:D000756 | Anemia, Sideroblastic | Iron | 6.56 | 16910769 | |
| MESH:D000756 | Anemia, Sideroblastic | Manganese | 6.56 | 16910769 | |
| MESH:D000787 | Angina Pectoris | Drugs, Chinese Herbal | 3.98 | 11477813 | |
| MESH:D000799 | Angioedema | Acetaminophen | 2.40 | 10982225 | |
| MESH:D000853 | Anophthalmos | Ethanol | 3.42 | 15513904 | |
| MESH:D000860 | Anoxia | Bleomycin | 4.00 | 15782499 | |
| MESH:D000881 | Anthrax | Ciprofloxacin | 5.26 | 20385868 | |
| MESH:D016736 | Antiphospholipid Syndrome | Ciprofloxacin | 5.26 | 9485080 | |
| MESH:D001004 | Anus Diseases | Drugs, Chinese Herbal | 4.51 | 15043669 | |
| MESH:D001005 | Anus Neoplasms | Dacarbazine | 4.84 | 12170190 | |
| MESH:D001008 | Anxiety Disorders | Ethanol | 4.90 | 11141031 | |
| MESH:D001008 | Anxiety Disorders | Valproic Acid | 4.90 | 17497229 | |
| MESH:D001014 | Aortic Aneurysm | Dinoprostone | 7.63 | 10231640 | |
| MESH:D001014 | Aortic Aneurysm | Indomethacin | 7.63 | 10231640 | |
| MESH:D017544 | Aortic Aneurysm, Abdominal | Benzo(a)pyrene | 12.07 | 19183758 | |
| MESH:D017544 | Aortic Aneurysm, Abdominal | Dinoprostone | 12.07 | 10388637 | |
| MESH:D017544 | Aortic Aneurysm, Abdominal | Indomethacin | 12.07 | 10388637 | |
| MESH:D001064 | Appendicitis | marker/mechanism | 16367942 | ||
| MESH:D001129 | Argyria | Silver | 5.43 | 16531870 | |
| MESH:D001145 | Arrhythmias, Cardiac | Iron | 3.11 | 16604332 | |
| MESH:D001161 | Arteriosclerosis | Acrolein | 9.22 | 15014928 | |
| MESH:D001161 | Arteriosclerosis | Cyclophosphamide | 9.22 | 15014928 | |
| MESH:D001161 | Arteriosclerosis | Ethinyl Estradiol | 9.22 | 11256880 | |
| MESH:D018771 | Arthralgia | Indomethacin | 3.72 | 2160914 | |
| MESH:D001168 | Arthritis | Leukotriene B4 | 4.75 | 11006272 | |
| MESH:D001169 | Arthritis, Experimental | Dexamethasone | 18.13 | 17659584 | |
| MESH:D001169 | Arthritis, Experimental | Ethinyl Estradiol | 18.13 | 15885639 | |
| MESH:D001169 | Arthritis, Experimental | Plant Extracts | 18.13 | 14686799 | |
| MESH:D001169 | Arthritis, Experimental | resveratrol | 18.13 | 17115116 | |
| MESH:D001169 | Arthritis, Experimental | Thalidomide | 18.13 | 9598899 | |
| MESH:D001169 | Arthritis, Experimental | Tretinoin | 18.13 | 16412693 | |
| MESH:D001169 | Arthritis, Experimental | Zymosan | 18.13 | 15142272 15188379 16872482 17659584 15944321 | |
| MESH:D015210 | Arthritis, Gouty | Drugs, Chinese Herbal | 4.31 | 19655406 | |
| MESH:D001172 | Arthritis, Rheumatoid | Curcumin | 6.94 | 16807698 | |
| MESH:D001172 | Arthritis, Rheumatoid | Indomethacin | 6.94 | 11248219 | |
| MESH:D001172 | Arthritis, Rheumatoid | Ozone | 6.94 | 15570426 | |
| MESH:D001172 | Arthritis, Rheumatoid | phenylmethylpyrazolone | 6.94 | 16390820 | |
| MESH:D001172 | Arthritis, Rheumatoid | Tretinoin | 6.94 | 16292516 | |
| MESH:D001249 | Asthma | 1,6-hexamethylene diisocyanate | 36.80 | 10934080 | |
| MESH:D001249 | Asthma | Budesonide | 36.80 | 18489783 12604023 10893010 15572850 20004779 12113382 15136378 | |
| MESH:D001249 | Asthma | Cilomilast | 36.80 | 16956605 | |
| MESH:D001249 | Asthma | epigallocatechin gallate | 36.80 | 16516891 | |
| MESH:D001249 | Asthma | Histamine | 36.80 | 16387687 | |
| MESH:D001249 | Asthma | Leukotriene B4 | 36.80 | 11006272 19667530 | |
| MESH:D001249 | Asthma | Mustard Gas | 36.80 | 10378619 | |
| MESH:D001249 | Asthma | Ozone | 36.80 | 17854713 16373670 | |
| MESH:D001249 | Asthma | phthalic anhydride | 36.80 | 3681491 | |
| MESH:D001249 | Asthma | S 28463 | 36.80 | 16361354 | |
| MESH:D001249 | Asthma | Toluene 2,4-Diisocyanate | 36.80 | 15590891 16792590 17015710 20032816 10934080 11467998 3040596 10797510 19187332 11077013 15590890 6091946 7684630 6091945 18394133 12684321 170078 15855793 16210060 12585506 8156442 12762349 11742282 | |
| MESH:D001249 | Asthma | Tretinoin | 36.80 | 16456186 | |
| MESH:D001249 | Asthma | trimellitic anhydride | 36.80 | 16141432 | |
| MESH:D001249 | Asthma | Vitamin A | 36.80 | 16732791 | |
| MESH:D001249 | Asthma | zafirlukast | 36.80 | 10817796 12742009 11393122 15170009 9690572 8162986 12114351 9620945 9847434 9701106 12604023 8222486 15572850 9412547 12189465 18489783 15136378 10967152 9196086 10027429 14609035 11061985 9027267 10359889 12113382 19667530 9377612 11070746 12583521 11596838 9825082 10929920 12095178 11570617 10934090 8087328 11885876 11694805 19681236 10852428 1673495 9949315 11991558 20332717 10386485 10439636 10780761 10064661 9620946 | |
| MESH:D001249 | Asthma | Zinc | 36.80 | 17085522 | |
| MESH:D055963 | Asthma, Aspirin-Induced | Aspirin | 6.35 | 20485159 12372130 | |
| MESH:D055963 | Asthma, Aspirin-Induced | zafirlukast | 6.35 | 19667532 | |
| MESH:D001250 | Asthma, Exercise-Induced | Leukotriene B4 | 7.58 | 19667531 | |
| MESH:D001250 | Asthma, Exercise-Induced | zafirlukast | 7.58 | 8389103 1554195 10984370 19667531 11953129 | |
| MESH:D001260 | Ataxia Telangiectasia | Iron | 8.38 | 15336622 | |
| MESH:D001260 | Ataxia Telangiectasia | Quercetin | 8.38 | 15336622 | |
| MESH:D050197 | Atherosclerosis | marker/mechanism | 9169506 | ||
| MESH:D050197 | Atherosclerosis | Acrolein | 24.39 | 16037261 17363696 16126721 | |
| MESH:D050197 | Atherosclerosis | Cadmium | 24.39 | 15687053 | |
| MESH:D050197 | Atherosclerosis | Curcumin | 24.39 | 18704882 | |
| MESH:D050197 | Atherosclerosis | Iron | 24.39 | 16632123 16640825 | |
| MESH:D050197 | Atherosclerosis | Mangifera indica extract | 24.39 | 18450471 | |
| MESH:D050197 | Atherosclerosis | mangiferin | 24.39 | 18450471 | |
| MESH:D050197 | Atherosclerosis | Phenytoin | 24.39 | 15136057 | |
| MESH:D050197 | Atherosclerosis | resveratrol | 24.39 | 17967414 16873680 | |
| MESH:D050197 | Atherosclerosis | Saponins | 24.39 | 18637019 | |
| MESH:D050197 | Atherosclerosis | Tetrahydrocannabinol | 24.39 | 15815632 | |
| MESH:D001289 | Attention Deficit Disorder with Hyperactivity | Fatty Acids, Omega-3 | 3.72 | 18448859 | |
| MESH:D001321 | Autistic Disorder | marker/mechanism | 16360218 | ||
| MESH:D001321 | Autistic Disorder | Acetaminophen | 4.94 | 18445737 | |
| MESH:D001321 | Autistic Disorder | Fatty Acids, Omega-3 | 4.94 | 16920077 | |
| MESH:D001321 | Autistic Disorder | Glutathione | 4.94 | 19056591 16917939 18929414 19267885 | |
| MESH:D001321 | Autistic Disorder | Iron | 4.94 | 17352947 | |
| MESH:D001321 | Autistic Disorder | Linoleic Acid | 4.94 | 18582451 | |
| MESH:D001321 | Autistic Disorder | Melatonin | 4.94 | 16897403 16919138 | |
| MESH:D001321 | Autistic Disorder | Methionine | 4.94 | 19267885 16917939 19056591 | |
| MESH:D001321 | Autistic Disorder | pioglitazone | 4.94 | 17207275 | |
| MESH:D001321 | Autistic Disorder | Terbutaline | 4.94 | 17400887 16417856 | |
| MESH:D001321 | Autistic Disorder | Valproic Acid | 4.94 | 15238991 18940202 18985861 18396377 18558336 17688650 18316065 18775368 17507914 19460635 20603192 19232924 17157402 18177632 16609825 | |
| MESH:D001327 | Autoimmune Diseases | Curcumin | 10.15 | 19761891 | |
| MESH:D001327 | Autoimmune Diseases | epigallocatechin gallate | 10.15 | 19761891 | |
| MESH:D001327 | Autoimmune Diseases | Quercetin | 10.15 | 19761891 | |
| MESH:D001424 | Bacterial Infections | Ciprofloxacin | 7.84 | 11505790 | |
| MESH:D001424 | Bacterial Infections | Iron | 7.84 | 16640825 | |
| MESH:D001471 | Barrett Esophagus | Tretinoin | 3.02 | 16935849 | |
| MESH:D001477 | Bartter Syndrome | Dinoprostone | 8.04 | 15976003 | |
| MESH:D001477 | Bartter Syndrome | Indomethacin | 8.04 | 10684365 | |
| MESH:D001480 | Basal Ganglia Diseases | Dichlorvos | 4.55 | 15303389 | |
| MESH:D001607 | Berylliosis | Prednisone | 4.32 | 18757698 | |
| MESH:D001714 | Bipolar Disorder | Valproic Acid | 4.50 | 20046352 17594078 | |
| MESH:D001714 | Bipolar Disorder | zonisamide | 4.50 | 16855456 15383137 | |
| MESH:D001768 | Blister | Mustard Gas | 3.72 | 19167455 | |
| MESH:D001778 | Blood Coagulation Disorders | arsenic trioxide | 11.23 | 16206674 | |
| MESH:D001778 | Blood Coagulation Disorders | pirinixic acid | 11.23 | 19483382 | |
| MESH:D001778 | Blood Coagulation Disorders | Tetrachlorodibenzodioxin | 11.23 | 12125929 | |
| MESH:D001778 | Blood Coagulation Disorders | Tretinoin | 11.23 | 16206674 16197459 | |
| MESH:D001836 | Body Weight Changes | Tetrachlorodibenzodioxin | 2.35 | 15340226 | |
| MESH:D001848 | Bone Diseases, Developmental | Tetrachlorodibenzodioxin | 4.32 | 15746008 | |
| MESH:D001848 | Bone Diseases, Developmental | Valproic Acid | 4.32 | 8888407 | |
| MESH:D001855 | Bone Marrow Diseases | Benzene | 3.78 | 16183116 | |
| MESH:D019046 | Bone Marrow Neoplasms | Cisplatin | 12.15 | 14601052 | |
| MESH:D019046 | Bone Marrow Neoplasms | Dactinomycin | 12.15 | 14601052 | |
| MESH:D019046 | Bone Marrow Neoplasms | Doxorubicin | 12.15 | 14601052 | |
| MESH:D001859 | Bone Neoplasms | Clodronic Acid | 7.03 | 17312309 | |
| MESH:D001859 | Bone Neoplasms | zoledronic acid | 7.03 | 16121404 16778634 19442620 15867366 11697798 17312309 | |
| MESH:D001862 | Bone Resorption | bisphenol A | 15.80 | 11985600 | |
| MESH:D001862 | Bone Resorption | Drugs, Chinese Herbal | 15.80 | 9881647 | |
| MESH:D001862 | Bone Resorption | Freund's Adjuvant | 15.80 | 16769263 | |
| MESH:D001862 | Bone Resorption | mangiferin | 15.80 | 9881647 | |
| MESH:D001862 | Bone Resorption | zoledronic acid | 15.80 | 16769263 11869084 8053405 15845617 18496637 18404659 | |
| MESH:D001913 | Bowen's Disease | imiquimod | 8.42 | 11207687 | |
| MESH:D001913 | Bowen's Disease | Sulindac | 8.42 | 11207687 | |
| MESH:D001929 | Brain Edema | Indomethacin | 3.58 | 11481608 | |
| MESH:D020201 | Brain Hemorrhage, Traumatic | Progesterone | 3.88 | 17868700 | |
| MESH:D001930 | Brain Injuries | Nitroprusside | 10.59 | 14637104 | |
| MESH:D001930 | Brain Injuries | Progesterone | 10.59 | 15845082 15665606 15380490 | |
| MESH:D001930 | Brain Injuries | Zinc | 10.59 | 17109824 | |
| MESH:D002545 | Brain Ischemia | Curcumin | 17.02 | 16770732 | |
| MESH:D002545 | Brain Ischemia | Ibuprofen | 17.02 | 15837124 | |
| MESH:D002545 | Brain Ischemia | Indomethacin | 17.02 | 12524144 | |
| MESH:D002545 | Brain Ischemia | Plant Extracts | 17.02 | 16041641 | |
| MESH:D002545 | Brain Ischemia | resveratrol | 17.02 | 17600658 | |
| MESH:D001932 | Brain Neoplasms | Aspirin | 10.47 | 15481559 | |
| MESH:D001932 | Brain Neoplasms | Curcumin | 10.47 | 17596214 | |
| MESH:D001932 | Brain Neoplasms | Doxorubicin | 10.47 | 17150277 | |
| MESH:D001932 | Brain Neoplasms | Epoxy Compounds | 10.47 | 12562636 | |
| MESH:D001943 | Breast Neoplasms | marker/mechanism | 19446661 | ||
| MESH:D001943 | Breast Neoplasms | alitretinoin | 42.45 | 16344269 | |
| MESH:D001943 | Breast Neoplasms | Apigenin | 42.45 | 17132221 16541309 | |
| MESH:D001943 | Breast Neoplasms | Ascorbic Acid | 42.45 | 16443354 | |
| MESH:D001943 | Breast Neoplasms | Aspirin | 42.45 | 15161893 | |
| MESH:D001943 | Breast Neoplasms | Benzene | 42.45 | 17162533 11921183 | |
| MESH:D001943 | Breast Neoplasms | Benzo(a)pyrene | 42.45 | 20146248 17474063 | |
| MESH:D001943 | Breast Neoplasms | bisphenol A | 42.45 | 17123778 | |
| MESH:D001943 | Breast Neoplasms | Calcitriol | 42.45 | 11237771 | |
| MESH:D001943 | Breast Neoplasms | Cisplatin | 42.45 | 19526202 18382427 | |
| MESH:D001943 | Breast Neoplasms | Curcumin | 42.45 | 18462866 18593918 16243823 19250217 | |
| MESH:D001943 | Breast Neoplasms | Cyclophosphamide | 42.45 | 15136595 17388661 17020986 18234424 16978400 11325840 15093573 12006526 18323546 | |
| MESH:D001943 | Breast Neoplasms | Dacarbazine | 42.45 | 17983394 | |
| MESH:D001943 | Breast Neoplasms | decitabine | 42.45 | 18320071 19208741 | |
| MESH:D001943 | Breast Neoplasms | Diethylnitrosamine | 42.45 | 17474063 | |
| MESH:D001943 | Breast Neoplasms | Diethylstilbestrol | 42.45 | 17129689 15324884 | |
| MESH:D001943 | Breast Neoplasms | Doxorubicin | 42.45 | 18695136 17369602 16096432 16935488 16264153 16595493 19526202 15634643 18628466 15994142 15136595 17426702 15939500 15567936 18234424 18382427 15668708 16115903 15692762 16322301 17983394 15993339 11325840 16826403 | |
| MESH:D001943 | Breast Neoplasms | Epoxy Compounds | 42.45 | 12562636 | |
| MESH:D001943 | Breast Neoplasms | Estradiol | 42.45 | 17289903 17018787 12948864 17261762 14630087 18497071 19861407 16675129 | |
| MESH:D001943 | Breast Neoplasms | FEC protocol | 42.45 | 15970926 16682728 17145825 | |
| MESH:D001943 | Breast Neoplasms | Fluorouracil | 42.45 | 16110121 15136595 16557594 19217205 16595493 18357371 18608205 | |
| MESH:D001943 | Breast Neoplasms | Formaldehyde | 42.45 | 15986119 | |
| MESH:D001943 | Breast Neoplasms | Genistein | 42.45 | 16873071 16541309 17200150 | |
| MESH:D001943 | Breast Neoplasms | Hexachlorobenzene | 42.45 | 12709520 15061365 | |
| MESH:D001943 | Breast Neoplasms | Indomethacin | 42.45 | 17401462 | |
| MESH:D001943 | Breast Neoplasms | Lindane | 42.45 | 14688026 | |
| MESH:D001943 | Breast Neoplasms | Malathion | 42.45 | 12762645 | |
| MESH:D001943 | Breast Neoplasms | Methylene Chloride | 42.45 | 15986119 | |
| MESH:D001943 | Breast Neoplasms | Methylnitrosourea | 42.45 | 16253758 11306469 14633655 | |
| MESH:D001943 | Breast Neoplasms | Nitric Oxide | 42.45 | 15631943 | |
| MESH:D001943 | Breast Neoplasms | Progesterone | 42.45 | 15562024 17614352 16175315 | |
| MESH:D001943 | Breast Neoplasms | Quercetin | 42.45 | 18628248 | |
| MESH:D001943 | Breast Neoplasms | resveratrol | 42.45 | 17534123 17651959 16393696 | |
| MESH:D001943 | Breast Neoplasms | Sulindac | 42.45 | 16642371 | |
| MESH:D001943 | Breast Neoplasms | Tamoxifen | 42.45 | 21138602 16202921 19066611 19011961 16273361 19142967 16873071 11161223 18997820 18855134 20859285 19084267 19410462 20135344 17440819 15668708 20065188 19115204 19200415 19155303 20005174 18629630 20390343 18351453 19244106 19221464 18821012 15565566 19288272 17893378 19059307 18815881 17261762 19189210 16818667 20544844 17242785 19189212 21152245 19103187 17049068 19487384 19289846 18425577 18984771 | |
| MESH:D001943 | Breast Neoplasms | Tetrachlorodibenzodioxin | 42.45 | 20435547 | |
| MESH:D001943 | Breast Neoplasms | Tetrachloroethylene | 42.45 | 15986119 | |
| MESH:D001943 | Breast Neoplasms | Toluene 2,4-Diisocyanate | 42.45 | 11921183 | |
| MESH:D001943 | Breast Neoplasms | Tretinoin | 42.45 | 16443354 16166294 16873071 | |
| MESH:D001943 | Breast Neoplasms | zoledronic acid | 42.45 | 18695136 16096432 | |
| MESH:D001982 | Bronchial Diseases | zafirlukast | 5.28 | 11994701 | |
| MESH:D016535 | Bronchial Hyperreactivity | Leukotriene B4 | 7.42 | 12794006 12654629 | |
| MESH:D016535 | Bronchial Hyperreactivity | Ozone | 7.42 | 18315731 17626835 15516495 14754758 18417511 19059883 16777450 | |
| MESH:D016535 | Bronchial Hyperreactivity | Toluene 2,4-Diisocyanate | 7.42 | 15590891 8156442 12507178 | |
| MESH:D001986 | Bronchial Spasm | Histamine | 4.38 | 18298128 | |
| MESH:D001989 | Bronchiolitis Obliterans | therapeutic | 16137903 | ||
| MESH:D001989 | Bronchiolitis Obliterans | Mustard Gas | 3.72 | 15286001 | |
| MESH:D001991 | Bronchitis | Antimony | 4.68 | 8768112 | |
| MESH:D029481 | Bronchitis, Chronic | Mustard Gas | 3.53 | 10378619 17687719 | |
| MESH:D001997 | Bronchopulmonary Dysplasia | Tretinoin | 8.29 | 16813970 | |
| MESH:D001997 | Bronchopulmonary Dysplasia | Vitamin A | 8.29 | 17426644 17377406 | |
| MESH:D002051 | Burkitt Lymphoma | arsenic trioxide | 2.97 | 11589617 | |
| MESH:D002056 | Burns | Ethanol | 11.12 | 16374292 | |
| MESH:D002056 | Burns | Indomethacin | 11.12 | 10459503 | |
| MESH:D002056 | Burns | Silver | 11.12 | 16531870 | |
| MESH:D002057 | Burns, Chemical | Plant Extracts | 3.89 | 9625245 | |
| MESH:D002100 | Cachexia | Ibuprofen | 12.96 | 15141370 | |
| MESH:D002100 | Cachexia | Indomethacin | 12.96 | 11239499 15625704 15141370 16537180 | |
| MESH:D002100 | Cachexia | Ozone | 12.96 | 16183385 | |
| MESH:D002105 | Cadmium Poisoning | Quercetin | 4.09 | 16962696 | |
| MESH:D002177 | Candidiasis | moxifloxacin | 5.18 | 16352735 | |
| MESH:D002181 | Candidiasis, Vulvovaginal | Estradiol | 8.45 | 16111702 | |
| MESH:D002181 | Candidiasis, Vulvovaginal | zafirlukast | 8.45 | 15170009 | |
| MESH:D019559 | Capillary Leak Syndrome | Terbutaline | 4.42 | 11713377 9428835 | |
| MESH:D002252 | Carbon Tetrachloride Poisoning | Carbon Tetrachloride | 8.99 | 16227642 18705752 15721981 16097048 15700767 16050911 15673190 10355542 3786805 16011737 16124888 16192424 | |
| MESH:D002252 | Carbon Tetrachloride Poisoning | Melatonin | 8.99 | 15700767 | |
| MESH:D002252 | Carbon Tetrachloride Poisoning | Vitamin E | 8.99 | 16050911 | |
| MESH:D002276 | Carcinoid Tumor | Dacarbazine | 19.22 | 16051944 | |
| MESH:D002276 | Carcinoid Tumor | Doxorubicin | 19.22 | 16051944 | |
| MESH:D002276 | Carcinoid Tumor | Fluorouracil | 19.22 | 16051944 | |
| MESH:D002276 | Carcinoid Tumor | Streptozocin | 19.22 | 16051944 | |
| MESH:D002277 | Carcinoma | Curcumin | 10.02 | 18593918 | |
| MESH:D002277 | Carcinoma | diisopropanolnitrosamine | 10.02 | 10463772 10945294 11442016 | |
| MESH:D002277 | Carcinoma | Fluorouracil | 10.02 | 17121937 | |
| MESH:D002277 | Carcinoma | Tetrachlorodibenzodioxin | 10.02 | 16835633 | |
| MESH:D002280 | Carcinoma, Basal Cell | imiquimod | 4.16 | 16302556 | |
| MESH:D018270 | Carcinoma, Ductal, Breast | Tamoxifen | 3.10 | 19066611 | |
| MESH:D018236 | Carcinoma, Embryonal | Tretinoin | 3.70 | 16168501 | |
| MESH:D006528 | Carcinoma, Hepatocellular | 2-Acetylaminofluorene | 41.33 | 3581430 3084413 6705139 17761372 10737359 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Acetaminophen | 41.33 | 3084413 | |
| MESH:D006528 | Carcinoma, Hepatocellular | anthra(1,9-cd)pyrazol-6(2H)-one | 41.33 | 19418558 | |
| MESH:D006528 | Carcinoma, Hepatocellular | arsenic trioxide | 41.33 | 16217749 15553829 14691202 11135700 15073043 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Carbon Tetrachloride | 41.33 | 18788625 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Cisplatin | 41.33 | 17982673 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Cyclophosphamide | 41.33 | 19701751 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Diethylnitrosamine | 41.33 | 18978308 21159647 20512989 18056438 16540662 20935162 16830150 17428255 10672840 20084675 17138121 18494052 3084413 20432363 19208518 19519916 16569478 18785209 20514400 19335982 19171122 20524982 17055752 3581430 20214788 19107877 16698587 20007298 18393292 19383236 17978847 19418558 16878318 16807293 18506893 20101231 16288022 10737359 19052882 17162532 18788625 19394651 16502159 18665156 20727157 19822196 19539802 18971187 19701751 16779866 16328049 16681979 19919837 18691550 16935385 11831363 18210153 17761372 17173139 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Diethylstilbestrol | 41.33 | 16924424 15948411 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Doxorubicin | 41.33 | 16234567 18059187 17876044 16023760 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Estradiol | 41.33 | 16924424 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Ethanol | 41.33 | 15289165 15763234 18788625 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Fluorouracil | 41.33 | 16332177 18930000 17045692 17088986 16799960 17971768 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Genistein | 41.33 | 16924424 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Indomethacin | 41.33 | 16391822 | |
| MESH:D006528 | Carcinoma, Hepatocellular | nimesulide | 41.33 | 16391822 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Plant Extracts | 41.33 | 18834353 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Quercetin | 41.33 | 12508355 19519916 | |
| MESH:D006528 | Carcinoma, Hepatocellular | resveratrol | 41.33 | 16227395 19321006 | |
| MESH:D006528 | Carcinoma, Hepatocellular | sodium arsenite | 41.33 | 16507464 17306315 15276417 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Tamoxifen | 41.33 | 16924424 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Thalidomide | 41.33 | 16313753 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Tretinoin | 41.33 | 1917145 | |
| MESH:D002278 | Carcinoma in Situ | bisphenol A | 3.55 | 17123778 | |
| MESH:D018827 | Carcinoma, Lewis Lung | Cyclophosphamide | 10.94 | 16152834 | |
| MESH:D018827 | Carcinoma, Lewis Lung | Indomethacin | 10.94 | 11053908 | |
| MESH:D018827 | Carcinoma, Lewis Lung | resveratrol | 10.94 | 16675471 | |
| MESH:D018276 | Carcinoma, Medullary | Indomethacin | 3.92 | 14736730 11352223 18791128 | |
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung | Cisplatin | 4.49 | 16685392 12023789 | |
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung | Curcumin | 4.49 | 18414057 | |
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung | zoledronic acid | 4.49 | 19233551 | |
| MESH:D021441 | Carcinoma, Pancreatic Ductal | Quercetin | 3.54 | 17234771 | |
| MESH:D002291 | Carcinoma, Papillary | arsenic trioxide | 3.42 | 19014326 | |
| MESH:D002292 | Carcinoma, Renal Cell | Cyclophosphamide | 13.02 | 16201981 | |
| MESH:D002292 | Carcinoma, Renal Cell | Dacarbazine | 13.02 | 16201981 | |
| MESH:D002292 | Carcinoma, Renal Cell | Doxorubicin | 13.02 | 16201981 1485588 | |
| MESH:D002292 | Carcinoma, Renal Cell | Fluorouracil | 13.02 | 18695887 | |
| MESH:D002292 | Carcinoma, Renal Cell | Indomethacin | 13.02 | 17341418 | |
| MESH:D002292 | Carcinoma, Renal Cell | zoledronic acid | 13.02 | 18507039 | |
| MESH:D018288 | Carcinoma, Small Cell | arsenic trioxide | 2.81 | 12490120 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Acetylcysteine | 41.82 | 17015178 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Benzo(a)pyrene | 41.82 | 20419170 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Bleomycin | 41.82 | 6189445 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Calcitriol | 41.82 | 11237771 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Cisplatin | 41.82 | 17066447 6189445 18337622 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Curcumin | 41.82 | 18462866 | |
| MESH:D002294 | Carcinoma, Squamous Cell | decitabine | 41.82 | 19215824 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Doxorubicin | 41.82 | 6189445 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Fluorouracil | 41.82 | 16757204 18986760 16280240 17066447 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Glutathione | 41.82 | 17015178 | |
| MESH:D002294 | Carcinoma, Squamous Cell | imiquimod | 41.82 | 16302556 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Indomethacin | 41.82 | 15482327 12636206 | |
| MESH:D002294 | Carcinoma, Squamous Cell | nimesulide | 41.82 | 15482327 | |
| MESH:D002294 | Carcinoma, Squamous Cell | resveratrol | 41.82 | 16227395 | |
| MESH:D002294 | Carcinoma, Squamous Cell | sodium arsenite | 41.82 | 18572023 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Tetradecanoylphorbol Acetate | 41.82 | 18922899 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Tretinoin | 41.82 | 16096774 16051514 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Zinc | 41.82 | 16543248 | |
| MESH:D002295 | Carcinoma, Transitional Cell | Amiloride | 8.72 | 14644129 | |
| MESH:D002295 | Carcinoma, Transitional Cell | Ciprofloxacin | 8.72 | 15028437 10741713 | |
| MESH:D002295 | Carcinoma, Transitional Cell | Tamoxifen | 8.72 | 17572228 | |
| MESH:D006332 | Cardiomegaly | Ethanol | 7.93 | 19332462 | |
| MESH:D006332 | Cardiomegaly | Plant Extracts | 7.93 | 17645561 | |
| MESH:D006332 | Cardiomegaly | Quercetin | 7.93 | 19794523 | |
| MESH:D006332 | Cardiomegaly | Tetrachlorodibenzodioxin | 7.93 | 18670907 18850075 16120746 | |
| MESH:D009202 | Cardiomyopathies | Anti-HIV Agents | 9.52 | 11706060 | |
| MESH:D009202 | Cardiomyopathies | Doxorubicin | 9.52 | 18627295 17974986 16269455 16278810 15505089 15811867 16109756 15792986 17351982 16455267 17519947 17382496 16364871 16612575 17308081 17928571 17131338 15476868 17329180 16952015 16731534 17924179 16651473 16242529 17007740 | |
| MESH:D009202 | Cardiomyopathies | Iron | 9.52 | 16640825 | |
| MESH:D009202 | Cardiomyopathies | pimagedine | 9.52 | 16612575 | |
| MESH:D002311 | Cardiomyopathy, Dilated | Antimony | 5.11 | 10334427 | |
| MESH:D002311 | Cardiomyopathy, Dilated | Doxorubicin | 5.11 | 17334414 16243910 | |
| MESH:D002311 | Cardiomyopathy, Dilated | Iron | 5.11 | 16604332 | |
| MESH:D002318 | Cardiovascular Diseases | Genistein | 10.75 | 16332659 | |
| MESH:D002318 | Cardiovascular Diseases | Hydrogen Peroxide | 10.75 | 16936243 | |
| MESH:D002318 | Cardiovascular Diseases | resveratrol | 10.75 | 15458977 | |
| MESH:D002318 | Cardiovascular Diseases | Tacrolimus | 10.75 | 17703430 | |
| MESH:D002318 | Cardiovascular Diseases | Zinc | 10.75 | 16936243 | |
| MESH:D002375 | Catalepsy | Tetrahydrocannabinol | 4.31 | 10318961 | |
| MESH:D002386 | Cataract | Acetaminophen | 9.05 | 10977129 | |
| MESH:D002386 | Cataract | Methylnitrosourea | 9.05 | 12484553 | |
| MESH:D002386 | Cataract | pimagedine | 9.05 | 17936468 15003327 | |
| MESH:D002386 | Cataract | Tretinoin | 9.05 | 17460283 | |
| MESH:D002418 | Cattle Diseases | Dichlorvos | 4.22 | 14651886 | |
| MESH:D002471 | Cell Transformation, Neoplastic | Acetylcysteine | 27.32 | 18226522 | |
| MESH:D002471 | Cell Transformation, Neoplastic | Cadmium | 27.32 | 17332340 | |
| MESH:D002471 | Cell Transformation, Neoplastic | cinnamic aldehyde | 27.32 | 8243401 | |
| MESH:D002471 | Cell Transformation, Neoplastic | Cyclosporine | 27.32 | 12371664 | |
| MESH:D002471 | Cell Transformation, Neoplastic | Diethylnitrosamine | 27.32 | 17174075 2727394 7505956 21159647 | |
| MESH:D002471 | Cell Transformation, Neoplastic | diisopropanolnitrosamine | 27.32 | 1399818 7505956 | |
| MESH:D002471 | Cell Transformation, Neoplastic | Dinoprostone | 27.32 | 16192471 | |
| MESH:D002471 | Cell Transformation, Neoplastic | Estradiol | 27.32 | 18566989 | |
| MESH:D002471 | Cell Transformation, Neoplastic | Galactosamine | 27.32 | 7505956 | |
| MESH:D002471 | Cell Transformation, Neoplastic | Methylnitrosourea | 27.32 | 2727394 7505956 | |
| MESH:D002471 | Cell Transformation, Neoplastic | sodium arsenite | 27.32 | 19524636 20056578 | |
| MESH:D002493 | Central Nervous System Diseases | Dichlorvos | 7.58 | 12670839 | |
| MESH:D002493 | Central Nervous System Diseases | Phenytoin | 7.58 | 4080065 | |
| MESH:D002524 | Cerebellar Ataxia | Antimony Sodium Gluconate | 5.17 | 16432602 | |
| MESH:D002543 | Cerebral Hemorrhage | phenylmethylpyrazolone | 4.43 | 19095969 | |
| MESH:D018290 | Cervical Intraepithelial Neoplasia | Tretinoin | 3.16 | 16129372 | |
| MESH:D002613 | Cheilitis | Anti-HIV Agents | 6.26 | 11488127 | |
| MESH:D002659 | Child Development Disorders, Pervasive | Methionine | 3.82 | 19267885 | |
| MESH:D002659 | Child Development Disorders, Pervasive | Valproic Acid | 3.82 | 20734317 | |
| MESH:D015362 | Child Nutrition Disorders | Vitamin A | 4.03 | 16153327 | |
| MESH:D018281 | Cholangiocarcinoma | Diethylnitrosamine | 8.82 | 19052882 | |
| MESH:D018281 | Cholangiocarcinoma | Tetrachlorodibenzodioxin | 8.82 | 16835633 | |
| MESH:D018281 | Cholangiocarcinoma | Thalidomide | 8.82 | 18291259 | |
| MESH:D002761 | Cholangitis | 1-Naphthylisothiocyanate | 4.74 | 12912871 | |
| MESH:D002764 | Cholecystitis | Indomethacin | 3.72 | 11181007 | |
| MESH:D002779 | Cholestasis | 1-Naphthylisothiocyanate | 16.31 | 15913567 18590720 15500046 16629650 18164287 7624871 19486331 12927374 | |
| MESH:D002779 | Cholestasis | Cyclosporine | 16.31 | 19486331 | |
| MESH:D002779 | Cholestasis | Ethinyl Estradiol | 16.31 | 17681005 15861022 16105132 17333356 16919318 17110522 11677210 | |
| MESH:D002779 | Cholestasis | Nitric Oxide | 16.31 | 16919318 | |
| MESH:D002779 | Cholestasis | pirinixic acid | 16.31 | 19176532 | |
| MESH:D002779 | Cholestasis | Vitamin A | 16.31 | 16175620 | |
| MESH:D002780 | Cholestasis, Intrahepatic | 1-Naphthylisothiocyanate | 4.40 | 19407337 10220858 | |
| OMIM:601042 | CHOREOATHETOSIS/SPASTICITY, EPISODIC | Phenytoin | 4.43 | 11748493 | |
| MESH:D002822 | Choriocarcinoma | Tretinoin | 3.70 | 16461808 | |
| MESH:D019457 | Chromosome Breakage | Sodium Selenite | 3.34 | 15894690 | |
| MESH:D015267 | Churg-Strauss Syndrome | zafirlukast | 4.94 | 9674492 | |
| MESH:D016770 | Ciliophora Infections | Formaldehyde | 4.23 | 12113305 | |
| MESH:D002971 | Cleft Lip | Ethanol | 4.62 | 15513904 | |
| MESH:D002971 | Cleft Lip | Phenytoin | 4.62 | 2227380 | |
| MESH:D002972 | Cleft Palate | Ethanol | 11.72 | 15513904 | |
| MESH:D002972 | Cleft Palate | Phenytoin | 11.72 | 6862529 1687470 3877104 10789828 2227380 6856622 | |
| MESH:D002972 | Cleft Palate | Tetrachlorodibenzodioxin | 11.72 | 15340226 16354765 8697196 15668235 12621046 | |
| MESH:D002972 | Cleft Palate | Tretinoin | 11.72 | 9407595 | |
| MESH:D002972 | Cleft Palate | Urethane | 11.72 | 12810352 | |
| MESH:D002972 | Cleft Palate | Vitamin A | 11.72 | 16054864 | |
| MESH:D003092 | Colitis | Amiloride | 28.53 | 12065299 | |
| MESH:D003092 | Colitis | Carbon Monoxide | 28.53 | 16365149 | |
| MESH:D003092 | Colitis | Curcumin | 28.53 | 16782535 18200517 16804969 | |
| MESH:D003092 | Colitis | resveratrol | 28.53 | 16474422 | |
| MESH:D003092 | Colitis | Selenium | 28.53 | 17936198 | |
| MESH:D003092 | Colitis | Thalidomide | 28.53 | 16680017 | |
| MESH:D003092 | Colitis | Tretinoin | 28.53 | 17035595 | |
| MESH:D003092 | Colitis | Trinitrobenzenesulfonic Acid | 28.53 | 18023891 16474422 17991707 16804969 16867261 16782535 17936198 11698051 18200517 | |
| MESH:D003093 | Colitis, Ulcerative | Dinitrochlorobenzene | 3.92 | 17373747 19159591 | |
| MESH:D003093 | Colitis, Ulcerative | Trinitrobenzenesulfonic Acid | 3.92 | 17276891 | |
| MESH:D003103 | Coloboma | Curcumin | 6.91 | 18809619 | |
| MESH:D003103 | Coloboma | Phenytoin | 6.91 | 9212184 | |
| MESH:D003110 | Colonic Neoplasms | therapeutic | 10866311 | ||
| MESH:D003110 | Colonic Neoplasms | 1,2-Dimethylhydrazine | 31.95 | 16293270 1113308 16338953 1933837 18155637 | |
| MESH:D003110 | Colonic Neoplasms | Aspirin | 31.95 | 12411196 | |
| MESH:D003110 | Colonic Neoplasms | Butyrates | 31.95 | 15936596 | |
| MESH:D003110 | Colonic Neoplasms | cinnamic aldehyde | 31.95 | 17510524 16343908 | |
| MESH:D003110 | Colonic Neoplasms | Curcumin | 31.95 | 16340194 19359593 | |
| MESH:D003110 | Colonic Neoplasms | decitabine | 31.95 | 17616700 | |
| MESH:D003110 | Colonic Neoplasms | Dexamethasone | 31.95 | 15824018 | |
| MESH:D003110 | Colonic Neoplasms | Fluorouracil | 31.95 | 17725105 16510598 17172411 15001691 17287894 17016597 17018589 18772588 16340194 17169374 | |
| MESH:D003110 | Colonic Neoplasms | Genistein | 31.95 | 17182828 | |
| MESH:D003110 | Colonic Neoplasms | Indomethacin | 31.95 | 15936596 15963497 11260862 15786552 15637740 15625704 | |
| MESH:D003110 | Colonic Neoplasms | irinotecan | 31.95 | 17287894 17725105 | |
| MESH:D003110 | Colonic Neoplasms | Iron | 31.95 | 16640825 | |
| MESH:D003110 | Colonic Neoplasms | polyphenols | 31.95 | 16293270 | |
| MESH:D003110 | Colonic Neoplasms | Quercetin | 31.95 | 17191121 11134977 19440933 19056647 16640504 17148506 15741050 | |
| MESH:D003110 | Colonic Neoplasms | resveratrol | 31.95 | 16338953 | |
| MESH:D003110 | Colonic Neoplasms | Sulindac | 31.95 | 12458338 12902858 | |
| MESH:D003110 | Colonic Neoplasms | Vitamin A | 31.95 | 16267017 17219422 | |
| MESH:D015179 | Colorectal Neoplasms | Acrolein | 19.76 | 17597105 | |
| MESH:D015179 | Colorectal Neoplasms | arsenic trioxide | 19.76 | 20501625 | |
| MESH:D015179 | Colorectal Neoplasms | Aspirin | 19.76 | 17047198 | |
| MESH:D015179 | Colorectal Neoplasms | Azacitidine | 19.76 | 19934284 | |
| MESH:D015179 | Colorectal Neoplasms | Cisplatin | 19.76 | 15273666 | |
| MESH:D015179 | Colorectal Neoplasms | Dacarbazine | 19.76 | 15273666 | |
| MESH:D015179 | Colorectal Neoplasms | decitabine | 19.76 | 18981723 | |
| MESH:D015179 | Colorectal Neoplasms | Doxorubicin | 19.76 | 18802399 18259882 | |
| MESH:D015179 | Colorectal Neoplasms | Fluorouracil | 19.76 | 18802399 18949393 15148649 18288408 16282729 17594712 16331619 17094418 17454858 17016601 18509181 17255274 16524972 14970324 17695437 16391804 16303861 15289873 20501625 18448328 17401013 18383874 | |
| MESH:D015179 | Colorectal Neoplasms | Indomethacin | 19.76 | 12606626 11197048 18059344 17054584 | |
| MESH:D015179 | Colorectal Neoplasms | irinotecan | 19.76 | 17454858 17159606 16303861 18259882 18509181 16391804 15273666 | |
| MESH:D015179 | Colorectal Neoplasms | nimesulide | 19.76 | 18349538 | |
| MESH:D015179 | Colorectal Neoplasms | Polychlorinated Biphenyls | 19.76 | 15531428 | |
| MESH:D015179 | Colorectal Neoplasms | Quercetin | 19.76 | 18852136 18095365 | |
| MESH:D015179 | Colorectal Neoplasms | resveratrol | 19.76 | 16550006 | |
| MESH:D015179 | Colorectal Neoplasms | Sulindac | 19.76 | 11197048 10666051 18059344 11076880 | |
| MESH:D003128 | Coma | Dichlorvos | 4.55 | 15303389 | |
| MESH:D003139 | Common Cold | Ascorbic Acid | 4.03 | 17323712 | |
| MESH:D003218 | Condylomata Acuminata | imiquimod | 5.68 | 16302556 11362904 | |
| MESH:D000013 | Congenital Abnormalities | Phenytoin | 5.15 | 10627286 | |
| MESH:D000013 | Congenital Abnormalities | Tetrachlorodibenzodioxin | 5.15 | 14669216 17141729 | |
| MESH:D003233 | Conjunctivitis, Allergic | zafirlukast | 4.49 | 15351322 | |
| MESH:D016510 | Corneal Neovascularization | Curcumin | 7.95 | 18497527 | |
| MESH:D016510 | Corneal Neovascularization | Thalidomide | 7.95 | 9301478 | |
| MESH:D003327 | Coronary Disease | resveratrol | 2.66 | 16507316 | |
| MESH:D023903 | Coronary Restenosis | arsenic trioxide | 2.81 | 12609071 | |
| MESH:D018352 | Coronavirus Infections | Indomethacin | 4.26 | 17302372 | |
| MESH:D003371 | Cough | Terbutaline | 7.07 | 19679606 | |
| MESH:D003371 | Cough | zafirlukast | 7.07 | 12095178 | |
| MESH:D003389 | Cranial Nerve Diseases | Thalidomide | 4.85 | 9200351 | |
| MESH:D019465 | Craniofacial Abnormalities | arsenic trioxide | 19.61 | 10525206 | |
| MESH:D019465 | Craniofacial Abnormalities | Benzene | 19.61 | 15643154 | |
| MESH:D019465 | Craniofacial Abnormalities | Dexamethasone | 19.61 | 17728286 | |
| MESH:D019465 | Craniofacial Abnormalities | Ethanol | 19.61 | 15513904 19302082 10194807 15451039 11198716 15451040 11873399 | |
| MESH:D019465 | Craniofacial Abnormalities | Lead | 19.61 | 19769572 | |
| MESH:D019465 | Craniofacial Abnormalities | Permethrin | 19.61 | 19861644 | |
| MESH:D019465 | Craniofacial Abnormalities | Phenytoin | 19.61 | 19952982 8986270 9212184 | |
| MESH:D019465 | Craniofacial Abnormalities | Reactive Oxygen Species | 19.61 | 15736158 | |
| MESH:D019465 | Craniofacial Abnormalities | Tetrachlorodibenzodioxin | 19.61 | 20055451 10048152 15322242 | |
| MESH:D019465 | Craniofacial Abnormalities | Thalidomide | 19.61 | 9200351 | |
| MESH:D019465 | Craniofacial Abnormalities | Tretinoin | 19.61 | 9224671 10589399 8800419 16925845 9211117 17551590 9142499 14991402 9125849 9664655 | |
| MESH:D019465 | Craniofacial Abnormalities | Valproic Acid | 19.61 | 8888407 16575769 17688650 | |
| MESH:D019465 | Craniofacial Abnormalities | Vitamin A | 19.61 | 10992263 | |
| MESH:D019465 | Craniofacial Abnormalities | Vitamin E | 19.61 | 19769572 | |
| MESH:D019465 | Craniofacial Abnormalities | Zinc | 19.61 | 19302082 | |
| MESH:D003424 | Crohn Disease | Thalidomide | 3.25 | 16078585 | |
| MESH:D003456 | Cryptorchidism | Diethylstilbestrol | 3.18 | 12952375 16002989 | |
| MESH:D003457 | Cryptosporidiosis | mangiferin | 4.41 | 16547730 | |
| MESH:D003490 | Cyanosis | Propanil | 4.95 | 4714336 | |
| MESH:D003550 | Cystic Fibrosis | Acetylcysteine | 13.21 | 19747007 | |
| MESH:D003550 | Cystic Fibrosis | Ciprofloxacin | 13.21 | 19747007 | |
| MESH:D003550 | Cystic Fibrosis | Glutathione | 13.21 | 19747007 | |
| MESH:D003550 | Cystic Fibrosis | pioglitazone | 13.21 | 19747007 | |
| MESH:D003550 | Cystic Fibrosis | zafirlukast | 13.21 | 15463842 | |
| MESH:D003556 | Cystitis | Acrolein | 7.31 | 12161096 | |
| MESH:D003556 | Cystitis | Cyclophosphamide | 7.31 | 16413132 16989017 18093676 18483878 18433785 12161096 15276878 16651033 15643279 18295254 12913760 17010015 16614059 18710439 12388444 10700343 18372110 11948286 10498854 17979934 | |
| MESH:D018856 | Cystitis, Interstitial | Prednisolone | 5.08 | 17714534 | |
| MESH:D007644 | Darier Disease | Fluorouracil | 3.36 | 16733453 | |
| MESH:D016757 | Death, Sudden, Cardiac | arsenic trioxide | 2.75 | 15213294 | |
| MESH:D003665 | Decompression Sickness | zafirlukast | 4.94 | 18309904 | |
| MESH:D003704 | Dementia | Lead | 6.19 | 16140633 | |
| MESH:D003704 | Dementia | Polychlorinated Biphenyls | 6.19 | 16140633 | |
| MESH:D015140 | Dementia, Vascular | Nitric Oxide | 4.52 | 17556102 | |
| MESH:D003711 | Demyelinating Diseases | Tamoxifen | 2.96 | 19031437 | |
| MESH:D003866 | Depressive Disorder | zonisamide | 3.81 | 16855456 | |
| MESH:D003872 | Dermatitis | Benzene | 7.32 | 15902427 | |
| MESH:D003872 | Dermatitis | Picryl Chloride | 7.32 | 18854230 15734285 16442096 | |
| MESH:D017449 | Dermatitis, Allergic Contact | marker/mechanism | 12484431 | ||
| MESH:D017449 | Dermatitis, Allergic Contact | 1,6-hexamethylene diisocyanate | 26.71 | 18759878 | |
| MESH:D017449 | Dermatitis, Allergic Contact | 2-(6-((3-(4-(diphenylmethoxy)piperidino)propyl)amino)imidazo(1,2-b)pyridazin-2-yl)-2-methylpropionic acid | 26.71 | 12438553 | |
| MESH:D017449 | Dermatitis, Allergic Contact | 4-phenylenediamine | 26.71 | 16533241 19470301 11298694 18759875 16823706 11906362 | |
| MESH:D017449 | Dermatitis, Allergic Contact | Cilomilast | 26.71 | 12956900 | |
| MESH:D017449 | Dermatitis, Allergic Contact | cinnamic aldehyde | 26.71 | 11042091 | |
| MESH:D017449 | Dermatitis, Allergic Contact | Dexamethasone | 26.71 | 12438553 | |
| MESH:D017449 | Dermatitis, Allergic Contact | dibenzothiazyl disulfide | 26.71 | 18568896 | |
| MESH:D017449 | Dermatitis, Allergic Contact | Dinitrochlorobenzene | 26.71 | 15491423 | |
| MESH:D017449 | Dermatitis, Allergic Contact | Formaldehyde | 26.71 | 15932584 16958921 15059100 14996049 12081698 | |
| MESH:D017449 | Dermatitis, Allergic Contact | mancozeb | 26.71 | 8807224 | |
| MESH:D017449 | Dermatitis, Allergic Contact | Picryl Chloride | 26.71 | 12484431 | |
| MESH:D017449 | Dermatitis, Allergic Contact | Toluene 2,4-Diisocyanate | 26.71 | 15491423 12956900 18759878 | |
| MESH:D003876 | Dermatitis, Atopic | marker/mechanism | 18249437 | ||
| MESH:D003876 | Dermatitis, Atopic | pirinixic acid | 6.09 | 18249437 | |
| MESH:D003876 | Dermatitis, Atopic | Prednisolone | 6.09 | 12811023 | |
| MESH:D003876 | Dermatitis, Atopic | zafirlukast | 6.09 | 11901593 | |
| MESH:D003877 | Dermatitis, Contact | 4-phenylenediamine | 19.18 | 11531941 | |
| MESH:D003877 | Dermatitis, Contact | Oxazolone | 19.18 | 15944321 12811023 | |
| MESH:D003877 | Dermatitis, Contact | Permethrin | 19.18 | 14617103 | |
| MESH:D003877 | Dermatitis, Contact | Picryl Chloride | 19.18 | 17392825 12811023 12631246 12188032 | |
| MESH:D003877 | Dermatitis, Contact | Toluene 2,4-Diisocyanate | 19.18 | 17010967 | |
| MESH:D003877 | Dermatitis, Contact | Urocanic Acid | 19.18 | 14617103 | |
| MESH:D009783 | Dermatitis, Occupational | mancozeb | 4.46 | 8807224 | |
| MESH:D003920 | Diabetes Mellitus | Iron | 11.63 | 16604332 16640825 | |
| MESH:D003920 | Diabetes Mellitus | Sodium Selenite | 11.63 | 16285004 | |
| MESH:D003920 | Diabetes Mellitus | Streptozocin | 11.63 | 16285004 | |
| MESH:D003920 | Diabetes Mellitus | Zinc | 11.63 | 16479319 | |
| MESH:D003921 | Diabetes Mellitus, Experimental | Cyclophosphamide | 12.93 | 15331540 11751995 10990075 | |
| MESH:D003921 | Diabetes Mellitus, Experimental | mangiferin | 12.93 | 12093613 19028559 | |
| MESH:D003921 | Diabetes Mellitus, Experimental | Quercetin | 12.93 | 19496084 | |
| MESH:D003921 | Diabetes Mellitus, Experimental | resveratrol | 12.93 | 16873680 | |
| MESH:D003921 | Diabetes Mellitus, Experimental | Streptozocin | 12.93 | 15862027 19298542 2177838 12083368 16684804 15298345 18603373 6379147 12446591 11260395 19960420 15831366 19496084 19586609 7637645 12093613 16286809 1374869 8740154 17874149 12644472 17442507 18715473 11055810 | |
| MESH:D003922 | Diabetes Mellitus, Type 1 | Cyclophosphamide | 6.52 | 18772604 | |
| MESH:D003922 | Diabetes Mellitus, Type 1 | Iron | 6.52 | 16506275 | |
| MESH:D003922 | Diabetes Mellitus, Type 1 | Streptozocin | 6.52 | 18603373 | |
| MESH:D003922 | Diabetes Mellitus, Type 1 | Vitamin A | 6.52 | 16506275 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Ascorbic Acid | 17.74 | 16506275 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Curcumin | 17.74 | 18403477 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Diethylnitrosamine | 17.74 | 20387270 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | epigallocatechin gallate | 17.74 | 16988119 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Genistein | 17.74 | 16647724 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Iron | 17.74 | 16506275 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | mangiferin | 17.74 | 11315760 9881663 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | pioglitazone | 17.74 | 16023994 12642470 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Streptozocin | 17.74 | 19647726 19586609 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Tetrachlorodibenzodioxin | 17.74 | 17107852 | |
| MESH:D058065 | Diabetic Cardiomyopathies | Streptozocin | 4.29 | 16025228 | |
| MESH:D003928 | Diabetic Nephropathies | Curcumin | 22.89 | 18204486 | |
| MESH:D003928 | Diabetic Nephropathies | Estradiol | 22.89 | 19279558 | |
| MESH:D003928 | Diabetic Nephropathies | mangiferin | 22.89 | 19706694 19960420 | |
| MESH:D003928 | Diabetic Nephropathies | Plant Extracts | 22.89 | 19706694 | |
| MESH:D003928 | Diabetic Nephropathies | resveratrol | 22.89 | 16286809 | |
| MESH:D003928 | Diabetic Nephropathies | Streptozocin | 22.89 | 19682444 19960420 | |
| MESH:D003928 | Diabetic Nephropathies | Tamoxifen | 22.89 | 19279558 | |
| MESH:D003929 | Diabetic Neuropathies | Progesterone | 3.09 | 17187935 | |
| MESH:D003930 | Diabetic Retinopathy | Streptozocin | 7.68 | 17662242 | |
| MESH:D003930 | Diabetic Retinopathy | Sulindac | 7.68 | 17621415 12861449 | |
| MESH:D003967 | Diarrhea | 3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol | 10.83 | 10611417 | |
| MESH:D003967 | Diarrhea | Dexamethasone | 10.83 | 7237001 | |
| MESH:D003967 | Diarrhea | Dinoprostone | 10.83 | 11488427 7237001 10446763 | |
| MESH:D003967 | Diarrhea | Indomethacin | 10.83 | 7237001 7907874 | |
| MESH:D003967 | Diarrhea | Prednisolone | 10.83 | 7237001 | |
| MESH:D004283 | Dog Diseases | Antimony | 4.23 | 12019027 | |
| OMIM:607208 | DRAVET SYNDROME | Phenytoin | 7.98 | 11748493 | |
| OMIM:607208 | DRAVET SYNDROME | zonisamide | 7.98 | 11748493 | |
| MESH:D003875 | Drug Eruptions | Phenytoin | 4.09 | 15024534 | |
| MESH:D004342 | Drug Hypersensitivity | Dacarbazine | 3.90 | 16508601 | |
| MESH:D056486 | Drug-Induced Liver Injury | marker/mechanism | 12153990 | ||
| MESH:D056486 | Drug-Induced Liver Injury | 1-Naphthylisothiocyanate | 40.77 | 18289764 17522070 20133375 7624871 | |
| MESH:D056486 | Drug-Induced Liver Injury | Acetaminophen | 40.77 | 12958197 2444490 19739265 11739529 12705907 15619225 11421492 14550746 11461765 18713872 15968718 16081117 19416960 12392966 17522070 12540782 16781746 10774834 19085960 16485898 14725611 12594235 16227642 10663392 11834606 12153990 14986274 11743745 16177239 17562736 16109766 16393943 10915739 19420014 11287661 19370779 18071297 19923254 17906064 19164858 11529661 | |
| MESH:D056486 | Drug-Induced Liver Injury | Acetylcysteine | 40.77 | 11287661 | |
| MESH:D056486 | Drug-Induced Liver Injury | Carbon Tetrachloride | 40.77 | 3786805 21278145 3732212 4309450 7120509 17522070 15027814 15968718 10092053 19085960 19336974 9327722 15998439 16177239 11566570 10915739 7179309 2869522 6623471 16227642 6884620 7440962 | |
| MESH:D056486 | Drug-Induced Liver Injury | Chloroform | 40.77 | 7440962 7120509 6884620 3104120 17522070 3732212 2862719 6623471 | |
| MESH:D056486 | Drug-Induced Liver Injury | Diethylnitrosamine | 40.77 | 19107877 | |
| MESH:D056486 | Drug-Induced Liver Injury | Diquat | 40.77 | 18164269 18445702 | |
| MESH:D056486 | Drug-Induced Liver Injury | Doxorubicin | 40.77 | 17416283 | |
| MESH:D056486 | Drug-Induced Liver Injury | Drugs, Chinese Herbal | 40.77 | 15027814 | |
| MESH:D056486 | Drug-Induced Liver Injury | Ethanol | 40.77 | 11566570 | |
| MESH:D056486 | Drug-Induced Liver Injury | Galactosamine | 40.77 | 15968718 | |
| MESH:D056486 | Drug-Induced Liver Injury | Halothane | 40.77 | 12919722 | |
| MESH:D056486 | Drug-Induced Liver Injury | manumycin | 40.77 | 19739265 | |
| MESH:D056486 | Drug-Induced Liver Injury | polyphenols | 40.77 | 19370779 | |
| MESH:D056486 | Drug-Induced Liver Injury | Selenium | 40.77 | 15131321 | |
| MESH:D056486 | Drug-Induced Liver Injury | Silver | 40.77 | 16531870 | |
| MESH:D056486 | Drug-Induced Liver Injury | Sodium Selenite | 40.77 | 15131321 | |
| MESH:D056486 | Drug-Induced Liver Injury | Tetrachlorodibenzodioxin | 40.77 | 20420201 | |
| MESH:D056486 | Drug-Induced Liver Injury | Valproic Acid | 40.77 | 1733752 19641884 | |
| MESH:D056486 | Drug-Induced Liver Injury | vinylidene chloride | 40.77 | 3697828 | |
| MESH:D056486 | Drug-Induced Liver Injury | zafirlukast | 40.77 | 11119397 12583521 | |
| MESH:D056487 | Drug-Induced Liver Injury, Chronic | Acetaminophen | 2.65 | 19426721 | |
| MESH:D004362 | Drug Toxicity | Cisplatin | 13.26 | 12231392 12649298 15033597 19839026 | |
| MESH:D004362 | Drug Toxicity | Doxorubicin | 13.26 | 18602426 | |
| MESH:D004362 | Drug Toxicity | phenylmethylpyrazolone | 13.26 | 12231392 12649298 | |
| MESH:D004362 | Drug Toxicity | Tetrachlorodibenzodioxin | 13.26 | 11462148 | |
| MESH:D004362 | Drug Toxicity | Zidovudine | 13.26 | 15040536 | |
| MESH:D015352 | Dry Eye Syndromes | Vitamin A | 4.37 | 16146918 | |
| MESH:D004374 | Ductus Arteriosus, Patent | Ibuprofen | 8.50 | 18450898 18446180 16133044 | |
| MESH:D004374 | Ductus Arteriosus, Patent | Indomethacin | 8.50 | 17190690 18446180 12774134 18043480 16133044 16326151 | |
| MESH:D004381 | Duodenal Ulcer | Curcumin | 7.76 | 17351913 | |
| MESH:D004381 | Duodenal Ulcer | Indomethacin | 7.76 | 17351913 11595415 17202747 11535926 11991626 17329845 11595431 17151854 16699067 17045617 10671773 | |
| MESH:D004381 | Duodenal Ulcer | Tacrolimus | 7.76 | 17202747 | |
| MESH:D004387 | Dupuytren Contracture | imiquimod | 5.34 | 16368197 | |
| MESH:D004417 | Dyspnea | Budesonide | 9.25 | 20016425 | |
| MESH:D004417 | Dyspnea | Chlorine | 9.25 | 20016425 | |
| MESH:D004417 | Dyspnea | Diazinon | 9.25 | 16487989 | |
| MESH:D004421 | Dystonia | Valproic Acid | 2.70 | 1851702 | |
| MESH:C538011 | Eales disease | Ascorbic Acid | 14.27 | 9068938 | |
| MESH:C538011 | Eales disease | Vitamin A | 14.27 | 9068938 | |
| MESH:C538011 | Eales disease | Vitamin E | 14.27 | 9068938 | |
| MESH:D004480 | Ectromelia | Vitamin A | 4.37 | 16054864 | |
| MESH:D004485 | Eczema | 2-(6-((3-(4-(diphenylmethoxy)piperidino)propyl)amino)imidazo(1,2-b)pyridazin-2-yl)-2-methylpropionic acid | 14.71 | 12438553 | |
| MESH:D004485 | Eczema | Dexamethasone | 14.71 | 12438553 | |
| MESH:D004485 | Eczema | Picryl Chloride | 14.71 | 17429439 | |
| MESH:D004485 | Eczema | Trioxsalen | 14.71 | 16259964 | |
| MESH:D004487 | Edema | Aspirin | 35.02 | 17259670 | |
| MESH:D004487 | Edema | Bleomycin | 35.02 | 17118201 | |
| MESH:D004487 | Edema | Cimetidine | 35.02 | 19703484 | |
| MESH:D004487 | Edema | Dexamethasone | 35.02 | 19703484 | |
| MESH:D004487 | Edema | Indomethacin | 35.02 | 8985016 16100529 7990266 7907874 10653021 19703484 8273558 | |
| MESH:D004487 | Edema | Mangifera indica extract | 35.02 | 16716910 16273134 15177302 | |
| MESH:D004487 | Edema | Mustard Gas | 35.02 | 9260866 11402378 11428631 11428647 | |
| MESH:D004487 | Edema | pirinixic acid | 35.02 | 12083418 | |
| MESH:D004487 | Edema | Plant Extracts | 35.02 | 12787963 | |
| MESH:D004487 | Edema | resveratrol | 35.02 | 8985016 | |
| MESH:D004487 | Edema | Tetrachlorodibenzodioxin | 35.02 | 12711302 11000095 | |
| MESH:D004487 | Edema | Tetradecanoylphorbol Acetate | 35.02 | 15177302 9599246 16716910 8273558 11698051 7812673 8113982 | |
| MESH:D004487 | Edema | zafirlukast | 35.02 | 15351322 | |
| MESH:D004487 | Edema | Zymosan | 35.02 | 7907874 | |
| MESH:D004489 | Edema, Cardiac | Tetrachlorodibenzodioxin | 7.16 | 15322242 16714409 18230668 | |
| MESH:D004489 | Edema, Cardiac | Tretinoin | 7.16 | 18230668 | |
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | 15-deoxy-delta(12,14)-prostaglandin J2 | 36.14 | 16844232 | |
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | 2,2-bis(4-glycidyloxyphenyl)propane | 36.14 | 16091293 | |
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | Calcitriol | 36.14 | 15138306 | |
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | ciglitazone | 36.14 | 16844232 | |
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | Ethinyl Estradiol | 36.14 | 12538720 | |
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | Phenytoin | 36.14 | 17654737 | |
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | Progesterone | 36.14 | 17692515 | |
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | resveratrol | 36.14 | 17872969 | |
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | T 0070907 | 36.14 | 16091293 | |
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | Tamoxifen | 36.14 | 19031437 | |
| MESH:D004701 | Endocrine Gland Neoplasms | decitabine | 3.66 | 19294695 | |
| MESH:D004714 | Endometrial Hyperplasia | Diethylstilbestrol | 7.17 | 16402032 | |
| MESH:D004714 | Endometrial Hyperplasia | Genistein | 7.17 | 16402032 | |
| MESH:D016889 | Endometrial Neoplasms | Diethylstilbestrol | 14.78 | 15700306 16804899 | |
| MESH:D016889 | Endometrial Neoplasms | Doxorubicin | 14.78 | 17359293 | |
| MESH:D016889 | Endometrial Neoplasms | Estradiol | 14.78 | 19148513 11473722 18566989 | |
| MESH:D016889 | Endometrial Neoplasms | Genistein | 14.78 | 11473722 | |
| MESH:D016889 | Endometrial Neoplasms | Tamoxifen | 14.78 | 19155303 20544844 16202921 17893378 | |
| MESH:D016889 | Endometrial Neoplasms | Tretinoin | 14.78 | 16569247 | |
| MESH:D004715 | Endometriosis | Ibuprofen | 23.36 | 15652904 | |
| MESH:D004715 | Endometriosis | Indomethacin | 23.36 | 15652904 | |
| MESH:D004715 | Endometriosis | Mifepristone | 23.36 | 16134523 | |
| MESH:D004715 | Endometriosis | Progesterone | 23.36 | 16134523 | |
| MESH:D004715 | Endometriosis | Sulindac | 23.36 | 15652904 | |
| MESH:D004715 | Endometriosis | Tetrachlorodibenzodioxin | 23.36 | 10568697 9294722 | |
| MESH:D004715 | Endometriosis | zafirlukast | 23.36 | 15019815 | |
| MESH:D004719 | Endomyocardial Fibrosis | Doxorubicin | 9.26 | 18037988 | |
| MESH:D004719 | Endomyocardial Fibrosis | Plant Extracts | 9.26 | 15268973 | |
| MESH:D019446 | Endotoxemia | Ibuprofen | 18.05 | 11545620 | |
| MESH:D019446 | Endotoxemia | Indomethacin | 18.05 | 18509659 | |
| MESH:D019446 | Endotoxemia | lipopolysaccharide, Escherichia coli 0111 B4 | 18.05 | 12954792 | |
| MESH:D019446 | Endotoxemia | Lipopolysaccharides | 18.05 | 15328337 17637181 15821434 | |
| MESH:D019446 | Endotoxemia | phenylmethylpyrazolone | 18.05 | 12954792 | |
| MESH:D004749 | Entamoebiasis | marker/mechanism | 16374615 | ||
| MESH:D004749 | Entamoebiasis | monocyte locomotion inhibitory factor | 5.22 | 16374615 | |
| MESH:D004751 | Enteritis | Clonidine | 11.40 | 8982514 | |
| MESH:D004751 | Enteritis | (glycyl-glycyl)GLP-2 | 11.40 | 10567023 | |
| MESH:D004751 | Enteritis | Indomethacin | 11.40 | 16328016 10567023 17763956 | |
| MESH:D020345 | Enterocolitis, Necrotizing | Indomethacin | 7.72 | 17980183 | |
| MESH:D020345 | Enterocolitis, Necrotizing | resveratrol | 7.72 | 17923197 | |
| MESH:D004802 | Eosinophilia | Cyclophosphamide | 20.50 | 11006010 | |
| MESH:D004802 | Eosinophilia | Histamine | 20.50 | 12689652 | |
| MESH:D004802 | Eosinophilia | Indomethacin | 20.50 | 11298111 | |
| MESH:D004802 | Eosinophilia | Prednisolone | 20.50 | 1355641 | |
| MESH:D004802 | Eosinophilia | Prednisone | 20.50 | 16111148 | |
| MESH:D004802 | Eosinophilia | Toluene 2,4-Diisocyanate | 20.50 | 8156442 | |
| MESH:D004802 | Eosinophilia | zafirlukast | 20.50 | 15351322 12742009 15696079 12189465 12689652 | |
| MESH:D004816 | Epidermal Necrolysis, Toxic | Phenytoin | 3.82 | 20235791 | |
| MESH:D004820 | Epidermolysis Bullosa | Phenytoin | 4.78 | 1399206 6251365 | |
| MESH:D004831 | Epilepsies, Myoclonic | Valproic Acid | 6.79 | 3659116 17275665 | |
| MESH:D004831 | Epilepsies, Myoclonic | zonisamide | 6.79 | 3659116 3691417 | |
| MESH:D004828 | Epilepsies, Partial | Phenytoin | 8.98 | 17116037 11558140 | |
| MESH:D004828 | Epilepsies, Partial | Valproic Acid | 8.98 | 3922381 16628512 | |
| MESH:D004828 | Epilepsies, Partial | zonisamide | 8.98 | 15140322 11558140 3691417 | |
| MESH:D004827 | Epilepsy | Phenytoin | 10.30 | 20417680 11434505 821787 | |
| MESH:D004827 | Epilepsy | Plant Extracts | 10.30 | 19439326 19700373 | |
| MESH:D004827 | Epilepsy | Tetrahydrocannabinol | 10.30 | 821787 | |
| MESH:D004827 | Epilepsy | Valproic Acid | 10.30 | 20417680 18234410 | |
| MESH:D004827 | Epilepsy | zonisamide | 10.30 | 20196486 | |
| MESH:D004832 | Epilepsy, Absence | Valproic Acid | 2.35 | 6426943 7562514 6254150 | |
| MESH:D017029 | Epilepsy, Complex Partial | Phenytoin | 7.04 | 7750514 | |
| MESH:D017029 | Epilepsy, Complex Partial | Valproic Acid | 7.04 | 7750514 | |
| MESH:D004830 | Epilepsy, Tonic-Clonic | Phenytoin | 9.97 | 3659116 | |
| MESH:D004830 | Epilepsy, Tonic-Clonic | Valproic Acid | 9.97 | 3659116 | |
| MESH:D004830 | Epilepsy, Tonic-Clonic | zonisamide | 9.97 | 3659116 3691417 | |
| MESH:D004890 | Erythema | Mustard Gas | 3.72 | 9357497 | |
| MESH:D004892 | Erythema Multiforme | Carbamates | 10.26 | 16750123 | |
| MESH:D004892 | Erythema Multiforme | Thiram | 10.26 | 16750123 | |
| MESH:D004931 | Esophageal Achalasia | Diethylnitrosamine | 3.66 | 16302075 | |
| MESH:D004938 | Esophageal Neoplasms | arsenic trioxide | 17.81 | 12903497 | |
| MESH:D004938 | Esophageal Neoplasms | Benzo(a)pyrene | 17.81 | 16530937 | |
| MESH:D004938 | Esophageal Neoplasms | Butylhydroxybutylnitrosamine | 17.81 | 1399818 | |
| MESH:D004938 | Esophageal Neoplasms | Cisplatin | 17.81 | 16785472 15464296 16481741 15173087 17638652 | |
| MESH:D004938 | Esophageal Neoplasms | diisopropanolnitrosamine | 17.81 | 1399818 | |
| MESH:D004938 | Esophageal Neoplasms | Ethanol | 17.81 | 16704527 | |
| MESH:D004938 | Esophageal Neoplasms | Fluorouracil | 17.81 | 17638652 16337965 16785472 15173087 16481741 | |
| MESH:D004938 | Esophageal Neoplasms | Indomethacin | 17.81 | 11005569 | |
| MESH:D004938 | Esophageal Neoplasms | Sulindac | 17.81 | 12235107 | |
| MESH:D004938 | Esophageal Neoplasms | Zinc | 17.81 | 16543248 | |
| MESH:D020329 | Essential Tremor | Lead | 8.54 | 18007985 14594619 | |
| MESH:D020329 | Essential Tremor | zonisamide | 8.54 | 17149715 18297619 | |
| MESH:D005076 | Exanthema | zonisamide | 4.65 | 15140322 | |
| MESH:D005124 | Eye Abnormalities | Tetrachlorodibenzodioxin | 4.84 | 11564622 | |
| MESH:D005124 | Eye Abnormalities | Tretinoin | 4.84 | 9664655 16938888 | |
| MESH:D005128 | Eye Diseases | Toluene 2,4-Diisocyanate | 4.32 | 18447907 | |
| MESH:D005141 | Eyelid Diseases | Formaldehyde | 4.93 | 14996049 | |
| MESH:D005221 | Fatigue | zonisamide | 4.65 | 17149715 | |
| MESH:D005234 | Fatty Liver | arsenic trioxide | 48.55 | 15073043 | |
| MESH:D005234 | Fatty Liver | Carbon Tetrachloride | 48.55 | 15959796 16239168 12795759 17595544 12631006 19224547 16045604 61145 | |
| MESH:D005234 | Fatty Liver | Curcumin | 48.55 | 19297423 | |
| MESH:D005234 | Fatty Liver | Cyclosporine | 48.55 | 19224547 | |
| MESH:D005234 | Fatty Liver | Diethylnitrosamine | 48.55 | 20387270 21071580 | |
| MESH:D005234 | Fatty Liver | Ethanol | 48.55 | 18620774 16409862 19236843 | |
| MESH:D005234 | Fatty Liver | Ethinyl Estradiol | 48.55 | 15345470 | |
| MESH:D005234 | Fatty Liver | Iron | 48.55 | 16640825 | |
| MESH:D005234 | Fatty Liver | mangiferin | 48.55 | 15975614 | |
| MESH:D005234 | Fatty Liver | phenylmethylpyrazolone | 48.55 | 12795759 | |
| MESH:D005234 | Fatty Liver | pirinixic acid | 48.55 | 19236843 20131406 | |
| MESH:D005234 | Fatty Liver | Plant Extracts | 48.55 | 15975614 | |
| MESH:D005234 | Fatty Liver | Tamoxifen | 48.55 | 14986274 19224547 | |
| MESH:D005234 | Fatty Liver | Valproic Acid | 48.55 | 19224547 14986274 | |
| MESH:D005234 | Fatty Liver | Zidovudine | 48.55 | 18299183 | |
| MESH:D005235 | Fatty Liver, Alcoholic | Ethanol | 4.21 | 17920746 | |
| MESH:D052776 | Female Urogenital Diseases | Diethylstilbestrol | 4.60 | 16002989 16611131 15751030 16513791 16534752 | |
| MESH:D052776 | Female Urogenital Diseases | Tamoxifen | 4.60 | 16709447 | |
| MESH:D005264 | Femoral Fractures | zoledronic acid | 4.39 | 16234978 | |
| MESH:D005310 | Fetal Alcohol Syndrome | Ethanol | 3.86 | 10194807 16946407 15513904 15451040 | |
| MESH:D005313 | Fetal Death | Phenytoin | 6.11 | 10627286 | |
| MESH:D005313 | Fetal Death | Tetrachlorodibenzodioxin | 6.11 | 11858732 | |
| MESH:D005315 | Fetal Diseases | Valproic Acid | 3.43 | 16575769 | |
| MESH:D005317 | Fetal Growth Retardation | Lead | 6.69 | 19769572 | |
| MESH:D005317 | Fetal Growth Retardation | Valproic Acid | 6.69 | 18558336 8888407 | |
| MESH:D005327 | Fetal Resorption | Vitamin A | 3.92 | 16054864 | |
| MESH:D005334 | Fever | Dinoprostone | 14.84 | 11852909 16997862 | |
| MESH:D005334 | Fever | Ibuprofen | 14.84 | 16997862 | |
| MESH:D005334 | Fever | Indomethacin | 14.84 | 17627676 11852909 10431976 | |
| MESH:D005334 | Fever | lipopolysaccharide, Escherichia coli 0111 B4 | 14.84 | 16997862 | |
| MESH:D005334 | Fever | Lipopolysaccharides | 14.84 | 9205823 11852909 | |
| MESH:D018221 | Fibromatosis, Abdominal | Sulindac | 8.22 | 14745880 | |
| MESH:D018221 | Fibromatosis, Abdominal | Tamoxifen | 8.22 | 14745880 | |
| MESH:D018222 | Fibromatosis, Aggressive | Dacarbazine | 16.56 | 19069698 | |
| MESH:D018222 | Fibromatosis, Aggressive | Doxorubicin | 16.56 | 19069698 | |
| MESH:D018222 | Fibromatosis, Aggressive | Sulindac | 16.56 | 19069698 | |
| MESH:D018222 | Fibromatosis, Aggressive | Tamoxifen | 16.56 | 19069698 | |
| MESH:D005354 | Fibrosarcoma | Indomethacin | 7.48 | 10962813 | |
| MESH:D005354 | Fibrosarcoma | Methylnitrosourea | 7.48 | 11555667 | |
| MESH:D005355 | Fibrosis | Carbon Tetrachloride | 28.98 | 18705752 | |
| MESH:D005355 | Fibrosis | Curcumin | 28.98 | 18705752 | |
| MESH:D005355 | Fibrosis | Cyclosporine | 28.98 | 12168785 12639820 | |
| MESH:D005355 | Fibrosis | Indomethacin | 28.98 | 17994277 | |
| MESH:D005355 | Fibrosis | Quercetin | 28.98 | 19474275 | |
| MESH:D005355 | Fibrosis | Terbutaline | 28.98 | 15467267 | |
| MESH:D005355 | Fibrosis | Tetrachlorodibenzodioxin | 28.98 | 20067830 | |
| MESH:D005355 | Fibrosis | Tretinoin | 28.98 | 17994277 | |
| MESH:D005355 | Fibrosis | Trinitrobenzenesulfonic Acid | 28.98 | 17994277 | |
| MESH:D005393 | Fish Diseases | Formaldehyde | 4.20 | 12113305 | |
| MESH:D005499 | Folliculitis | Indomethacin | 3.72 | 11298111 | |
| MESH:D005621 | Friedreich Ataxia | Iron | 4.02 | 16604332 16640825 | |
| MESH:D005706 | Gallbladder Neoplasms | arsenic trioxide | 2.88 | 16904648 | |
| MESH:D005739 | Gas Poisoning | Budesonide | 7.52 | 20016425 | |
| MESH:D005739 | Gas Poisoning | Chlorine | 7.52 | 20016425 | |
| MESH:D005756 | Gastritis | Acetaminophen | 21.05 | 16983495 | |
| MESH:D005756 | Gastritis | Diquat | 21.05 | 15046732 | |
| MESH:D005756 | Gastritis | Ethanol | 21.05 | 15046732 | |
| MESH:D005756 | Gastritis | Indomethacin | 21.05 | 15046732 | |
| MESH:D005756 | Gastritis | Zinc | 21.05 | 17241300 | |
| MESH:D005764 | Gastroesophageal Reflux | Sulindac | 3.64 | 11910360 | |
| MESH:D005770 | Gastrointestinal Neoplasms | Curcumin | 3.30 | 18462866 | |
| MESH:D005833 | Genital Neoplasms, Female | Diethylstilbestrol | 8.08 | 16452187 | |
| MESH:D005833 | Genital Neoplasms, Female | sodium arsenite | 8.08 | 16452187 | |
| MESH:D005871 | Giant Lymph Node Hyperplasia | Thalidomide | 4.85 | 12701121 | |
| MESH:D005885 | Gingival Hyperplasia | Cyclosporine | 8.18 | 8708960 | |
| MESH:D005885 | Gingival Hyperplasia | Phenytoin | 8.18 | 9029455 | |
| MESH:D019214 | Gingival Overgrowth | Phenytoin | 4.78 | 14659971 16390469 | |
| MESH:D005909 | Glioblastoma | Aspirin | 23.38 | 12870263 | |
| MESH:D005909 | Glioblastoma | Curcumin | 23.38 | 17596214 | |
| MESH:D005909 | Glioblastoma | Dacarbazine | 23.38 | 12592361 12853885 | |
| MESH:D005909 | Glioblastoma | Doxorubicin | 23.38 | 17150277 | |
| MESH:D005909 | Glioblastoma | Genistein | 23.38 | 16598420 | |
| MESH:D005909 | Glioblastoma | Indomethacin | 23.38 | 12870263 | |
| MESH:D005909 | Glioblastoma | Manganese | 23.38 | 17043766 | |
| MESH:D005909 | Glioblastoma | Quercetin | 23.38 | 19804834 | |
| MESH:D005909 | Glioblastoma | Tretinoin | 23.38 | 17312396 | |
| MESH:D005910 | Glioma | Fluorouracil | 9.39 | 16145905 | |
| MESH:D005910 | Glioma | Indomethacin | 9.39 | 18371953 16487511 | |
| MESH:D005910 | Glioma | Methylnitrosourea | 9.39 | 9825942 | |
| MESH:D005910 | Glioma | Quercetin | 9.39 | 17643826 | |
| MESH:D005910 | Glioma | Thalidomide | 9.39 | 16327979 | |
| MESH:D018316 | Gliosarcoma | Cyclophosphamide | 4.08 | 11389073 | |
| MESH:D005911 | Gliosis | Paraquat | 3.71 | 11124998 | |
| MESH:D005922 | Glomerulonephritis, IGA | deoxynivalenol | 3.79 | 15173396 16524712 | |
| MESH:D005923 | Glomerulosclerosis, Focal Segmental | Indomethacin | 6.18 | 11849393 | |
| MESH:D005923 | Glomerulosclerosis, Focal Segmental | pioglitazone | 6.18 | 16687628 | |
| MESH:D044882 | Glucose Metabolism Disorders | Mangifera indica extract | 5.30 | 16273134 | |
| MESH:D006030 | Glycosuria, Renal | Mercuric Chloride | 4.49 | 2918855 | |
| MESH:D006058 | Gonadal Disorders | Tetrachlorodibenzodioxin | 3.14 | 10696789 | |
| MESH:D006073 | Gout | Indomethacin | 3.92 | 11248219 | |
| MESH:D006086 | Graft vs Host Disease | Cyclophosphamide | 7.78 | 11014644 16376943 15172196 | |
| MESH:D006086 | Graft vs Host Disease | Tacrolimus | 7.78 | 16376943 | |
| MESH:D017789 | Granuloma, Pyogenic | imiquimod | 5.68 | 16302556 | |
| MESH:D006130 | Growth Disorders | Amiloride | 7.92 | 19703807 | |
| MESH:D006130 | Growth Disorders | Tacrolimus | 7.92 | 11041285 | |
| MESH:D006130 | Growth Disorders | Zinc | 7.92 | 17217573 | |
| MESH:D006261 | Headache | Aspirin | 14.16 | 15240983 | |
| MESH:D006261 | Headache | Nitric Oxide | 14.16 | 11284996 11554966 | |
| MESH:D006261 | Headache | zafirlukast | 14.16 | 10386485 9377612 | |
| MESH:D006261 | Headache | zonisamide | 14.16 | 17149715 | |
| MESH:D006258 | Head and Neck Neoplasms | Cisplatin | 22.85 | 15464296 15102660 | |
| MESH:D006258 | Head and Neck Neoplasms | Curcumin | 22.85 | 18829502 18462866 | |
| MESH:D006258 | Head and Neck Neoplasms | decitabine | 22.85 | 19215824 | |
| MESH:D006258 | Head and Neck Neoplasms | Doxorubicin | 22.85 | 15692506 | |
| MESH:D006258 | Head and Neck Neoplasms | Fluorouracil | 22.85 | 15162350 18337622 15102660 | |
| MESH:D006258 | Head and Neck Neoplasms | Indomethacin | 22.85 | 15482327 | |
| MESH:D006258 | Head and Neck Neoplasms | nimesulide | 22.85 | 15482327 | |
| MESH:D006258 | Head and Neck Neoplasms | Tretinoin | 22.85 | 16096774 | |
| MESH:D034381 | Hearing Loss | Cisplatin | 3.02 | 19898482 | |
| MESH:D006317 | Hearing Loss, Noise-Induced | Tretinoin | 3.70 | 16084493 | |
| MESH:D006319 | Hearing Loss, Sensorineural | Cisplatin | 3.15 | 15464296 | |
| MESH:D006330 | Heart Defects, Congenital | Ascorbic Acid | 13.36 | 16080930 | |
| MESH:D006330 | Heart Defects, Congenital | Benzo(a)pyrene | 13.36 | 20471113 | |
| MESH:D006330 | Heart Defects, Congenital | Tetrachlorodibenzodioxin | 13.36 | 10048152 11294989 | |
| MESH:D006330 | Heart Defects, Congenital | Tretinoin | 13.36 | 14991402 9664655 | |
| MESH:D006330 | Heart Defects, Congenital | Vitamin A | 13.36 | 10992263 16080930 | |
| MESH:D006330 | Heart Defects, Congenital | Vitamin E | 13.36 | 16080930 | |
| MESH:D006331 | Heart Diseases | Antimony Sodium Gluconate | 14.86 | 11049798 | |
| MESH:D006331 | Heart Diseases | Ciprofloxacin | 14.86 | 11505790 | |
| MESH:D006331 | Heart Diseases | Doxorubicin | 14.86 | 14766674 18674790 18006777 16144979 16495754 16244372 17875725 17888722 16879835 12587719 16707910 16330681 16244371 | |
| MESH:D006331 | Heart Diseases | mangiferin | 14.86 | 12093613 | |
| MESH:D006331 | Heart Diseases | Streptozocin | 14.86 | 12093613 | |
| MESH:D006331 | Heart Diseases | Urethane | 14.86 | 16046796 | |
| MESH:D006333 | Heart Failure | Doxorubicin | 10.78 | 17481944 | |
| MESH:D006333 | Heart Failure | pirinixic acid | 10.78 | 20558911 | |
| MESH:D006333 | Heart Failure | Plant Extracts | 10.78 | 18097624 | |
| MESH:D006333 | Heart Failure | Selenium | 10.78 | 17162251 | |
| MESH:D006333 | Heart Failure | Zinc | 10.78 | 17162251 | |
| MESH:D006335 | Heart Injuries | Zinc | 4.31 | 17074742 | |
| MESH:D016481 | Helicobacter Infections | Ciprofloxacin | 6.54 | 17643012 | |
| MESH:D016481 | Helicobacter Infections | Zinc | 6.54 | 17241300 | |
| MESH:D006390 | Hemangioendothelioma | 2-Acetylaminofluorene | 3.87 | 6705139 | |
| MESH:D006391 | Hemangioma | imiquimod | 5.34 | 16302556 | |
| MESH:D006394 | Hemangiosarcoma | 2-Acetylaminofluorene | 5.07 | 6705139 | |
| MESH:D006394 | Hemangiosarcoma | Doxorubicin | 5.07 | 15692506 | |
| MESH:D006402 | Hematologic Diseases | Benzene | 6.59 | 16183116 | |
| MESH:D006402 | Hematologic Diseases | Zidovudine | 6.59 | 12579204 | |
| MESH:D006432 | Hemochromatosis | Iron | 3.31 | 16640825 17236123 16574947 17255318 17053826 16604332 | |
| MESH:D006457 | Hemoglobinuria, Paroxysmal | Cyclosporine | 2.99 | 15720958 | |
| MESH:D006463 | Hemolytic-Uremic Syndrome | Lipopolysaccharides | 3.08 | 16366002 | |
| MESH:D006467 | Hemophilia A | Cyclophosphamide | 3.88 | 11918545 | |
| MESH:D006470 | Hemorrhage | Tetrachlorodibenzodioxin | 2.02 | 11000095 | |
| MESH:D006486 | Hemosiderosis | Iron | 3.77 | 16604332 | |
| MESH:D006501 | Hepatic Encephalopathy | Indomethacin | 3.24 | 15633222 | |
| MESH:D006504 | Hepatic Veno-Occlusive Disease | Cyclophosphamide | 4.08 | 14986274 | |
| MESH:D006505 | Hepatitis | 1-Naphthylisothiocyanate | 19.17 | 18590720 | |
| MESH:D006505 | Hepatitis | Carbon Tetrachloride | 19.17 | 19900420 19110552 | |
| MESH:D006505 | Hepatitis | Diazinon | 19.17 | 16487989 | |
| MESH:D006505 | Hepatitis | Drugs, Chinese Herbal | 19.17 | 18339527 | |
| MESH:D006505 | Hepatitis | zafirlukast | 19.17 | 12189465 | |
| MESH:D006505 | Hepatitis | Zymosan | 19.17 | 19110552 | |
| MESH:D006526 | Hepatitis C | marker/mechanism | |||
| MESH:D019698 | Hepatitis C, Chronic | Indomethacin | 3.31 | 15135802 | |
| MESH:D006525 | Hepatitis, Viral, Human | Iron | 4.02 | 16640825 | |
| MESH:D006527 | Hepatolenticular Degeneration | Iron | 6.66 | 17182432 | |
| MESH:D006527 | Hepatolenticular Degeneration | Zinc | 6.66 | 17276780 | |
| MESH:D006529 | Hepatomegaly | Iron | 6.60 | 16890145 | |
| MESH:D006529 | Hepatomegaly | pirinixic acid | 6.60 | 18467677 16221962 19176532 19772884 | |
| MESH:D006529 | Hepatomegaly | Tetrachlorodibenzodioxin | 6.60 | 15340226 12621046 16120746 | |
| MESH:D015417 | Hereditary Sensory and Motor Neuropathy | Curcumin | 3.63 | 17701891 | |
| MESH:D006548 | Hernia, Diaphragmatic | Ascorbic Acid | 6.97 | 16863852 16490937 | |
| MESH:D006548 | Hernia, Diaphragmatic | Dexamethasone | 6.97 | 7520565 | |
| MESH:D006548 | Hernia, Diaphragmatic | Vitamin A | 6.97 | 15707848 16490937 16863852 16292552 16877224 17436238 | |
| MESH:D006548 | Hernia, Diaphragmatic | Vitamin E | 6.97 | 16863852 16490937 | |
| MESH:D006558 | Herpes Genitalis | Estradiol | 3.58 | 15709030 | |
| MESH:D006561 | Herpes Simplex | Mangifera indica extract | 12.04 | 10715843 | |
| MESH:D006561 | Herpes Simplex | mangiferin | 12.04 | 10715843 | |
| MESH:D006561 | Herpes Simplex | Plant Extracts | 12.04 | 10715843 | |
| MESH:D006561 | Herpes Simplex | resveratrol | 12.04 | 16876885 | |
| MESH:D015658 | HIV Infections | marker/mechanism | 10202824 | ||
| MESH:D015658 | HIV Infections | Anti-HIV Agents | 9.71 | 11464145 | |
| MESH:D015658 | HIV Infections | Iron | 9.71 | 16597321 | |
| MESH:D015658 | HIV Infections | Plant Extracts | 9.71 | 12878215 | |
| MESH:D015658 | HIV Infections | Vitamin A | 9.71 | 16960176 | |
| MESH:D015658 | HIV Infections | Zidovudine | 9.71 | 11698656 11363243 20032539 11141242 17358032 | |
| MESH:D006679 | HIV Seropositivity | Vitamin A | 4.17 | 17209195 | |
| MESH:D006689 | Hodgkin Disease | Bleomycin | 15.56 | 17606976 15147373 18501091 | |
| MESH:D006689 | Hodgkin Disease | Cisplatin | 15.56 | 16170182 16200630 | |
| MESH:D006689 | Hodgkin Disease | Cyclophosphamide | 15.56 | 16135485 17606976 | |
| MESH:D006689 | Hodgkin Disease | Dacarbazine | 15.56 | 18501091 16170182 | |
| MESH:D006689 | Hodgkin Disease | Doxorubicin | 15.56 | 15147373 18501091 17606976 | |
| MESH:D006689 | Hodgkin Disease | Prednisone | 15.56 | 16794504 17606976 16135485 | |
| MESH:D006689 | Hodgkin Disease | sodium arsenite | 15.56 | 12676792 | |
| MESH:D006734 | Horse Diseases | Dichlorvos | 4.55 | 16402567 | |
| MESH:D019584 | Hot Flashes | Estradiol | 8.92 | 17088409 | |
| MESH:D019584 | Hot Flashes | Plant Extracts | 8.92 | 17454163 16566672 14716179 | |
| MESH:D019584 | Hot Flashes | Vitamin E | 8.92 | 14716179 | |
| OMIM:609423 | HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO | marker/mechanism | |||
| MESH:D018327 | Hutchinson's Melanotic Freckle | imiquimod | 5.68 | 16302556 | |
| MESH:D006849 | Hydrocephalus | Valproic Acid | 3.43 | 17688650 | |
| MESH:D006869 | Hydronephrosis | Lithium Chloride | 8.23 | 19797860 | |
| MESH:D006869 | Hydronephrosis | Tetrachlorodibenzodioxin | 8.23 | 16959395 8697196 18606429 15340226 16354765 | |
| MESH:D012001 | Hyperacusis | Aspirin | 4.31 | 15240983 | |
| MESH:D006930 | Hyperalgesia | Acetaminophen | 18.30 | 16870215 | |
| MESH:D006930 | Hyperalgesia | Dinoprostone | 18.30 | 16793879 | |
| MESH:D006930 | Hyperalgesia | Ethanol | 18.30 | 18783367 | |
| MESH:D006930 | Hyperalgesia | Freund's Adjuvant | 18.30 | 16769263 | |
| MESH:D006930 | Hyperalgesia | Indomethacin | 18.30 | 12727271 | |
| MESH:D006930 | Hyperalgesia | Tretinoin | 18.30 | 16870215 | |
| MESH:D006930 | Hyperalgesia | zoledronic acid | 18.30 | 16769263 | |
| MESH:D034321 | Hyperamylasemia | Indomethacin | 4.26 | 17883296 | |
| MESH:D006932 | Hyperbilirubinemia | Carbon Tetrachloride | 3.10 | 16899240 | |
| MESH:D006934 | Hypercalcemia | zoledronic acid | 3.72 | 19622757 18089816 | |
| MESH:D006937 | Hypercholesterolemia | Curcumin | 5.03 | 18704882 | |
| MESH:D006937 | Hypercholesterolemia | resveratrol | 5.03 | 17188708 | |
| MESH:D006940 | Hyperemia | Indomethacin | 7.99 | 12524144 | |
| MESH:D006940 | Hyperemia | Nitric Oxide | 7.99 | 11156591 | |
| MESH:D017681 | Hypereosinophilic Syndrome | Tretinoin | 3.16 | 16778211 | |
| MESH:D006941 | Hyperesthesia | Dichlorvos | 5.23 | 12563396 | |
| MESH:D006943 | Hyperglycemia | methyl isocyanate | 8.43 | 8440870 | |
| MESH:D006943 | Hyperglycemia | pirinixic acid | 8.43 | 20558911 | |
| MESH:D006943 | Hyperglycemia | Quercetin | 8.43 | 11834736 18262572 | |
| MESH:D020138 | Hyperhomocysteinemia | Phenytoin | 5.58 | 10459572 | |
| MESH:D020138 | Hyperhomocysteinemia | Plant Extracts | 5.58 | 16484555 | |
| MESH:D006946 | Hyperinsulinism | mangiferin | 3.74 | 9881663 11315760 | |
| MESH:D006949 | Hyperlipidemias | Indomethacin | 11.22 | 17546600 | |
| MESH:D006949 | Hyperlipidemias | mangiferin | 11.22 | 15975614 | |
| MESH:D006949 | Hyperlipidemias | Plant Extracts | 11.22 | 15268973 15975614 | |
| MESH:D006949 | Hyperlipidemias | resveratrol | 11.22 | 16873680 | |
| MESH:D006965 | Hyperplasia | Diethylstilbestrol | 3.05 | 14722030 12960047 | |
| MESH:D006967 | Hypersensitivity | Mangifera indica extract | 10.42 | 16536907 | |
| MESH:D006967 | Hypersensitivity | mangiferin | 10.42 | 16536907 | |
| MESH:D006967 | Hypersensitivity | phthalic anhydride | 10.42 | 7930309 | |
| MESH:D006967 | Hypersensitivity | Toluene 2,4-Diisocyanate | 10.42 | 11019492 10880147 | |
| MESH:D006968 | Hypersensitivity, Delayed | indirubin | 8.28 | 11275354 | |
| MESH:D006968 | Hypersensitivity, Delayed | Picryl Chloride | 8.28 | 11275354 | |
| MESH:D006973 | Hypertension | Amiloride | 9.64 | 18524855 15174897 19344079 | |
| MESH:D006973 | Hypertension | Benzene | 9.64 | 17940673 | |
| MESH:D006973 | Hypertension | Cyclosporine | 9.64 | 10903974 | |
| MESH:D006973 | Hypertension | Dexamethasone | 9.64 | 17042910 | |
| MESH:D006973 | Hypertension | Quercetin | 9.64 | 18356687 | |
| MESH:D006973 | Hypertension | Tetrachlorodibenzodioxin | 9.64 | 18850075 18670907 | |
| MESH:D006975 | Hypertension, Portal | Carbon Tetrachloride | 2.69 | 15338365 | |
| MESH:D046110 | Hypertension, Pregnancy-Induced | Clonidine | 4.76 | 16612254 | |
| MESH:D006976 | Hypertension, Pulmonary | Nitric Oxide | 5.10 | 15838368 | |
| MESH:D006976 | Hypertension, Pulmonary | zafirlukast | 5.10 | 12781059 | |
| MESH:D006984 | Hypertrophy | Ibuprofen | 3.65 | 16672835 | |
| MESH:D017379 | Hypertrophy, Left Ventricular | phenylmethylpyrazolone | 6.45 | 15824197 | |
| MESH:D017379 | Hypertrophy, Left Ventricular | resveratrol | 6.45 | 17488730 | |
| MESH:D006985 | Hyperventilation | Terbutaline | 4.66 | 10895896 | |
| MESH:D006986 | Hypervitaminosis A | Vitamin A | 4.71 | 16054864 | |
| MESH:D006996 | Hypocalcemia | zoledronic acid | 4.74 | 12669777 | |
| MESH:D007003 | Hypoglycemia | Glyburide | 4.61 | 10918110 | |
| MESH:D007006 | Hypogonadism | Iron | 3.25 | 16640825 | |
| MESH:D007008 | Hypokalemia | Terbutaline | 4.66 | 17292646 | |
| MESH:D020514 | Hypokalemic Periodic Paralysis | Amiloride | 4.42 | 19822448 | |
| MESH:C537153 | Hypomagnesemia primary | Tacrolimus | 4.72 | 11041285 | |
| MESH:D007021 | Hypospadias | Diethylstilbestrol | 6.60 | 16002989 | |
| MESH:D007021 | Hypospadias | Ethinyl Estradiol | 6.60 | 16945680 16569931 | |
| MESH:D007022 | Hypotension | Tacrolimus | 3.82 | 11041285 | |
| MESH:D007035 | Hypothermia | Tetrahydrocannabinol | 4.53 | 10318961 | |
| MESH:D007037 | Hypothyroidism | Iron | 3.68 | 16640825 | |
| MESH:D007077 | Ileal Diseases | Indomethacin | 3.58 | 10574470 18306037 | |
| MESH:D007079 | Ileitis | Indomethacin | 3.92 | 10647630 10651667 16133968 | |
| MESH:D007154 | Immune System Diseases | Cyclophosphamide | 14.55 | 16076520 | |
| MESH:D007154 | Immune System Diseases | mangiferin | 14.55 | 16076520 | |
| MESH:D007154 | Immune System Diseases | Silver | 14.55 | 17996693 | |
| MESH:D007235 | Infant, Premature, Diseases | Ibuprofen | 9.39 | 16133044 | |
| MESH:D007235 | Infant, Premature, Diseases | Indomethacin | 9.39 | 16133044 | |
| MESH:D020244 | Infarction, Middle Cerebral Artery | Progesterone | 6.84 | 15869954 | |
| MESH:D020244 | Infarction, Middle Cerebral Artery | resveratrol | 6.84 | 17600658 | |
| MESH:D007246 | Infertility | Diethylstilbestrol | 10.52 | 15036965 | |
| MESH:D007246 | Infertility | Thiram | 10.52 | 6420938 | |
| MESH:D007246 | Infertility | Ziram | 10.52 | 6420938 | |
| MESH:D007247 | Infertility, Female | Ethinyl Estradiol | 2.13 | 12013081 | |
| MESH:D007248 | Infertility, Male | Atrazine | 24.31 | 12948887 | |
| MESH:D007248 | Infertility, Male | Cyclophosphamide | 24.31 | 7193160 16517039 | |
| MESH:D007248 | Infertility, Male | decitabine | 24.31 | 17581917 | |
| MESH:D007248 | Infertility, Male | Diazinon | 24.31 | 12948887 16466525 | |
| MESH:D007248 | Infertility, Male | Diquat | 24.31 | 4850670 | |
| MESH:D007248 | Infertility, Male | Ethinyl Estradiol | 24.31 | 17937319 | |
| MESH:D007248 | Infertility, Male | Lead | 24.31 | 16780224 | |
| MESH:D007248 | Infertility, Male | Methylnitrosourea | 24.31 | 7193160 | |
| MESH:D007248 | Infertility, Male | Paraquat | 24.31 | 4850670 | |
| MESH:D007248 | Infertility, Male | sodium arsenite | 24.31 | 12646999 15346721 | |
| MESH:D007249 | Inflammation | Amiloride | 83.20 | 17237260 | |
| MESH:D007249 | Inflammation | Bleomycin | 83.20 | 17118201 | |
| MESH:D007249 | Inflammation | Cilomilast | 83.20 | 16956605 17155857 | |
| MESH:D007249 | Inflammation | Curcumin | 83.20 | 16956363 18403477 17151092 | |
| MESH:D007249 | Inflammation | Dexamethasone | 83.20 | 8960868 11099482 | |
| MESH:D007249 | Inflammation | Diethylnitrosamine | 83.20 | 18785209 | |
| MESH:D007249 | Inflammation | ethylisopropylamiloride | 83.20 | 17237260 | |
| MESH:D007249 | Inflammation | Fatty Acids, Omega-3 | 83.20 | 17296493 | |
| MESH:D007249 | Inflammation | Freund's Adjuvant | 83.20 | 16793879 | |
| MESH:D007249 | Inflammation | Ibuprofen | 83.20 | 3291741 | |
| MESH:D007249 | Inflammation | Indomethacin | 83.20 | 7812673 12568917 3291741 | |
| MESH:D007249 | Inflammation | Lipopolysaccharides | 83.20 | 17237260 9205823 12878042 17255318 17963957 | |
| MESH:D007249 | Inflammation | Mangifera indica extract | 83.20 | 15177302 15222974 | |
| MESH:D007249 | Inflammation | mangiferin | 83.20 | 15222974 | |
| MESH:D007249 | Inflammation | Mustard Gas | 83.20 | 9260866 9357497 17524151 11428631 11428620 11402378 8975870 11428647 16001271 | |
| MESH:D007249 | Inflammation | nimesulide | 83.20 | 11438310 | |
| MESH:D007249 | Inflammation | pioglitazone | 83.20 | 16908763 | |
| MESH:D007249 | Inflammation | Plant Extracts | 83.20 | 12787963 19332304 15997105 16366677 | |
| MESH:D007249 | Inflammation | polyphenols | 83.20 | 16366677 | |
| MESH:D007249 | Inflammation | Prednisone | 83.20 | 16111148 | |
| MESH:D007249 | Inflammation | Progesterone | 83.20 | 15869954 | |
| MESH:D007249 | Inflammation | Quartz | 83.20 | 11306444 | |
| MESH:D007249 | Inflammation | resveratrol | 83.20 | 16366677 | |
| MESH:D007249 | Inflammation | Silver | 83.20 | 17996693 | |
| MESH:D007249 | Inflammation | Sulindac | 83.20 | 3291741 | |
| MESH:D007249 | Inflammation | Tamoxifen | 83.20 | 19457130 | |
| MESH:D007249 | Inflammation | Tetrachlorodibenzodioxin | 83.20 | 12878042 12200463 | |
| MESH:D007249 | Inflammation | Tetradecanoylphorbol Acetate | 83.20 | 7812673 11698051 8273558 15177302 7562506 | |
| MESH:D007249 | Inflammation | Thalidomide | 83.20 | 16134734 | |
| MESH:D007249 | Inflammation | zafirlukast | 83.20 | 11438310 18309904 | |
| MESH:D007249 | Inflammation | Zymosan | 83.20 | 11289658 8014878 | |
| MESH:D015212 | Inflammatory Bowel Diseases | Curcumin | 5.60 | 18200517 18596194 | |
| MESH:D015212 | Inflammatory Bowel Diseases | Leukotriene B4 | 5.60 | 11006272 | |
| MESH:D015212 | Inflammatory Bowel Diseases | Trinitrobenzenesulfonic Acid | 5.60 | 18200517 | |
| MESH:D007251 | Influenza, Human | pyrrolidine dithiocarbamic acid | 20.08 | 18473937 | |
| MESH:D007251 | Influenza, Human | Quercetin | 20.08 | 16624496 | |
| MESH:D007251 | Influenza, Human | resveratrol | 20.08 | 16624496 | |
| MESH:D007251 | Influenza, Human | Selenium | 20.08 | 16624496 | |
| MESH:D007251 | Influenza, Human | Vitamin E | 20.08 | 16624496 | |
| MESH:D007299 | Insect Bites and Stings | Permethrin | 4.38 | 12749493 15189238 12971516 | |
| MESH:D007333 | Insulin Resistance | bisphenol A | 11.46 | 16393666 | |
| MESH:D007333 | Insulin Resistance | Estradiol | 11.46 | 16393666 16627594 | |
| MESH:D007333 | Insulin Resistance | mangiferin | 11.46 | 11315760 | |
| MESH:D007333 | Insulin Resistance | pirinixic acid | 11.46 | 16306350 | |
| MESH:D007333 | Insulin Resistance | Sodium Selenite | 11.46 | 14714311 | |
| MESH:D007410 | Intestinal Diseases | Indomethacin | 16.19 | 18236018 15831440 15610444 17329856 17994277 11713966 11855677 11686837 10210152 | |
| MESH:D007410 | Intestinal Diseases | Nitric Oxide | 16.19 | 11713966 10210152 11574821 | |
| MESH:D007410 | Intestinal Diseases | pimagedine | 16.19 | 11713966 | |
| MESH:D007410 | Intestinal Diseases | Tretinoin | 16.19 | 17994277 | |
| MESH:D007410 | Intestinal Diseases | Trinitrobenzenesulfonic Acid | 16.19 | 17994277 | |
| MESH:D007414 | Intestinal Neoplasms | caffeic acid phenethyl ester | 12.80 | 10783313 | |
| MESH:D007414 | Intestinal Neoplasms | Curcumin | 12.80 | 10783313 | |
| MESH:D007414 | Intestinal Neoplasms | Plant Extracts | 12.80 | 12351151 12584176 12628509 | |
| MESH:D007414 | Intestinal Neoplasms | Sulindac | 12.80 | 12584176 12663524 12628509 10213222 12351151 10223192 | |
| MESH:D007417 | Intestinal Polyps | Sulindac | 3.63 | 12394442 11245490 | |
| MESH:D002532 | Intracranial Aneurysm | phenylmethylpyrazolone | 6.42 | 19381132 | |
| MESH:D002532 | Intracranial Aneurysm | Reactive Oxygen Species | 6.42 | 19381132 | |
| MESH:D019586 | Intracranial Hypertension | Indomethacin | 9.39 | 15241188 | |
| MESH:D019586 | Intracranial Hypertension | Vitamin A | 9.39 | 15955940 | |
| MESH:D019189 | Iron Metabolism Disorders | Iron | 7.09 | 17163184 | |
| MESH:D019189 | Iron Metabolism Disorders | Lipopolysaccharides | 7.09 | 17255318 | |
| MESH:D043183 | Irritable Bowel Syndrome | Zymosan | 4.40 | 17553498 | |
| MESH:D007511 | Ischemia | Mangifera indica extract | 14.62 | 16273134 | |
| MESH:D007511 | Ischemia | mangiferin | 14.62 | 16806951 | |
| MESH:D007511 | Ischemia | phenylmethylpyrazolone | 14.62 | 16301206 | |
| MESH:D007511 | Ischemia | Zinc | 14.62 | 16584753 | |
| MESH:D002546 | Ischemic Attack, Transient | zonisamide | 5.44 | 9372210 | |
| MESH:D007569 | Jaw Abnormalities | Ethanol | 9.54 | 15513904 | |
| MESH:D007569 | Jaw Abnormalities | Tetrachlorodibenzodioxin | 9.54 | 16580747 | |
| MESH:D007569 | Jaw Abnormalities | Tretinoin | 9.54 | 15992940 17551590 | |
| MESH:D007579 | Jejunal Diseases | Indomethacin | 3.58 | 10574470 16133968 18306037 | |
| MESH:D007589 | Job's Syndrome | marker/mechanism | 16112032 | ||
| MESH:D007627 | Keloid | Quercetin | 3.54 | 17086741 | |
| MESH:D007638 | Keratoconjunctivitis Sicca | Cyclosporine | 2.99 | 15604871 | |
| MESH:D007642 | Keratosis | imiquimod | 5.14 | 16302556 | |
| MESH:D017492 | Keratosis, Seborrheic | alitretinoin | 4.20 | 16144296 | |
| MESH:D007673 | Kidney Cortex Necrosis | Cisplatin | 3.69 | 15464296 | |
| MESH:D007674 | Kidney Diseases | Acetaminophen | 56.80 | 12587719 15629191 | |
| MESH:D007674 | Kidney Diseases | Acrolein | 56.80 | 12488133 | |
| MESH:D007674 | Kidney Diseases | Cadmium | 56.80 | 16962696 16322080 16226777 | |
| MESH:D007674 | Kidney Diseases | Cadmium Chloride | 56.80 | 16962696 | |
| MESH:D007674 | Kidney Diseases | caffeic acid phenethyl ester | 56.80 | 15369732 | |
| MESH:D007674 | Kidney Diseases | Cisplatin | 56.80 | 12649298 15190930 19839026 12231392 18289764 | |
| MESH:D007674 | Kidney Diseases | Cyclosporine | 56.80 | 8314463 10903974 18776723 | |
| MESH:D007674 | Kidney Diseases | Dichlorvos | 56.80 | 16798900 | |
| MESH:D007674 | Kidney Diseases | Doxorubicin | 56.80 | 15369732 15699352 16775033 | |
| MESH:D007674 | Kidney Diseases | Estradiol | 56.80 | 15618244 | |
| MESH:D007674 | Kidney Diseases | Indomethacin | 56.80 | 17190690 | |
| MESH:D007674 | Kidney Diseases | mangiferin | 56.80 | 12093613 | |
| MESH:D007674 | Kidney Diseases | phenylmethylpyrazolone | 56.80 | 18085390 | |
| MESH:D007674 | Kidney Diseases | Quercetin | 56.80 | 16962696 | |
| MESH:D007674 | Kidney Diseases | sodium arsenite | 56.80 | 20008137 | |
| MESH:D007674 | Kidney Diseases | Streptozocin | 56.80 | 12093613 | |
| MESH:D007674 | Kidney Diseases | Tacrolimus | 56.80 | 11041285 | |
| MESH:D007674 | Kidney Diseases | vinylidene chloride | 56.80 | 7839370 | |
| MESH:D007674 | Kidney Diseases | Vitamin E | 56.80 | 12488133 | |
| MESH:D007674 | Kidney Diseases | Zinc | 56.80 | 16960431 | |
| MESH:D007676 | Kidney Failure, Chronic | Doxorubicin | 13.08 | 16707910 | |
| MESH:D007676 | Kidney Failure, Chronic | Hydrogen Peroxide | 13.08 | 16518626 | |
| MESH:D007676 | Kidney Failure, Chronic | Selenium | 13.08 | 16518626 | |
| MESH:D007676 | Kidney Failure, Chronic | Zinc | 13.08 | 16518626 | |
| MESH:D007680 | Kidney Neoplasms | Cyclosporine | 16.44 | 12371664 | |
| MESH:D007680 | Kidney Neoplasms | Diethylstilbestrol | 16.44 | 15003126 16762066 14681315 | |
| MESH:D007680 | Kidney Neoplasms | diisopropanolnitrosamine | 16.44 | 6582329 | |
| MESH:D007680 | Kidney Neoplasms | Estradiol | 16.44 | 15610895 | |
| MESH:D007680 | Kidney Neoplasms | Fluorouracil | 16.44 | 16985049 | |
| MESH:D007680 | Kidney Neoplasms | Tamoxifen | 16.44 | 18625569 | |
| MESH:D007680 | Kidney Neoplasms | Zidovudine | 16.44 | 12579204 | |
| MESH:D007683 | Kidney Tubular Necrosis, Acute | Cisplatin | 3.36 | 11231351 | |
| MESH:D007855 | Lead Poisoning | Lead | 4.50 | 16700817 | |
| MESH:D007859 | Learning Disorders | bioallethrin | 15.53 | 7589230 | |
| MESH:D007859 | Learning Disorders | Diethylstilbestrol | 15.53 | 17184923 | |
| MESH:D007859 | Learning Disorders | Ethanol | 15.53 | 15451040 | |
| MESH:D007859 | Learning Disorders | Lead | 15.53 | 16384672 | |
| MESH:D007859 | Learning Disorders | mangiferin | 15.53 | 19182383 | |
| MESH:D007877 | Legionnaires' Disease | therapeutic | 11349020 | ||
| MESH:D007889 | Leiomyoma | Curcumin | 3.22 | 18555241 | |
| MESH:D007896 | Leishmaniasis | marker/mechanism | 17218153 16540374 | ||
| MESH:D007896 | Leishmaniasis | Amphotericin B | 10.95 | 17205440 20404924 21063981 | |
| MESH:D007896 | Leishmaniasis | Antimony | 10.95 | 10953559 15220340 21182181 21063981 12019027 | |
| MESH:D007896 | Leishmaniasis | Antimony Sodium Gluconate | 10.95 | 20139272 8059918 7960131 7945751 | |
| MESH:D007896 | Leishmaniasis | Nitric Oxide | 10.95 | 17218153 | |
| MESH:D016773 | Leishmaniasis, Cutaneous | marker/mechanism|therapeutic | 9234779 20102417 8154019 | ||
| MESH:D016773 | Leishmaniasis, Cutaneous | Antimony | 7.17 | 19141829 11475954 8889330 | |
| MESH:D016773 | Leishmaniasis, Cutaneous | Antimony Sodium Gluconate | 7.17 | 10886148 11528583 10233236 2166429 1311351 10786029 1329273 1322070 15610669 1323630 7570843 15234329 14512915 8407083 1314873 9234779 19744259 10617787 7724530 2160914 10647737 10542306 15259478 9314461 15678803 17278657 12032913 9299828 9770149 20438389 9499605 7682386 | |
| MESH:D016773 | Leishmaniasis, Cutaneous | Indomethacin | 7.17 | 10320625 12228301 11703811 | |
| MESH:D007897 | Leishmaniasis, Mucocutaneous | therapeutic | 7854095 | ||
| MESH:D007897 | Leishmaniasis, Mucocutaneous | Antimony | 7.51 | 9643325 10651420 10881086 7854095 11370249 | |
| MESH:D007897 | Leishmaniasis, Mucocutaneous | Antimony Sodium Gluconate | 7.51 | 1322070 2173461 16135192 7519887 1645930 1325634 | |
| MESH:D007898 | Leishmaniasis, Visceral | therapeutic | 1901333 7854095 | ||
| MESH:D007898 | Leishmaniasis, Visceral | Amphotericin B | 9.03 | 15868188 16131481 10603400 17035822 10569788 16269185 9756784 18765878 9625910 18087708 9498473 11049798 7983993 17911647 | |
| MESH:D007898 | Leishmaniasis, Visceral | Antimony | 9.03 | 8142506 20495762 11105143 1899875 7854095 7875148 7554475 | |
| MESH:D007898 | Leishmaniasis, Visceral | Antimony Sodium Gluconate | 9.03 | 15868188 11751149 12379707 15716043 12955641 7498017 7903366 17300636 1658990 12718341 9856145 11049798 1315396 1852133 8916804 10617787 11035738 8607595 7932924 18765878 10952587 16117959 15610669 1314709 12803856 20576500 1319700 15328135 10569788 1315397 15518175 17911647 7715298 17382981 1337639 2098410 11069076 9844051 7844400 7983993 9665985 10805470 15896700 16432602 10604050 12898450 12870129 16131481 1645929 10467834 9625910 1659303 10603400 11398119 8394861 9531339 9756784 9498473 11417033 10886148 | |
| MESH:D007898 | Leishmaniasis, Visceral | Thalidomide | 9.03 | 16514283 | |
| MESH:D053609 | Lethargy | Terbutaline | 4.86 | 10895896 | |
| MESH:D007938 | Leukemia | arsenic trioxide | 24.38 | 15070760 | |
| MESH:D007938 | Leukemia | Azacitidine | 24.38 | 19148494 | |
| MESH:D007938 | Leukemia | Benzene | 24.38 | 15935818 14694614 17119257 18335105 | |
| MESH:D007938 | Leukemia | Curcumin | 24.38 | 18462866 | |
| MESH:D007938 | Leukemia | Cyclophosphamide | 24.38 | 10602166 | |
| MESH:D007938 | Leukemia | decitabine | 24.38 | 19235587 18980019 | |
| MESH:D007938 | Leukemia | Genistein | 24.38 | 17468513 18980019 | |
| MESH:D007938 | Leukemia | Permethrin | 24.38 | 12937054 | |
| MESH:D007938 | Leukemia | Quercetin | 24.38 | 17468513 | |
| MESH:D007938 | Leukemia | Tretinoin | 24.38 | 17143497 | |
| MESH:D004915 | Leukemia, Erythroblastic, Acute | Doxorubicin | 3.70 | 16085563 | |
| MESH:D015451 | Leukemia, Lymphocytic, Chronic, B-Cell | Cyclophosphamide | 4.08 | 17802794 18587576 17296974 17658394 17008537 18172266 | |
| MESH:D015451 | Leukemia, Lymphocytic, Chronic, B-Cell | Drugs, Chinese Herbal | 4.08 | 15802533 | |
| MESH:D007945 | Leukemia, Lymphoid | mancozeb | 4.89 | 16132792 | |
| MESH:D015459 | Leukemia-Lymphoma, Adult T-Cell | arsenic trioxide | 12.45 | 12560223 17077332 | |
| MESH:D015459 | Leukemia-Lymphoma, Adult T-Cell | Curcumin | 12.45 | 16106398 | |
| MESH:D015459 | Leukemia-Lymphoma, Adult T-Cell | Zidovudine | 12.45 | 20370541 | |
| MESH:D015459 | Leukemia-Lymphoma, Adult T-Cell | zoledronic acid | 12.45 | 18089816 | |
| MESH:D007948 | Leukemia, Monocytic, Acute | anthra(1,9-cd)pyrazol-6(2H)-one | 16.58 | 16972261 | |
| MESH:D007948 | Leukemia, Monocytic, Acute | arsenic trioxide | 16.58 | 16972261 | |
| MESH:D007948 | Leukemia, Monocytic, Acute | PD 98059 | 16.58 | 16972261 | |
| MESH:D007948 | Leukemia, Monocytic, Acute | U 0126 | 16.58 | 16972261 | |
| MESH:D015464 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | arsenic trioxide | 10.34 | 14633726 | |
| MESH:D015464 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Cyclophosphamide | 10.34 | 10373061 | |
| MESH:D015464 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Indomethacin | 10.34 | 16572323 10785260 15631656 | |
| MESH:D015464 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | mangiferin | 10.34 | 15498116 | |
| MESH:D007951 | Leukemia, Myeloid | arsenic trioxide | 16.10 | 19077051 | |
| MESH:D007951 | Leukemia, Myeloid | Azacitidine | 16.10 | 19077051 | |
| MESH:D007951 | Leukemia, Myeloid | Benzene | 16.10 | 17506065 | |
| MESH:D007951 | Leukemia, Myeloid | decitabine | 16.10 | 18454857 19117987 17236224 | |
| MESH:D007951 | Leukemia, Myeloid | Tretinoin | 16.10 | 19285840 16482212 16932348 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | arsenic trioxide | 11.25 | 16467208 17050201 16968895 19850784 20471514 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | Azacitidine | 11.25 | 17596541 18720364 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | Benzene | 11.25 | 19478238 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | decitabine | 11.25 | 18704418 18460780 19387464 19010910 18206229 17679729 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | Indomethacin | 11.25 | 18360721 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | Thalidomide | 11.25 | 18720364 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | Tretinoin | 11.25 | 19850784 16294345 17596541 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | Valproic Acid | 11.25 | 16294345 17596541 | |
| MESH:D015477 | Leukemia, Myelomonocytic, Chronic | decitabine | 4.01 | 18055864 | |
| MESH:D054429 | Leukemia, Myelomonocytic, Juvenile | Azacitidine | 3.83 | 19299654 | |
| MESH:D015473 | Leukemia, Promyelocytic, Acute | arsenic trioxide | 9.06 | 12018890 16823087 19225113 17649720 16331271 9834237 11161223 15213294 17712046 16891316 16330433 17107899 15748426 11468182 15622746 12712474 15336539 16112521 16966277 19075265 17217047 19642359 12679006 19035177 17869043 | |
| MESH:D015473 | Leukemia, Promyelocytic, Acute | caffeic acid phenethyl ester | 9.06 | 16766008 | |
| MESH:D015473 | Leukemia, Promyelocytic, Acute | resveratrol | 9.06 | 16087638 | |
| MESH:D015473 | Leukemia, Promyelocytic, Acute | Tretinoin | 9.06 | 19075265 16766008 17649720 16331271 9834237 17506722 19035177 17368321 17361223 19225113 19642359 16935935 16891316 16140955 17107899 15748426 17712046 17217047 17339181 19029980 17294898 17301526 16788101 12679006 16823087 | |
| MESH:D015458 | Leukemia, T-Cell | arsenic trioxide | 7.13 | 16882451 | |
| MESH:D015458 | Leukemia, T-Cell | Curcumin | 7.13 | 16106398 | |
| MESH:D007964 | Leukocytosis | Indomethacin | 9.60 | 16537180 | |
| MESH:D007964 | Leukocytosis | zafirlukast | 9.60 | 18489783 | |
| MESH:D007969 | Leukomalacia, Periventricular | Indomethacin | 4.26 | 17980183 | |
| MESH:D007970 | Leukopenia | Ciprofloxacin | 11.59 | 17846019 | |
| MESH:D007970 | Leukopenia | Cyclophosphamide | 11.59 | 11830472 10052129 | |
| MESH:D007970 | Leukopenia | Lipopolysaccharides | 11.59 | 15821434 | |
| MESH:D020961 | Lewy Body Disease | Iron | 4.02 | 16563566 | |
| MESH:D056929 | Liddle Syndrome | Amiloride | 4.56 | 19344079 | |
| MESH:D017880 | Limb Deformities, Congenital | Ethanol | 13.26 | 17676605 | |
| MESH:D017880 | Limb Deformities, Congenital | Methylnitrosourea | 13.26 | 15526292 | |
| MESH:D017880 | Limb Deformities, Congenital | Thalidomide | 13.26 | 10473037 | |
| MESH:D017880 | Limb Deformities, Congenital | Tretinoin | 13.26 | 9224671 | |
| MESH:D017880 | Limb Deformities, Congenital | Vitamin A | 13.26 | 16054864 | |
| MESH:D008064 | Lipidoses | Tamoxifen | 2.04 | 15342952 17567588 | |
| MESH:D008101 | Liver Abscess, Amebic | Indomethacin | 4.26 | 11479899 | |
| MESH:D008103 | Liver Cirrhosis | Carbon Tetrachloride | 18.85 | 21278145 16943688 17334410 11408273 11903743 17174718 16221502 17157831 16239168 | |
| MESH:D008103 | Liver Cirrhosis | Diethylnitrosamine | 18.85 | 20032147 19638242 18522880 18407596 18665156 | |
| MESH:D008103 | Liver Cirrhosis | Drugs, Chinese Herbal | 18.85 | 17163593 | |
| MESH:D008103 | Liver Cirrhosis | Ethanol | 18.85 | 15289165 | |
| MESH:D008103 | Liver Cirrhosis | Iron | 18.85 | 16640825 | |
| MESH:D008103 | Liver Cirrhosis | Plant Extracts | 18.85 | 17157831 | |
| MESH:D008103 | Liver Cirrhosis | Thalidomide | 18.85 | 16943688 17174718 | |
| MESH:D008103 | Liver Cirrhosis | Vitamin A | 18.85 | 16256175 | |
| MESH:D008104 | Liver Cirrhosis, Alcoholic | Ethanol | 3.67 | 18295389 | |
| MESH:D008105 | Liver Cirrhosis, Biliary | Sulindac | 3.15 | 12468960 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | therapeutic | 16953842 12389079 17347453 15996030 | ||
| MESH:D008106 | Liver Cirrhosis, Experimental | Carbon Tetrachloride | 46.01 | 18705752 10355542 17698563 15650968 15057751 18317297 18277467 15052691 15370692 12632512 17481882 16192424 17714472 17631135 14512876 11481614 15673190 16033810 18054572 15893842 12898905 15876570 18472332 17565644 12649538 17640975 17708605 12445421 18251166 17900296 14748882 12667390 15730626 17525996 17805973 18205269 15338365 13678700 15931870 18187930 16136751 18420326 17823541 18418968 14716496 12609069 12666154 18395095 17922224 18166357 16015684 18156304 17557913 17976157 16638106 16011737 12445418 17766677 18210741 18263696 18376398 14716833 16248980 14724832 14620537 16097048 16116963 18481824 12389079 15959796 18472094 17944888 12632514 18279442 18395914 20821823 15925388 17721639 18006644 12958196 17869086 18429990 15818738 12741479 18412020 16027843 12546737 15362042 17761835 18339082 12586293 15996030 15123356 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Curcumin | 46.01 | 17355460 18705752 18006644 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Dexamethasone | 46.01 | 16718785 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Dinoprostone | 46.01 | 15816358 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Doxorubicin | 46.01 | 16595196 16439617 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Drugs, Chinese Herbal | 46.01 | 17881167 15754396 17348192 18567088 15339415 15744066 17629604 12632512 15849816 15383259 15818738 16610055 17666798 18606216 17036385 15763062 15864749 18371158 15641146 18237412 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | epigallocatechin gallate | 46.01 | 17481882 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Estradiol | 46.01 | 14716833 14659978 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Ethanol | 46.01 | 18166357 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Genistein | 46.01 | 17823541 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Glucosylceramides | 46.01 | 17698563 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Indomethacin | 46.01 | 18194892 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Lipopolysaccharides | 46.01 | 12878042 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Melatonin | 46.01 | 16703270 15298665 15925388 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Methionine | 46.01 | 15158331 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | oxymatrine | 46.01 | 18395914 15633229 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | pioglitazone | 46.01 | 16484506 15052691 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | pirinixic acid | 46.01 | 15474484 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Plant Extracts | 46.01 | 15479170 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Poly I-C | 46.01 | 18166357 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | pyrrolidine dithiocarbamic acid | 46.01 | 15078482 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Quercetin | 46.01 | 12741479 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Tamoxifen | 46.01 | 18564211 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Tetrachlorodibenzodioxin | 46.01 | 12878042 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Thalidomide | 46.01 | 15465738 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Tretinoin | 46.01 | 16248980 18397230 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Vitamin A | 46.01 | 16248980 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Vitamin E | 46.01 | 16169303 | |
| MESH:D008107 | Liver Diseases | 1-Naphthylisothiocyanate | 33.34 | 17184895 | |
| MESH:D008107 | Liver Diseases | Acetaminophen | 33.34 | 12587719 19460945 16610002 19014921 11587558 12969438 16611625 19784758 | |
| MESH:D008107 | Liver Diseases | Antimony Sodium Gluconate | 33.34 | 7570843 | |
| MESH:D008107 | Liver Diseases | Carbon Monoxide | 33.34 | 17173083 | |
| MESH:D008107 | Liver Diseases | Carbon Tetrachloride | 33.34 | 17285989 15720792 16964402 16246199 15830285 | |
| MESH:D008107 | Liver Diseases | Curcumin | 33.34 | 16956363 | |
| MESH:D008107 | Liver Diseases | Diethylnitrosamine | 33.34 | 17034775 | |
| MESH:D008107 | Liver Diseases | Dinoprostone | 33.34 | 15816358 | |
| MESH:D008107 | Liver Diseases | Drugs, Chinese Herbal | 33.34 | 17207593 | |
| MESH:D008107 | Liver Diseases | Lindane | 33.34 | 1715830 | |
| MESH:D008107 | Liver Diseases | nimesulide | 33.34 | 16867024 | |
| MESH:D008107 | Liver Diseases | Phenytoin | 33.34 | 14986274 | |
| MESH:D008107 | Liver Diseases | Plant Extracts | 33.34 | 17034775 | |
| MESH:D008107 | Liver Diseases | polyphenols | 33.34 | 16698588 | |
| MESH:D008107 | Liver Diseases | Sulindac | 33.34 | 16867024 14986274 | |
| MESH:D008107 | Liver Diseases | Tetrachloroethylene | 33.34 | 17267091 | |
| MESH:D008107 | Liver Diseases | Vitamin A | 33.34 | 16175620 | |
| MESH:D008108 | Liver Diseases, Alcoholic | Ethanol | 11.02 | 17347304 17207112 | |
| MESH:D008108 | Liver Diseases, Alcoholic | Iron | 11.02 | 17207112 16737972 | |
| MESH:D008108 | Liver Diseases, Alcoholic | Vitamin A | 11.02 | 16762690 | |
| MESH:D017093 | Liver Failure | Carbon Tetrachloride | 7.32 | 15123358 | |
| MESH:D017093 | Liver Failure | Galactosamine | 7.32 | 11023982 | |
| MESH:D017114 | Liver Failure, Acute | Acetaminophen | 5.09 | 17185352 16871587 | |
| MESH:D017114 | Liver Failure, Acute | Carbon Tetrachloride | 5.09 | 16899240 14706259 | |
| MESH:D008113 | Liver Neoplasms | 2,4,5,2',4',5'-hexachlorobiphenyl | 43.61 | 18644402 16835634 | |
| MESH:D008113 | Liver Neoplasms | 2-Acetylaminofluorene | 43.61 | 10672840 11376686 16273603 14678523 18001218 10737359 | |
| MESH:D008113 | Liver Neoplasms | arsenic trioxide | 43.61 | 14682389 | |
| MESH:D008113 | Liver Neoplasms | Benzo(a)pyrene | 43.61 | 21137059 20195826 | |
| MESH:D008113 | Liver Neoplasms | Carbon Tetrachloride | 43.61 | 19294768 | |
| MESH:D008113 | Liver Neoplasms | Diethylnitrosamine | 43.61 | 19255062 12112319 19850985 21278145 20434301 20492335 21167192 19690152 20583210 20101389 19996281 18977376 20405173 19638242 15885732 18644402 2862719 20137499 19427195 19426721 19833225 15175105 9163691 18754104 19256749 19254457 19551842 10737359 16942905 20452335 18978307 19812893 20501860 18648771 21047994 19499222 19642983 19294768 19090486 12771043 2422723 20118626 19073162 21071580 | |
| MESH:D008113 | Liver Neoplasms | Diethylstilbestrol | 43.61 | 16712894 15890375 | |
| MESH:D008113 | Liver Neoplasms | Drugs, Chinese Herbal | 43.61 | 18339527 | |
| MESH:D008113 | Liver Neoplasms | Epoxy Compounds | 43.61 | 12562636 | |
| MESH:D008113 | Liver Neoplasms | Fluorouracil | 43.61 | 17045692 18383874 16603448 15113037 | |
| MESH:D008113 | Liver Neoplasms | Iron | 43.61 | 20302851 16640825 | |
| MESH:D008113 | Liver Neoplasms | Piperonyl Butoxide | 43.61 | 15890375 18648771 20101389 19690152 | |
| MESH:D008113 | Liver Neoplasms | pirinixic acid | 43.61 | 16377806 20007298 15890375 | |
| MESH:D008113 | Liver Neoplasms | Plant Extracts | 43.61 | 19168119 | |
| MESH:D008113 | Liver Neoplasms | Quercetin | 43.61 | 18980244 | |
| MESH:D008113 | Liver Neoplasms | resveratrol | 43.61 | 19073162 19812893 19321006 20405173 | |
| MESH:D008113 | Liver Neoplasms | sodium arsenite | 43.61 | 16712894 15276417 | |
| MESH:D008113 | Liver Neoplasms | Tamoxifen | 43.61 | 16684651 | |
| MESH:D008113 | Liver Neoplasms | Tetrachlorodibenzodioxin | 43.61 | 16984957 | |
| MESH:D008113 | Liver Neoplasms | Urethane | 43.61 | 16391232 17559639 17093202 | |
| MESH:D008114 | Liver Neoplasms, Experimental | 2-Acetylaminofluorene | 32.21 | 534488 6150874 1399818 | |
| MESH:D008114 | Liver Neoplasms, Experimental | arsenic trioxide | 32.21 | 20377131 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Ascorbic Acid | 32.21 | 18544905 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Benzene | 32.21 | 12562636 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Carbon Tetrachloride | 32.21 | 15583823 12014681 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Diethylnitrosamine | 32.21 | 18544905 3124819 16267830 19519916 18079962 9362446 19009564 18253720 18775883 18164116 19539802 19126423 18308698 21159647 16842330 17174075 18282651 2563599 17854601 18093689 17942915 19004024 | |
| MESH:D008114 | Liver Neoplasms, Experimental | diisopropanolnitrosamine | 32.21 | 1399818 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Doxorubicin | 32.21 | 16842330 17085340 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Hexachlorobenzene | 32.21 | 1423854 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Polychlorinated Biphenyls | 32.21 | 1423854 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Quercetin | 32.21 | 19519916 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Tetrachlorodibenzodioxin | 32.21 | 12151625 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Tetrachloroethylene | 32.21 | 7955063 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Vitamin A | 32.21 | 17113696 | |
| MESH:D008133 | Long QT Syndrome | arsenic trioxide | 2.20 | 15213294 | |
| MESH:D038061 | Lower Extremity Deformities, Congenital | Methylnitrosourea | 4.05 | 16080182 | |
| MESH:D008171 | Lung Diseases | Acetylcysteine | 24.64 | 12815614 | |
| MESH:D008171 | Lung Diseases | Acrolein | 24.64 | 11504702 | |
| MESH:D008171 | Lung Diseases | Ascorbic Acid | 24.64 | 16863852 | |
| MESH:D008171 | Lung Diseases | methyl isocyanate | 24.64 | 1396463 | |
| MESH:D008171 | Lung Diseases | Mustard Gas | 24.64 | 18702808 18161513 | |
| MESH:D008171 | Lung Diseases | Ozone | 24.64 | 19066396 8266340 | |
| MESH:D008171 | Lung Diseases | sodium arsenite | 24.64 | 19095001 | |
| MESH:D008171 | Lung Diseases | Vitamin A | 24.64 | 16863852 | |
| MESH:D008171 | Lung Diseases | Vitamin E | 24.64 | 16863852 | |
| MESH:D017563 | Lung Diseases, Interstitial | Benzene | 11.05 | 14698565 | |
| MESH:D017563 | Lung Diseases, Interstitial | Valproic Acid | 11.05 | 17228818 | |
| MESH:D017563 | Lung Diseases, Interstitial | zonisamide | 11.05 | 17228818 | |
| MESH:D008173 | Lung Diseases, Obstructive | zafirlukast | 4.60 | 9847434 | |
| MESH:D055370 | Lung Injury | Ciprofloxacin | 17.55 | 18197910 | |
| MESH:D055370 | Lung Injury | Lipopolysaccharides | 17.55 | 21114838 | |
| MESH:D055370 | Lung Injury | Nitric Oxide | 17.55 | 11395602 | |
| MESH:D055370 | Lung Injury | Ozone | 17.55 | 20417186 | |
| MESH:D055370 | Lung Injury | pyrrolidine dithiocarbamic acid | 17.55 | 16129981 | |
| MESH:D055370 | Lung Injury | vinylidene chloride | 17.55 | 3697828 | |
| MESH:D008175 | Lung Neoplasms | 2-Acetylaminofluorene | 78.62 | 11376686 | |
| MESH:D008175 | Lung Neoplasms | alitretinoin | 78.62 | 16413115 | |
| MESH:D008175 | Lung Neoplasms | arsenic trioxide | 78.62 | 19825857 11798837 | |
| MESH:D008175 | Lung Neoplasms | Ascorbic Acid | 78.62 | 16401635 | |
| MESH:D008175 | Lung Neoplasms | Azacitidine | 78.62 | 21224363 | |
| MESH:D008175 | Lung Neoplasms | Benzene | 78.62 | 12562636 | |
| MESH:D008175 | Lung Neoplasms | Benzo(a)pyrene | 78.62 | 20064080 20464547 6695378 18816296 20135361 18569708 17053015 18520028 20869020 | |
| MESH:D008175 | Lung Neoplasms | Bleomycin | 78.62 | 6189445 | |
| MESH:D008175 | Lung Neoplasms | Budesonide | 78.62 | 16885199 17163412 12117777 | |
| MESH:D008175 | Lung Neoplasms | ciglitazone | 78.62 | 15899809 | |
| MESH:D008175 | Lung Neoplasms | Ciprofloxacin | 78.62 | 20211752 | |
| MESH:D008175 | Lung Neoplasms | Cisplatin | 78.62 | 6189445 11798837 17225452 | |
| MESH:D008175 | Lung Neoplasms | Curcumin | 78.62 | 19359593 16243823 18462866 | |
| MESH:D008175 | Lung Neoplasms | Dexamethasone | 78.62 | 15824018 11195469 | |
| MESH:D008175 | Lung Neoplasms | Diethylnitrosamine | 78.62 | 20512841 20970405 21163286 6695378 | |
| MESH:D008175 | Lung Neoplasms | diisopropanolnitrosamine | 78.62 | 1399818 | |
| MESH:D008175 | Lung Neoplasms | Doxorubicin | 78.62 | 17418594 6189445 | |
| MESH:D008175 | Lung Neoplasms | Drugs, Chinese Herbal | 78.62 | 18339527 | |
| MESH:D008175 | Lung Neoplasms | Epoxy Compounds | 78.62 | 12562636 | |
| MESH:D008175 | Lung Neoplasms | Fluorouracil | 78.62 | 15246190 | |
| MESH:D008175 | Lung Neoplasms | Indomethacin | 78.62 | 16537180 11497255 11053908 | |
| MESH:D008175 | Lung Neoplasms | Iron | 78.62 | 16640825 | |
| MESH:D008175 | Lung Neoplasms | mangiferin | 78.62 | 18520028 18816296 18569708 | |
| MESH:D008175 | Lung Neoplasms | Melatonin | 78.62 | 17195641 | |
| MESH:D008175 | Lung Neoplasms | methyl 2-cyano-3,12-dioxoolean-1,9-dien-28-oate | 78.62 | 17363558 | |
| MESH:D008175 | Lung Neoplasms | Methylene Chloride | 78.62 | 15172992 | |
| MESH:D008175 | Lung Neoplasms | Methylnitrosourea | 78.62 | 18062963 | |
| MESH:D008175 | Lung Neoplasms | Mustard Gas | 78.62 | 8781369 3148597 | |
| MESH:D008175 | Lung Neoplasms | Ozone | 78.62 | 7614698 8597069 | |
| MESH:D008175 | Lung Neoplasms | Plant Extracts | 78.62 | 20869020 | |
| MESH:D008175 | Lung Neoplasms | Quartz | 78.62 | 11306444 | |
| MESH:D008175 | Lung Neoplasms | Quercetin | 78.62 | 16280456 | |
| MESH:D008175 | Lung Neoplasms | sodium arsenite | 78.62 | 16712894 19931552 17306315 17077188 15276417 | |
| MESH:D008175 | Lung Neoplasms | Sulindac | 78.62 | 15713900 19359593 | |
| MESH:D008175 | Lung Neoplasms | Tamoxifen | 78.62 | 18625569 | |
| MESH:D008175 | Lung Neoplasms | Tetrachlorodibenzodioxin | 78.62 | 19555203 11884234 | |
| MESH:D008175 | Lung Neoplasms | Tetradecanoylphorbol Acetate | 78.62 | 11807781 | |
| MESH:D008175 | Lung Neoplasms | Urethane | 78.62 | 10997738 14587096 6695378 16007126 15166089 11307925 16289808 11062179 15902970 12117781 16204055 11552296 10822126 11074608 11323394 11497255 16926031 16788158 12957351 10530776 11544531 10779650 11807781 17195641 11992545 15136453 11893704 16391232 12466968 17093202 17255336 11246140 12765245 7750092 16337739 | |
| MESH:D008175 | Lung Neoplasms | Vitamin E | 78.62 | 11062179 | |
| MESH:D008175 | Lung Neoplasms | Zidovudine | 78.62 | 18800350 | |
| MESH:D008178 | Lupus Erythematosus, Cutaneous | Fluorouracil | 3.36 | 15086387 | |
| MESH:D008180 | Lupus Erythematosus, Systemic | Melatonin | 3.32 | 16373423 | |
| MESH:D008181 | Lupus Nephritis | Diethylstilbestrol | 3.72 | 15166399 | |
| MESH:D008223 | Lymphoma | Benzene | 21.07 | 17119257 17584886 | |
| MESH:D008223 | Lymphoma | Curcumin | 21.07 | 18462866 | |
| MESH:D008223 | Lymphoma | Cyclophosphamide | 21.07 | 12854902 | |
| MESH:D008223 | Lymphoma | decitabine | 21.07 | 19470736 | |
| MESH:D008223 | Lymphoma | Diethylstilbestrol | 21.07 | 15700306 | |
| MESH:D008223 | Lymphoma | Doxorubicin | 21.07 | 16098063 | |
| MESH:D008223 | Lymphoma | Methylnitrosourea | 21.07 | 16257854 11418001 | |
| MESH:D008223 | Lymphoma | Nitric Oxide | 21.07 | 16166326 | |
| MESH:D016393 | Lymphoma, B-Cell | Cyclophosphamide | 13.52 | 16675587 | |
| MESH:D016393 | Lymphoma, B-Cell | Methylnitrosourea | 13.52 | 14633661 | |
| MESH:D016393 | Lymphoma, B-Cell | resveratrol | 13.52 | 17088997 | |
| MESH:D016393 | Lymphoma, B-Cell | Sodium Selenite | 13.52 | 14737004 | |
| MESH:D008228 | Lymphoma, Non-Hodgkin | Cyclophosphamide | 7.44 | 11911406 | |
| MESH:D008228 | Lymphoma, Non-Hodgkin | Doxorubicin | 7.44 | 17654614 | |
| MESH:D008228 | Lymphoma, Non-Hodgkin | resveratrol | 7.44 | 14749477 | |
| MESH:D016399 | Lymphoma, T-Cell | 3-(4-methylphenylsulfonyl)-2-propenenitrile | 11.57 | 16173963 | |
| MESH:D016399 | Lymphoma, T-Cell | Curcumin | 11.57 | 16173963 | |
| MESH:D016399 | Lymphoma, T-Cell | Doxorubicin | 11.57 | 15621674 | |
| MESH:D008231 | Lymphopenia | Antimony Sodium Gluconate | 4.97 | 9770149 | |
| MESH:D008268 | Macular Degeneration | Iron | 2.99 | 16640825 | |
| MESH:D052801 | Male Urogenital Diseases | Diethylstilbestrol | 4.06 | 16002989 | |
| MESH:D015674 | Mammary Neoplasms, Animal | Benzene | 8.71 | 12562636 | |
| MESH:D015674 | Mammary Neoplasms, Animal | resveratrol | 8.71 | 15688416 | |
| MESH:D015674 | Mammary Neoplasms, Animal | Tamoxifen | 8.71 | 19428831 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Benzene | 35.54 | 11921183 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Clodronic Acid | 35.54 | 17312309 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Doxorubicin | 35.54 | 15458769 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Drugs, Chinese Herbal | 35.54 | 14758024 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Estradiol | 35.54 | 16891317 11807958 17203775 11408345 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Genistein | 35.54 | 14578162 12929590 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Ibuprofen | 35.54 | 10697514 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Methylnitrosourea | 35.54 | 14633655 15313902 10838139 10767621 15688392 15113128 17020996 11751437 16051031 11807958 16944150 16619500 19196723 14999141 12931682 17131329 16827153 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Progesterone | 35.54 | 17203775 11408345 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | resveratrol | 35.54 | 11606380 8985016 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Selenium | 35.54 | 15318939 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Tamoxifen | 35.54 | 14580682 16827153 11731420 19196722 19196723 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Tetradecanoylphorbol Acetate | 35.54 | 8985016 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Zinc | 35.54 | 12773700 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | zoledronic acid | 35.54 | 17312309 | |
| MESH:D020149 | Manganese Poisoning | Estradiol | 14.10 | 19453300 | |
| MESH:D020149 | Manganese Poisoning | Manganese | 14.10 | 16568477 16551646 19453300 | |
| MESH:D020149 | Manganese Poisoning | Tamoxifen | 14.10 | 19453300 | |
| MESH:D008527 | Medulloblastoma | Tretinoin | 1.99 | 17453147 | |
| MESH:D008545 | Melanoma | Bleomycin | 27.94 | 15577320 | |
| MESH:D008545 | Melanoma | Cisplatin | 27.94 | 16809738 18176117 15577323 18332650 17761969 12883367 16248763 12393984 16432458 12374674 17023156 11135225 18505091 | |
| MESH:D008545 | Melanoma | Curcumin | 27.94 | 18462866 17885582 | |
| MESH:D008545 | Melanoma | Dacarbazine | 27.94 | 12025231 11135225 18089842 11746506 18505091 17239242 17761969 17508024 17562445 12202904 10623706 18445842 16809738 16508601 16034308 17576460 15577323 12640292 12535206 18176117 17973783 16273263 17119449 15577320 12556972 16098027 15917704 18281670 12417787 16928243 16939954 18332650 11712820 15176220 16248763 17709802 16760174 16225601 15020614 12883367 17334785 12393984 15522559 12439608 11254118 16966688 17023156 17623835 | |
| MESH:D008545 | Melanoma | decitabine | 27.94 | 16505122 17785578 | |
| MESH:D008545 | Melanoma | Dinitrochlorobenzene | 27.94 | 17334785 12202904 | |
| MESH:D008545 | Melanoma | Doxorubicin | 27.94 | 16827129 | |
| MESH:D008545 | Melanoma | epigallocatechin gallate | 27.94 | 17992120 11746506 | |
| MESH:D008545 | Melanoma | Histamine | 27.94 | 17709802 | |
| MESH:D008545 | Melanoma | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide | 27.94 | 16487513 | |
| MESH:D008545 | Melanoma | Reactive Oxygen Species | 27.94 | 17992120 | |
| MESH:D008545 | Melanoma | resveratrol | 27.94 | 17992120 | |
| MESH:D008545 | Melanoma | sodium arsenite | 27.94 | 19082730 16487513 | |
| MESH:D008545 | Melanoma | Sulindac | 27.94 | 16642371 | |
| MESH:D008545 | Melanoma | Tamoxifen | 27.94 | 12393984 19393235 | |
| MESH:D008545 | Melanoma | Thalidomide | 27.94 | 16098027 17089043 12829675 | |
| MESH:D008545 | Melanoma | Tretinoin | 27.94 | 16752155 | |
| MESH:D018328 | Melanoma, Amelanotic | Cisplatin | 11.51 | 15990972 | |
| MESH:D018328 | Melanoma, Amelanotic | Dacarbazine | 11.51 | 15990972 | |
| MESH:D018328 | Melanoma, Amelanotic | Tamoxifen | 11.51 | 15990972 | |
| MESH:D008546 | Melanoma, Experimental | Acetaminophen | 10.45 | 19513568 | |
| MESH:D008546 | Melanoma, Experimental | Acrolein | 10.45 | 10803710 | |
| MESH:D008546 | Melanoma, Experimental | Cyclophosphamide | 10.45 | 16388313 | |
| MESH:D008569 | Memory Disorders | Curcumin | 11.72 | 17263510 | |
| MESH:D008569 | Memory Disorders | Ethanol | 11.72 | 18411066 15451040 | |
| MESH:D008569 | Memory Disorders | Lead | 11.72 | 17263510 16384672 | |
| MESH:D008569 | Memory Disorders | mangiferin | 11.72 | 19182383 | |
| MESH:D008591 | Meningomyelocele | Tretinoin | 3.02 | 16940565 | |
| MESH:D008607 | Mental Retardation | Phenytoin | 2.98 | 9212184 | |
| MESH:D008654 | Mesothelioma | therapeutic | 12768194 | ||
| MESH:D008654 | Mesothelioma | Atrazine | 9.87 | 1916698 | |
| MESH:D008654 | Mesothelioma | Cisplatin | 9.87 | 17638057 | |
| MESH:D008654 | Mesothelioma | Doxorubicin | 9.87 | 17638057 | |
| MESH:D008654 | Mesothelioma | Selenium | 9.87 | 15107826 | |
| MESH:D008654 | Mesothelioma | zoledronic acid | 9.87 | 16675582 | |
| MESH:D008659 | Metabolic Diseases | phenylmethylpyrazolone | 6.63 | 16301206 | |
| MESH:D008659 | Metabolic Diseases | resveratrol | 6.63 | 17112576 | |
| MESH:D008664 | Metal Metabolism, Inborn Errors | Cyclosporine | 3.33 | 16801185 | |
| MESH:D008679 | Metaplasia | Ozone | 3.65 | 10496685 | |
| MESH:D008708 | Methemoglobinemia | Propanil | 4.45 | 4714336 2237922 2315934 | |
| MESH:D048629 | Micronuclei, Chromosome-Defective | Zidovudine | 4.38 | 17358032 | |
| MESH:D008881 | Migraine Disorders | Aspirin | 11.29 | 15240983 | |
| MESH:D008881 | Migraine Disorders | Indomethacin | 11.29 | 11903285 | |
| MESH:D008881 | Migraine Disorders | Nitric Oxide | 11.29 | 11701602 | |
| MESH:D008881 | Migraine Disorders | Valproic Acid | 11.29 | 18803445 18765137 | |
| MESH:D008881 | Migraine Disorders | zafirlukast | 11.29 | 10759916 | |
| MESH:D020326 | Migraine without Aura | Dinoprostone | 10.23 | 11304026 | |
| MESH:D020326 | Migraine without Aura | Nitric Oxide | 10.23 | 14659530 11304026 | |
| MESH:D020326 | Migraine without Aura | Nitrites | 10.23 | 11304026 | |
| MESH:D028361 | Mitochondrial Diseases | Doxorubicin | 3.16 | 15792986 | |
| MESH:D009006 | Monosomy | Azacitidine | 4.63 | 19299654 | |
| MESH:D016472 | Motor Neuron Disease | Dichlorvos | 4.89 | 11282359 | |
| MESH:D009062 | Mouth Neoplasms | Benzo(a)pyrene | 7.42 | 16381670 | |
| MESH:D009062 | Mouth Neoplasms | Fluorouracil | 7.42 | 16757204 18986760 | |
| MESH:D009062 | Mouth Neoplasms | Indomethacin | 7.42 | 12636206 | |
| MESH:D009069 | Movement Disorders | Manganese | 3.66 | 16551646 | |
| MESH:D052016 | Mucositis | Doxorubicin | 7.69 | 17415656 | |
| MESH:D052016 | Mucositis | irinotecan | 7.69 | 17159606 | |
| MESH:D009101 | Multiple Myeloma | arsenic trioxide | 30.50 | 19417148 11468182 14977855 15949261 19549372 | |
| MESH:D009101 | Multiple Myeloma | Azacitidine | 30.50 | 19549372 18443271 | |
| MESH:D009101 | Multiple Myeloma | Benzene | 30.50 | 17119195 | |
| MESH:D009101 | Multiple Myeloma | Curcumin | 30.50 | 19372569 | |
| MESH:D009101 | Multiple Myeloma | decitabine | 30.50 | 18172295 | |
| MESH:D009101 | Multiple Myeloma | Dexamethasone | 30.50 | 15867202 15744524 16118317 | |
| MESH:D009101 | Multiple Myeloma | resveratrol | 30.50 | 16267019 17049120 17935668 16490592 17164350 14749477 | |
| MESH:D009101 | Multiple Myeloma | Thalidomide | 30.50 | 19372569 19112201 15939924 17168659 15920492 15867202 15741222 19112817 15744524 16445831 | |
| MESH:D009101 | Multiple Myeloma | Vitamin A | 30.50 | 16374440 | |
| MESH:D009101 | Multiple Myeloma | zoledronic acid | 30.50 | 18089719 19621390 16996129 | |
| MESH:D009101 | Multiple Myeloma | zonisamide | 30.50 | 11868602 | |
| MESH:D009102 | Multiple Organ Failure | Zymosan | 3.86 | 12130978 12879239 15241586 15259001 18160304 17724436 10479408 15834315 10890648 15213630 | |
| MESH:D020528 | Multiple Sclerosis, Chronic Progressive | Iron | 4.22 | 17086897 | |
| MESH:D009128 | Muscle Spasticity | 3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol | 4.67 | 17220914 | |
| MESH:D009134 | Muscular Atrophy, Spinal | Curcumin | 12.97 | 17962980 | |
| MESH:D009134 | Muscular Atrophy, Spinal | epigallocatechin gallate | 12.97 | 17962980 | |
| MESH:D009134 | Muscular Atrophy, Spinal | resveratrol | 12.97 | 17962980 | |
| MESH:D009135 | Muscular Diseases | pirinixic acid | 2.12 | 16239165 | |
| MESH:D009139 | Musculoskeletal Abnormalities | Valproic Acid | 2.70 | 8888407 | |
| MESH:D009164 | Mycobacterium Infections | Ciprofloxacin | 4.14 | 10063276 | |
| MESH:D009181 | Mycoses | Iron | 4.02 | 16640825 | |
| MESH:D009182 | Mycosis Fungoides | arsenic trioxide | 8.84 | 18349030 | |
| MESH:D009182 | Mycosis Fungoides | Trioxsalen | 8.84 | 16259964 | |
| MESH:D009190 | Myelodysplastic Syndromes | arsenic trioxide | 22.42 | 16105982 16882451 | |
| MESH:D009190 | Myelodysplastic Syndromes | Azacitidine | 22.42 | 19805378 17611569 18720364 17596541 | |
| MESH:D009190 | Myelodysplastic Syndromes | Ciprofloxacin | 22.42 | 9809623 | |
| MESH:D009190 | Myelodysplastic Syndromes | decitabine | 22.42 | 19010910 16882708 19157545 18608210 | |
| MESH:D009190 | Myelodysplastic Syndromes | Dexamethasone | 22.42 | 9809623 | |
| MESH:D009190 | Myelodysplastic Syndromes | Thalidomide | 22.42 | 18720364 | |
| MESH:D009190 | Myelodysplastic Syndromes | Tretinoin | 22.42 | 17596541 | |
| MESH:D009190 | Myelodysplastic Syndromes | Valproic Acid | 22.42 | 17596541 | |
| MESH:D009203 | Myocardial Infarction | Aspirin | 13.55 | 12692751 | |
| MESH:D009203 | Myocardial Infarction | Doxorubicin | 13.55 | 19429709 15857846 | |
| MESH:D009203 | Myocardial Infarction | Genistein | 13.55 | 17141266 | |
| MESH:D009203 | Myocardial Infarction | mangiferin | 13.55 | 16538859 19172585 16697266 16584858 17052832 | |
| MESH:D009203 | Myocardial Infarction | pirinixic acid | 13.55 | 19151258 | |
| MESH:D009203 | Myocardial Infarction | Quercetin | 13.55 | 19595682 | |
| MESH:D009203 | Myocardial Infarction | resveratrol | 13.55 | 17015251 16525036 16456233 17188708 16317513 17125593 | |
| MESH:D017202 | Myocardial Ischemia | Iron | 8.22 | 16604332 | |
| MESH:D017202 | Myocardial Ischemia | resveratrol | 8.22 | 17125593 17015251 | |
| MESH:D017202 | Myocardial Ischemia | Tetrachlorodibenzodioxin | 8.22 | 12213967 | |
| MESH:D015428 | Myocardial Reperfusion Injury | Estradiol | 13.92 | 16810080 | |
| MESH:D015428 | Myocardial Reperfusion Injury | Genistein | 13.92 | 17141266 | |
| MESH:D015428 | Myocardial Reperfusion Injury | Iron | 13.92 | 16604332 | |
| MESH:D015428 | Myocardial Reperfusion Injury | pirinixic acid | 13.92 | 16411023 | |
| MESH:D015428 | Myocardial Reperfusion Injury | Quercetin | 13.92 | 19207477 | |
| MESH:D009205 | Myocarditis | resveratrol | 3.34 | 17322642 | |
| MESH:D020191 | Myoclonic Epilepsies, Progressive | Phenytoin | 8.40 | 17484760 | |
| MESH:D020191 | Myoclonic Epilepsies, Progressive | zonisamide | 8.40 | 9477142 | |
| MESH:D009224 | Myotonia Congenita | Phenytoin | 3.99 | 1896199 | |
| MESH:D009298 | Nasal Polyps | zafirlukast | 4.94 | 10665187 12053594 | |
| MESH:D009325 | Nausea | Aspirin | 11.81 | 15240983 | |
| MESH:D009325 | Nausea | zafirlukast | 11.81 | 10386485 | |
| MESH:D009325 | Nausea | zonisamide | 11.81 | 16855456 | |
| MESH:D009336 | Necrosis | Melatonin | 6.88 | 12195237 | |
| MESH:D009336 | Necrosis | zafirlukast | 6.88 | 15028970 | |
| MESH:D016870 | Neisseriaceae Infections | Ciprofloxacin | 4.91 | 20378725 | |
| MESH:D009349 | Nematode Infections | Dichlorvos | 4.69 | 16402567 | |
| MESH:D009361 | Neoplasm Invasiveness | Amiloride | 9.54 | 14644129 | |
| MESH:D009361 | Neoplasm Invasiveness | arsenic trioxide | 9.54 | 16624393 | |
| MESH:D009361 | Neoplasm Invasiveness | Curcumin | 9.54 | 18495463 | |
| MESH:D009362 | Neoplasm Metastasis | Acetylcysteine | 19.67 | 14720322 | |
| MESH:D009362 | Neoplasm Metastasis | Clodronic Acid | 19.67 | 17312309 | |
| MESH:D009362 | Neoplasm Metastasis | Diethylnitrosamine | 19.67 | 3581430 9029167 | |
| MESH:D009362 | Neoplasm Metastasis | Doxorubicin | 19.67 | 18259882 | |
| MESH:D009362 | Neoplasm Metastasis | Indomethacin | 19.67 | 11239499 11053908 16537180 | |
| MESH:D009362 | Neoplasm Metastasis | irinotecan | 19.67 | 18259882 | |
| MESH:D009362 | Neoplasm Metastasis | punarnavine | 19.67 | 19171408 | |
| MESH:D009362 | Neoplasm Metastasis | Tamoxifen | 19.67 | 19393235 | |
| MESH:D009362 | Neoplasm Metastasis | zoledronic acid | 19.67 | 15867366 17312309 19139120 | |
| MESH:D009364 | Neoplasm Recurrence, Local | Tamoxifen | 1.84 | 19410462 | |
| MESH:D009369 | Neoplasms | 2,4,5,2',4',5'-hexachlorobiphenyl | 41.80 | 8820588 | |
| MESH:D009369 | Neoplasms | 2-butenal | 41.80 | 10626223 | |
| MESH:D009369 | Neoplasms | Acrolein | 41.80 | 17329238 | |
| MESH:D009369 | Neoplasms | alitretinoin | 41.80 | 16946489 | |
| MESH:D009369 | Neoplasms | Benzo(a)pyrene | 41.80 | 11141357 | |
| MESH:D009369 | Neoplasms | Cisplatin | 41.80 | 16773208 | |
| MESH:D009369 | Neoplasms | Cyclophosphamide | 41.80 | 18854779 | |
| MESH:D009369 | Neoplasms | decitabine | 41.80 | 19116145 17925555 19470736 | |
| MESH:D009369 | Neoplasms | Diethylstilbestrol | 41.80 | 15313581 | |
| MESH:D009369 | Neoplasms | Fluorouracil | 41.80 | 18600527 18239605 16928823 | |
| MESH:D009369 | Neoplasms | Lindane | 41.80 | 16818664 12807735 | |
| MESH:D009369 | Neoplasms | Methylnitrosourea | 41.80 | 15533788 | |
| MESH:D009369 | Neoplasms | pirinixic acid | 41.80 | 17405874 | |
| MESH:D009369 | Neoplasms | Quercetin | 41.80 | 15185748 | |
| MESH:D009369 | Neoplasms | ribosome inactivating protein, Viscum | 41.80 | 18602257 | |
| MESH:D009369 | Neoplasms | sodium arsenite | 41.80 | 11559025 | |
| MESH:D009369 | Neoplasms | Tetrachloroethylene | 41.80 | 11911487 | |
| MESH:D009369 | Neoplasms | Tretinoin | 41.80 | 16594593 16946489 | |
| MESH:D009369 | Neoplasms | Urethane | 41.80 | 15625555 | |
| MESH:D009374 | Neoplasms, Experimental | Indomethacin | 17.83 | 15625704 10663608 | |
| MESH:D009374 | Neoplasms, Experimental | Methylnitrosourea | 17.83 | 12696579 | |
| MESH:D009374 | Neoplasms, Experimental | resveratrol | 17.83 | 8985016 | |
| MESH:D009374 | Neoplasms, Experimental | sodium arsenite | 17.83 | 20056578 | |
| MESH:D009374 | Neoplasms, Experimental | Toluene 2,4-Diisocyanate | 17.83 | 1670384 | |
| MESH:D009374 | Neoplasms, Experimental | Urethane | 17.83 | 15582191 | |
| MESH:D009376 | Neoplasms, Hormone-Dependent | Curcumin | 6.09 | 12497104 | |
| MESH:D009376 | Neoplasms, Hormone-Dependent | Tamoxifen | 6.09 | 19189210 19196722 19200415 | |
| MESH:D009389 | Neovascularization, Pathologic | Estradiol | 2.34 | 17289903 | |
| MESH:D009393 | Nephritis | Acrolein | 4.83 | 12653641 | |
| MESH:D009395 | Nephritis, Interstitial | Cisplatin | 6.17 | 15464296 | |
| MESH:D009395 | Nephritis, Interstitial | Ibuprofen | 6.17 | 6375363 | |
| MESH:D009401 | Nephrosis | Doxorubicin | 3.36 | 16636307 16899518 | |
| MESH:D009402 | Nephrosis, Lipoid | Cyclosporine | 2.99 | 17954296 | |
| MESH:D009404 | Nephrotic Syndrome | Cyclosporine | 8.44 | 19348381 18481113 | |
| MESH:D009404 | Nephrotic Syndrome | Doxorubicin | 8.44 | 16889571 15640375 | |
| MESH:D009404 | Nephrotic Syndrome | Iron | 8.44 | 17178036 | |
| MESH:D009410 | Nerve Degeneration | Dichlorvos | 20.95 | 11282359 17850875 | |
| MESH:D009410 | Nerve Degeneration | Ibuprofen | 20.95 | 10961664 | |
| MESH:D009410 | Nerve Degeneration | mancozeb | 20.95 | 15350641 | |
| MESH:D009410 | Nerve Degeneration | Manganese | 20.95 | 16551646 | |
| MESH:D009410 | Nerve Degeneration | mangiferin | 20.95 | 17433543 | |
| MESH:D009410 | Nerve Degeneration | Paraquat | 20.95 | 16893418 | |
| MESH:D009410 | Nerve Degeneration | Rotenone | 20.95 | 17356569 15790535 18619942 | |
| MESH:D009421 | Nervous System Malformations | bisphenol A | 25.61 | 16427766 11399458 | |
| MESH:D009421 | Nervous System Malformations | Diethylstilbestrol | 25.61 | 11399458 | |
| MESH:D009421 | Nervous System Malformations | Estradiol | 25.61 | 11399458 16427766 | |
| MESH:D009421 | Nervous System Malformations | Genistein | 25.61 | 16427766 | |
| MESH:D009421 | Nervous System Malformations | Tetrachlorodibenzodioxin | 25.61 | 14600291 | |
| MESH:D009421 | Nervous System Malformations | Thalidomide | 25.61 | 16859833 | |
| MESH:D009421 | Nervous System Malformations | Tretinoin | 25.61 | 9125849 | |
| MESH:D009423 | Nervous System Neoplasms | Curcumin | 4.17 | 18462866 | |
| MESH:D009436 | Neural Tube Defects | Acetylcysteine | 28.07 | 19446573 | |
| MESH:D009436 | Neural Tube Defects | arsenic trioxide | 28.07 | 10525206 | |
| MESH:D009436 | Neural Tube Defects | Benzene | 28.07 | 15643154 | |
| MESH:D009436 | Neural Tube Defects | mancozeb | 28.07 | 15864902 | |
| MESH:D009436 | Neural Tube Defects | Phenytoin | 28.07 | 9118846 | |
| MESH:D009436 | Neural Tube Defects | sodium arsenite | 28.07 | 12854658 | |
| MESH:D009436 | Neural Tube Defects | Tetrahydrocannabinol | 28.07 | 19040278 | |
| MESH:D009436 | Neural Tube Defects | Tretinoin | 28.07 | 9142499 | |
| MESH:D009436 | Neural Tube Defects | Valproic Acid | 28.07 | 16359493 8888407 | |
| MESH:D009436 | Neural Tube Defects | Vitamin A | 28.07 | 17400914 | |
| MESH:D009442 | Neurilemmoma | Methylnitrosourea | 4.06 | 11555667 | |
| MESH:D019954 | Neurobehavioral Manifestations | Plant Extracts | 3.78 | 17168769 | |
| MESH:D009447 | Neuroblastoma | Cisplatin | 8.13 | 8761367 | |
| MESH:D009447 | Neuroblastoma | Cyclophosphamide | 8.13 | 16115947 8761367 15176712 | |
| MESH:D009447 | Neuroblastoma | Doxorubicin | 8.13 | 15555623 | |
| MESH:D009447 | Neuroblastoma | irinotecan | 8.13 | 8761367 | |
| MESH:D019636 | Neurodegenerative Diseases | Acetaminophen | 28.82 | 18514411 | |
| MESH:D019636 | Neurodegenerative Diseases | Acrolein | 28.82 | 11342003 | |
| MESH:D019636 | Neurodegenerative Diseases | Dichlorvos | 28.82 | 16635102 | |
| MESH:D019636 | Neurodegenerative Diseases | Diethylnitrosamine | 28.82 | 20387270 | |
| MESH:D019636 | Neurodegenerative Diseases | Indomethacin | 28.82 | 12349958 | |
| MESH:D019636 | Neurodegenerative Diseases | Iron | 28.82 | 16604332 17296847 | |
| MESH:D019636 | Neurodegenerative Diseases | resveratrol | 28.82 | 17652729 | |
| MESH:D019636 | Neurodegenerative Diseases | Sulindac | 28.82 | 16850258 17266991 | |
| MESH:D019636 | Neurodegenerative Diseases | Tacrolimus | 28.82 | 15081597 | |
| MESH:D017599 | Neuroectodermal Tumors | Cisplatin | 10.95 | 8761367 | |
| MESH:D017599 | Neuroectodermal Tumors | Cyclophosphamide | 10.95 | 8761367 12837982 | |
| MESH:D017599 | Neuroectodermal Tumors | irinotecan | 10.95 | 8761367 | |
| MESH:D020078 | Neurogenic Inflammation | Quercetin | 6.21 | 17929310 | |
| MESH:D020078 | Neurogenic Inflammation | resveratrol | 6.21 | 17929310 | |
| MESH:D009461 | Neurologic Manifestations | Diethylnitrosamine | 3.66 | 20387270 | |
| MESH:D020258 | Neurotoxicity Syndromes | Dichlorvos | 9.80 | 12186780 | |
| MESH:D020258 | Neurotoxicity Syndromes | Fluorouracil | 9.80 | 16436463 | |
| MESH:D020258 | Neurotoxicity Syndromes | Glyburide | 9.80 | 16725203 | |
| MESH:D020258 | Neurotoxicity Syndromes | Malathion | 9.80 | 15081274 | |
| MESH:D009503 | Neutropenia | Ciprofloxacin | 11.28 | 17846019 | |
| MESH:D009503 | Neutropenia | Cyclophosphamide | 11.28 | 8291058 | |
| MESH:D009503 | Neutropenia | Leukotriene B4 | 11.28 | 8305713 | |
| MESH:D009503 | Neutropenia | Mustard Gas | 11.28 | 16761898 7688884 | |
| MESH:D009669 | Nose Neoplasms | diisopropanolnitrosamine | 5.88 | 10463772 11442016 10945294 | |
| MESH:D009669 | Nose Neoplasms | Formaldehyde | 5.88 | 4038687 | |
| MESH:D009765 | Obesity | Ascorbic Acid | 6.94 | 17217161 | |
| MESH:D009765 | Obesity | Curcumin | 6.94 | 19297423 | |
| MESH:D009765 | Obesity | pirinixic acid | 6.94 | 20558911 | |
| MESH:D009765 | Obesity | Plant Extracts | 6.94 | 19056576 20132043 | |
| MESH:D009765 | Obesity | rimonabant | 6.94 | 18773755 20518802 19046740 | |
| MESH:D007752 | Obstetric Labor, Premature | Indomethacin | 8.68 | 6374098 | |
| MESH:D007752 | Obstetric Labor, Premature | Terbutaline | 8.68 | 14998686 | |
| MESH:D009784 | Occupational Diseases | Benzene | 5.35 | 17178637 15935809 17479406 16737584 15576619 15612468 17119257 15727169 15913788 | |
| MESH:D009784 | Occupational Diseases | Toluene 2,4-Diisocyanate | 5.35 | 6091946 3040596 12585506 18394133 11077013 8156442 6091945 | |
| MESH:D009845 | Oligospermia | Cyclophosphamide | 3.31 | 16517039 | |
| MESH:D009914 | Oral Submucous Fibrosis | marker/mechanism | 16311067 | ||
| MESH:D010003 | Osteoarthritis | Aspirin | 9.13 | 7009135 | |
| MESH:D010003 | Osteoarthritis | Ibuprofen | 9.13 | 7009135 | |
| MESH:D010003 | Osteoarthritis | Indomethacin | 9.13 | 7009135 | |
| MESH:D010003 | Osteoarthritis | Iron | 9.13 | 16640825 | |
| MESH:D010005 | Osteoarthropathy, Secondary Hypertrophic | Dinoprostone | 5.02 | 18500342 | |
| MESH:D010009 | Osteochondrodysplasias | Thiram | 4.33 | 15899490 17954590 15518828 | |
| MESH:D010014 | Osteolysis | zoledronic acid | 3.95 | 15867366 | |
| MESH:D010018 | Osteomalacia | Phenytoin | 3.99 | 17016548 | |
| MESH:D010024 | Osteoporosis | anthranilic acid | 10.85 | 17042918 | |
| MESH:D010024 | Osteoporosis | Curcumin | 10.85 | 18719352 | |
| MESH:D010024 | Osteoporosis | Genistein | 10.85 | 19401787 | |
| MESH:D010024 | Osteoporosis | Iron | 10.85 | 16640825 16648989 | |
| MESH:D010024 | Osteoporosis | zoledronic acid | 10.85 | 17882678 | |
| MESH:D015663 | Osteoporosis, Postmenopausal | Drugs, Chinese Herbal | 13.13 | 16548355 | |
| MESH:D015663 | Osteoporosis, Postmenopausal | Genistein | 13.13 | 16169203 | |
| MESH:D015663 | Osteoporosis, Postmenopausal | Quercetin | 13.13 | 19495926 | |
| MESH:D015663 | Osteoporosis, Postmenopausal | resveratrol | 13.13 | 17513867 | |
| MESH:D012516 | Osteosarcoma | Doxorubicin | 2.88 | 15930896 | |
| MESH:D010049 | Ovarian Diseases | bisphenol A | 3.55 | 11985600 | |
| MESH:D010051 | Ovarian Neoplasms | arsenic trioxide | 39.94 | 19769630 12452020 16624393 | |
| MESH:D010051 | Ovarian Neoplasms | Benzene | 39.94 | 12562636 | |
| MESH:D010051 | Ovarian Neoplasms | Cisplatin | 39.94 | 17225452 19769630 15464296 6897625 | |
| MESH:D010051 | Ovarian Neoplasms | Curcumin | 39.94 | 18462866 19020741 | |
| MESH:D010051 | Ovarian Neoplasms | decitabine | 39.94 | 19331143 19259094 | |
| MESH:D010051 | Ovarian Neoplasms | Estradiol | 39.94 | 19401270 | |
| MESH:D010051 | Ovarian Neoplasms | Genistein | 39.94 | 19005980 | |
| MESH:D010051 | Ovarian Neoplasms | Luteolin | 39.94 | 19005980 | |
| MESH:D010051 | Ovarian Neoplasms | Medroxyprogesterone Acetate | 39.94 | 17393432 | |
| MESH:D010051 | Ovarian Neoplasms | Mifepristone | 39.94 | 16525653 | |
| MESH:D010051 | Ovarian Neoplasms | Progesterone | 39.94 | 17393432 16525653 | |
| MESH:D010051 | Ovarian Neoplasms | Quercetin | 39.94 | 19005980 | |
| MESH:D010051 | Ovarian Neoplasms | sodium arsenite | 39.94 | 15276417 17306315 | |
| MESH:D010051 | Ovarian Neoplasms | Thalidomide | 39.94 | 16288038 | |
| MESH:D010051 | Ovarian Neoplasms | Tretinoin | 39.94 | 16936753 | |
| MESH:D010051 | Ovarian Neoplasms | U 0126 | 39.94 | 16211241 | |
| MESH:D010051 | Ovarian Neoplasms | Urethane | 39.94 | 16391232 | |
| MESH:D010146 | Pain | Acetaminophen | 35.54 | 16870215 | |
| MESH:D010146 | Pain | Aspirin | 35.54 | 6363464 6995502 | |
| MESH:D010146 | Pain | Cyclophosphamide | 35.54 | 18093676 12161096 | |
| MESH:D010146 | Pain | Ibuprofen | 35.54 | 3291741 | |
| MESH:D010146 | Pain | Indomethacin | 35.54 | 13679232 3291741 17627676 17440234 | |
| MESH:D010146 | Pain | Mangifera indica extract | 35.54 | 15177302 16273134 | |
| MESH:D010146 | Pain | nimesulide | 35.54 | 11438310 | |
| MESH:D010146 | Pain | Phenytoin | 35.54 | 15215642 | |
| MESH:D010146 | Pain | rimonabant | 35.54 | 18987195 | |
| MESH:D010146 | Pain | Sulindac | 35.54 | 3291741 | |
| MESH:D010146 | Pain | Tretinoin | 35.54 | 16870215 | |
| MESH:D010146 | Pain | zafirlukast | 35.54 | 15935457 11438310 | |
| MESH:D010146 | Pain | zoledronic acid | 35.54 | 16475674 | |
| MESH:D010146 | Pain | zonisamide | 35.54 | 17666864 16217643 15140322 | |
| MESH:D010149 | Pain, Postoperative | Ibuprofen | 6.72 | 16678543 | |
| MESH:D010149 | Pain, Postoperative | Indomethacin | 6.72 | 18702446 12538197 | |
| MESH:D010190 | Pancreatic Neoplasms | arsenic trioxide | 46.60 | 15580305 | |
| MESH:D010190 | Pancreatic Neoplasms | Cisplatin | 46.60 | 19003803 | |
| MESH:D010190 | Pancreatic Neoplasms | Curcumin | 46.60 | 19401701 17440100 19196508 | |
| MESH:D010190 | Pancreatic Neoplasms | Cyclophosphamide | 46.60 | 11332152 | |
| MESH:D010190 | Pancreatic Neoplasms | Dacarbazine | 46.60 | 11583197 | |
| MESH:D010190 | Pancreatic Neoplasms | decitabine | 46.60 | 19294695 | |
| MESH:D010190 | Pancreatic Neoplasms | Diethylnitrosamine | 46.60 | 16540662 | |
| MESH:D010190 | Pancreatic Neoplasms | Ethanol | 46.60 | 12384795 | |
| MESH:D010190 | Pancreatic Neoplasms | Fluorouracil | 46.60 | 16500647 16929163 19003803 15113037 | |
| MESH:D010190 | Pancreatic Neoplasms | Ibuprofen | 46.60 | 12384795 | |
| MESH:D010190 | Pancreatic Neoplasms | mancozeb | 46.60 | 16965848 8603375 | |
| MESH:D010190 | Pancreatic Neoplasms | Methylnitrosourea | 46.60 | 16965848 | |
| MESH:D010190 | Pancreatic Neoplasms | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide | 46.60 | 11504793 | |
| MESH:D010190 | Pancreatic Neoplasms | Quercetin | 46.60 | 16965848 | |
| MESH:D010190 | Pancreatic Neoplasms | Reactive Oxygen Species | 46.60 | 15580305 | |
| MESH:D010190 | Pancreatic Neoplasms | Sulindac | 46.60 | 11504793 16820089 | |
| MESH:D010190 | Pancreatic Neoplasms | Tetradecanoylphorbol Acetate | 46.60 | 15976015 | |
| MESH:D010190 | Pancreatic Neoplasms | Tretinoin | 46.60 | 15976015 | |
| MESH:D010195 | Pancreatitis | Antimony Sodium Gluconate | 19.11 | 7519887 | |
| MESH:D010195 | Pancreatitis | Cimetidine | 19.11 | 10484002 | |
| MESH:D010195 | Pancreatitis | Dichlorvos | 19.11 | 16258382 | |
| MESH:D010195 | Pancreatitis | Indomethacin | 19.11 | 17883296 15028970 | |
| MESH:D010195 | Pancreatitis | phenylmethylpyrazolone | 19.11 | 20035747 | |
| MESH:D010195 | Pancreatitis | Trinitrobenzenesulfonic Acid | 19.11 | 17698068 | |
| MESH:D010195 | Pancreatitis | zafirlukast | 19.11 | 15028970 | |
| MESH:D016584 | Panic Disorder | Ethinyl Estradiol | 2.33 | 11578682 | |
| MESH:D010212 | Papilloma | Butylhydroxybutylnitrosamine | 14.63 | 7296757 | |
| MESH:D010212 | Papilloma | Hydrogen Peroxide | 14.63 | 12065085 | |
| MESH:D010212 | Papilloma | Iron | 14.63 | 12065085 | |
| MESH:D010212 | Papilloma | Plant Extracts | 14.63 | 15173996 16517061 | |
| MESH:D010212 | Papilloma | Tetradecanoylphorbol Acetate | 14.63 | 18404319 12065085 18922899 8330346 | |
| MESH:D010235 | Paraganglioma | arsenic trioxide | 2.81 | 19927285 | |
| MESH:D010257 | Paraneoplastic Syndromes | Indomethacin | 4.26 | 16537180 | |
| MESH:D020447 | Parasomnias | Iron | 4.56 | 17352947 | |
| MESH:D010291 | Paresis | Thalidomide | 4.85 | 9200351 | |
| MESH:D010292 | Paresthesia | zonisamide | 5.44 | 17149715 | |
| MESH:D010300 | Parkinson Disease | Acrolein | 20.00 | 17690948 | |
| MESH:D010300 | Parkinson Disease | Atrazine | 20.00 | 17218051 | |
| MESH:D010300 | Parkinson Disease | Ditiocarb | 20.00 | 11445065 | |
| MESH:D010300 | Parkinson Disease | Iron | 20.00 | 16563566 16640825 | |
| MESH:D010300 | Parkinson Disease | Manganese | 20.00 | 11181820 | |
| MESH:D010300 | Parkinson Disease | mangiferin | 20.00 | 17433543 | |
| MESH:D010300 | Parkinson Disease | Paraquat | 20.00 | 11124998 15451049 16510128 11445065 11181820 12911755 16140633 15824117 | |
| MESH:D010300 | Parkinson Disease | Polychlorinated Biphenyls | 20.00 | 16702228 | |
| MESH:D010300 | Parkinson Disease | Rotenone | 20.00 | 19232380 11535288 18191903 19114014 16140633 15451049 16412576 11445065 18619942 | |
| MESH:D010300 | Parkinson Disease | zonisamide | 20.00 | 11755227 17200492 13677302 19594199 20196486 | |
| MESH:D010302 | Parkinson Disease, Secondary | Dichlorvos | 6.82 | 12645970 | |
| MESH:D010302 | Parkinson Disease, Secondary | Paraquat | 6.82 | 16190885 | |
| MESH:D020734 | Parkinsonian Disorders | Indomethacin | 11.22 | 12349958 | |
| MESH:D020734 | Parkinsonian Disorders | Manganese | 11.22 | 16140633 | |
| MESH:D020734 | Parkinsonian Disorders | Melatonin | 11.22 | 15574749 | |
| MESH:D020734 | Parkinsonian Disorders | Rotenone | 11.22 | 18197244 15795934 15574749 15927086 | |
| MESH:D051302 | Paroxysmal Hemicrania | Indomethacin | 4.26 | 11903285 | |
| MESH:D010382 | Peliosis Hepatis | 1-Naphthylisothiocyanate | 8.99 | 20133375 | |
| MESH:D010382 | Peliosis Hepatis | Tetrachlorodibenzodioxin | 8.99 | 12520081 | |
| MESH:D010409 | Penile Diseases | Antimony | 4.34 | 9643325 | |
| MESH:D010437 | Peptic Ulcer | Indomethacin | 3.72 | 11148446 | |
| MESH:D010438 | Peptic Ulcer Hemorrhage | Aspirin | 4.11 | 11156591 | |
| MESH:D010493 | Pericarditis | Antimony | 4.68 | 20465667 | |
| MESH:D010518 | Periodontitis | Antimony Sodium Gluconate | 12.36 | 1325634 | |
| MESH:D010518 | Periodontitis | Indomethacin | 12.36 | 17225004 | |
| MESH:D010518 | Periodontitis | mangiferin | 12.36 | 19026997 | |
| MESH:D010523 | Peripheral Nervous System Diseases | Cisplatin | 2.96 | 15464296 | |
| MESH:D016491 | Peripheral Vascular Diseases | Cadmium | 3.95 | 15687053 | |
| MESH:D010538 | Peritonitis | marker/mechanism | 19804847 | ||
| MESH:D010538 | Peritonitis | Glucans | 17.07 | 19804847 | |
| MESH:D010538 | Peritonitis | Melatonin | 17.07 | 15707874 | |
| MESH:D010538 | Peritonitis | Ozone | 17.07 | 16369182 | |
| MESH:D010538 | Peritonitis | Thioglycolates | 17.07 | 19804847 16751407 19641140 18628355 15707874 19180231 11985352 | |
| MESH:D010538 | Peritonitis | Zymosan | 17.07 | 19641140 18977430 15259001 18760300 18557954 17371808 17826846 11985352 19088179 14761945 15979727 | |
| MESH:D010612 | Pharyngitis | zafirlukast | 5.28 | 9377612 10386485 | |
| MESH:D020795 | Photophobia | Aspirin | 4.31 | 15240983 | |
| MESH:D010787 | Photosensitivity Disorders | Acrolein | 4.29 | 11550810 | |
| MESH:D003557 | Phyllodes Tumor | Dacarbazine | 9.56 | 17983394 | |
| MESH:D003557 | Phyllodes Tumor | Doxorubicin | 9.56 | 17983394 | |
| MESH:D010900 | Pituitary Diseases | Diethylstilbestrol | 9.26 | 14722030 | |
| MESH:D010900 | Pituitary Diseases | Iron | 9.26 | 16604332 | |
| MESH:D010911 | Pituitary Neoplasms | Diethylstilbestrol | 7.48 | 16977796 15687265 | |
| MESH:D010911 | Pituitary Neoplasms | Urethane | 7.48 | 16391232 | |
| MESH:D010954 | Plasmacytoma | Selenium | 3.44 | 15087411 | |
| MESH:D010997 | Pleural Neoplasms | Cisplatin | 9.13 | 17638057 | |
| MESH:D010997 | Pleural Neoplasms | Doxorubicin | 9.13 | 17638057 | |
| MESH:D011014 | Pneumonia | Bleomycin | 20.11 | 17071938 16317386 18024389 | |
| MESH:D011014 | Pneumonia | Epoxy Compounds | 20.11 | 12504350 | |
| MESH:D011014 | Pneumonia | Lipopolysaccharides | 20.11 | 11605937 12224865 | |
| MESH:D011014 | Pneumonia | Ozone | 20.11 | 18929643 18007984 18381685 | |
| MESH:D011014 | Pneumonia | Paraquat | 20.11 | 12504350 | |
| MESH:D011015 | Pneumonia, Aspiration | Nitric Oxide | 3.92 | 18573544 | |
| MESH:D011041 | Poisoning | Diazinon | 9.84 | 17603234 | |
| MESH:D011041 | Poisoning | Dichlorvos | 9.84 | 18072136 17157343 12460839 16036766 17603234 15303389 | |
| MESH:D011041 | Poisoning | Iron | 9.84 | 16604332 | |
| MESH:D011041 | Poisoning | Mustard Gas | 9.84 | 15727166 | |
| MESH:D017689 | Polydactyly | Phenytoin | 3.76 | 9212184 | |
| MESH:D011115 | Polyneuropathies | Dichlorvos | 4.22 | 12563396 | |
| MESH:D011141 | Polyuria | Lithium Chloride | 4.57 | 19692487 | |
| MESH:D017499 | Porokeratosis | alitretinoin | 4.55 | 16144296 | |
| MESH:D017119 | Porphyria Cutanea Tarda | Hexachlorobenzene | 10.88 | 9918132 | |
| MESH:D017119 | Porphyria Cutanea Tarda | Iron | 10.88 | 16640825 | |
| MESH:D017119 | Porphyria Cutanea Tarda | Tetrachlorodibenzodioxin | 10.88 | 18163543 | |
| MESH:D011230 | Precancerous Conditions | Cyclosporine | 7.96 | 12371664 | |
| MESH:D011230 | Precancerous Conditions | Diethylnitrosamine | 7.96 | 2563599 | |
| MESH:D011230 | Precancerous Conditions | Quercetin | 7.96 | 19056647 | |
| MESH:D054198 | Precursor Cell Lymphoblastic Leukemia-Lymphoma | Cyclophosphamide | 9.27 | 21297632 | |
| MESH:D054198 | Precursor Cell Lymphoblastic Leukemia-Lymphoma | Dexamethasone | 9.27 | 21297632 | |
| MESH:D054198 | Precursor Cell Lymphoblastic Leukemia-Lymphoma | Prednisolone | 9.27 | 17031469 | |
| MESH:D054198 | Precursor Cell Lymphoblastic Leukemia-Lymphoma | Thalidomide | 9.27 | 17031469 | |
| MESH:D011225 | Pre-Eclampsia | Iron | 5.49 | 16640825 | |
| MESH:D011225 | Pre-Eclampsia | Zinc | 5.49 | 17114810 | |
| MESH:D047928 | Premature Birth | Indomethacin | 3.72 | 17000239 | |
| MESH:D011297 | Prenatal Exposure Delayed Effects | bisphenol A | 20.01 | 10548101 | |
| MESH:D011297 | Prenatal Exposure Delayed Effects | Diethylstilbestrol | 20.01 | 17184923 | |
| MESH:D011297 | Prenatal Exposure Delayed Effects | Lead | 20.01 | 16384672 | |
| MESH:D011297 | Prenatal Exposure Delayed Effects | resveratrol | 20.01 | 16679765 | |
| MESH:D011297 | Prenatal Exposure Delayed Effects | Tetrachlorodibenzodioxin | 20.01 | 11118676 11222880 11896295 11399792 | |
| MESH:D011297 | Prenatal Exposure Delayed Effects | Valproic Acid | 20.01 | 20603192 | |
| MESH:D055728 | Primary Myelofibrosis | decitabine | 3.32 | 17616702 | |
| MESH:D017096 | Prion Diseases | Amphotericin B | 5.47 | 12755626 | |
| MESH:D011470 | Prostatic Hyperplasia | Calcitriol | 3.35 | 15572423 | |
| MESH:D019048 | Prostatic Intraepithelial Neoplasia | bisphenol A | 6.13 | 20887781 | |
| MESH:D019048 | Prostatic Intraepithelial Neoplasia | Estradiol | 6.13 | 20887781 | |
| MESH:D011471 | Prostatic Neoplasms | Apigenin | 21.27 | 17132221 | |
| MESH:D011471 | Prostatic Neoplasms | arsenic trioxide | 21.27 | 19131511 | |
| MESH:D011471 | Prostatic Neoplasms | Azacitidine | 21.27 | 18324645 | |
| MESH:D011471 | Prostatic Neoplasms | Benzo(a)pyrene | 21.27 | 17292933 | |
| MESH:D011471 | Prostatic Neoplasms | bisphenol A | 21.27 | 16740699 | |
| MESH:D011471 | Prostatic Neoplasms | Cadmium | 21.27 | 17075824 | |
| MESH:D011471 | Prostatic Neoplasms | Calcitriol | 21.27 | 16289102 16644109 18247401 12479363 15754350 | |
| MESH:D011471 | Prostatic Neoplasms | Curcumin | 21.27 | 11398177 12497104 18226269 18769126 10851300 18156803 15129424 | |
| MESH:D011471 | Prostatic Neoplasms | Cyclophosphamide | 21.27 | 17136230 | |
| MESH:D011471 | Prostatic Neoplasms | Dichlorvos | 21.27 | 12661182 | |
| MESH:D011471 | Prostatic Neoplasms | Diethylstilbestrol | 21.27 | 15846301 17136230 15046698 | |
| MESH:D011471 | Prostatic Neoplasms | Doxorubicin | 21.27 | 16888761 15897917 16868541 16729912 15749863 18437689 | |
| MESH:D011471 | Prostatic Neoplasms | Estradiol | 21.27 | 16740699 | |
| MESH:D011471 | Prostatic Neoplasms | Fluorouracil | 21.27 | 19082440 18626508 | |
| MESH:D011471 | Prostatic Neoplasms | Genistein | 21.27 | 16925846 15378649 15256057 | |
| MESH:D011471 | Prostatic Neoplasms | Ibuprofen | 21.27 | 17409433 | |
| MESH:D011471 | Prostatic Neoplasms | Lindane | 21.27 | 12661182 14688026 | |
| MESH:D011471 | Prostatic Neoplasms | Methylnitrosourea | 21.27 | 12376480 15682402 | |
| MESH:D011471 | Prostatic Neoplasms | Plant Extracts | 21.27 | 17804756 14666653 | |
| MESH:D011471 | Prostatic Neoplasms | Polychlorinated Biphenyls | 21.27 | 15721890 | |
| MESH:D011471 | Prostatic Neoplasms | Prednisone | 21.27 | 16888761 | |
| MESH:D011471 | Prostatic Neoplasms | pyrrolidine dithiocarbamic acid | 21.27 | 16139439 | |
| MESH:D011471 | Prostatic Neoplasms | Quercetin | 21.27 | 17292933 14715546 | |
| MESH:D011471 | Prostatic Neoplasms | resveratrol | 21.27 | 17718901 17675339 15767336 17636462 16731767 17804756 | |
| MESH:D011471 | Prostatic Neoplasms | Simazine | 21.27 | 12661182 | |
| MESH:D011471 | Prostatic Neoplasms | sodium arsenite | 21.27 | 16039940 | |
| MESH:D011471 | Prostatic Neoplasms | Sodium Selenite | 21.27 | 18760546 | |
| MESH:D011471 | Prostatic Neoplasms | Tamoxifen | 21.27 | 15067354 | |
| MESH:D011471 | Prostatic Neoplasms | Thalidomide | 21.27 | 16729912 | |
| MESH:D011471 | Prostatic Neoplasms | Thiram | 21.27 | 19789329 | |
| MESH:D011471 | Prostatic Neoplasms | Vitamin E | 21.27 | 15084515 | |
| MESH:D011471 | Prostatic Neoplasms | Zinc | 21.27 | 16517595 12429649 16700911 16606632 | |
| MESH:D011471 | Prostatic Neoplasms | zoledronic acid | 21.27 | 12438248 19103299 | |
| MESH:D011507 | Proteinuria | Ibuprofen | 14.87 | 6375363 | |
| MESH:D011507 | Proteinuria | Indomethacin | 14.87 | 11849393 | |
| MESH:D011507 | Proteinuria | pioglitazone | 14.87 | 16687628 | |
| MESH:D011507 | Proteinuria | Prednisone | 14.87 | 16636307 | |
| MESH:D011507 | Proteinuria | Tretinoin | 14.87 | 16636307 | |
| MESH:D011528 | Protozoan Infections | Iron | 4.56 | 16640825 | |
| MESH:D011536 | Prurigo | Thalidomide | 4.85 | 12755975 | |
| MESH:D011537 | Pruritus | Ethinyl Estradiol | 4.88 | 16919318 15861022 | |
| MESH:D011537 | Pruritus | Mustard Gas | 4.88 | 18058305 | |
| MESH:D019310 | Pseudolymphoma | Phenytoin | 7.79 | 12752131 1419762 8603615 | |
| MESH:D019310 | Pseudolymphoma | Valproic Acid | 7.79 | 11422049 12752131 | |
| MESH:D011565 | Psoriasis | Cyclosporine | 5.24 | 16882103 | |
| MESH:D011565 | Psoriasis | Leukotriene B4 | 5.24 | 11006272 | |
| MESH:D011565 | Psoriasis | Trioxsalen | 5.24 | 16259964 | |
| MESH:D011625 | Pterygium | Tretinoin | 3.36 | 16723453 | |
| MESH:D011629 | Puberty, Precocious | bisphenol A | 3.36 | 10548101 | |
| MESH:D029424 | Pulmonary Disease, Chronic Obstructive | zafirlukast | 4.00 | 12781059 12877822 | |
| MESH:D011654 | Pulmonary Edema | Bleomycin | 14.20 | 15808516 | |
| MESH:D011654 | Pulmonary Edema | Terbutaline | 14.20 | 10903255 | |
| MESH:D011654 | Pulmonary Edema | Thiourea | 14.20 | 10849556 | |
| MESH:D011654 | Pulmonary Edema | zafirlukast | 14.20 | 18309904 | |
| MESH:D011656 | Pulmonary Emphysema | Curcumin | 3.22 | 19168576 | |
| MESH:D011657 | Pulmonary Eosinophilia | Ascorbic Acid | 8.11 | 14606601 | |
| MESH:D011657 | Pulmonary Eosinophilia | Toluene 2,4-Diisocyanate | 8.11 | 14606601 | |
| MESH:D011658 | Pulmonary Fibrosis | Bleomycin | 10.79 | 17177178 16314464 21435439 14609568 17434272 17241526 15322207 11554783 18162602 16115399 12574379 12624602 18008008 15541506 | |
| MESH:D011658 | Pulmonary Fibrosis | Cyclophosphamide | 10.79 | 16636934 | |
| MESH:D011658 | Pulmonary Fibrosis | Drugs, Chinese Herbal | 10.79 | 16987627 | |
| MESH:D011658 | Pulmonary Fibrosis | methyl isocyanate | 10.79 | 7708994 | |
| MESH:D011658 | Pulmonary Fibrosis | Mustard Gas | 10.79 | 17266442 10334151 17894541 17720292 17620002 | |
| MESH:D011658 | Pulmonary Fibrosis | Paraquat | 10.79 | 17997886 16324872 | |
| MESH:D011833 | Radiation Injuries, Experimental | mangiferin | 4.95 | 15830843 | |
| MESH:D012003 | Rectal Fistula | Ciprofloxacin | 9.81 | 18371140 | |
| MESH:D012003 | Rectal Fistula | Drugs, Chinese Herbal | 9.81 | 15043669 | |
| MESH:D012004 | Rectal Neoplasms | Fluorouracil | 2.74 | 16160472 18722050 18286688 15538739 | |
| MESH:D000608 | Renal Aminoacidurias | Mercuric Chloride | 4.65 | 2918855 | |
| MESH:D051437 | Renal Insufficiency | Acrolein | 9.29 | 12732208 | |
| MESH:D051437 | Renal Insufficiency | Cisplatin | 9.29 | 15464296 | |
| MESH:D051437 | Renal Insufficiency | Doxorubicin | 9.29 | 17922066 | |
| MESH:D051436 | Renal Insufficiency, Chronic | resveratrol | 4.13 | 16325855 | |
| MESH:D015427 | Reperfusion Injury | phenylmethylpyrazolone | 7.80 | 16041266 15948865 14654979 16753835 15629865 15086910 | |
| MESH:D015427 | Reperfusion Injury | pirinixic acid | 7.80 | 19058328 | |
| MESH:D015427 | Reperfusion Injury | resveratrol | 7.80 | 15827377 16314181 17058453 17520802 16317513 | |
| MESH:D015427 | Reperfusion Injury | zafirlukast | 7.80 | 12967936 | |
| MESH:D012120 | Respiration Disorders | Chlorine | 8.45 | 18579056 | |
| MESH:D012120 | Respiration Disorders | Cilomilast | 8.45 | 17155857 | |
| MESH:D012128 | Respiratory Distress Syndrome, Adult | Acetylcysteine | 18.10 | 12210543 | |
| MESH:D012128 | Respiratory Distress Syndrome, Adult | Curcumin | 18.10 | 18379247 10666014 | |
| MESH:D012128 | Respiratory Distress Syndrome, Adult | Dexamethasone | 18.10 | 18379247 11700416 | |
| MESH:D012128 | Respiratory Distress Syndrome, Adult | Paraquat | 18.10 | 11700416 | |
| MESH:D012128 | Respiratory Distress Syndrome, Adult | pyrrolidine dithiocarbamic acid | 18.10 | 16129981 | |
| MESH:D012128 | Respiratory Distress Syndrome, Adult | Terbutaline | 18.10 | 2878809 | |
| MESH:D012127 | Respiratory Distress Syndrome, Newborn | Vitamin A | 4.37 | 16877224 | |
| MESH:D012130 | Respiratory Hypersensitivity | Lipopolysaccharides | 10.26 | 10835634 | |
| MESH:D012130 | Respiratory Hypersensitivity | phthalic anhydride | 10.26 | 20219652 | |
| MESH:D012130 | Respiratory Hypersensitivity | Toluene 2,4-Diisocyanate | 10.26 | 16940033 7692837 20219652 | |
| MESH:D012130 | Respiratory Hypersensitivity | trimellitic anhydride | 10.26 | 20219652 | |
| MESH:D012131 | Respiratory Insufficiency | Dichlorvos | 4.28 | 17350689 15303389 | |
| MESH:D012135 | Respiratory Sounds | Atrazine | 11.76 | 11874814 | |
| MESH:D012135 | Respiratory Sounds | Dichlorvos | 11.76 | 17119214 16611668 | |
| MESH:D012135 | Respiratory Sounds | Malathion | 11.76 | 17119214 11874814 | |
| MESH:D012135 | Respiratory Sounds | Paraquat | 11.76 | 11874814 | |
| MESH:D015619 | Respiratory System Abnormalities | Tetrachlorodibenzodioxin | 2.45 | 18990726 | |
| MESH:D012140 | Respiratory Tract Diseases | Dichlorvos | 9.88 | 16611668 17119214 | |
| MESH:D012140 | Respiratory Tract Diseases | Malathion | 9.88 | 17119214 | |
| MESH:D012140 | Respiratory Tract Diseases | Toluene 2,4-Diisocyanate | 9.88 | 18447907 | |
| MESH:D012148 | Restless Legs Syndrome | Iron | 3.35 | 16930377 | |
| MESH:D012162 | Retinal Degeneration | Methylnitrosourea | 8.18 | 18155124 18172121 | |
| MESH:D012162 | Retinal Degeneration | Paraquat | 8.18 | 16458197 | |
| MESH:D012162 | Retinal Degeneration | Zinc | 8.18 | 16584753 | |
| MESH:D012174 | Retinitis Pigmentosa | Ascorbic Acid | 2.72 | 16849425 | |
| MESH:D012175 | Retinoblastoma | Methylnitrosourea | 4.06 | 11555667 | |
| MESH:D012206 | Rhabdomyolysis | Prednisolone | 5.08 | 9296927 | |
| MESH:D012208 | Rhabdomyosarcoma | decitabine | 10.73 | 19155313 | |
| MESH:D012208 | Rhabdomyosarcoma | Tretinoin | 10.73 | 16116481 16283617 | |
| MESH:D012208 | Rhabdomyosarcoma | Valproic Acid | 10.73 | 19155313 | |
| MESH:D012220 | Rhinitis | Aspirin | 13.42 | 12372130 | |
| MESH:D012220 | Rhinitis | Histamine | 13.42 | 12689652 | |
| MESH:D012220 | Rhinitis | phthalic anhydride | 13.42 | 3681491 | |
| MESH:D012220 | Rhinitis | Toluene 2,4-Diisocyanate | 13.42 | 19050374 | |
| MESH:D012220 | Rhinitis | zafirlukast | 13.42 | 12742009 7767514 20332717 | |
| MESH:D012221 | Rhinitis, Allergic, Perennial | Drugs, Chinese Herbal | 6.98 | 15015336 | |
| MESH:D012221 | Rhinitis, Allergic, Perennial | Toluene 2,4-Diisocyanate | 6.98 | 15015336 12617775 | |
| MESH:D006255 | Rhinitis, Allergic, Seasonal | Toluene 2,4-Diisocyanate | 4.07 | 19075512 | |
| MESH:D012468 | Salivary Gland Neoplasms | Progesterone | 2.12 | 18045962 | |
| MESH:D012481 | Salmonella Infections, Animal | marker/mechanism | 16002714 | ||
| MESH:D012509 | Sarcoma | Curcumin | 11.98 | 18462866 | |
| MESH:D012509 | Sarcoma | Dacarbazine | 11.98 | 17898927 18313854 | |
| MESH:D012509 | Sarcoma | Doxorubicin | 11.98 | 15625365 17710206 16767912 17203757 18313854 15675481 | |
| MESH:D012509 | Sarcoma | Polysaccharides | 11.98 | 18753065 | |
| MESH:D012512 | Sarcoma, Ewing's | arsenic trioxide | 17.98 | 16646077 | |
| MESH:D012512 | Sarcoma, Ewing's | Cisplatin | 17.98 | 14601052 | |
| MESH:D012512 | Sarcoma, Ewing's | Dactinomycin | 17.98 | 14601052 | |
| MESH:D012512 | Sarcoma, Ewing's | Doxorubicin | 17.98 | 16326096 14601052 | |
| MESH:D012512 | Sarcoma, Ewing's | zoledronic acid | 17.98 | 16121404 | |
| MESH:D012514 | Sarcoma, Kaposi | Doxorubicin | 8.21 | 17846226 | |
| MESH:D012514 | Sarcoma, Kaposi | imiquimod | 8.21 | 16302556 | |
| MESH:D012554 | Schistosomiasis japonica | Quercetin | 4.09 | 16862918 | |
| MESH:D012555 | Schistosomiasis mansoni | Nitric Oxide | 4.07 | 9673227 | |
| MESH:D012559 | Schizophrenia | Methionine | 2.82 | 15737665 | |
| MESH:D012559 | Schizophrenia | Valproic Acid | 2.82 | 19110320 15737665 | |
| MESH:D019873 | Schnitzler Syndrome | Thalidomide | 4.50 | 16096327 | |
| MESH:D012595 | Scleroderma, Systemic | Cyclophosphamide | 7.26 | 16636934 | |
| MESH:D012595 | Scleroderma, Systemic | Formaldehyde | 7.26 | 14979077 | |
| MESH:D012640 | Seizures | Clonidine | 11.32 | 10087439 | |
| MESH:D012640 | Seizures | Dichlorvos | 11.32 | 17157343 12660363 | |
| MESH:D012640 | Seizures | Ethanol | 11.32 | 9754883 | |
| MESH:D012640 | Seizures | Lindane | 11.32 | 15475178 12842176 7539098 | |
| MESH:D012640 | Seizures | Phenytoin | 11.32 | 16876388 3137016 3691417 10029267 19919933 11044598 9844417 15946322 | |
| MESH:D012640 | Seizures | Valproic Acid | 11.32 | 14763951 16876388 3137016 11738929 11044598 17978042 1511512 15475178 | |
| MESH:D012640 | Seizures | zonisamide | 11.32 | 11879338 9806000 11755227 16180713 12941455 10029267 16876388 15946322 18455367 11044598 9844417 16938433 11518630 11442880 9046859 | |
| MESH:D018805 | Sepsis | Curcumin | 5.52 | 18389075 | |
| MESH:D018805 | Sepsis | Zymosan | 5.52 | 11441115 | |
| MESH:D012772 | Shock, Septic | 1-(beta-naphthylmethyl)-6,7-dihydroxy-1,2,3,4-tetra-hydroisoquinoline | 18.72 | 11961057 | |
| MESH:D012772 | Shock, Septic | lipoteichoic acid | 18.72 | 19573522 | |
| MESH:D012772 | Shock, Septic | Mangifera indica extract | 18.72 | 15177305 | |
| MESH:D012772 | Shock, Septic | mangiferin | 18.72 | 15177305 | |
| MESH:D012772 | Shock, Septic | Terbutaline | 18.72 | 3431524 | |
| MESH:D012852 | Sinusitis | zafirlukast | 4.27 | 10665187 10386485 | |
| MESH:D012851 | Sinus Thrombosis, Intracranial | Aspirin | 3.86 | 12269725 | |
| MESH:D012871 | Skin Diseases | Ascorbic Acid | 5.67 | 18709164 | |
| MESH:D012871 | Skin Diseases | Mustard Gas | 5.67 | 16961503 12880345 15451306 | |
| MESH:D012871 | Skin Diseases | Vitamin A | 5.67 | 18709164 | |
| MESH:D012871 | Skin Diseases | Vitamin E | 5.67 | 18709164 | |
| MESH:D012878 | Skin Neoplasms | Benzo(a)pyrene | 27.47 | 19755658 10029692 | |
| MESH:D012878 | Skin Neoplasms | Doxorubicin | 27.47 | 15692506 | |
| MESH:D012878 | Skin Neoplasms | Hydrogen Peroxide | 27.47 | 12065085 | |
| MESH:D012878 | Skin Neoplasms | Iron | 27.47 | 12065085 | |
| MESH:D012878 | Skin Neoplasms | mancozeb | 27.47 | 1733566 | |
| MESH:D012878 | Skin Neoplasms | Plant Extracts | 27.47 | 16517061 15173996 | |
| MESH:D012878 | Skin Neoplasms | resveratrol | 27.47 | 15837718 8985016 | |
| MESH:D012878 | Skin Neoplasms | sodium arsenite | 27.47 | 18572023 19524636 | |
| MESH:D012878 | Skin Neoplasms | Tetrachlorodibenzodioxin | 27.47 | 16192470 | |
| MESH:D012878 | Skin Neoplasms | Tetradecanoylphorbol Acetate | 27.47 | 11807781 8985016 12065085 8330346 18404319 | |
| MESH:D012878 | Skin Neoplasms | Tretinoin | 27.47 | 16467112 | |
| MESH:D012878 | Skin Neoplasms | Urethane | 27.47 | 11807781 | |
| MESH:D012893 | Sleep Disorders | Melatonin | 4.06 | 16919138 16897403 18182647 | |
| MESH:D020178 | Sleep Disorders, Circadian Rhythm | Melatonin | 5.18 | 18078449 19452292 | |
| MESH:D007319 | Sleep Initiation and Maintenance Disorders | Clonidine | 6.25 | 18280681 | |
| MESH:D007319 | Sleep Initiation and Maintenance Disorders | Melatonin | 6.25 | 18078449 | |
| MESH:D055752 | Small Cell Lung Carcinoma | Cisplatin | 3.89 | 15464296 | |
| MESH:D012912 | Sneezing | Toluene 2,4-Diisocyanate | 4.07 | 19075512 19050374 | |
| MESH:D012983 | Soft Tissue Neoplasms | Doxorubicin | 3.17 | 17203757 16767912 15625365 | |
| MESH:D013088 | Spermatocele | Diethylstilbestrol | 11.85 | 16709447 16002989 | |
| MESH:D013088 | Spermatocele | Ethinyl Estradiol | 11.85 | 16709447 | |
| MESH:D013088 | Spermatocele | Tamoxifen | 11.85 | 16709447 | |
| OMIM:102530 | SPERMATOGENIC FAILURE 6 | Cyclophosphamide | 4.08 | 16517039 | |
| MESH:D013119 | Spinal Cord Injuries | Progesterone | 6.17 | 15862959 16503802 | |
| MESH:D013119 | Spinal Cord Injuries | Tamoxifen | 6.17 | 19457130 | |
| MESH:D016135 | Spinal Dysraphism | sodium arsenite | 5.47 | 12854658 | |
| MESH:D016135 | Spinal Dysraphism | Valproic Acid | 5.47 | 19490988 | |
| MESH:D013163 | Splenomegaly | Antimony Sodium Gluconate | 4.83 | 9665985 | |
| MESH:D013226 | Status Epilepticus | Valproic Acid | 8.03 | 12833885 | |
| MESH:D013226 | Status Epilepticus | zonisamide | 8.03 | 12833885 | |
| MESH:D013262 | Stevens-Johnson Syndrome | Phenytoin | 10.91 | 20235791 | |
| MESH:D013262 | Stevens-Johnson Syndrome | Prednisolone | 10.91 | 12239465 | |
| MESH:D013262 | Stevens-Johnson Syndrome | zonisamide | 10.91 | 12239465 | |
| MESH:D013272 | Stomach Diseases | Dexamethasone | 5.70 | 15472012 | |
| MESH:D013272 | Stomach Diseases | Indomethacin | 5.70 | 10192188 15472012 16184426 15038085 18209964 10215738 18545984 10486359 17638125 17160473 16280098 17207306 16113693 | |
| MESH:D013274 | Stomach Neoplasms | arsenic trioxide | 21.10 | 17007042 | |
| MESH:D013274 | Stomach Neoplasms | Benzene | 21.10 | 12562636 | |
| MESH:D013274 | Stomach Neoplasms | Benzo(a)pyrene | 21.10 | 2093021 20155912 | |
| MESH:D013274 | Stomach Neoplasms | Cisplatin | 21.10 | 17522103 15958060 18396642 | |
| MESH:D013274 | Stomach Neoplasms | decitabine | 21.10 | 19037991 | |
| MESH:D013274 | Stomach Neoplasms | Dichlorvos | 21.10 | 11397402 | |
| MESH:D013274 | Stomach Neoplasms | Diethylnitrosamine | 21.10 | 18456281 | |
| MESH:D013274 | Stomach Neoplasms | diisopropanolnitrosamine | 21.10 | 1399818 | |
| MESH:D013274 | Stomach Neoplasms | Drugs, Chinese Herbal | 21.10 | 18339527 | |
| MESH:D013274 | Stomach Neoplasms | Epoxy Compounds | 21.10 | 12562636 | |
| MESH:D013274 | Stomach Neoplasms | Ethanol | 21.10 | 18456281 | |
| MESH:D013274 | Stomach Neoplasms | Fluorouracil | 21.10 | 18396642 16951190 16424979 19015929 17522103 19084572 17498489 17172411 15786421 18567086 | |
| MESH:D013274 | Stomach Neoplasms | Indomethacin | 21.10 | 15609394 | |
| MESH:D013274 | Stomach Neoplasms | irinotecan | 21.10 | 15723263 | |
| MESH:D013274 | Stomach Neoplasms | Methylnitrosourea | 21.10 | 15930296 18593901 16257854 | |
| MESH:D013274 | Stomach Neoplasms | Tretinoin | 21.10 | 17261132 | |
| MESH:D013274 | Stomach Neoplasms | Zidovudine | 21.10 | 17696246 | |
| MESH:D013276 | Stomach Ulcer | Acetylcysteine | 37.61 | 17918041 | |
| MESH:D013276 | Stomach Ulcer | Ascorbic Acid | 37.61 | 18726076 | |
| MESH:D013276 | Stomach Ulcer | Curcumin | 37.61 | 19188055 16631530 | |
| MESH:D013276 | Stomach Ulcer | Dexamethasone | 37.61 | 15138204 | |
| MESH:D013276 | Stomach Ulcer | Ethanol | 37.61 | 16755016 17189318 17918041 9211565 11906479 9562338 | |
| MESH:D013276 | Stomach Ulcer | Indomethacin | 37.61 | 16934674 16631530 16169175 15138204 18193104 17135157 17657623 12077510 18087811 16755016 15255614 17918041 18726076 11906479 17654042 1323529 11595415 17977527 16252198 17627676 11523592 10423059 11729361 10750652 18299717 18543354 11145282 17895592 18237397 16397915 11595431 18431645 18209962 10878458 12787963 16150113 12498302 15104355 12500499 18181030 12467913 14567935 | |
| MESH:D013276 | Stomach Ulcer | Mangifera indica extract | 37.61 | 19305363 | |
| MESH:D013276 | Stomach Ulcer | mangiferin | 37.61 | 17918041 | |
| MESH:D013276 | Stomach Ulcer | Melatonin | 37.61 | 16150113 12500499 11523592 | |
| MESH:D013276 | Stomach Ulcer | Nitric Oxide | 37.61 | 15138204 | |
| MESH:D013276 | Stomach Ulcer | pimagedine | 37.61 | 18209962 | |
| MESH:D013276 | Stomach Ulcer | Plant Extracts | 37.61 | 17135157 18193104 18237397 15255614 12787963 | |
| MESH:D013276 | Stomach Ulcer | Ranitidine | 37.61 | 18726076 17135157 18087811 16397915 17895592 | |
| MESH:D013276 | Stomach Ulcer | Thalidomide | 37.61 | 15138204 | |
| MESH:D020521 | Stroke | Acrolein | 10.56 | 16269634 | |
| MESH:D020521 | Stroke | Ascorbic Acid | 10.56 | 16403987 16517955 | |
| MESH:D020521 | Stroke | Aspirin | 10.56 | 16403987 | |
| MESH:D020521 | Stroke | Vitamin E | 10.56 | 16517955 | |
| OMIM:601367 | STROKE, ISCHEMIC | resveratrol | 3.17 | 16321402 | |
| MESH:D013322 | Strongyloidiasis | Dichlorvos | 4.69 | 14651886 | |
| MESH:D013345 | Subarachnoid Hemorrhage | Drugs, Chinese Herbal | 4.31 | 17634840 | |
| MESH:D019966 | Substance-Related Disorders | bisphenol A | 2.60 | 16684133 16045194 | |
| MESH:D013375 | Substance Withdrawal Syndrome | Ethanol | 2.97 | 9754883 | |
| MESH:D013398 | Sudden Infant Death | Iron | 4.02 | 16640825 | |
| MESH:D015173 | Supratentorial Neoplasms | Cyclophosphamide | 3.63 | 12837982 | |
| MESH:D013610 | Tachycardia | Nitroprusside | 7.07 | 15306635 | |
| MESH:D013610 | Tachycardia | Terbutaline | 7.07 | 10895896 | |
| MESH:D013705 | Temporomandibular Joint Disorders | Plant Extracts | 8.48 | 17997062 | |
| MESH:D013705 | Temporomandibular Joint Disorders | polyphenols | 8.48 | 17997062 | |
| MESH:D013736 | Testicular Neoplasms | Cisplatin | 3.28 | 15464296 17225452 | |
| MESH:D013921 | Thrombocytopenia | 1-Naphthylisothiocyanate | 5.73 | 20133375 | |
| MESH:D013921 | Thrombocytopenia | Lipopolysaccharides | 5.73 | 15821434 | |
| MESH:D019851 | Thrombophilia | Ethinyl Estradiol | 2.27 | 11994571 | |
| MESH:D013927 | Thrombosis | Aspirin | 4.98 | 17672075 | |
| MESH:D013927 | Thrombosis | Ethinyl Estradiol | 4.98 | 15669648 | |
| MESH:D013953 | Thymus Neoplasms | Benzene | 7.51 | 10850423 | |
| MESH:D013953 | Thymus Neoplasms | Methylnitrosourea | 7.51 | 11418001 | |
| MESH:D013959 | Thyroid Diseases | Tetrachlorodibenzodioxin | 2.46 | 12697716 | |
| MESH:D013964 | Thyroid Neoplasms | arsenic trioxide | 25.68 | 19014326 | |
| MESH:D013964 | Thyroid Neoplasms | Butyrates | 25.68 | 17967635 | |
| MESH:D013964 | Thyroid Neoplasms | Dacarbazine | 25.68 | 11815960 15634649 | |
| MESH:D013964 | Thyroid Neoplasms | decitabine | 25.68 | 17967635 | |
| MESH:D013964 | Thyroid Neoplasms | Diethylnitrosamine | 25.68 | 7505956 | |
| MESH:D013964 | Thyroid Neoplasms | diisopropanolnitrosamine | 25.68 | 7505956 1399818 6582329 3289735 | |
| MESH:D013964 | Thyroid Neoplasms | Doxorubicin | 25.68 | 17909728 16010429 | |
| MESH:D013964 | Thyroid Neoplasms | Indomethacin | 25.68 | 11352223 14736730 18791128 | |
| MESH:D013964 | Thyroid Neoplasms | Methylnitrosourea | 25.68 | 3078959 7505956 | |
| MESH:D013964 | Thyroid Neoplasms | Tretinoin | 25.68 | 16026305 17045167 | |
| MESH:D013978 | Tibial Fractures | Estradiol | 3.23 | 19048282 | |
| MESH:D014062 | Tongue Neoplasms | Fluorouracil | 13.06 | 16280240 | |
| MESH:D014062 | Tongue Neoplasms | resveratrol | 13.06 | 16227395 | |
| MESH:D014062 | Tongue Neoplasms | Tretinoin | 13.06 | 16051514 | |
| MESH:D014062 | Tongue Neoplasms | Zinc | 13.06 | 16543248 | |
| MESH:D016171 | Torsades de Pointes | arsenic trioxide | 2.57 | 15213294 | |
| MESH:D014123 | Toxoplasmosis | Ciprofloxacin | 4.58 | 20186551 | |
| MESH:D014178 | Translocation, Genetic | Valproic Acid | 3.78 | 17262798 | |
| MESH:D014202 | Tremor | Lead | 4.07 | 21145352 | |
| MESH:D014235 | Trichinellosis | Mangifera indica extract | 9.99 | 14669257 | |
| MESH:D014235 | Trichinellosis | mangiferin | 9.99 | 14669257 | |
| MESH:D014352 | Trypanosomiasis | Antimony | 4.48 | 15220340 | |
| MESH:D014376 | Tuberculosis | marker/mechanism | |||
| MESH:D014376 | Tuberculosis | Iron | 4.55 | 16597321 | |
| MESH:D014376 | Tuberculosis | Tretinoin | 4.55 | 16040207 | |
| MESH:D014402 | Tuberous Sclerosis | marker/mechanism | |||
| MESH:D014456 | Ulcer | Indomethacin | 3.47 | 10574470 17380554 | |
| MESH:D020194 | Unverricht-Lundborg Syndrome | Valproic Acid | 8.03 | 3119515 | |
| MESH:D020194 | Unverricht-Lundborg Syndrome | zonisamide | 8.03 | 11814737 | |
| MESH:D014511 | Uremia | methyl isocyanate | 5.49 | 8440870 | |
| MESH:D001749 | Urinary Bladder Neoplasms | 2-Acetylaminofluorene | 33.22 | 15867355 1399818 15289314 | |
| MESH:D001749 | Urinary Bladder Neoplasms | arsenic trioxide | 33.22 | 12973940 20435036 11780464 12845720 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Benzo(a)pyrene | 33.22 | 17053015 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Butylhydroxybutylnitrosamine | 33.22 | 1399818 7296757 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Ciprofloxacin | 33.22 | 10741713 15028437 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Cisplatin | 33.22 | 15464296 12973940 17225452 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Curcumin | 33.22 | 18593936 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Cyclophosphamide | 33.22 | 14692829 | |
| MESH:D001749 | Urinary Bladder Neoplasms | decitabine | 33.22 | 17616700 19087683 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Diethylstilbestrol | 33.22 | 16712894 16452187 17306315 | |
| MESH:D001749 | Urinary Bladder Neoplasms | diisopropanolnitrosamine | 33.22 | 1399818 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Doxorubicin | 33.22 | 17653716 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Quercetin | 33.22 | 16720314 | |
| MESH:D001749 | Urinary Bladder Neoplasms | sodium arsenite | 33.22 | 16452187 17306315 11723127 16712894 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Tamoxifen | 33.22 | 17572228 16712894 8653321 | |
| MESH:D014564 | Urogenital Abnormalities | Valproic Acid | 3.23 | 8888407 | |
| MESH:D014565 | Urogenital Neoplasms | Curcumin | 3.83 | 18462866 | |
| MESH:D014570 | Urologic Diseases | Diazinon | 3.83 | 16487989 | |
| MESH:D014581 | Urticaria | Acetaminophen | 13.63 | 10982225 | |
| MESH:D014581 | Urticaria | Aspirin | 13.63 | 20485159 10982225 | |
| MESH:D014581 | Urticaria | Histamine | 13.63 | 18298128 | |
| MESH:D014581 | Urticaria | nimesulide | 13.63 | 10982225 | |
| MESH:D014581 | Urticaria | zafirlukast | 13.63 | 14512923 14713918 | |
| MESH:D002583 | Uterine Cervical Neoplasms | Cisplatin | 20.37 | 16803524 | |
| MESH:D002583 | Uterine Cervical Neoplasms | Diethylstilbestrol | 20.37 | 16175088 | |
| MESH:D002583 | Uterine Cervical Neoplasms | Fluorouracil | 20.37 | 16803524 | |
| MESH:D002583 | Uterine Cervical Neoplasms | resveratrol | 20.37 | 17473185 | |
| MESH:D002583 | Uterine Cervical Neoplasms | sodium arsenite | 20.37 | 11813266 | |
| MESH:D002583 | Uterine Cervical Neoplasms | Tretinoin | 20.37 | 16129372 | |
| MESH:D014591 | Uterine Diseases | bisphenol A | 9.02 | 14652134 | |
| MESH:D014591 | Uterine Diseases | Diethylstilbestrol | 9.02 | 14652134 | |
| MESH:D014594 | Uterine Neoplasms | Benzene | 15.77 | 12562636 | |
| MESH:D014594 | Uterine Neoplasms | Diethylstilbestrol | 15.77 | 15809267 16690809 | |
| MESH:D014594 | Uterine Neoplasms | Ethinyl Estradiol | 15.77 | 14692618 | |
| MESH:D014594 | Uterine Neoplasms | resveratrol | 15.77 | 17044934 | |
| MESH:D014594 | Uterine Neoplasms | Sulindac | 15.77 | 18645019 | |
| MESH:D014604 | Uveal Neoplasms | decitabine | 8.03 | 17785578 | |
| MESH:D014604 | Uveal Neoplasms | Tretinoin | 8.03 | 16752155 | |
| MESH:D014605 | Uveitis | Cyclosporine | 12.02 | 1336536 | |
| MESH:D014605 | Uveitis | Dexamethasone | 12.02 | 1336536 | |
| MESH:D014605 | Uveitis | Zymosan | 12.02 | 11006244 | |
| MESH:D014625 | Vaginal Neoplasms | Cisplatin | 15.08 | 15577323 | |
| MESH:D014625 | Vaginal Neoplasms | Dacarbazine | 15.08 | 15577323 | |
| MESH:D014625 | Vaginal Neoplasms | Diethylstilbestrol | 15.08 | 16002989 16513791 | |
| MESH:D014625 | Vaginal Neoplasms | Zidovudine | 15.08 | 12579204 | |
| MESH:D014652 | Vascular Diseases | sodium arsenite | 7.40 | 17056641 | |
| MESH:D014652 | Vascular Diseases | Thalidomide | 7.40 | 15741222 | |
| MESH:D054079 | Vascular Malformations | Tetrachlorodibenzodioxin | 3.14 | 12125929 | |
| MESH:D019043 | Vascular Neoplasms | Urethane | 4.46 | 10620525 | |
| MESH:D014657 | Vasculitis | zafirlukast | 4.49 | 12189465 | |
| MESH:D020301 | Vasospasm, Intracranial | Ibuprofen | 7.46 | 19057314 | |
| MESH:D020301 | Vasospasm, Intracranial | Nitric Oxide Donors | 7.46 | 19057314 | |
| MESH:D020246 | Venous Thrombosis | Ethinyl Estradiol | 2.22 | 15869587 14671159 | |
| MESH:D018487 | Ventricular Dysfunction, Left | Doxorubicin | 13.23 | 16364871 17334414 17638931 17678736 | |
| MESH:D018487 | Ventricular Dysfunction, Left | Plant Extracts | 13.23 | 18097624 | |
| MESH:D018487 | Ventricular Dysfunction, Left | resveratrol | 13.23 | 17488730 | |
| MESH:D018487 | Ventricular Dysfunction, Left | rimonabant | 13.23 | 17678736 | |
| MESH:D020257 | Ventricular Remodeling | Plant Extracts | 3.89 | 18097624 | |
| MESH:D014802 | Vitamin A Deficiency | Vitamin A | 3.92 | 16175781 16960172 16146918 | |
| MESH:D014820 | Vitiligo | Tretinoin | 7.01 | 16761959 | |
| MESH:D014820 | Vitiligo | Trioxsalen | 7.01 | 16259964 | |
| MESH:D014839 | Vomiting | Cisplatin | 11.10 | 11897121 | |
| MESH:D014839 | Vomiting | Indomethacin | 11.10 | 11897121 | |
| MESH:D014839 | Vomiting | zonisamide | 11.10 | 17157078 | |
| MESH:D014860 | Warts | imiquimod | 5.34 | 16368197 | |
| MESH:D019282 | Wasting Syndrome | Tetrachlorodibenzodioxin | 2.80 | 15886252 | |
| MESH:D015431 | Weight Loss | Bleomycin | 8.24 | 12624602 | |
| MESH:D015431 | Weight Loss | rimonabant | 8.24 | 20107430 | |
| MESH:D009396 | Wilms Tumor | Tretinoin | 2.68 | 16287080 | |
| MESH:D014947 | Wounds and Injuries | Drugs, Chinese Herbal | 5.02 | 16313111 | |
| MESH:D014947 | Wounds and Injuries | Plant Extracts | 5.02 | 19894650 20213670 | |
| MESH:D014985 | Xerophthalmia | Cyclosporine | 2.99 | 17120751 |
| Pathway ID | Pathway Name |
|---|---|
| KEGG:05143 | African trypanosomiasis |
| KEGG:05330 | Allograft rejection |
| KEGG:05146 | Amoebiasis |
| KEGG:04612 | Antigen processing and presentation |
| KEGG:05142 | Chagas disease (American trypanosomiasis) |
| KEGG:04060 | Cytokine-cytokine receptor interaction |
| KEGG:05332 | Graft-versus-host disease |
| KEGG:04630 | Jak-STAT signaling pathway |
| KEGG:05140 | Leishmaniasis |
| KEGG:05144 | Malaria |
| KEGG:05162 | Measles |
| KEGG:04650 | Natural killer cell mediated cytotoxicity |
| KEGG:04380 | Osteoclast differentiation |
| KEGG:03050 | Proteasome |
| KEGG:04140 | Regulation of autophagy |
| KEGG:05323 | Rheumatoid arthritis |
| REACT:6900 | Signaling in Immune system |
| KEGG:05322 | Systemic lupus erythematosus |
| KEGG:04660 | T cell receptor signaling pathway |
| KEGG:04350 | TGF-beta signaling pathway |
| KEGG:05145 | Toxoplasmosis |
| KEGG:05152 | Tuberculosis |
| KEGG:04940 | Type I diabetes mellitus |
| No data |
| Releated disease ID | Related disease Name |
|---|---|
| PA443624 | Carcinoma, Renal Cell |
| PA444987 | Multiple Sclerosis |
| PA446438 | Kidney Failure |
| PA443815 | Crohn Disease |
| PA444620 | Inflammation |
| Releated drug ID | Related drug Name |
|---|---|
| PA164749376 | interferon alfacon-1 |
| PA448478 | l-arginine |
| PA164747225 | l-citrulline |
| PA450635 | nitric oxide |
| PA450039 | interferon beta-1b |
| PA10072 | epoetin alfa |
| PA451578 | tacrolimus |